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ABSIRA( I
This thesis addresses two important research questions. First, are common mental 
disorders commoner in epilepsy? Second, what are the instruments of psychiatric 
research that may be employed to assess psychiatric disorders in epilepsy? Two 
studies were conducted as part of this thesis: the first a primary care-based case- 
control study, and second, a study among institutionalised patients with epilepsy Both 
studies used several psychiatric measures, and compared them with two gold 
standards: ICD-10 Criteria and “clinical significance” ratings.
Common mental disorders were significantly commoner in the epilepsy group than 
among controls. The instruments tested demonstrated good sensitivity and specificity, 
and we present revised cut-olTscores for epilepsy populations. Psychiatric symptoms 
specific to epilepsy w ere good predictors of psychiatric caseness. The psychiatric 
measures used appeared to correlate better with clinical significance ratings than w ith 
ICD-IO criteria. Psychiatric co-morbidity rather than seizure severity had a significant 
impact on subjective handicap.
The institutional study revealed high rates of psychiatric co-morbidity, significantly 
more in patients with cognitive impairment. While different measures were correlated 
for overall psychiatric caseness, individual symptom categories were poorly 
correlated. An exploratory factor analysis of the NPI yielded a reliable and 
interpretable four-factor solution indicating good content validity. However, no
measure appeared lo peildrm well, against either "clinical signilkance or K l)-l() 
ratings, indicating poor concurrent validity.
These studies show that psychiatric co-morbidity is over-represented in epilepsy, and 
that it has a significant impact on disablement. Symptom-based measures of 
psychological burden may be more sensitive than conventional criteria in identifying 
psychiatric disorders in epilepsy. Both these studies favour the "clinical significance” 
approach in assessing patients with epilepsy. The burden of epilepsy specific 
psychiatric co-morbidity must also be explored systematically in future studies. The 
results from these studies underline the need for public health planners to address 
mental health issues in epilepsy.
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1.1. PsychÎHlric Kpiilcmiolo^> : Historical Introduction & Ovcrvic»
Psychiatric epidemiology is the study ol'the distribution of mental disorders in 
populations and of risk factors associated with their onset and course.
Epidemiological methods provide the tools to conduct systematic research in 
aetiology and genetics and serve as the basis of outcome studies and clinical trials. 
Epidemiology can be considered as one of the scientific foundations of psychiatry 
(Tohen et al., 2000)
1.1.1. Studies in the USA
Studies done in the I Inited States of America have been divided into first, second, and 
third generation studies (Dohrenwend, 1995). The first generation studies were 
conducted at the end of the nineteenth and through the first half of the twentieth 
century. Early examples of path-breaking studies done in this period include that done 
in the 1920 s by (ioldberger (Terris, 1964) examining the role of nutritional 
deficiencies in the development of psychosis due to Pellagra. The second-generation 
studies followed World War II, as in this period, psychiatric illness was the leading 
cause for men being rejected from military service, and perhaps more importantly a 
mtyor cause of discharge from the services and occupancy of half the hospital beds in 
the USA. The main improvement in the second-generation studies was that subjects 
were directly interviewed. Further, this period witnessed clinical and reliability 
studies, and the use of the 1st edition of the DSM (DSM-1) (APA, 1952) for 
classification.
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I I 1.1. Siibsci|ucnl Dcvclopmciils in PsNchialric I pulcinioloüN
I'he US/UK diagnostic project (Cooper et al., 1972) clearly illustrated the need to use 
standardised diagnostic instruments in psychiatric epidemiology. The development of 
the Feighner criteria (Feighner et al, 1972) and the accompanying Renard Diagnostic 
Interview Schedule (Flelzer et al., 1981), and the development of Research Diagnostic 
Criteria (Katz et al., 1979) followed.
I I I 2 The Fpidemiologic Catchment Area (FC A) Study
The t'CA study was a landmark third generation study conducted in the U.S.A. 
Sponsored by the National Institutes of Mental Health (NIMH), this was a large 
population-based study to determine the prevalence of mental disorders and the 
amount and type of mental health services provided for those in need (Regier & 
Kaelber, 1995). One of the core features of the FCA was its use of the Diagnostic 
Interview Schedule (DIS) and DSM-III criteria for diagnosis.
Five sites were selected through a peer-reviewed process from all applications 
received in response to the NIMH solicitation. The FCA Study estimated lifetime 
prevalence, I -month prevalence, and 6-month prevalence. It also estimated new cases 
during a I-year period (1-year cumulative incidence) and the services received during 
that time by the populations under study. The lifetime prevalence of any disorder in 
the DIS was 32.2%. Substance use disorder at 16.4% showed the highest prevalence 
followed by anxiety disorder at 14.6%. Anxiety disorders and afl'ective disorders 
together formed the greatest proportion of all psychiatric co-morhidity.
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rhe liCA study also dcnionslralcd a treatment gap tor mental disorder, with 
only 28.5% ot people with a DIS mental disorder having had a mental health visit in 
the past year, and only 60-70% of people with significant mental disorders 
(schizophrenia, bipolar disorder, somatization disorder and panic disorder) obtaining 
care.
1.1.1 3 The National Co-morbidity Survey (NCS)
Built on the experience ot the IX ’A study, the NCS was designed to estimate the 
prevalence and co-morbidity ot mental and substance use disorders in a representative 
sample from the continental United States (Kessler et al., 1994). The NCS focussed 
on individuals aged 15-54 years, used a stratified probability sampling procedure and 
included only non-institutionalised persons Researchers sampled individuals in all 48 
contiguous states for a total of 8098 subjects, 82.6% of the target population.
A modified version of the Composite International Diagnostic Interview 
(CIDl) known as the University of Michigan CIDI (Kessler et al., 1998) was utilised. 
The lifetime prevalence of any NCS disorder was 48.7% and the 1-year prevalence 
was 29.5%. As in the EC A survey reviewed earlier depressive and anxiety disorders 
formed a substantial proportion of psychiatric morbidity both in the lifetime and 1- 
year periods. In contrast, non-affective psychosis and mania formed only a small 
proportion of the overall figure.
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1.1.2. International Studies
While the developing world has not gone un-represented. studies being conducted in 
countries like India, Brazil, and Kenya, the proportion of research involving the 
developing world has been limited. An important international study that bridged this 
knowledge gap is described briefly herein, as it addressed many issues pertinent to 
common mental disorders the study of which forms an important component of this 
thesis.
1. 1.2.1. WHO Collaborative Study on Psychological Problems in Health Care
The WHO established this study as prospective, cross-cultural, epidemiological 
investigation to answer several important research and care related issues with respect 
to mental health in the developing world (Ustun & Sartorius, 1995). The study had a 
wide choice of sociocultural settings in which, no previous studies had taken place.
The study population consisted of consecutive patients attending the 
participating general health care facilities. Patients between the ages of 18 and 65 
were included and screened using the General Health Questionnaire-12 item version 
(GHQ-12). As there were differences between centres both in terms of patient 
turnover and in terms of GHQ scores in the pilot project, centre-specific procedures 
for screening patients, and centre specific norms for GHQ scoring were developed.
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Phase II coiisislcd of a standardised in-patient inters lew lastinu about an hour. 
I'his comprised of a section on the patients presenting complaint; the pathway to their 
health care visit: the primary care version ol'the CIDI: inlormation on physical and 
psychological co-morbidity; assessments of social disability: the CiHQ-34, self rated 
health status, and for clinically trained interviewers; clinical diagnosis according to 
ICD-IO and DSM-lll-R criteria The phase II subjects were follovved-up at three and 
twelve months The GHQ-28 was used in the three-month follow-up and the CIDI in 
the twelve-month I'ollow-up.
In order to compare, reliably, a host of variables across cultures, the multi-trait 
multi-method approach was adopted (Campbell and I iske. 1959) I he strategy was to 
measure the same characteristic by two or more different methods, and then assess the 
correlation of alternative measures of the same construct and consistency of results 
across measures.
Twenty-four percent of consecutive attenders had current mental disorders 
reaching ICD-IO criteria for well-defined disorders (depression, dysthymia, anxiety 
disorder, agoraphobia, panic, somatization disorder, neurasthenia, hypochondriasis, 
alcohol dependence and harmful use) over all the centres A further 9% had clinically 
significant symptoms clustering in anxiety, depression and somatisation groups that 
did not meet ICD-IO criteria for a psychiatric disorder (sub-threshold disorders). 31% 
had two or more mental disorder symptoms. There were wide variations in prevalence 
across the centres on all the three different measures of case-identification (CIDI, 
GHQ and primary care physician), ranging from a high estimate of 52.5% in Santiago 
de Chile to a low of 7.3% in Shanghai. However, the rank ordering of the centres
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îicross Ihc three measures was comparable, thus milicaimg that there were true 
dilVerenccs between the centres (Cioldberg and Lecrubier. 1995).
The commonest ICD-IO diagnoses were current depression (10.4%), 
generalised anxiety disorder (7.9%), neurasthenia (5 .4%) and harmful use of alcohol 
(3.3%). Agoraphobia (with and without panic). Panic disorder and Hypochondriasis 
formed the lower end of the spectrum (between 0.5 and I . I %). There was a wide 
spread of prevalence rates for both the common disorders (depression and anxiety), 
and wide variation among centres, depression being commoner in some and anxiety in 
others While age did not account for ditTerences in prevalence, gender did, with the 
Odds Ratio for all centres being 1.89, females being tw ice as likely as males to suffer 
from depression. While factors such as physical health and parity had no impact on 
prevalence, education did, with those having had the most years of full-time education 
having lower rates than those who were educationally disadvantaged. This however 
may be consequent to educational level acting as a proxy to social advantage 
(Goldberg and Lecrubier, 1995).
1.1.3 Studies in the United Kingdom
1.1.3.1. British Psychiatric Morbidity Survey
With mounting evidence about the massive global burden of mental illness, the 
Department of Health in Great Britain outlined a greater understanding of mental 
disorders through research, and the development of appropriate strategies to reduce 
the burden of mental health among its key objectives. As part of the agenda to
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improve inlormaiioii and nndcrslandina aboiil menial illness. Ihe Deparimenl of 
Health commissioned the Office of National Statistics to survey psychiatric morbidity 
of the country in collaboration with an advisory group of psychiatric epidemiologists 
(Jenkins et al.. 1997a). I he purpose was to give a national picture of the prevalence, 
severity and duration of mental health and their accompanying disability: associated 
risk factors; and the extent to which health and social care needs are met by services, 
this being the first national survey in any country to collect such information 
simultaneously
Four separate surveys had been completed by 1998 (Jenkins. 1997b: 1998). 
They were, a priv ate household survey using postcode address files of small users as 
the sampling frame: institutional survey selecting randomly from hospitals, residential 
homes, hostels and group homes; a supplementary sample of people w ith known 
psychosis (to obtain information about service use) drawn from general practitioners 
and country mental health teams in the same 200 postal sectors: and a survey of 
homeless people in temporary accommodation, night shelters, or day centre attendees.
All responders in the household survey were interviewed hy trained 
interviewers using the Clinical Interview Schedule -  Revised (Lewis et al., 1992) 
leading to lCD-10 diagnostic categories; a psychosis screening questionnaire specially 
developed for the survey (Behhington and Nayani, 1995): questions about alcohol and 
drug misuse/dependence (using quality/frequency questions from national surveys): 
questions about stressful life events, social supports, social disability, activities of 
daily living, education and employment; questions about long standing medical illness 
and medication. I hose subjects scoring 12 and over in the CIS-R were interviewed
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using (he SCAN and also were asked luKhei detailed t|ueslions ahoiil use ol health, 
social and voluntary care services, and inlormal care I he procedure in the 
institutional survey was identical except that proxy interviews were carried out for 
those who were unable to co-operate, and in the supplementary sample all were 
assessed using the SCAN. In night shelters and day centres, there was a perceived 
need for shortened questionnaires, and the 12 item General Health Questionnaire 
replaced the CIS-R, as did shortened versions of the questionnaires on other variables.
The household survey (Jenkins ct al.. 1997b) achieved a response rate of 80%. 
The overall period prevalence (one-week) of neurotic disorders among adults was 160 
per 1000. Thus one in six adults' aged 16-64 had su tiered from a neurotic disorder in 
the week prior to their assessment. The prevalence of neurotic disorders in women 
(195/1000) was higher than in men (123/1000) the odds ratio being 1.63. Marital 
status was strongly associated with neurotic disorder; rates were substantially higher 
in separated, divorced and w idowed individuals of both sexes and among cohabiting 
women. Unemployed people were about twice as likely to suffer neurotic disorders 
compared with people in work; those living in urban settings are likely to suffer 1.5 
times as much than the rural dwellers. Individuals with neuroses were twice as likely 
to have sought a general practitioner (GP) consultation in the last week. However, one 
quarter of those with a neurotic disorder had not sought any professional help.
One adult in 20 had experienced symptoms of alcohol dependence in the 
preceding year, and one in 40, dependence on drugs. Alcohol dependence was twice 
as common and drug dependence five times as common among those who were 
unemployed. The overall prevalence of psychosis in the household survey was 4 per
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I ()()(). \Mih Ihc prcviilcncc among urban dwellers being iwiee thal lor ihose living in 
rural areas I wo-lhirds were in touch with specialist services, while IX% had seen 
only their CiP in the year prior to the interview. A further 18% said that they had never 
sought prolessional help. A very significant proportion o f those with psychiatric 
disorder in the household survey, not only psychosis, but neurosis as well, 
experienced social disability.
In the institutional survey, 70% of those residents for whom diagnosis were 
obtained, su tiered from a psychotic illness (schizophrenia, schizoatïective, delusional 
disorders); 8% from an affective psychoses, and 8% from a neurotic disorder. The 
distribution of disorders varied depending on the setting- schizophrenia and related 
disorders being more common in the hospital than in the residential setting (74% vs. 
67%). and the converse being true for neurotic disorder (12% vs. 4%). Patients with 
psychotic disorders tended to stay in the institution for longer periods than those with 
neurotic disorders.
In the survey of the homeless, that tapped various sources, the prevalence of 
neurosis was 38% among hospital residents, 35% among those living in private sector 
leased accommodation, 60% among night shelter residents, 57% among the homeless 
sleeping rough and using day centres. The prevalence of psychosis was 8% among 
hospital residents, 2% among private sector leased accommodation residents, and was 
not estimated among those sleeping rough. The comparative figure tor those living in 
households was 0.4%. The prevalence of alcohol dependence was 16% among hostel 
residents, 3% among those living in private sector leased accommodation, 44% 
among night shelter residents, and 50% among homeless people sleeping rough
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(compared lo 5'’ool people living in households). I he prevalence ol diiig dependence 
was 6% in hoslel residents (11% including cannabis dependence). 22% in night 
shelter residents (29% including cannabis), and 12% in those sleeping rough (24% 
including cannabis)
This study illustrates that psychiatric disorders are a significant public health 
problem in the UK and an important cause of considerable disablement and distress. 
The link with social and educational disadvantage and the treatment gap identified 
point to the need for social needs to be addressed along with health needs (Jenkins et 
al., I997a.b: 1998).
I I 4 Conclusions from this Section
In sum, these epidemiological studies have helped achieve significant progress in 
psychiatric research Data from across the world has demonstrated quite clearly that 
psychiatric disorders especially common mental disorders, are w idely prevalent, and 
constitute a significant burden on public health services and the community.
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1.2. ( ommoii IMciiIhI Disorder
rhe vast majority ot'psychiatric disorders encountered in primary care are 
characterised by symptoms ot anxiety, depression and other symptoms of “neurosis”. 
They are referred to as minor or mild psychiatric disorders in contrast to the more 
“major” psychotic disorders, which are serious and cause signitlcant disability, but 
tend to be much less common.
Goldberg and Huxley (1992) coined the term common mental disorder” to 
describe these disorders “that are commonly encountered in community settings, and 
whose occurrence signals a breakdown in normal tunctioning”. These “Common 
Mental Disorders” (referred to hencclbrth as C M l)) arc an important cause of 
morbidity worldwide (Ustun et al., 1995). may be associated with significant 
disability (Ormel & Costa E Silva, 1995), and in about half the cases may become 
chronic (Mann et al., 1981).
It is also noteworthy that mood disorders, an important component of CMD, 
are common in psychological autopsy studies of suicides. CMDs therefore cause not 
just morbidity and disablement, but are an important cause of mortality due to self- 
harm. This is important with regard to epilepsy as it is well recognised that Sudden 
Unexpected Deaths in Epilepsy (SUDEP) do occur, and that in a proportion of cases 
self-harm is the cause (Sander, 2002).
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This ihcsis cxainmcs ihc prcxalcncc ol C M!) in palicnls wilh cpiicpsx 
compared lo populalion-bascd control subjects, and studies the role ol C M l) as a 
cause of disablement in epilcpsx. C'MI3s are therefore reviewed in detail here
1.2.1. Classification of Common Mental Disorders
The two major classillcatory systems of psychiatric disorders are the IC'D-10 
of the World Health Organisation (WHO) (WHO, 1992a) and the Diagnostic and 
Statistical Manual- fourth edition (DSM-IV) of the American Psychiatric Association 
(APA, 1994). While the DSM-IV and its precursor DSM-III are widely used and 
indeed preferred in main research settings, the ICD is the more international ol the 
classifications, arising from consultation among experts and research around the 
world In ICD-IO CMD are classified mainly under two categories: “Neurotic, stress 
related and somatoform disorders (F40-48)” and “Mood (affective) disorders (F30- 
39)” with numerous sub-categories in each section. There however remain a number 
of conceptual and practical problems. There is considerable overlap between these 
categories. For example, the co-morbidity between depression and anxiety is high, 
and it is often difficult to decide which the primary illness is. Further, some problems 
included here such as Obsessive-Compulsive disorder or OCD (F42), are rare in 
community surveys, while others (e.g. Social Phobia- F40.I) may not be considered a 
disorder.
A primary care version of ICD-IO has been developed for use in general 
medical and primary care health settings. This was developed as classifications used 
by psychiatrists are generally found to be too complicated for use in general medical
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sellings and (iPs arc unlikely lo use ihese elassilleaiions in iheir praeliee -(Jenkins el 
al., 1998). I he primar> care version is brief (conlaining a small number of 
caiegories), easy to understand, linked with advice on management (including 
treatment), compatible with the full version of the IC'D-10 and other classifications, 
and is reliable (Ustun et al., 1995). The categories chosen for inclusion in this version 
the ICD-IO PHC are all reasonably common in primary care settings. The 
arrangement of the categories generally follows ICD-IO although some categories 
(example depression, anxiety, stress-related disorders and unexplained somatic 
symptoms) have been grouped together, reflecting the difllculties in making sharp 
distinctions in primary care settings. Field trials have been conducted in many centres 
(Ustun et al, 1995). The ICD-IO PHC has been found useful in both recognition and 
management of mental disorders in these settings, increasing the range of symptoms 
considered by primary care practitioners, and adding to the management of depressive 
illness including changes in prescribing practices (Goldberg & Lecrubier, 1995).
I 2.2. Defining a Case
Unlike physical disorders, psychiatric disorders do not have clear markers that lead to 
diagnosis and case finding. Clinicians and scientists have thus relied upon clinical 
symptoms and syndromes for diagnostic purposes, and over the years consensus has 
developed over certain broad classes of classification. In the past two or three 
decades, the growth and development of psychiatric epidemiology has led to a shift in 
focus from studies in institutional settings to those in the community, leading to 
discussion and debate about diagnosis in psychiatric epidemiology (Williams et al., 
1980; Wing et al., 1981). Two important aspects related lo diagnosis in
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cpiilciniololîical siincNs. case ilellniUon (Ihc dclinealion ol crilcna loi icganlinu an 
individual as sulïcrint» from disease) and case idcnliflcalion (Ihe melhods used lo 
identity members ol Ihe study population who fu lfil these criteria) are discussed here
As psychiatric illness is not measurable in the same way as physical illness, 
the decision as to whether a given individual suffers from a psychiatric disorder is 
based on the opinion of psychiatrists, which is considered to be the gold standard. 
Such opinion is derived from clinical experience and applied either in a single stage 
(as the criterion for caseness) or in two stages with probable cases being identified by 
screening, which is then confirmed or eliminated in psychiatric inter view
I lowe\ er. the concept of the clinically identified patient being used as the 
yardstick in epidemiology is itself controversial for several reasons I he clinical 
process is fundamentally different from the epidemiological process In clinical 
practice the psychiatrist is presented with a problem and the decision he/she is faced 
with is about the nature of the problem. However, the epidemiologist in psychiatry 
has a more fundamental issue at hand- i.e., is there a problem here, or in other words 
is this given individual a case? Thus, in this setting, caseness is neither assumed nor 
implied, and precise measurement of cases and accurate definition are important. 
Following on from this basic difference, there are linked differences in definition and 
reliability between the settings. Diagnosis in clinical psychiatry is rather more 
intuitive and thus non-standardised. In contrast, operationalised criteria for diagnosis 
and standardised instruments of psychiatric research have greatly increased the 
reliability of diagnosis in research settings.
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Thus, al llrsl sight the concept ol ps\chiatric cascncss see ins al best conliising 
and possibly even unhelplul (Prince. IW8). I or example, the estimates ol depression 
in later life, in one comprehensive review on the subject, varied from 2% to 13% 
based on the criteria used tor diagnosis This depended on whether the diagnostic 
criteria used in the concerned study were broad or narrow. Broad criteria are often 
based on a clinician's impression ol clinical significance” (of severity and/or causing 
distress/disablement), and narrow criteria such as DSM, focus on a small and 
ubiquitous group of subjects with severe psychiatric disorder.
Thus the correct question is usually not so much ‘What is a case?' as ‘A case 
for what?' (Prince, 1998). I he narrow criteria for major depression define a small 
proportion of persons with an unarguably severe form of depressive disorder, 
implying strong construct validity. This may be eminently suitable when it comes to a 
randomised controlled trial (R C f) of a new treatment for depression, or indeed to 
identify a pure case tor a genetic linkage study. However, these criteria will not suit 
all purposes, missing as they would the large proportion of subjects whom clinicians 
would typically diagnose and treat in the community. Further, although depressed 
persons are known to be heavy users of health and social services, cases of major 
depression account for a very small proportion of this excess, which is mainly made 
up of cases with “common mental disorder”. Further, diagnostic criteria may be 
capricious, many persons meeting some but not all the requisite case criteria, and 
nevertheless experiencing a significant intensity of symptoms, and loss of quality of 
life (Prince, 1998).
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I 2 2.1 Mclhtklological Problciiis wilhC'asc I iniling
Psychiatric research has for the past two decades heen preoccupied with the first task 
of science, i .e., learning how to define and measure the phenomena with which it 
deals (Thompson, 1989). The situation is complex due to several factors;
• The absence of tests of diagnostic utility that can distinguish between different 
types of psychiatric disorder
•  The inability to relate severity of the disorder to severity of psychiatric 
symptoms
• The limited transferability of psychiatric ratings between situations- i.e., 
between different groups of patients, di Ocrent raters, different cultures, and in 
the same group at different times
The pragmatic researcher has to accept these limitations, by accepting the 
inadequacies of knowledge, and measuring as accurately as possible, under the 
circumstances (Thompson, 1989). A product of the standardisation of clinical practice 
and understanding in psychiatry, are rating scales.
I 2.2.1.1. Which Symptoms to Measure?
In general, few symptoms can be described as being characteristic of a mental 
disorder, even in the setting of the hospital. This becomes true in the community 
setting, with symptoms in this setting ol\en being non-specific in nature. Case finding 
instruments are generally developed through a process of consultation among experts
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will) idc*ntir> a ptH>l ul common s\mpioms chataclcrislic ol ihc given disorder. Some 
items that comprise such instruments are also included on the basis ol their ability to 
discriminate between cases and non-cases A third factor that may play a role in case 
identification is symptom patterns, a particular combination o f symptoms having 
superior discriminatory power when compared to individual symptoms, highlighting 
the need to assess clinical and statistical relationships.
Therefore, there are two major difficulties to surmount before a tool could be 
devised, aimed at measuring psychiatric disorder First, to define what is meant by the 
term, so that it does not become meaningless: and second, to show that there is some 
common factor among the now limited domain of psychiatric disorders (Goldberg & 
Williams, 1988). Generic screening tools such as the GHQ are based largely on 
hierarchical models of diagnosis, w herein the more differentiated symptoms often 
distract attention from, or override the lesser. Foulds and Bedford (1975) also 
provided evidence for supposing that most patients with psychiatric disorders are 
disturbed at the lowest level of their hierarchy, what they referred to as dysthymic 
disorders. "An individual falling into any of these states may be said to be disturbed, 
emotionally stirred up, and altered in this respect from his normal self. Such states are 
therefore common to almost all psychiatric patients, and hence as a class, have little or 
no discriminating power. They are more 'understandable' than the symptoms of the 
other classes, are perhaps more often related to prevailing circumstances and are 
experienced by most of us at some time and with some intensity". Goldberg and 
Williams (1988) noted that two additional features might be added to the 
aforementioned description -  tendency to develop minor somatic symptoms, and 
changes in outwardly observable social behaviour.
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1.2.2.1.2. I low arc Symptoms to he Measured
Some instruments rely upon the number ol symptoms, each sy mptom being of 
equivalent value; and the subjects with a greater number of symptoms (possibly of 
low severity) are more likely to be recognised than subjects with fewer symptoms of 
significant severity. A good early example of such an instrument is the Langner 22 
item screening inventory (Langner, 1962). More traditionally however, the presence 
of a critical number of a particular constellation of symptoms experienced over a 
critical length of time has traditionally been employed to diagnose psychiatric 
disorder (Goldberg & Huxley, 1992).
It is therefore often of more interest to be able to examine a profile of scores 
rather than a single score. There are several scaled scoring tests to choose from, and 
most can be used as general case detectors by adding the scaled scores together. For 
example, the scaled General Health Questionnaire or GHQ-28 was derived by factor 
analysis, and consists of four sub-scales for somatic symptoms, anxiety and insomnia, 
social dysfunction and severe depression (Goldberg & Williams, 1988).
Counting the number of key symptoms that patients report on a standardised 
research interview, and expressing the result on a scale can also measure severity of 
disorder. The index of definition (ID) is such a scale derived from the Present State 
Examination and expresses a degree of certainty that a diagnosable mental disorder is 
present (Wing et al., 1978). Respondents with non-specific symptoms will score ID2 
or 3, sub-threshold disorders score 1D4, definitely diagnosable disorders at the
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ihrcshold score 11)5: and scores above lhal represent an increasing severity ol 
undoubted mental disorders. A similar system is used in Schedules for C linical 
Assessment in Neuropsychiatry (SCAN) (WHO. 1995).
The time-period over which symptoms are to he measured is also important. 
For example, Salkind (1976) described three patterns ol anxiety, short lived 
symptoms due to stress, baseline sub-threshold symptoms exacerbated hy stress that 
eventually resolve, and chronic symptoms. Here, the first group would he considered 
normal, exemplifying the importance of a minimum duration of symptoms for the 
diagnosis of psychiatric disorder. Transient mental symptoms related to stress are 
common and part of normal human experience: they should not he diagnosed as a 
disorder unless they meet minimal time criteria. I raditionally, this period is two 
weeks for depression (WHO, 1992a) and is used to exclude adjustment disorders due 
to stressful life events. The second group may have subjects predisposed to 
developing significant symptoms when exposed to stress, hy virtue of premorbid 
state, personality and past experience. Indeed, a number of subjects with chronic or 
recurrent symptoms would fall in this group. The third group on the other hand may 
consist of subjects with personality disorders. It is noteworthy that many chronic and 
disabling states, generalised anxiety disorder and dysthymia, for example, require a 
time criterion of several weeks of active symptoms to be fulfilled, before such a 
diagnosis can be made.
Further, in the measurement of symptoms and its interpretation, the role of 
response bias needs to he considered. The common response styles that alTect results 
include acquiescence set (tendency to agree or disagree with items irrespective of
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Jhcir contenu, and social dcsirabilil> set (tciulcncN to agree with items considered hy 
the respondent as socially desirable) While the former can he minimised hy balancing 
questions that require positive and negative responses (half each), psychological 
disorders by their very nature are considered socially undesirable, and the latter bias 
may not be responsive to such measures.
1.2.2.1.3. Estimating the Validity of Such Measurement
The validity of an instrument is defined as "the degree to which it measures what it is 
designed to measure" (Marder, 1995) Several types of validity have been described 
here. Face validity describes the degree to w hich the scale appears to measure what it 
claims to measure; Content validity refers to w hether the content of the instrument is 
appropriate to the variable being measured; Criterion oriented validity is demonstrated 
by comparing the instrument with generally agreed upon objective external criterion; 
Concurrent validity and predictive validity are two types of criterion-oriented validity. 
Concurrent validity is the demonstration of a correlation between scores and the 
external criterion, both measurements being made at the same time. Predictive 
validity is the demonstration that scores predict the later occurrence of the external 
criterion/particular outcome.
Scores on instruments like the (il IQ can be interpreted in three ways -  First, 
they can be regarded as a measure of the severity of the psychological disorder. No 
assumptions need to be made about where normality ends and caseness begins. The 
most appropriate approach to establish validity in this sense will be to compute a 
correlation co-elTicienl between the scores on the questionnaire and some measure of
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Ihc scvcrilN ol psNchialnc illness derived from ihe crilerion inler\ lew Second. lhc\ 
can he used lo esliinale ihe pres alence ofpsychialric illness, using a procedure b\ 
which scores are adjusied b> means of validity coeftlcients to obtain an unbiased 
estimate of the true prevalence. Third, they can be regarded as an indicator of 
morbidity ; in this use. the proportion of subjects with high scores is regarded as an 
indicator of psychiatric disorder.
The decision as to what is to be held as a "high score" is usually determined by 
finding the best trade-olT between two validity coefficients (Goldberg & Williams. 
1988). The validity coefficients most commonly estimated and used are:
•  Specificity -proportion of true normals correctly identified
•  Sensitivity -  proportion of true cases correctly identified
•  Misclassification rate -  proportion of respondents correctly identified
•  Positive predictive value -  proportion of high scorers who are cases
•  Negative predictive value -  proportion of low scorers who arc not cases
However, these measures only provide information about the performance of a 
screening instrument at one cut-off point. They do not provide information about the 
discriminating ability of the instrument across the total spectrum of morbidity, neither 
do they assess for the elfect of varying the threshold score, nor they permit accurate 
comparison of the two screening tests. These latter assessments can be easily 
accomplished b> receiver (or relative) operating characteristic (ROC ) analysis -  a 
technique that is reviewed in detail herein (4.8.2, pg 178).
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I 2 2.1.4. Understanding (he I  asc Versus Non-case C oncept
II'psychiatric morbidity were considered to be distributed across a continuum, the 
concept of a case -  non-case dichotomy would appear meaningless. However, 
distinguishing ill people from those who are not an important part not just of clinical 
care, but of epidemiological studies and of health care provision/planning as well. The 
cut-off points assigned to distinguish a case from a non-case, differ not Just between 
instruments, but also within the same instrument at dilTerent points in time and when 
it is being used for different purposes. Misclassification of cases and non-cases is not 
uncommon, as the vast majority of these instruments measure probability as opposed 
to absolutes. However, depending on the purpose for which the given instrument is 
being used, the misclassification rate can be minimised, either by increasing the 
threshold score to improve specificity and lower sensitivity, or by decreasing the 
score to achieve the converse
1.2.2.2. Recognition of Common Mental Disorders in Primary Care
The recognition of common mental disorders in the primary care setting is often 
rather more problematic than one would expect. Recognition rates vary, depending on 
the setting (personal vs. clinic centre) (Ustun & Von Korff, 1995); the physician 
(psychologically minded or not) (Goldberg & Huxley, 1992) and the instruments 
employed (clinical ratings, self-rating questionnaire, structured or semi-structured 
interviews, and so on). A number of papers have attempted to study the relative merits 
of different tools often with interesting results (Brugha et al., 2001).
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The VMIO skilly Dl psNcholDgicai problems in primar\ eaie (l islun &
Sarlorius. IW5). ilesenbed in detail earlier in Ibis section, examined the recognition 
rate ol common mental disorders by primary care physicians. Three dilTerent 
techniques ol case identification were employed:
( I ) Cases with diagnosable psychiatric disorder using IC I)-10 criteria, 
derived from the CIDI-PHC interview.
(2) A high score on the General Health Questionnaire (Gl IQ)- self- 
report by the patient.
(3) Cases identified by the clinician as currently sulTering from a 
common mental disorder on clinical grounds.
Similar prevalence figures were identified using the CIDI (24%). (illQ  (23.2%) and 
clinician ratings (23.4%) (Goldberg & Lecrubier, 1995). The strongest relationship 
was between the clinician ratings and GHQ (p<O.OOI), followed by GHQ and CIDI 
(/7<0.(X)2) and finally CIDI and clinician ratings (^0.05). It could be said with 
respect to this study that clinician ratings were in greater agreement with patient self- 
ratings, when compared to the ratings on a structured clinical interview administered 
by a non-clinician
Thus, any community-based study of common mental disorders would do well 
to include apart from structured screening instruments and semi-structured interviews, 
a clinician rating of psychiatric caseness. This may especially be true when the 
disorder in question (such as epilepsy) may have unusual presentations of common 
mental disorder, or indeed, when the study concerned addresses multicultural 
populations
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2. KI‘ II)KMI<)I.<)<;\ Ol- Kl'iI.KPSN -  AN OVKRVIKW
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2.1. Iiicideiicc Hiiti l’revülcnce
I pilcpsN is ihc commonest serious neurological condition Despite this, valid 
epidemiological indices have varied considerably in dilTerent studies A number of 
factors have contributed to this discrepancy in figures; differences in inclusion 
criteria, classification, diagnosis and case ascertainment methods across studies; and 
the relative paucity of longitudinal studies, save a few examples in the west (Sander & 
Shorvon, 2002). While discrepant figures are a problem, generic to epidemiological 
studies of common medical disorders, there are problems peculiar to epilepsy that are 
reviewed here.
The incidence has been found to be around 50 cases per 100,000 persons, per 
year (with a range of 40-70/100,000/year). The figure given for developing countries 
is generally higher in the range of 100-190/100,000/year (Hauser, 1998; McDonald et 
a l . 2000). A large population-based study in Ecuador identified all individuals with a 
history of seizures, including those with newly diagnosed non-lebrile seizures (acute 
symptomatic seizures were included) and some children with multiple febrile 
seizures. The incidence was higher than many other reports 190/100,000 based on the 
number of persons with seizures seen in the year before the survey, although the 
incidence of neurologically confirmed cases was 30% lower (Placencia et al., 1992).
I he usual prevalence figure given is about 5-10 cases per 1000 persons, 
excluding febrile convulsions, single seizures and inactive cases. The lifetime 
prevalence of seizures (the risk of having a non-lcbrilc epileptic seizure at some point 
in an average lifetime) is between 2 and 5%. I his difference between lifetime
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prevalence and aeli\e epiiepss indicates lhal the majorits ol patients cithei uo into 
remission or die (Sander &  Shorvon, 2(K)0).
2.1.1. Age Specific Incidence & Prevalence
Epilepsy is a disease with onset at extremes of life, at least in industrialised countries. 
Where prov ided, age-specific incidence is consistently high in the youngest age 
groups, with the highest incidence occurring during the first few months of life 
Incidence falls dramatically after the first year, and remains stable until adolescence, 
when it falls again (Hauser et al., 1993; Cam field & Camfield. 1994). In most 
industrialised countries, age specific incidence is lowest during the adult years, and 
increases again in old age, populations over 70 having a greater risk than children 
(Hauser, 1998: Sander & Shorvon, 2002).
Age adjusted prevalence per 1000 population has varied greatly from 3.6 to
41.3. even in studies involving similar methodologies, protocols, and even 
investigators. Stringent case verification procedures may explain some differences as 
demonstrated in the study in Ecuador, in part (Placencia et al., 1992). When active 
prevalence (number of active cases) as opposed to lifetime prevalence is studied, a 
pattern of increasing active prevalence observed with each subsequent age group, with 
the highest prevalence occurring in the elderly, as demonstrated in both the Rochester 
(Hauser et al., 1991 ) and Icelandic (Olaffson et al., 1996).
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2.2. Risk Factors
Most population-based studies of epilepsy provide information regarding presumed 
aetiology. While definitions for inclusion are seldom provided, the proportion of cases 
with an identified antecedent (remote symptomatic epilepsy) is relatively consistent, 
ranging from roughly a quarter to a third of all patients surveyed. In children, epilepsy 
associated with neurological deficits from hirth is the most important single 
aetiological relationship, whereas cerebrovascular disease is the most common!) 
identified cause among adults (Hauser. 1998).
Brain trauma, stroke, central nervous system infection, and degenerative brain 
disease are readily identified as antecedents of epilepsy. While specific causes are 
noted in certain geographical regions, a definitive cause is identified in only one-third 
of newly identified cases There are interesting contrasts between developed and 
developing nations with cerebrovascular disease being the commonest cause in the 
former (Hauser et al.. 1993) and CNS infections, cerebral palsy (especially in 
children) in the latter (C'arpio & Hauser, 1993). However, even in incidence studies in 
endemic areas, neurocysticercosis only accounts for a small proportion of newly 
diagnosed cases (Diaz et al., 1992) raising questions about the importance of such 
factors.
Epidemiological studies have helped to confirm the role of these factors and to 
quantitate the risk Thus the risk of epilepsy in someone with a penetrating head 
injury acquired during military service is more than 500 times than that expected in 
general populations (Salazar ct a l. 1985). In contrast, those with a history of head
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injury with loss ol consciousness or amnesia ol less than 30 minules. ha\e no increase 
in risk (Anncgers el al.. 19X0). While stroke closely follows head injury with a risk 
ratio of 20; brain infections such as encephalitis and meningitis have a risk ratio of 16 
and 10 respectively; degenerative brain disorders like Alzheimer's disease, 
hypertension and heart disease, neurological disorders like Multiple sclerosis, 
depression, alcohol and substance abuse, all have risk ratios between 10 and 3; with 
psychotropic drugs and treatments, tricyclic drugs, neuroleptics, electroconvulsive 
therapy (EîC I ) only marginally increasing the risk (1.5) (Hauser, 1998)
While there is a continued belief that adverse prenatal and perinatal events are 
associated w ith an increased risk of epilepsy, it has not been demonstrated at least in 
the developed world that these factors increase the risk of epilepsy, in the absence of 
neurological handicap Epidemiological evidence also does not support a causal 
association between febrile convulsions and epilepsy (Hauser, 1998). While over 200 
syndromes in w hich seizures are a part of the phenotype have been identified, these 
largely follow simple inheritance patterns, and are mostly rare or indeed very rare, 
accounting for only 1% of all epilepsy. These include neurocutaneous, 
neurodegenerative, inherited metabolic disorders and inherited malformations of 
cortical development. On the other hand, epilepsies with predominantly a complex 
genetic predisposition are common and account for about 50% of all genetically based 
epilepsies (Johnson & Sander, 2001). Thus, most common hereditary epilepsies 
exhibit a complex pattern of inheritance and are either examples of polygenic 
disorders or multi f actorial inheritance.
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Although genetic research in epiiepss is developing exponentially, in the 
absence ot other information it has been proposed that epilepsy in a first-degree 
relative increases the risk three fold (Annegers, 1982). I he absolute increase is 
modified by which first-degree relative is afïected (sibling, mother, father); the 
seizure type and aetiology of epilepsy in the affected relative, and the 
electroencephalographic pattern in the relative or individual in question (Hauser,
1998).
23 , Natural History
Prognosis in epilepsy is the prospect of attaining seizure freedom once epilepsy has 
been established. Seventy to eighty per cent of people developing epilepsy will remit, 
while the remaining continue to have seizures despite optimum treatment. Remission 
usually occurs within the first 5-year period, and for most people therefore, epileps> is 
a relatively short-lived condition (Sander. 1993; 1995).
2.3.1. Recurrence After the First Seizure
While earlier recurrence studies suggested that most patients with a single seizure had 
no further attacks, the incidence of epilepsy in population studies is greater than that 
of single seizures. Estimates of the risk of recurrence after the first seizure have varied 
from 27% to 81% (Hart et al.. 1990; Berg & Shinnar, 1991), with estimates at the 
lower end of the range being derived f rom hospital-based studies, while estimates 
from community studies are at the top level.
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h has been suggcslcd lhal ihis variai ion may be an died oT ihe lime ol enliy 
lo Ihe sliidy bias (Sander, 2003). As Ihe risk of seizure reeiirrenee is grealer in Ihe 
weeks lollowing ihe initial seizure (Sander, 1993,1995; Sander & Sillanpaa. 1998), a 
prolonged interval between the initial seizure and recruitment into a study may result 
in the second seizure having already occurred, leading to the patient not being 
included, and thus an underestimated recurrence risk. A large hospital-based study 
clearly showed this; a recurrence rate of 15% was reported among patients registered 
alter eight weeks ol their first seizure compared to 50% in patients registered within 
the first lour weeks (Hopkins et al., 1988).
The impact of treatment on the risk of recurrence has been assessed in only a 
fev\ studies In one study, patients were randomised either to treatment, or to no­
treatment after a first convulsion (First Seizure Trial Group, 1993) Recurrence at 24 
months in the treated group was 26% compared to 51% for those untreated. The 
impact ol early treatment on the long-term prognosis of epilepsy remains poorly 
understood.
2 .3 .2. The Natural History of Treated Epilepsy
2.3.2.1. Newly Diagnosed Epilepsy
[ here have been a number of hospital-based prospective studies reporting the effect of 
treatment in newly diagnosed cases (Sander & Sillanpaa, 1998). Overall, the 1-year- 
rcmission rales in these studies have varied between 58-95%. with most studies 
reporting rates between 65-80%.
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The prognosis lor remission of partial seizures is less good In one large study, 
complex partial seizures were controlled in only 16-43% of patients, w hile those w ith 
only secondarily generalised attacks control this was achieved in 48-53% at one year 
(Mattson et al.. 1985). Most studies have reported outcome to he less favourable in 
patients with multiple seizure types, associated neurological deficit and behavioural or 
psychiatric disturbance (Sander & Sillanpaa, 1998).
t wo large community-based studies have looked into the long-term remission 
of treated epilepsy. In Rochester, 15 years after onset, 76% of patients were in a five- 
year remission (Annegers et al., 1979). In Kent, 73% of patients entered remission 
(Goodridge & Shorvon, 1983). In both studies, most patients who entered remission 
did so in the first 2 years and as time elapsed, the prospect of entering remission 
decreased.
2.3.2.2. Chronic fpilepsy
All hospital studies of newly diagnosed epilepsy have consistently demonstrated that 
26-30% of patients do not enter remission (Sander & Sillanpaa, 1998). This has been 
confirmed by community studies (Annegers et al., 1979; Goodridge & Shorvon,
1983).
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2 3.2.2.1. Drug WiClidrawal and Sci/.iirc Kclap.sc
Seventy to eighty percent of patients on AHD treatment will eventually become 
seizure-free (Sander; 1993, 1995). As AKDs have long-term side etTects, withdrawal 
is considered after a substantial remission period I here are, however, risks of relapse 
in doing so. The probability of relapse has varied between 11^1% (Sander, 2003).
A number of risk factors for seizure recurrence after discontinuation of 
treatment have been identified (MRC, 1991: Berg & Shinnar, 1994). These include a 
long history of seizures before remission, more than one seizure type, the presence of 
a structural brain lesion, the presence of abnormal neurological signs, a past history of 
remission and relapses and juvenile myoclonic epilepsy. Whether EEG is helpful in 
predicting recurrence remains controversial in adults In children, however, the 
presence of slow background rhythms or frankly, abnormal discharges in the record 
indicates an increased risk of recurrence
2.3.3. The Natural History of Untreated Epilepsy
As outcome studies of epilepsy have almost invariably been of the treated condition, 
the probability of spontaneous remission in an individual patient and the effect of 
early treatment on the outcome remain unknown (Sander, 2003).
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2.3.3.1. Spt)nlanciHi.s Kcinission
Patients with epilepsy in developing countries may have had untreated epilepsy Ibr 
long periods of time (Sander; 1993, 1995). It these patients were to never remit, the 
prevalence rate tor epilepsy in developing countries would be much higher than those 
found in the developed world (5-10/1,000) (Sander & Shorvon, 1996). While some 
studies in developing countries have reported higher prevalence rates tor epilepsy, 
these have generally been small studies involving selected populations, possibly with 
higher rates of degenerative CNS disease, parasitic infestation or specific epileptic 
syndromes (Sander & Shorvon, 1996).
Further, large prevalence studies in largely untreated populations in 
developing countries have reported similar rates to those found in the developed 
countries (Bharucha et al.. 1988; Li et al., 1985; Placencia et al., 1992). While this 
may be because epilepsy leads to higher mortality rates in these countries, it is 
unlikely to account for the whole difference. Lack of optimal case ascertainment 
procedures for active seizures, or indeed missing cases in remission rather than active 
cases, may explain these results (Sander, 1993; Sander & Shorvon, 1996). A more 
plausible explanation would be that some of the patients do enter spontaneous 
remission. Two small retrospective studies, one carried in a hospital clinic in Finland 
(Keranen & Riekkinen, 1993) and the other in a rural community in Southern India 
(Mani et al., 1993) seem to support this explanation: both reported a remission rate of 
50% in untreated patients.
2 3.3.2. I:Heels ol l-arly Alii) Treatment on Prognosis
Observations on the efficacy of treatment in patients with chronic epilepsy w ho had 
not previously received AED treatment have now been made in 3 ditïerent studies in 
the developing countries (Watts, 1992; Feksi et al.. 1991 ; Placencia, 1993). These 
studies involving more than 1,000 patients, have found that neither the duration of the 
condition nor the number of seizures before treatment w ere predictors of outcome.
I his offers some evidence against the view that unless treatment is given early, 
chronic epilepsy will develop.
2.3.4. Prognosis
Sander (2003) has classified epileptic syndromes into four groups based on prognosis. 
These groups are to some extent static and self-contained, and migration from one 
group to another is unlikely unless new factors arise, for instance exposure to a novel 
AED, surgical intervention, or the widening of a lesion. Patients will fall in to one of 
these prognostic groups and this is likely to be pre-determined by the epileptic 
syndrome
2.3.4.1. Excellent Prognosis
In this group syndromes and conditions are self-limiting and very benign. They may 
comprise about 20-30% of all people who develop epileptic attacks. Usually, only a 
few seizures occur. Patients commonly do not require AED treatment, as spontaneous 
remission is the rule. Conditions include benign neonatal convulsions, fifth-day
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sci/urcs. (he bcmgii partial epilepsies, and benign myoclonic epilepss ol inlanc) and 
some of (be epilepsies w ith seizures precipitated by specillc modes of activ ation 
(acute symptomatic seizures).
2.3.4.2. Good Prognosis
Epilepsies in this group are usually benign, are short lived and may comprise about 
30-40% of all people who develop epileptic attacks. Seizures are easily controlled 
with AEDs. Once remission is achieved, this is permanent and AEDs can be 
successfully tapered otT. It could be argued that in this group AEDs are curative or 
suppressant until the epileptic diathesis resolves spontaneously. Conditions include 
childhood absence epilepsy, epilepsy with generalised tonic clonic seizures on 
awakening, non-specific generalised tonic clonic seizures in patients with no 
neurological signs, and some of the localisation-related epilepsies (both cryptogenic 
and symptomatic types).
2.3.4.3. Uncertain Prognosis
In this group, there is a long-term tendency to seizures, and it comprises about 10- 
20% of people who develop epilepsy. Patients often remit with AED therapy but may 
relapse if AEDs are stopped, thus treatment usually is a lifetime prospect. Conditions 
include juvenile myoclonic epilepsy, and the bulk of the localisation-related epilepsies 
(both cryptogenic and symptomatic). Some patients in the latter group may. however, 
be amenable to surgical intervention, with subsequent change in prognostic group.
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2 3 4 4 Bad Prognosis
This group comprises up lo 20% ol all people who develop epileptic attacks. Al'Ds in 
this group are palliative rather than suppressive of seizures. There is a continuous 
tendency for seizures, despite intensive treatment with all AEDs. Although, 
occasionally patients may move to the uncertain prognosis group when exposed to a 
novel AED. Some patients in this group may also be amenable to surgical intervention 
with subsequent change in prognostic group. Conditions include seizures associated 
with neurological deficit present from birth (tuberous sclerosis, Sturge-Weber, 
malformations, cerebral palsy, etc.), epilepsia partialis continua, progressive 
myoclonic epilepsies and other progressive neurological diseases. West Syndrome. 
Lennox-Gastaut Syndrome and others where atonic/tonic seizures are a prominent 
feature, localisation-related seizures associated with gross structural lesions and some 
of localisation-related cry ptogenic epilepsies.
Thus, the outcome of epilepsy is determined to a large extent by its aetiology 
and studies reporting outcome need to be encouraged to classify all reported cases 
according to epileptic syndromes rather than seizure type (Sander, 2003).
2.4. Mortality
While epilepsy is often assumed to be a benign condition with relatively low 
mortality, there is considerable evidence to the contrary. Consistent increases have 
been reported in the mortality of people with epilepsy, especially younger patients and 
those with severe epilepsy (Sander, 2002).
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I liühcr Sliindardiscd Morlality Ratios (SMR) ha\c been reported Ibr males 
w hen compared to t'emales. the highest SMRs being in the 0 40 year age group, and 
the lowest SMRs being in the 75+ age group. Two community studies found overall 
SMRs to be 2-3 times higher than those of the general population, the risk being 
largely limited to the first 10 years after diagnosis (Hauser et a l. 1980; Lhatoo et al.,
2001) I his may suggest that increased mortality was due to the underlying cause of 
epilepsy (brain tumours, head injury, vascular events etc ) rather than due to any other 
factor (Sander. 2002).
Seizure type seems to play a role -  both partial and complex partial seizures 
alone are not associated with an increased SMR w hen compared with general 
population. Although those in remission have been shown to be at higher risk in some 
studies (Sander, 2002). Primary or secondary generalised seizures have a higher SMR 
-  2.4 overall but 3.5 in the first year after diagnosis, with myoclonic seizures being 
highest at 4 .1 (Hauser et al., 1980; Lhatoo et al., 2001 ). Severity of epilepsy has been 
show n to increase risk of mortality in some studies (Sander. 2002). Higher mortality 
rates for non-Caucasian populations have been reported in America, although this 
may be a reflection of socio-economic status, rather than a true biological increase 
(Chandra et a l, 1994).
Causes of death in epilepsy include bronchopneumonia, which is strongly 
associated with epilepsy irrespective of age, and cancer the SMR and PMR for which 
arc consistently elevated, even after primary brain tumours have been excluded. Some 
studies have linked this excess mortality to the diagnosis of neoplasm preceding the 
diagnosis of epilepsy rather than the other way around (Chandra et al., 1994;
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KIcncnnan cl al.. IVV3) A hiüh score i)l'licpalobiliar> neoplasm has been teporieci in 
studies of small selected institutionalised groups (Klenemian el al., 1993)
Deaths directly related to epilepsy are sub-divided into the following 
categories; status epilepticus, sudden unexpected death (SUDEP) and accidents.
Status epilepticus has a high fatality rate of between 10-20%, although studies have 
failed to differentiate between individuals with epilepsy, and those who had no 
previous seizures. SUDEP is defined as a non-traumatic unwitnessed death occurring 
in a person with epilepsy, who had been previously healthy and for whom no cause of 
death is found even alter a thorough post-mortem examination (Lathers & Schraeder.
1990). Explanations include suffocation during a seizure, deleterious etTects of AEDs, 
autonomic seizures a fleeting the heart, cardiac arrhythmias and the release of 
endogenous opioids, although a single pathogenic mechanism remains elusive 
Frequent convulsive seizures, lack of nighttime supervision, use of more than one 
AED, frequent visits to Accident and Emergency Departments, have all been 
identified as risk factors Annual mortality rates of sudden death have varied from one 
per 200/ one per 370. depending on the population studied (Sander, 2002).
i
People with epilepsy have a higher risk of accidents, drowning and suicide. 
AEDs may contribute to the increased mortality although evidence in this regard is 
not robust, and barbiturates and hydantoins have been shown to have oncogenic 
potential (Sander. 2002).
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2.5. >Mcflio(lol(»f’iral Problems in Kpi(lemioi<» i^cHl Studies ol I pilepsy
DilTcrcnces in inclusion criteria, classification, diagnosis, and case ascertainment 
methods have led to considerable variations in incidence and prevalence figures, and 
will be discussed in detail herein.
2 5 1 Case Ascertainment
2 5.11. Deficiencies in Patient Reporting
I Inlike many other ailments, the bulk of seizure disorders do not have physical 
manifestations, and are of a transient and unpredictable nature (Sander & Shorvon, 
1987). The diagnosis is based on “history” or “chance observation of a seizure”, both 
of which have inherent problems. Patients may often be unaware of their symptoms, 
misinterpret them, fail to report these due to misperception and other such factors, or 
even in some cases conceal them due to the significant stigma attached to the 
condition Social customs also influence the reporting and diagnosis of epilepsy. For 
e.g., in places like Japan where families sleep together, there may be a higher 
reporting of seizures in their offspring by the mothers (Tsuboi, 1984). Under reporting 
is not confined to developing nations however, and studies in Metropolitan London 
(Hopkins & Scrambler, 1977) and Newcastle upon Tyne (Miller et al., I960), and 
Japan (Tsuboi, 1984) have shown that 14-20% of children with epilepsy had never 
consulted a doctor. Therefore, To be comprehensive, community studies should be 
independent of pre-existing medical records and use a highly sensitive questionnaire 
(Sander & Shorvon, 1987).
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2.5.1.2. Dcllciciicics in Sci/iirc Diagnosis
The diagnosis of epilepsy as noted previously is essentially clinical, and may 
therefore be both dilTicult and delayed. The differential diagnosis encompasses the 
gamut of disorders with transient alterations of consciousness, and in practice, both 
false positive and false negative diagnoses are common (Sander & Shorvon. 1987). 
Syncope is frequently misdiagnosed as epilepsy (Sisodiya, 2002). as are non-epileptic 
seizures, which are misdiagnosed as epilepsy in 5-20% of cases (Betts. 2002) and 
often have psychogenic origins. In a study of 106 newly diagnosed hospital cases, 24 
months had elapsed before a correct diagnosis was made in 25% of cases and this may 
have an impact on incidence and prevalence (Shorvon, 1982). However, many 
epidemiological surveys fail to acknowledge this problem, and a number of studies 
rely upon loosely defined diagnostic criteria and specialist opinion, an approach that 
researchers in other chronic disorders have chosen to reject (Sander & Shorvon,
1987).
2.5.1.3. Case Ascertainment Methods
The most common published method of ascertainment is the retrospective reviews, 
which are sources of inaccuracy and under-reporting (Zielenski, 1974). Case records 
are usually review ed for a mention of fits/seizures/epilepsy; prescription of 
anticonvulsants; request for EEG; or a diagnostic index is used. Differing diagnostic 
and therapeutic practices and temporal changes within or between different centres 
are invariably ignored (Sander & Shorvon, 1987). A retrospective record review may 
be followed by an interview of positively identified cases. A case register is another
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mclhod. which, ifcslablishcd vvilh careful prccaulioiis. has advanlagcs over Ihc 
rclrospcclive record reviews. Other approaches include: house-house surveys which 
have the advantage of being prospective, and not relying on prior diagnosis that are 
both expensive and time consuming; the use of public health, school or institutional 
records to conduct a survey. However, these surveys depend upon screening 
questionnaires and trained health personnel (not medically qualified), and in the 
absence of well-validated instruments can produce fallacious results.
2.5.2. Classification and Case Definition
C ases are commonly classified based on seizure type and aetiology. However, 
accurate classification is dependant on good history taking and observation, as well as 
in-depth knowledge of the system in use. Laboratory tests such as the EEG may 
contribute to diagnosis but cannot confirm this.
In epidemiological studies, it is important to follow an international 
classification system and fixed criteria upon which the diagnosis of seizures could be 
made. An internationally agreed classification of seizure type has been proposed 
which incorporates EEG data (ILAE, 1981). In designing an epidemiological study it 
must be borne in mind that hospital specialists in the face of EEG evidence often fail 
to agree with each other (Lavy et al., 1972). Classification by aetiology is interesting 
and may achieve importance in specific locations, such as the study of 
neurocysticercosis in parts of Central and South America. It is evident however, that 
the successful detection of an aetiological factor depends on the extent of
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invesligalion and unless ihis is standardised and specified in any large-scale study, 
evaluation can be problematic (Sander &  Shorvon, 1987).
A further methodological issue is the definition of epilepsy. If  single seizures, 
neonatal seizures, febrile seizures and seizures in acute illnesses are included, the 
incidence and prevalence figures may be elevated several fold (Sander & Shorvon,
2002). Indeed, one difllculty is that many published reports in the past failed to 
include this crucial piece of information. Further, the issue of active versus inactive 
seizures had plagued epilepsy research for years. There were proponents of the view 
“once an epileptic, always an epileptic” (Lennox, 1960), which is contrary to evidence 
from epidemiological studies reviewed herein. The guidelines for epidemiological 
studies in epilepsy proposed by the ILAE and reviewed herein (ILAE, 1993), have 
clearly defined active epilepsy as at least one epileptic seizure in the past five years 
regardless of anti-epileptic treatment, which has to some extent put an end to this 
debate,
2.5.3. Selection Bias
Even with satisfactory ascertainment, classification and case definition, population 
selection bias may influence study results. There most certainly are regional 
differences in vital statistics reflecting geographic, ethnic and genetic, environmental 
and socio-economic factors. For this reason the demographic characteristics of the 
population should be well described, and the analysis should account for such 
differences. It is also important to avoid obvious errors such as sampling a selected 
population (those in an institution or those selected into the armed services for
70
example) or sample in areas lhal are endemic lor any disease I'aelor under sludy 
(neurocysticercosis for example). Age standardisation ol data is important, as is the 
assessment o f the natural history o f the illness and the role o f treatment (Sander &  
Shorvon, 1987).
2.6. ILAE Guidelines for Epidemiological Studies on Epilepsy
The International League Against Epilepsy (ILAE) established a Commission on 
Epidemiology and prognosis under the chairmanship of Dr. Pierre Jallon from 
Geneva, Switzerland. The guidelines proposed by this commission (ILAE, 1993) are 
summarised herein:
The first step in field studies is the use of a screening instrument adapted to 
the population at risk. The sensitivity and specificity of the questionnaire must be 
tested and validated, and the methods clearly described.
The diagnosis of epilepsy in epidemiological studies is clinical and should be 
derived by medical history, seizure description, and neurological examination, by an 
experienced medical professional using standardised diagnostic criteria.
Rigorous definitions are important: the categories being epileptic seizure, 
epilepsy, status epilepticus, active epilepsy, epilepsy in remission with/without 
treatment, febrile seizure, neonatal seizure, febrile seizure with neonatal seizure and 
non-epileptic events. Epilepsy is defined as “a condition characterised by recurrent 
(two or more) epileptic seizures, unprovoked by any immediate identified cause.
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Multiple sci/urcs occurring in a 24-hour period arc considered a single event. An 
episode of status epilepticus is considered a single event. Individuals who have only 
febrile seizures/neonatal seizures as herein defined are excluded from this category '.
A prevalent case with active epilepsy is defined as “a person with epilepsy who has 
had at least one epileptic seizure in the past five years, regardless of AED treatment'. 
A case under treatment is someone w ith correct diagnosis of epilepsy receiving (or 
having received) AEDs on prevalence day.
For the purpose of an epidemiological study, the detailed ILAE classification 
may be too extensive. A clinical classification is thus proposed with seizures being 
classified into four categories: generalised (including tonic, clonic, tonic-clonic, 
myoclonic, absence); partial (simple partial, complex partial, partial epileptic seizure 
of unknown type, partial seizure-secondarily generalised); multiple seizure types 
(when each type is described); and unclassified when information is inadequate.
Epileptic seizures are also divided into provoked and unprovoked based on 
whether a precipitating insult is perceived. Provoked seizures are also called acute 
symptomatic seizures and occur in temporal correlation with a CNS insult or injury. 
Unprovoked seizures are categorised into remote symptomatic (static insult such as 
infection, cerebral trauma, cerebrovascular disease) or unprovoked seizures of 
unknown aetiology. The latter is sub-divided into idiopathic (to indicate certain partial 
and generalised epilepsy syndromes with particular clinical and EEG findings, and 
known cause as commonly believed) and cryptogenic which is used to include partial 
or generalised unprovoked epilepsies in which no factor associated with increased risk 
of seizures has been identified.
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A lew cpidciiiiological indices are recommended: Poinl pre\ alenee, period 
prevalence, lifetime prevalence, incidence, incidence rale, incidence density, 
cumulative incidence and standardised mortality ratio.
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3.1'SNCIIIA I RIC (:0-M0KKil)l lA IN l l'll I:I'S\
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3.1. liistorical iiitrodiiclioii
3.1.1. Pre-nineteenth Century Literature
The interface between epilepsy and psychiatry has a long and chequered history. Both 
have links with god, demons and witches, and the supernatural; and have evoked 
prejudice, disaffection and malediction from other members of society (Trimble.
1991).
The Greeks referred to epilepsy as “the sacred disease”. The earliest writings 
were those of Hippocrates (460-377 BC) (Adams, 1939), who in his monograph “On 
the Sacred Disease” opined that it was a natural affection, with a hereditary origin, 
with its pathogenesis in the brain. The brain was thus the seat of both the falling 
sickness and madness, and both were related to the phlegm (Trimble, 1991 ).
There are several other examples from this period that link epilepsy and 
behaviour. The story of Hercules, whose birth was delayed by Hera, in order to favour 
the earlier delivery and succession of Eurystheus to the throne of Greece, has been 
alluded to in the writings of both Hippocrates and Aristotle. Hercules is believed to 
have killed his own children in a “seizure” of madness. The supposition that this was 
epileptic, relates to a Hippocratic treatise: “when the uterus is near the liver and the 
hypochondrium and produces suffocation, the woman turns up the while of her eyes, 
become cold, gnashes her teeth, saliva flows into her mouth, and she resembles the 
persons seized by a Herculean disease” (Temkin, 1971). Aristotle, in a treatise that 
considered “why talented individuals are melancholic?” gives Hercules as an
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example; I or he apparently had this constitution and Iherelore epileptic alllietions 
were called aller him the sacred disease” by ancients (Simon, 1978).
This relationship between epilepsy and melancholia was also referred to by 
Hippocrates who stated, “Melancholics ordinarily become epileptics, and epileptics 
melancholics, what determines the preference is the direction the malady takes: if it 
bears upon the body, epilepsy, if upon the intelligence, melancholy” (Lewis, 1934). 
fbese ideas link with the Galenic concept of humours and their relationship with 
temperament. According to Galen, Temperament was a somatic rather than 
psychological state, and was derived by a combination of the four basic humours -  
phlegm, blood, black bile and yellow bile. Melancholia was related to black bile, but 
was also related to “raving”, and to epilepsy (Trimble, 1991). For Galen the two had a 
related pathogenesis: “This humour arises in some people in large quantity either 
because of their original humoural constitution or their customary diet which is 
transformed into this humour by digestion in the blood vessels. Like thick phlegm, 
this heavy atrabilious blood obstructs the passage through the middle or posterior 
cavity of the brain and sometimes causes epilepsy. When its excess pervades the brain 
matter itself, it causes melancholy” (Siegel, 1973). The perception of epilepsy in 
conjunction with other periodic afflictions including varieties of mental illness, all 
linked to the moon was also prevalent among the Romans. This led to the condition 
being referred to as morbidus lunaticus and to the development of the term “lunatic”.
These early writings linking epilepsy and mental illness notwithstanding, with 
the waning of Greek influence on Roman scholars, there were no new advances in 
medical thinking, until the Renaissance ( frimble, 1991 ). Some of the focus during
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this period shilled lo Ihe Arab world/ where loo, associations between epileps\ . 
mental illness, and demons remained. Some ver> good descriptions linking religiosity, 
epilepsy and mental illness emerged during this period, the visions of many 
soothsayers and prophets being alluded to as manifestations of epilepsy. Both 
Mohammed (Howden, 1873) and Saint Paul of Tarsus (Landsborough, 1987) are 
examples of religious prophets who were described to periodically hear voices and 
fall to the ground 1 here is thus considerable ancient literature emphasising the 
associations between epilepsy, ecstasy and prophecy (Temkin, 1971).
The links between the demons, the moon and epilepsy, continued into the 18th 
century. They extended far beyond lay and theological considerations into the 
writings of such physicians as Stahl (1695-1734), Hoffman (1660-1742), van 
Swieten (1700-1772) and even Willis (1621-1675) (Trimble, 1991). Allusions to the 
devil (Harle, 1729) and the moon (Mead, 1746) were commonplace during this 
period. The first substantial treatise on epilepsy published by Tissot (1770), opposed 
ideas about lunar influences, but linked epilepsy to masturbation. These ideas had a 
profound influence on epilepsy for years to come, and were linked to the introduction 
of bromides for the treatment of the condition. Similarly, the link between 
masturbation and mental illness too lived on for generations (Trimble, 1991).
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j  1.1 I l !pilcpsy & PsychiatrN in Ihc I Vih and Parly 2()lh C enturies
The growth of hospitals, led to patients with epilepsy previously incarcerated in 
prisons (along with the insane), to occupy several hospital wards. Epilepsy was a 
particularly common diagnosis in asylums, and in some, epileptics were segregated in 
separate wards. While many older asylums excluded patients with epilepsy especially 
when it was associated with insanity The prognosis of the condition believed to be 
particularly poor in that case (Griesinger, 1857), county asylums that were built later 
did accept patients with epilepsy The Commissioners in Lunacy reported that in 1887 
there were 1,294 patients with epilepsy in various asylums in England and Wales, 
from a total of 14,336 and 9% of insane patients brought under treatment that year had 
epilepsy (Savage, 1892).
This concentration on patients in asylums had some interesting consequences. 
The first was that, patients were subjected to close medical scrutiny and this led to a 
number of interesting observational studies and findings thereof. Second, the policies 
of the day meant that, the more severely affected patients with epilepsy were looked 
after and followed up by psychiatrists in asylums, and those with less severe forms of 
the illness remained in the community, and were treated by general physicians and 
neurologists of the day (Trimble, 1991).
At this time a greater recognition of the mental health problems that afflicted 
patients with epilepsy also became more evident. Pinel, a leading physician in Paris 
(credited with Tuke and Connolly for the so-called unchaining of patients in the 
asylum-workhouses), noted that insanity complicated with epilepsy was a frequent
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problem, and lhal Ihe prognosis was poor I le advocated Ihe separation o f patients 
with epilepsy, and went on to prescribe special procedures for their care.
However, it was in Germany that a considerable literature evolved during this 
period. The German psychiatrists in that period were all somatics rather psychics, 
which essentially means that they believed in the organic basis of mental disorder 
(Schmitz, 1998). Flemming (1859) had a special interest in alternating states of 
epilepsy and insanity, and in his influential textbook. Pathology and Therapy of 
Psychoses observed “Epilepsy and mental disorder are two states of illness of the very 
closest relationship; they represent identical pathological conditions in two different 
areas of the nervous system”. While Friedrich Hoffman (1862) introduced the term 
epileptic equivalents” for mental disorder in epilepsy, Heindrich Hoffman (1859) 
recognised that epilepsy and mental disorder often develop into one another.
Following on from the influential works of Griesinger ( 1868), Samt (1875,
1876) developed a bewildering classification of epilepsy with 12 categories. He re­
introduced the term “epileptic equivalents” and was convinced that, this was a highly 
specific category with clinically proven seizures not being mandatory for diagnosis. 
Sommer ( 1881) in the same period acknowledging the concept of equivalents in 
people with epilepsy, with the exception of those who did not have clear aetiological 
antecedents, suggested the term “psychic status epilepticus” or “epileptic rudiment” 
for these states. There was considerable disagreement among these “experts” which is 
documented in elegant reviews by Trimble (1991) and Schmitz (1992, 1998).
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Hy llic beginning ofllic 2()lh ccnlury, Ihc case ofepileps) was being taken 
over by neurologists, and the emphasis had shifted to the classillcation oI seizures and 
their treatment. Important contributions in this period came from authors such as 
BonhoetTer (1909) who in a discussion on epileptic equivalents and their specific 
psychopathology described the non-specific presentation and multiple aetiologies of 
organic psychosis (acute exogenous reaction). The nature of the relationship between 
epilepsy and schizophrenia was discussed extensively in the context of unitary vs. 
combined, composite or hybrid psychosis.
Kraepelin, the outstanding pioneer of the modem psychiatric classification, 
succeeded in identifying most of the psychiatric disorders of epilepsy that can be 
presently recognized (Kraepelin, 1923). Kraepelin pointed out that all psychiatric 
changes manifest in the preictal or postictal phases may also occur interictally, 
independent of convulsive events, thus indicating their kinship; seizures may also 
appear interspersed in the course of the psychiatric disorders. The most commonly 
encountered interictal dysphoric episodes (Verstimmungen) are characterized by 
irritability, depressive and at times euphoric moods, anxiety, headaches, and 
insomnia. They occurred in like manner every few days to every few months and 
lasted for a few hours up to two days. The same dysphoric symptoms also can be 
observed in the prodrome of a seizure or postictally. Kraepelin then noted dysphoric 
episodes with psychotic symptoms, i.e., interictal events with hallucinatory or 
delusional content developing as expansions of dysphoric episodes. These psychotic 
episodes usually occurred in clear consciousness and lasted a mere few days; only in 
isolated cases the psychotic state persisted for weeks or even months and may then 
superficially look highly similar to certain forms of dementia praecox. More
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promincnl among the psychotic episodes ol epilepsy at that time, were eonlusional- 
amnestic episodes with clouded consciousness termed twilight states 
( Dâmmerzustânde), lasting for mere hours to at the most 1/2 weeks. They were 
chiefly observed subsequent to seizures (at times following a brief lucid interval), at 
times preictally, and occasionally independent of observed seizures. Dysphoric 
symptoms were marked during the twilight states, with episodes of violent rage, or 
extreme anxiety, or impulsive suicide attempts; exalted religious states were often 
observed. Kraepelin noted that it was dilTicult to distinguish different forms of the 
twilight states. Finally, Kraepelin defined personality changes (VerblOdung) 
characterized by slow-viscous and circumstantial mental processes, and by a highly 
ethical and helpful attitude with an unusual predilection for religious ideas that 
contrasted starkly with the episodic irritability and tendency to explosive fury. 
Kraepelin's findings are of particular importance because they document the 
psychopathology of epilepsy before effective antiepileptic drugs were available 
(Blumer, personal communication).
An important contribution in this period came from the work of Laszlo von 
Meduna, who postulated a biological antagonism between epilepsy and schizophrenia 
based on his observations that true combinations of these disorders occurred in only 
one out of 6000 psychiatric cases. Better prognosis in those with the combination than 
those with pure epilepsy, and observations in numerous case studies (including his 
own) that patients experienced a remission of psychotic symptoms following 
spontaneous epileptic seizures. Meduna’s writings have been criticised as being 
flawed (Schmitz, 1998); however it has been suggested that he believed in a 
syndromic affinity between epilepsy and schizophrenia, and an antagonism between
symplDins. psNchosis and sci/iircs (Wolf & I'rimblc. I9S5). Nevertheless. Meduna 
( 1935) did sueeesslully introduce convulsive therapy for psychosis with camphor 
injections, and the rest as they say is history!
Other important and rather startling contributions were to to I low: The 
introduction of the EEG as a diagnostic tool revolutionised research in this area, as 
did the introduction of new drugs such as Ethosuximide. Heinrich Landoldt re­
discovered epileptic equivalents using this tool, and his work prompted a lively 
discussion, which is well reviewed in the contemporary essays by Janz (1969, 1997, 
1998). In a careful study combining clinical and EEG parameters in a series of 
patients with epilepsy and behavioural symptoms Landolt (1953, 1958) identified four 
types of distinct psychotic episodes: Post-paroxysmal twilight states, the petit mal- 
status of Lennox, productive psychotic episodes with "forced normalization” of the 
EEG, episodes with an increase of electroencephalographic pathology (psycho- 
organic episodes). It was Landolt’s description of normal electroencephalograms in 
association with psychotic illness, the forced or paradoxical normalization of the EEG 
with psychotic episodes, which renewed interest in the potential antagonisms between 
seizures and psychosis that drew the greatest attention.
Soon after, Dongier (1959) published the results of a European study on the 
clinical and EEG phenomena of psychosis in epilepsy. She studied the relationship 
between clinical and EEG features and patterns of psychopathology. In this study 
patients with centrencephalic epilepsy were as likely as those with psychomotor 
epilepsy to develop psychotic episodes. Patients in the centrencephalic group had 
associated confusional states and psychotic symptoms that were largely transient with
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chamctcrislic HI Xi fcaUires. On Ihc olhcr hand, palicnls in the ps\ chomolor group did 
noi sulVer fVom confusion, had more prolonged episodes of psychosis, and 
demonstrated more atTective and anxiety features.
3 1.1.2. Contemporary Research in the 20th Centuiy
Slater and Beard (1963) published their classic five-part paper on the schizophrenia 
like psychoses of epilepsy. Following on from the work of Bartlett (1957), Denis Hill 
(1953), Desmond Pond (1957) and others, these authors systematically examined 69 
patients with epileptic psychoses -  31 from the National Hospital for Neurology and 
Neurosurgery, and 38 from the Maudsley Hospital, both in London (UK). In all cases 
thus included, the diagnosis of epilepsy was supported by EEG, the diagnosis of 
schizophrenia made by an experienced psychiatrist and in the authors’ opinion, 
schizophrenia would have been the diagnosis of choice in the absence of epilepsy. 
Based on their results the authors opined that the combination was not due to chance. 
The pre-morbid personality was normal but showed evidence of change in the pre- 
psychotic period; both long duration and increased frequency of epilepsy were 
associated with the development of psychotic symptoms; although the onset of 
psychoses was generally unrelated to seizures, in a proportion of cases a falling 
frequency of seizures before psychotic symptoms began was noted; insidious onset 
and chronic course were frequent; the full spectrum of schizophrenic symptoms were 
observed with no special distinguishing features. This paper, although in a highly 
selected population, was the first to study a reasonable large sample of patients with 
schizophrenia like psychoses of epilepsy, using a contemporary research approach.
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I lor I lcnr> ( l%9) sel about trying to investigate the link between epileptic 
psychoses and the epileptic process. Fifty patients with psychoses ol epilepsy drawn 
from the Maudsley Hospital were compared with 50 controls randomly chosen from 
neurology wards with EEG evidence of temporal lobe disturbance The two groups 
were compared across 71 variables designed to evaluate according to the author-  
sociological, personality, epileptic, psychiatric, genetic, neurological, 
electrophysiological, and psychometric characteristics of the two populations. Patients 
with psychosis were found to have fewer psychomotor/psycho-sensory seizures; 
experience convulsive/ictal manifestations less frequently; have epilepsy 1 itéraiised to 
the dominant hemisphere; have an excess of bilateral loci; have fewer minor temporal 
seizures. Further patients with schizophrenia like psychoses, when compared to those 
with affective psychoses were found to have greater evidence of brain damage and 
preponderance of epilepsy literalised to the non-dominant hemisphere. This study 
confirmed several observations of Dongier, and provided further evidence for 
Landolt's observations on Forced Normalization, and the later description of 
alternative psychoses (in the absence of EEG evidence of forced normalization) by 
Tellenbach (1969).
Significant literature that has followed these early efforts, is reviewed in the 
section on Neuropsychiatrie epidemiology.
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3.2. Neuropsychiatrie Epidemiology in Epilepsy
Although the interface between epilepsy and psychiatry has stimulated considerable 
interest (and research) over the years, much of this has been in the hospital and in 
institutional populations There have been very few studies conducted in 
representative populations in the community, and epidemiological data is scant. The 
paucity of epidemiological research at this interface is in stark contrast with 
developments both in epilepsy per se, and in mental health research. The 
epidemiology of epilepsy has been well studied in many countries and considerable 
data, both descriptive and analytical (reviewed in section 2 and elsewhere -  see 
Hauser, 1998 for example) are now available. Indeed, epilepsy has been subjected to 
the gamut of epidemiological research including cross-sectional, case-control and 
cohort studies (Hauser, 1998).
Impressive developments have also taken place in the field of mental health 
epidemiology. Efforts by the World Health Organisation’s Division of Mental Health, 
and other pioneering organisations around the world have led to a significant 
understanding of the epidemiology of psychiatric disorders. This has also led to the 
development of now universally accepted classificatory systems in psychiatry, such as 
the Diagnostic and Statistical Manual (DSM-IV) now in its fourth edition (APA, 
1994), and the mental disorders component of the International Classification of 
Diseases, now in its tenth edition (lCD-10) (WHO, 1992a).
The commonly held conviction among epileptologists and neuropsychiatrists 
is that psychiatric disorders are not only common in epilepsy, but that distinct and
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iinit|iic roriiis ol'psNchopalhology are prcvalenl Krishnamoorlh) (2()()0). In Ihc pasl 
three decades attention has been directed towards discrete Ibrms ol psychopathology 
in epilepsy such as the temporal lobe personality (Waxman and Geschw ind: Bear and 
Pedio, 1977; Blumer, 2000), inter- and post-ictai psychosis (Trimble, 1992; I'oone) 
and inter-ictal dysphoric disorder (Blumer 1995,2000). This combined with the 
observation of similarities in behaviour during seizures and in psychopathological 
states has strengthened the notion of an affinity between epilepsy and psychiatric 
disorder. Yet, the evidence that psychiatric disorders are over represented in epilepsy 
is far t'rom convincing, with conflicting results in different studies (Krishnamoorthy, 
2001).
In this section, the Neuropsychiatrie epidemiology of epilepsy is reviewed in 
three parts; first, the important and considerable interface between epilepsy and 
learning disability and the specific literature thereof; second, a review of studies in 
hospital and institutional populations which have included eclectic subject cohorts 
resident in these settings; and third, epidemiological studies of psychiatric co­
morbidity in adult populations with epilepsy, resident in the community.
3.3. Neuropsychiatrie Epidemiology at the Interface Between Epilepsy &  
Learning Disability
1 he literature with regard to epilepsy and psychiatric disorder in learning disabled 
populations is rather complex. In general, there is an over-representation of both 
epilepsy and behaviour problems in subjects with learning disability (LD). 
Community studies have indicated prevalence rates of epilepsy ranging from 6%
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among children wilh mild LD (IQ 50 70) (Ross & IVckham. I9S3). to 24% in severe 
I D (IQ <50) (StetTenberg et al., 1995) and 50% in profound LD (IQ <20) (Corbett,
1988). A reasonable global estimate therefore is that between 15% (mild LD with 
IQ>50) and 30% (severe LD- IQ <50) have co-morbid epilepsy (Sillanpaa, 1996).
On the other hand, it has been estimated that around 50% of subjects with LD 
in a hospital/institutional setting will pose management problems due to psychiatric 
disturbance. Affective and schizophrenic disorders, dementing syndromes, early 
childhood autism, hyperkinetic syndromes, neurotic, conduct and personality 
disorders, whether or not associated with epilepsy have been reported in this 
population (Reid, 1983).
3.3.1. Are Psychiatric Disorders Over-Represented in Subjects with LD and Epilepsy?
Given the background of high psychiatric co-morbidity in both LD and epilepsy, one 
would expect the burden of psychiatric co-morbidity to be significant in cases where 
both conditions co-exist. However, literature on psychopathology among subjects 
with epilepsy and LD is sparse and contradictory.
Rutter et al. (1970) in the Isle of Wight survey demonstrated clearly that there 
was an association between epilepsy and psychiatric disorder. They showed that while 
psychiatric morbidity was 6.6% in a control group of children, the figure rose to 
11.6% with physical disorder and 34.3% with brain disorder. Further, in comparing 
two groups with brain lesions they also demonstrated that psychiatric co-morbidity 
was higher in the group with seizures (58.3%) than in the group that was seizure-free 
(37.5%).
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l:yman et al. ( l%9) studied mentally handicapped populations in three large 
hospitals in the USA and reported that hyperactivity, aggression, problems with 
speech, and ditViculties with eating/dressing were more common among 
institutionalised subjects with epilepsy and mental handicap. Capes and Moore (1970) 
compared 2 1 factors of maladaptive behaviour between 229 subjects with epilepsy 
and a non-matched control group of 511 in Arizona Children’s Colony, and found 
significant ditYerences in 16 out of 21 factors -  hyperactivity, aggression and 
withdrawal in particular
In another large population-based study, Lund (1985a) identified 324 mentally 
retarded adults in the county of Aarhus in Denmark, five of whom did not meet WHO 
criteria for mental retardation, and 17 of whom (mainly younger individuals living in 
the community) refused to take part. 302 individuals with mental retardation were 
examined with regard to epilepsy and psychiatric disorder using the Medical Research 
Council (MRC) schedule of handicaps, behaviours and skills (MBS) (Wing L., 1980) 
and a schedule of psychiatric symptoms (Lund L , 1985b). In 55 (18.2%) epileptic 
seizures had occurred some time during their lives, and in 25 (8.3%) in the last year 
before investigation (active epilepsy). Increasing degree of mental retardation was 
associated with an increased prevalence of epilepsy and psychiatric disorder. 
Psychiatric disorders were strongly correlated with epilepsy, with 56% of mentally 
handicapped persons with active epilepsy sulTering from a psychiatric disorder, as 
compared with 26% of those without seizures, a statistically significant difference. 
However, this study failed to use a matched control group, which may in part explain 
these findings.
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On the other hand, Corbett in the Camberwell Study (1981) did not llnd any 
significant difference in the frequency of behavioural disturbance, in comparing 
children with mental handicap with/without epilepsy. This latter study included 
patients in the community and in both hospital and non-hospital care. This finding 
was also supported by Deb et al. (1987) who failed to find any difference in the rates 
of maladaptive behaviour when they compared adults with epilepsy with a matched 
group of adults without epilepsy in a mental handicap institution. Similar findings 
were also reported in a study by Espie et al. (1989) that compared behaviour among 
people with mental handicap and epilepsy who lived in the community and attended 
day centres.
Deb and Hunter in a series of papers (1991 a,b,c) reported studies of 
maladaptive behaviour, psychiatric illness and personality disorders in subjects with 
mental handicap and epilepsy. They compared 150 subjects with mental handicap and 
epilepsy with a similar number of subjects with mental handicap but no epilepsy, 
using the Profile of Abilities and Adjustment Schedule for maladaptive behaviour. 
They found that while over half the total study population showed some severe 
maladaptive behaviour, the problems in the epilepsy population were slightly more 
severe. The difference was not statistically significant (1991a).
In summary therefore, while there is little doubt that patients with LD and 
epilepsy have high rates of psychiatric co-morbidity (as high as 90% in some series), 
it is not entirely clear if an increased burden of psychiatric disorder attributable to 
epilepsy exists in this population.
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3.3.2. Patterns of Psychiatric Co-Morbidity in Subjects with LD and Lpilcpsy
Attempts to classify psychiatric disorders in children with LD and/or active epilepsy 
have been few. Hyperactivity, rage, antisocial behaviour and schizophrenia-like 
psychosis have all been reported, particularly in connection with temporal lobe 
epilepsy (Rutter, 1970; Caplan, 1991).
In Lund’s series (1985b), the author using previously modified (for mental 
retardation) versions of Feighner’s criteria and DSM III criteria identified an overall 
prevalence of 27.1%, which is lower than most other studies. When patterns of 
psychopathology were compared, apart from a generic behaviour disorder category 
(10.9%), psychoses of uncertain type (5%), dementia and early childhood autism 
(3.6% each), neurosis (2%), schizophrenia (1.3%) and affective disorder ( 1.7%) were 
all identified. No cases of alcohol or drug abuse were identified in this study
In Deb and Hunter’s series ( I99Ia,b,c) mild to moderately impaired subjects 
with good communication skills who were positive on the PAA schedule for 
psychiatric illness were interviewed using the Present State Examination interview 
schedule, while those with severe mental retardation were observed and information 
collected from their medical notes and from the carers. Psychiatric diagnosis was 
made based on DSM-III-R criteria (Deb & Hunter, I99Ib). Psychiatric illness was 
diagnosed in almost one-quarter of the population studied, but was commoner in the 
non-epilepsy group than in the epilepsy group, the difference being statistically 
significant.
90
There w ere however, dislinel patterns of psychiatrie disorder reported in the 
epilepsy group. I or example, changeable mood -  although this did not reach 
statistical significance. Other ditYerences of interest were the relative absence of 
bipolar disorder in the epilepsy group and the relative over-representation ofnon- 
atfective psychoses in the epilepsy group, for which there is epidemiological evidence 
(.lalava & Sillanpaa, 1998). There also were differences between community and 
hospital populations -  behaviour such as irritability progressing to aggression being 
more commonly reported in the hospital population.
I hey also compared mild to moderately handicapped people with epilepsy and 
w ithout, using the Standardised Assessment of Personality and the T-L Personality 
Behaviour Inventory. They found that 26% of the entire cohort had an abnormal 
personality score according to the SAP schedule, and a significant proportion of these 
were personality disorders. The vast majority of those with high SAP scores were in­
patients. However, there were no statistically significant differences between epilepsy 
and non-epilepsy groups (Deb & Hunter, 1991c).
In a representative population-based study Steffenberg et al. (1996) identified 
98 children with MR and active epilepsy, from among 48,873 children living in 
Goteborg (Sweden), through multiple search procedures. The children were between 
8-16 years of age, and of 98 identified, five had died and three declined to be 
examined. An experienced child neuropsychiatrist examined 90 children by 
interviewing the mother or principal caregiver using the Handicap, Behaviour and 
Skills Schedule, each interview lasting between 60-150 minutes. Further, each child 
was observed for 30 minutes. Other scales used in this study included the Childhood
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Autism Rating Scale and Autistic behaviour C hecklist, Asperger Syndrome 
Diagnostic Checklist, and Cilobal/Social and Occupational Function Assessment 
Scales (GAPS & SOFAS). In addition to co-morbid psychiatric disorder, cerebral 
palsy, visual and hearing deficits and self-injurious behaviour were all rated for.
Fifty three (57%) of 90 children received at least one psychiatric diagnosis. 
Autistic Disorder was the most common diagnosis (24/90); followed by Autistic IJke 
Condition (10/90); Attention Deficit Hyperactivity Disorder (6/90); Asperger 
Syndrome, Autistic Traits and Overanxious Disorder (3/90 each); stereotypy/habit 
disorder, elective mutism, conduct disorder, chronic motor tic disorder (1/90 each). 
28(31%) of children in this sample had self injurious behaviour. Interestingly, a 
further 30 of these 90 children, many with profound mental retardation and severe 
communication difficulties, were classified as “uncategorisable conditions and 
dementias”, and only 5 of 90 subjects were declared normal. Medical syndromes 
(excluding epilepsy syndromes) were observed in 11 subjects, 8 of who were in the 
Autistic Disorder (AD) group, none in the Autistic Like Condition (ALC) group and 3 
in the non-AD/ALC group, this difference being statistically significant (p<0.001 ). 
Psychiatric co-morbidity was generally high, with a number of patients meeting more 
than one diagnosis, although in some conditions such as ALC, Asperger and Autistic 
Traits, diagnostic criteria such as DSM were not used. This study also showed that 
AD in particular, was associated significantly with temporal lobe epilepsy. 
Interestingly too, the percentages of psychiatric disorder (AD for e.g.) were not 
significantly different between mild mental retardation (MMR) and severe mental 
retardation (SMR) groups, which is different from other series (Wing, 1993).
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The aiilhors ol (his study have argued elsewhere (SlelTenberg U & SielTenberg 
S, 1999) that that the low prevalence of psychiatric disorder (57%) may be down to 
the very large proportion (almost a third) classified as “unrecognisable condition and 
dementia”. Further, the finding that AD was by far the commonest psychiatric 
disorder, while not entirely commonplace, is supported by the strong associations 
between autism and epilepsy reported elsewhere (Olsson et al., 1988). The use of 
specific instruments targeted towards the identification of AD in this study, which has 
not been done in other studies, may explain this finding at least in part.
3.3.3. Neuropsychiatrie epidemiology at the interface between epilepsy and LD; 
summary of current studies
As reviewed herein, the evidence about the relative frequency of psychiatric disorder 
in learning disabled populations with epilepsy is both confusing and contradictory. 
Further, there are a number of specific issues that have not been addressed before.
First, what is available in the main is prevalence data from hospital, institution 
and a few community-based studies. However, while data of this nature inform about 
the public health burden of such co-morbidity, it do not help in making scientific 
inferences about important factors such as causality and risk. Good analytical 
epidemiology is required for this, and can only be achieved through well-designed 
and conducted cohort and case control studies, based on the population.
Second, although specific behaviour patterns have been observed, few studies 
have compared generic and epilepsy specific behaviours in these populations. The
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study of generic psNehopalholog> is important Ibr purposes of comparing the learning 
disabled population with eo-morbid epilepsy, with learning disabled populations 
without epilepsy, and indeed non-learning disabled populations in the community. On 
the other hand, as demonstrated by Steffenberg et al. (1996), the use of instruments 
that can assess for specific behaviours such as the Autistic Spectrum Disorders, 
aggression, psychosis etc , is likely to yield rich data, and provide greater 
understanding about the nature and mechanisms of psychopathology at this interface. 
Apart from being of heuristic interest, this data has practical implications as well, with 
psychiatric and psychological interventions for example being behaviour specific to a 
very great extent.
Third, it is important to note that a number of the studies have used 
instruments that have not been specifically developed either for epilepsy or for LD. In 
recent times various influential groups have been working towards building consensus 
in the choice of outcome measures (Kerr & Espie, 1997 for e.g.). Appropriate 
measures include -  datasets for aetiology and seizure type, seizure frequency, 
behaviour, social interaction, patient independence, contact and participation, general 
well being and quality of life including carer’s quality of life. It has been suggested 
that a range of standard outcome measures he used in researching this interface, and 
that these should he sensitive to change, include information on individual 
characteristics, and allow for variables such as treatment compliance and 
environmental con founders. In addition, there may he room for new technologies such 
as direct observation through computer systems and video recordings.
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lourlh, ihcrc is considerable debate about the choice ol psychopathology 
measure. In a recent review and position statement lispie et al. ( 1997) have short­
listed several measures, and compared their relative attributes. I he Psychopathology 
Instrument for Mentally Retarded Adults (Senatore, 1985), the PAS-ADD (Moss et al, 
1993), Aberrant Behaviour Checklist (Aman et al., 1985)), Psychosocial Behaviour 
Scale (Espie et al., 1988), Adaptive Behaviour Scales- Part Two (Guess et al., 1990), 
Attention Deficit and Hyperactivity Questionnaire (Boudreault et al., 1988), Society 
for the Study of Behavioural Phenotypes (SSBP)- Postal Questionnaire (O’ Brein,
1996) are all instruments that have been used fairly extensively in this area. The 
precise choice of instrument(s) will have to be made following a careful review of the 
study objectives, balanced against the relative abilities and characteristics of these 
instruments, and pragmatic concerns. In addition to this list above, there may be some 
justification in including a scale for autistic behaviours following on from 
Steffenberg’s influential paper (1996), and a structured carer report for 
psychopathology such as the Neuropsychiatrie Inventory (Cummings et al., 1994). 
Such structured carer-rated information, which has not been ascertained in many 
previous studies, may be potentially valuable in developing interventions for LD &  
epilepsy.
Fifth, it has been pointed out that LD can be a state dependent phenomenon, 
and thus potentially reversible (Besag, 2001). State dependent LD can broadly be of 
two types -  drug- and epilepsy- induced. Drugs like phenobarbitone, primidone, 
benzodiazepines and sodium valproate are known to cause cognitive deficits (the 
latter producing an encephalopathy) resulting in state dependent LD. On the other 
hand, epilepsy induced state dependant LD may result from the ictal effects of sub-
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clinical sci/iircs. local discharges, posl-iclal stales, non-convulsivc status and the 
syndrome ol lilectrical Status lipileplicus in Sleep (ESES). While state dependent LI) 
may only form a small proportion of LD cases, its reversible nature dictates that it is 
examined for and carefully excluded in LD studies including population-based 
studies. Screening instruments sensitive to these phenomena thus need to be 
developed, and incorporated into the package of diagnostic measures used.
Finally, in an ideal world, cohorts/registries of LD should be established 
prospectively, and include each patient who receives LD diagnosis. Prospective 
follow-up of such a cohort for co-morbid epilepsy and/or psychopathology, and 
nested case-control studies for risk factors, aetiology, biological and clinical 
correlates, quality of life, prognostic indicators, treatment response and other 
measures of outcome would reveal valuable epidemiologically valid information at 
this interface. The use of standard outcome measures as outlined previously would of 
course, greatly aid the research process. However, this approach is tedious, expensive 
and long drawn out. And not surprisingly the gamut of research thus far has come 
from Northern Europe, where health care systems include the establishment and 
maintenance of registries.
In conclusion, neuropsychiatrie epidemiology at the interface between LD and 
epilepsy is poorly researched. A better understanding about this interface, would no 
doubt lead to focussed interventions in the community and resultant improvements in 
health care for learning disabled populations with co-morbid epilepsy (Beber et al., 
1999 for e.g.). The development of consensus (Kerr & Espie, 1997), the identification 
of reliable and valid outcome measures and development priorities (Espie et a l,
1997); detailed studies based in the community (Steffenberg et al., 1996); as well as
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tcccnl comprehensive reviews of 1.1) and epilepsy (Sillanpaa et al., 1999), have set the 
stage for high quality research elTorts at this interlace that must Ibllow in the years to
come.
3.4. Neuropsychiatrie Epidemiology in Adult Non-Learning Disabled 
Populations with Epilepsy
3.4.1. A Review of Large Hospital and Institution-Based Studies
A number of studies in this area have been hospital/institution-based. While the strong 
selection bias in these studies makes the extrapolation of their findings difficult to the 
majority of patients with epilepsy, who live in the community, the contribution of 
these studies to the current understanding of psychopathology in epilepsy has been 
invaluable and they are briefly reviewed here.
Currie et al. (1971 ) surveyed 666 patients recorded to have features of 
temporal lobe epilepsy in the hospital diagnostic index and the records of the 
neurology, neurosurgery and EEG departments. They found 375(56%) to be normal, 
127(19%) to be anxious, 71(11%) to be depressed, 47(7%) to be aggressive, 41(6%) 
to be obsessive and 38(6%) to have a severe disturbance of affect.
Smith et al. (1986) studied 622 patients in a nation-wide co-operative study 
spanning 10 Veterans Administration Medical centres in the USA, using a battery of 
neuropsychological testing procedures. The majority of patients were not on 
anticonvulsant drugs at the time of initial testing, and the few who were, had sub-
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Ihcrapciilic levels on measuremenl. They louiul lhat patients with epilepsy scored 
significantly and consistently below the level ol the 74 control subjects on all but 
three behavioural measures. Differences reaching statistical significance were found 
on tests of motor function (Finger Tapping, Pegboard, Colour Naming), cognitive- 
attention (Digit Symbol, Discrimination Reaction Time, Word Fluency), and subtests 
of the Profile of Mood States (tension, depression, vigour and confusion). These they 
felt provided a profile of behavioural characteristics of unmedicated patients with 
epilepsy.
Gureje (1991) evaluated 204 unselected patients with epilepsy attending a 
neurological clinic using the Clinical Interview Schedule (Goldberg et al., 1970). 37% 
emerged as psychiatric cases; of these 53% had a neurosis, 29% had a psychosis, and 
7% were diagnosed to have a personality disorder.
Mendez et al. (1993) conducted a retrospective investigation of neurology 
clinic attenders. They found that interictal schizophrenic disorders occurred in 
149(9.25%) of 1,611 patients with epilepsy as compared to only 23(1.06%) of 2,167 
patients with migraine. They went on in the latter part of the study to compare 62 
epilepsy and schizophrenia patients with 62 patients who had epilepsy alone on 6 
seizure variables and 62 patients with schizophrenia alone on 10 psychosis variables.
The epilepsy and schizophrenia group was found to have a later age of onset 
of epilepsy with more complex partial seizures, more patients with auras and fewer 
patients with generalised epilepsy. Except for increased suicidal behaviour, patients 
with epilepsy did not differ from controls on psychosis variables; however psychotic 
symptoms often emerged with increased seizure activity. They felt that the data
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supported a distinct association ol schizophrenic disorders w ith epilepsy, particularly 
w ith seizures emanating from the temporal limbic system.
Manchanda et ai. (1996) studied 300 consecutive patients with refractive to 
treatment, admitted to for evaluation of their candidature for epilepsy surgery over a 
six year period. Of these 231 had a temporal lobe focus, 43 had a non-temporal lobe 
focus and 26 generalised and multifocal seizure onset. 142 (47.3%) emerged as 
psychiatric cases based on DSM Ill-R criteria. A principal axis 1 diagnosis was made 
in 88(29.3) patients. Anxiety disorders (10.7%) and Schizophrenia (4.3%) were the 
most common axis I diagnosis. Dependent and avoidant personality traits were 
frequent (18%) although patients rarely fulfilled criteria for a personality disorder.
3.4.2. Population-based Studies
One of the earliest investigations to be carried out was that of Pond and Bidwell 
(1960), who surveyed patients from 14 general practices in the South East of England. 
They found that 29% of 245 patients had psychological disorders of sufficient severity 
to seek treatment, i.e., conspicuous morbidity. The main criticism levelled against this 
study is its use of a social worker rather than a trained mental health professional, and 
a lack of standardised techniques to assess patients with epilepsy for psychiatric co­
morbidity. The strength of this study however lies in its recognising, four decades 
earlier, the importance of an epidemiological approach.
Gudmundsson (1966) personally surveyed 987 patients with epilepsy living in 
Iceland and reported that 512(52%) had personality changes of various kinds. Of
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Ihcsc 271(27.5%) were described as i\nid. 73(7.4%) as ixolhymic and I68( 17.0%) as 
neurotic. More men were ixoid and more women neurotic. While Gudmundsson, 
unlike Pond, personally examined every subject, the method of measurement, clinical 
terminology and classification used have few parallels today, and no attempts were 
made to reduce bias. However, the high proportion of subjects with behavioural 
changes in this community-based population is striking and worthy of note.
Edeh and Toone (1987) conducted a survey in general practises in South 
London. They interviewed 88 adult patients with epilepsy drawn from general 
practises in the area, using the Clinical Interview Schedule, and reported that 48% 
emerged as psychiatric cases. They also found that while patients with TLE and Focal 
non-TLE did not differ in terms of psychiatric morbidity, both groups were 
significantly more impaired than patients with primary generalised epilepsy. The 
techniques of ascertainment used in this study are commendable. Subjects with 
epilepsy underwent both CT scans and EEC tests, in confirmation of their diagnosis. 
The study also used a validated instrument for common mental disorder, the CIS-R. In 
criticism, however, it must be said that the study failed to examine matched 
population-based controls, psychopathology specific to epilepsy was not examined. 
And while cases with psychosis were identified, no validated diagnostic instrument 
for psychosis was administered, the ClS-R being a validated instrument for common 
mental disorder alone.
Cockerell et al. (1996) conducted a nation-wide survey of acute psychological 
disorders (APD) in patients with epilepsy using the British Neurological Surveillance 
Unit. 64 incident cases were ascertained over a period of one year. Thirty-one were
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considered to have API) due lo ictai/posl-iclal aeli\ il\ and 33 were inler-ielai. In 30% 
of eases the API) was reported by the referring physician lo be secondary to an Anti 
lipileptic Drug. The drugs most commonly implicated were carbamazepine, 
lamotrigine and vigabatrin. The broad psychiatric categories diagnosed included 
Delirium (25%), Schizophreniform (31%), Affective (30%), Delusional (5%) and 
other disorders (9%). The findings of this study are of interest as it gives us crude 
incidence figures of acute psychiatric disorder in epilepsy and highlights the 
importance of anti-epileptic drugs in precipitating co-morbid psychiatric illness in 
epilepsy. However, as the study used a reporting system, rather than a population 
based cohort, the results cannot be used to generate population-based incidence 
figures, or be generalised.
Jacoby et al. (1996) retrospectively examined the clinical course of epilepsy in 
subjects with epilepsy, and the associations between seizure severity, psychological 
morbidity and disablement. Subjects were drawn from the records of 31 general 
practitioners in the UK, and 71% of all subjects responded, when contacted. Twelve 
percent of the total sample had a past psychiatric history. Of the 696 respondents 46% 
reported being in a 2-year remission, and 51% reported being seizure free in the past 
year. Overall 25% of subjects were classified by the Hospital Anxiety Scale as being 
anxious and 9% as being depressed (total scores >11 on the relevant subscales). A 
clear relationship was observed between the level of current seizure activity and the 
subject’s psychological well being. Current level of seizure activity also influenced 
subjects’ perceptions about the impact of epilepsy and the treatment on their daily 
lives. Seizure severity also influenced life fulfilment but not material fulfilment. Both 
anxiety and depression scores correlated with current seizure activity (p<0.001). In
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(he nuillivariate analysis, current seizure activity was the only clinical variable that 
explained the most variation in psychosocial functioning. Other variables such as age 
of onset and duration of epilepsy were also important in explaining variation in 
depression scores. Age was also important in explaining the variation in the stigma 
scales.
In a fiirther paper arising from the aforementioned study, Baker et al. (1996) 
examined the relationship between clinical, demographic and psychosocial variables. 
Each individual who took part in the study completed the Liverpool seizure severity 
scale, impact of epilepsy scale, adverse drug events profile, hospital anxiety and 
depression scale, sigma scale (for the assessment of perceived stigma) and 
information about seizure variables (frequency, age of onset, duration etc.). Both 
anxiety and depression on the HADS were good predictors of impact in the 
multivariate analysis. Seizure frequency was a significant predictor of scores on the 
anxiety and depression scales and on the impact and stigma scales. The amount of 
variance explained by seizure frequency was negligible in comparison to that 
explained by the psychosocial variables. However, when patients who had seizures in 
the past 12 months were examined, seizure severity became an important predictor of 
depression, anxiety and impact scores.
Jalava and Sillanpaa (1996) examined a prospective population-based cohort 
(mean follow-up of 35 years) of patients with epilepsy since childhood, for co-morbid 
somatic, psychosomatic and psychiatric disorders. The main advantage of this study 
was that patients had been included in the register as children, and thus naturalistic 
follow up data was available. In comparison with random controls, patients with
02
epilepsy had a Idiir-lbid risk of psychiatric disorders or combinations of somatic, 
psychosomatic/psychiatric disorders. Thus patients with childhood onset epilepsy 
demonstrated a higher risk for psychiatric/psychosomatic disorders and this appeared 
to be related to epilepsy and not AED administration.
This is perhaps the only cohort study of psychiatric co-morbidity in epilepsy 
and the findings have great relevance. The results clearly indicate that subjects with 
epilepsy are at higher risk of developing co-morbid psychiatric illness, when 
compared to population-based controls, and indicate the need for greater provision for 
psychiatric treatment in primary care settings for epilepsy. However, as individual 
cases were not ascertained in any systematic way, it is possible that the findings do 
not represent the true extent of co-morbidity, subtle nevertheless disabling forms of 
psychopathology, or those not requiring medical attention or admission, being missed. 
This is of relevance, as subtle forms of psychopathology that often do not meet 
conventional diagnostic criteria, may be over-represented in epilepsy.
Bredkjaer et al. (1998) conducted a record linkage study in Denmark between 
a sample of people with epilepsy from the National Patient Register and the Danish 
Psychiatric Register. They found that the incidence of non-organic non-aflfective 
psychoses including personality disorders that were broadly within the Schizophrenia 
Spectrum, was significantly increased for both men and women with epilepsy, even 
after excluding all people diagnosed as suffering from a learning disability or 
substance misuse. The standardised incidence ratio was significantly increased for the 
entire schizophrenia spectrum (/?<10 -8), non-affective psychosis (/?<10-8) and 
schizophrenia alone (/xO.OOOl).
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In the absence ol long-lcrni prospeclivc data, Ihis study based on national 
registers provides evidence that, disorders in the schizophrenia spectrum, are clearly 
over-represented in epilepsy The study enabled the calculation of more sophisticated 
epidemiological indices, such as standardised incidence ratio that have not been 
estimated in previous studies. However, the methodological limitations of reliance 
upon a case-register, i.e., the lack of standardisation of ascertainment methods, both 
for epilepsy and psychoses, and the exclusion of more subtle cases, or those not 
requiring admission, do apply here.
Stefansson et al. (1998) conducted a case-control study comparing the 
prevalence of non-organic psychiatric disorders among patients with epilepsy, and 
controls with other somatic diseases, both groups being of normal intelligence. The 
two groups were drawn from a disability register of the State Social Security Institute 
in Iceland. 241 index cases meeting inclusion criteria were identified in this way and 
the ratio between subject (epilepsy) and control (somatic illness) cases was 1:2. 
Psychiatric diagnosis was present among 35% of cases as compared to 30% of 
controls, the difference not being statistically significant Psychiatric disorders were 
however significantly more common in men with epilepsy than women, the difference 
being due to a significantly higher rate of psychosis, particularly schizophrenia or 
paranoid states among men.
O’Donoghue et al (1999) examined 169 subjects with epilepsy in two large 
general practices in the UK. The Hospital Anxiety and Depression Scale was used to 
diagnose anxiety and depression and the Subjective Handicap in Epilepsy scale to 
assess disablement. Seizure frequency was assessed but not seizure severity. An
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iissDciiUion was established between seizure I'requencN and subjective handicap; the 
less IVequent the seizures, the lower the level of subjective handicap. About half of all 
patients with more than one seizure per month were severely handicapped. A 
comparison between more and less than one seizure per month was significant on four 
of the scales.
Thirty four percent of subjects had consulted their GP at some time for 
psychiatric symptoms, depression (23%), anxiety (6.5%) and overdose (6%) being the 
commonest symptoms. The prevalence of recorded psychiatric symptoms in the 2 
years before the study, in patients with active epilepsy was 20%, in those with 
remitted epilepsy on treatment was 18%, and in the remitted oIT treatment group the 
prevalence was 17%. About one-half of patient having more than one seizure per 
month and one-fifth of those in remission were classified as having definite anxiety or 
definite depression using the HADS. Table-1 summarises the key epidemiological 
studies of neuropsychiatrie co-morbidity in epilepsy.
Table L  Important Epidemiological Studies of Neuropsychiatrie Co-Morbidity in 
Epilepsy.
Y e ^ 1 n vestigators/Country Results Comments
Study in 14 general practices
I960 Pond and Bid well (UK)
29% of 245 patients had 
significant morbidity
Conducted by Psychiatric Social 
Worker
Instruments not standardized
1966
1
Personal survey by expert
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(iiidmiindsson
(Iceland)
1987 Edeh and Toone (UK)
1996 Cockerell et al. (UK)
1996 Jacoby el al. (UK)
512(52%) or987 patients 
had personality changes
48% of 88 patients 
emerged as cases
64 incident cases of acute 
psychological disorder on 
AED institution
Large community-based 
study -  696 subjects
25% classified as anxious
and 9% as depressed
Instruments and diagnosis not 
standardized
Primary care-based
Sophisticated case 
ascertainment
Standard instruments but not
epilepsy specific
Nation wide survey
Relied on reporting system
Crude data on incidence -
cannot be generalised
Ascertainment of epilepsy based 
on GP records
Seizure severity and age 
at epilepsy onset were 
significant predictors of 
depression, stigma and 
marital status.
HADS used with cut-off scores
of 11 to identify psychiatric
caseness
Large sample, sophisticated 
statistical techniques
However instruments employed 
including HADS have not been 
validated in epilepsy 
populations
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1996 Baker et al. (UK)
[examined the relationship 
between seizure severity 
and psychosocial 
variables
Both HADS anxiety and 
depression- good 
predictors ot'impact
Seizure frequency 
significant predictor of 
HADS scores and impact 
and stigma scales
Psychosocial variables 
explain greatest 
proportion of variance
Patients with seizures in 
the past 12 months; 
seizure severity important 
predictor of psychosocial 
variables.
Same large sample as .lacob\ ct 
al. above: criticisms about 
ascertainment as above
Measurement of psychosocial 
variables by widely used 
instruments- not necessarily 
epilepsy specific
Absence of gold-standard 
measures except seizure severity
HADS not diagnostic of 
psychiatric disorder although it 
is a validated measure of 
psychological morbidity
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19%
Jalava and Sillanpaa 
(Finland)
1998
Bredjkaer et al. 
(Denmark)
patients with epilepsy- 
tbur-tbld risk of'somatic, 
psychosomatic/ 
psychiatric disorder in 
combination compared to 
population-based controls
Results related to epilepsy 
and not AED 
administration
Incidence of 
Schizophrenia Spectrum 
psychoses significantly 
increased for both men 
and women with epilepsy
Standardised incidence 
ratio for the entire 
schizophrenia spectrum 
(p<10-8), non-affective 
psychosis (p<10-8) and 
schizophrenia alone
(p<0.0001).
Prospective cohort study with 
35 year follow-up (only cohort 
study to date)
Results clearly indicate that 
subjects with epilepsy are at 
higher risk of developing co- 
morbid psychiatric illness
Record linkage study between a 
sample of people with epilepsy 
from the National Patient 
Register and the Danish 
Psychiatric Register
Enabled the calculation of 
sophisticated epidemiological 
indices not estimated in 
previous studies
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1998
Stefansson et al. 
(Iceland)
1999
O’Donoghue et al. 
(UK)
Psychiatrie diagnosis in 
35% of 241 epilepsy 
cases as compared to 30% 
of controls, the difference 
not being statistically 
significant
Significantly higher rate 
of schizophrenia among
men.
Between one-third and 
one-half of all patients 
diagnosed to be ‘cases’ on 
HADS
One third of patients with 
active epilepsy severely 
handicapped by their 
condition
Patients with epilepsy, and 
controls with other somatic 
diseases, both groups being of 
normal intelligence drawn from 
a disability register of the State 
Social Security Institute
Good ascertainment: screening 
and examination by specialists
Association between 
seizure severity, 
frequency and subjective 
handicap
Psychological morbidity
Measurement of seizure severity 
not well standardised
Associations between seizure 
severity/frequency, 
psychological morbidity and 
subjective handicap were not 
studied
Lack of sophistication in 
statistical methodology
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poorly recognised hy 1 IADS used with cut-off scores
OF s of 10/11 for definite and 7/8 for
borderline
SF-36 good generic measure of
disablement used here
3.4.3. Summary of Findings; Neuropsychiatrie Epidemiology of Epilepsy
Psychiatric disorders are common in epilepsy, and encompass the spectrum of 
conditions from those that are a direct consequence of epileptogenic activity, to others 
that are merely co-morbid.
There is considerable evidence from epidemiological research to suggest that 
the psychoses are greatly over-represented in epilepsy; the evidence for an over­
representation of other psychiatric disorders is less compelling.
While hospital-based data indicates the presence of epilepsy specific 
psychopathology, this has never been examined in the epidemiological setting.
Further, instruments such as the NBl that are supposedly sensitive to epilepsy specific 
psychopathology have not been validated in this setting.
Systematic population-based research using reliable methods of ascertainment, 
and controls matched for age, sex, disability and ethnicity, based on the I LAE 
classification of neuropsychiatrie disorders in epilepsy, incorporating instruments of
10
psychiatrie research as well as scales lor sei/.iire se\ erit\ and disahlenient need to he 
conducted in the future.
3.4.4. Classification of Psychiatric Co-morbidity in Epilepsy
3.4.4.1. Why a Separate Classification?
The primary reason to develop a system of classification is to ensure that specialists 
around the world have no difficulty in communicating scientifically with one another. 
This is perhaps more important in psychiatry, a speciality that relies on clear and 
concise descriptions in the absence of diagnostic tests. A reliable system of 
classification that can be applied across the board is essential for clinical and 
scientific progress.
The classification of psychiatric disorders in epilepsy has always been 
controversial. There are two main schools of thought. First is that the existing systems 
of classification in psychiatry, the ICD, now in its tenth edition and the DSM, in its 
fourth edition, have made adequate provision for “organic” conditions like epilepsy, 
and further sub-systems of classification would only add to their complexity. Second, 
most often voiced by neuropsychiatrists with an interest in epilepsy, that the existing 
systems of classification are hopelessly inadequate as far as neurological disorders in 
general and epilepsy are specifically concerned.
The question “are psychiatric disorders commoner in epilepsy?” has not been 
answered convincingly to date. While there seems little room to doubt that the
I I I
psychoses are over-represented in epilepsy perhaps ten limes as common as in the 
general population, the evidence with regard to common mental disorders is tar Irom 
clear. This is largely due to the paucit> ol epidemiological studies of psychiatric co­
morbidity in epilepsy (Krishnamoorthy, 2001 ; 2002).
One criticism that has been put forth about the studies that have been done is 
that the instruments used are most often generic to mental disorder rather than specific 
to epilepsy. Yet, in contrast to this, a number of hospital/clinic-based studies have 
drawn attention to psychopathology that is specific to epilepsy including personality 
change, psychoses, affective disorder, and phobic-anxiety disorders (Trimble, 1991 ; 
Blumer, 2000).
Unfortunately, instruments such as the Neurobehavioral Inventory for 
Epilepsy (modified version of the Bear-Fedio scale), developed specifically for 
epilepsy (Blumer, 1995), have not been subject to rigorous psychometric testing and 
have failed to gain widespread acceptance. The failure to consistently demonstrate an 
over-representation of psychiatric disorders in epilepsy when compared to some other 
chronic illness groups, in several studies, may thus be due to the use of inappropriate 
instruments that are not sensitive to epilepsy related neuropsychiatrie disorders, rather 
than a difference in prevalence (Krishnamoorthy, 2001 ; 2002).
Were we to accept that neuropsychiatrie disorders specific to epilepsy exist, 
the reasons to develop a system of classification become immediately obvious. Indeed 
it could be argued that such a classification framework is necessary for any
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prospcclivch designed investigations ol epilepsy speeille disorders in coninuinity- 
based studies.
3.4.4.2. What are the Neuropsychiatrie Disorders Specific to fpilepsy, and How could 
they be Classified?
The neuropsychiatrie disorders specific to epilepsy represent the gamut of 
neuropsychiatry. Included are the so-called organic mental disorders such as post-ictal 
confusional states and complex partial status with psychopathological manifestations; 
personality changes (the Gastaut-Geschwind syndrome of temporal lobe epilepsy, and 
the labile personality of Juvenile Myoclonic Epilepsy); a spectrum of psychoses with 
varying intensity, features and manifestations depending on the temporal relationship 
with seizure(s) (Trimble, 1991); and a spectrum of neuroses with predominantly 
affective features (Blumer, 20(X)). These disorders are also inexorably linked to their 
relationship with the seizure(s) per se (pre-ictal, post-ictal, inter-ictal and perhaps 
peri-ictal); their relationship to the EEG, (for example. Forced Normalization of 
Landolt and alternative psychosis of Tellenbach) (Krishnamoorthy & Trimble, 1999); 
and their relationship to anti-epileptic drug (AED) therapy (the AED induced 
neuropsychiatrie disorders) (Trimble, 1998). Thus any classificatory system will need 
to take all these factors into consideration.
Further, it is important to acknowledge that patients with epilepsy like all 
patients with chronic medical illnesses have greater vulnerability to co-morbid 
psychiatric disorders that match existing descriptions in ICD-10 and DSM-IV. It 
would serve little purpose to try and re-classify these disorders when associated with
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epilepsy, i he jiicigemenl about whether to record the illness in the given patient as a 
co-morbid disorder or as an epilepsy specific disorder would he best le I t to the 
clinician dealing with that individual case. It also goes without saying that such a 
classificatory system should link closely with the I LAE Classification of Epilepsies 
and Epileptic Syndromes.
The inclusion of non-epileptic attack disorder (NEAD) in such a classification 
is rather more controversial, as there is a growing understanding that NEAD is, in a 
number of subjects, the manifestation of a much wider spectrum of psychopathology 
than that specific to epilepsy (Brown & Trimble, 2000).
There is little doubt that classifications grounded in aetiology and 
pathophysiology are an ideal that must be aspired for in the long term. However, our 
understanding of causation and its mechanisms in psychiatry, even the 
neuropsychiatry of epilepsy, is fairly rudimentary. And much ground needs to be 
covered before we can move with any certainty towards such etiological models. 
Further, etiological systems of classification require specialised knowledge and access 
to supportive investigative techniques. Both of these are unavailable in a number of 
settings, particularly in the developing world. Classificatory systems that aim to he 
culture-free and acceptable across the board would do well to adopt a descriptive 
approach based on a good history and clear clinical descriptions that mirrors good 
clinical practice around the world, and makes few demands in terms of specialist 
expertise or investigation (Krishnamoorthy, 2000a).
3 A A3. Towards a System of Classification -  The ILAE Proposal.
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While there are dilTerent ways ol classilying mental states, the clinical approach ol 
observing patients over a prolonged period of time is by tar the most important. 
Further, while there is good empirical evidence to suggest that the psychiatric 
disorders of epilepsy are clinically distinct, they do not find a place in the current 
classificatory systems in psychiatry, such as ICD-10 and DSM-IV. Besides, 
operational rules that exist ensure that they are subsumed within categories (organic 
mental disorder for example), in a way that may neither be appropriate nor accurate. 
As these disorders are phenomenologically distinct, and may respond to specific 
therapeutic measures (IDD. Blumer, 2000 for example), this is clearly unsatisfactory . 
Modem efforts must be directed at developing a more comprehensive and acceptable 
system of classification, for psychiatric disorders in epilepsy. With this in mind the 
First Psychobiology Commission of the International League Against Epilepsy 
(ILAE) established a sub-commission to work towards the development of a 
classificatory system. The work of this sub-commission is contained in a report 
submitted to the ILAE with a view to publication in Epilepsia, which was the result of 
extensive deliberations, and is reproduced herein with the kind permission of the 
commission chair. Prof. MR Trimble.
3.4.4.4. The Problem of Co-morbidity
Patients with epilepsy, similar to patients with other chronic medical illness, have a 
significant liability to co-morbid psychiatric disorders (Krishnamoorthy, 2002a). 
These co-morbid disorders do not usually have specific distinguishing features, which
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scparalc Ihcm from those seen in other nieiheal illnesses or those seen in the 
community.
Included here are anxiety and phobic disorders, minor/major depression, 
obsessive-compulsive disorder etc. In addition, patients with epilepsy also suffer from 
co-morbid major psychiatric disorders such as bipolar-atTective disorder and 
undifferentiated forms of schizophrenia. Co-morbid mental disorders therefore should 
be classified using conventional criteria.
Suggestion: Ignore the presence of epilepsy in making the diagnosis to prevent 
the imposition of the “Organic” category in these conventional psychiatric 
classifications.
3 .4.4.5. Psychopathology as a Presenting Feature of Epileptic Seizures
Psychiatric symptoms are often a feature of the seizure itself Auras of simple partial 
seizures include psychiatric symptoms like anxiety and panic, hallucinations in 
various modalities and even transient abnormal beliefs. Abnormal (sometimes bizarre) 
behaviour can also characterise partial seizures arising from the frontal and temporal 
lobes that often do not generalise. Sub-clinical seizure activity (often non-convulsive 
status) can also present with catatonic features, and other neuropsychiatrie 
manifestations like apathy and aggression (Trimble, 1991).
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Well-dellncd iclal stales arc included here:
• Complex partial seizure status: presents with impaired awareness
• Simple partial seizure status (aura continua): presents with intact awareness
• Absence status (spike-wave stupor): presents with a stuporous state and at 
times with minor myoclonic manifestations
Specify: Relationship to EEG as described later in this paper
3.4.4.6. Psychiatric Disorders with Ictal Associations that are Specific to Epilepsy
There are disorders that are seen specifically in patients with epilepsy. These have 
distinct clinical descriptions and may respond to specific forms of treatment. These 
can be broadly divided into the following categories:
3.4.4.6.1. Cognitive Dysfunction
Patients with epilepsy refractory to treatment suffer from cognitive dysfunction either 
due to the epilepsy itself, due to the complications of epilepsy, or due to anti-epileptic 
drugs. Impairments include difficulties with memory, language, executive functions, 
visuospatial ability and sensorimotor/perceptual functions. These may be general or 
specific (Perrine & Kiolbasa, 1999).
Some specific neurocognitive deficits such as the Landau-Kleffner syndrome, 
which can be associated with specific EEC changes such as Electrical Status
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I pilcplicus of Slow Wave Sleep (l*SI:S). or C onliniioiis Spike and Wave in Slow 
Wave Sleep (CSWS) to be included here (Besag. 2001 ).
3 .4.4 6.2. Psychoses of Epilepsy
2.1. Inter-ictal psychosis of epilepsy: This is a paranoid psychosis with strong 
affective components but not affective flattening usually. Features may include 
command hallucinations, third person auditory hallucinations and other first rank 
symptoms. There is a preoccupation with religious themes. Personality and affect tend 
to be well preserved unlike in other forms of schizophrenic psychosis. Psychotic 
features are usually independent of seizures, although they may become manifest as 
seizure freedom lessens (Trimble, 1991).
Include: Schizophrenia-like psychosis of epilepsy
Exclude: Cases fulfilling criteria for undifferentiated or hebephrenic schizophrenia.
2.2. Alternative psychosis: The patient alternates between periods of clinically 
manifest seizures and normal behaviour, and other periods of seizure freedom 
accompanied by a behavioural disturbance. The behavioural disturbance is often 
accompanied by paradoxical normalisation of the EEG (forced normalisation) 
(Landolt, 1953; 1958). The behavioural disturbance is polymorphic with paranoid and 
affective features. The diagnosis of Alternative Psychosis (Tellenbach, 1961) should 
be made in the absence of the EEG. If  EEG confirmation is available, the diagnosis 
should be qualified further as “with forced normalization of the EEG”.
Include: Forced Normalization/Paradoxical Normalization (Wolf, 1991). Include also 
cases with relative normalization as defined by Krishnamoorthy and Trimble (1999).
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l-xcliide; Continuing inlcr-iclal ps\chosis or post-ictal psychosis (recent cluster ol 
seizures); non-convulsive status with psychiatric manifestations.
2.3. Post-ictal psychosis: Follows clusters of seizures (rarely single seizures) usually 
after a 24-48 hour period of relative calm (the lucid interval). These episodes can last 
from a few days to several weeks, but usually subside in one/two weeks. Confusion 
and amnesia may be present. The content of thought is paranoid and visual and 
auditory hallucinations may be present. Manifestations are often polymorphic with 
affective features and a strong religious theme (Trimble, 1991).
Include: Cases with a clear history of a cluster of seizures or an isolated single seizure 
(in a patient who has been seizure free). The first manifestation of abnormal 
behaviour should occur within a seven-day period from the last seizure (Logsdail & 
Toone, 1988).
Exclude: Post-ictal confusion; non-convulsive status with psychiatric manifestations.
3.4.4 4.5. Aflfective-Somatoform (dysphoric) Disorders of Epilepsy
Intermittent affective-somatoform symptoms are frequently present in chronic 
epilepsy. They present in a pleomorphic pattern and include eight symptoms: 
irritability, depressive moods, anergia, insomnia, atypical pains, anxiety, and euphoric 
moods. They occur at various intervals and tend to last from hours to two/three days, 
although they might on occasion last longer. Some of the symptoms may be present 
continually at a baseline from which intermittent fluctuations occur. The presence of 
at least three symptoms generally coincides with significant disability (Blumer, 2000).
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I he same aIIeeli\e-somalnInrm symploms occur during the prodromal and post-ictal 
phases and need to be coded as such if they are of clinical significance.
3.4.44.5.1. Inferictal dysphoric disorder: Intermittent dysphoric symptoms (at least 
three of the above) are present, each to a troublesome degree. In women the disorder 
is manifest (or accentuated) in the pre-menstrual phase.
3.4.4 4.5.2. Prodromal dysphoric disorder: Irritability or other dysphoric symptoms 
may precede a seizure by hours or days and cause significant impairment
3.4.4.4.5 3. Post-ictal dysphoric disorder: Symptoms of anergia or headaches as well 
as depressed mood, irritability or anxiety may develop after a seizure and be 
prolonged or exceptionally severe.
3.4.4.4.5 4. Alternative affective-somatoform syndromes: Depression, anxiety, 
depersonalisation, derealisation, and even non-epileptic seizures have been reported 
as presenting manifestations of forced normalization (Wolf, 1991). These may be 
diagnosed in the absence of an EEG as described previously, and in the face of EEG 
evidence coded as “with forced normalization of EEG”.
Include: Brief lasting but disabling changes in affect. Exclude: Patients fulfilling ICD- 
10 and DSM-IV criteria for major depression, dysthymia and cyclothymia.
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3.4.4.4.6. Personality disorders
Patients with chronic epilepsy may show distinct personality changes that tend to be 
subtle. Three types are recognised;
(1) A deepening of emotionality with serious, highly ethical and 
spiritual demeanour (Geschwind, 1977).
(2) A tendency to be particularly detailed, orderly and persistent in 
speech and action viz. viscosity (Blumer, 1995).
(3) A labile affect with suggestibility and immaturity (referred to as 
eternal adolescence) (Trimble, 2000).
They may be coded as personality disorders only if present to a degree that interferes 
significantly with social adjustment.
3.4.4.4.6.1 .Hyper-ethical or hyper-religious groups
3.4.4.4.6 2 Viscous group
3.4.4.4.6 3 Labile group
3...4.10.Mixed (two or more of the above)
3...4.11.0ther
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Diagnosis should he coded in Ihe category as foliovvs;
• No personality trait accentuation or disorder
• Personality trait accentuation, but not disorder
• Personality disorder specific to epilepsy
Exclude; Patients fulfilling criteria for well-defined DSM-IV or ICD-10 personality 
disorders
3.4.4.4 7. Specific Phobic Fears
Specific phobic tears such as fear of seizures (Newsom-Davis, 1998), agoraphobia 
and social phobia may occur due to recurrent seizures. This may either be part of the 
interictal dysphoric disorder, in which case that diagnosis is preferred, or alone, in 
which case they should be coded here. Unlike co-morbid psychiatric disorder, the 
phobic fears revolve around epilepsy and the fear of the situation and subsequent 
avoidance is linked to the fear of having a seizure in that situation and the possible 
consequences.
3.4.4.4.8. Other Relevant Information (to be recorded in all patients if possible)
( 1 ) Relationship to EEG change: Characteristic changes in EEG could accompany 
disorders with psychiatric presentations such as generalised absence status, simple 
and complex partial seizures, encephalopathy (organic brain syndrome) etc., or there 
may be an absence or reduction of EEG abnormalities, compared to previous and 
subsequent EEGs as in forced normalisation. The EEG is thus an important
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iiîvcsligativc l(X)l and the findings at the time nl psychiatric disturbance need to be 
coded separately as follows:
• EEG not available/not done
•  EEG remains unchanged
• Non-specific EEG change
•  Specific EEG change (please specify)
(2) Anticonvulsant induced psychiatric disorders: As drugs used in the treatment of 
epilepsy may contribute to the development of psychiatric disorders, it is important 
that this is specified as an additional category. As both anticonvulsant induction 
(Trimble, 1998) and withdrawal (Ketter, 1994) are known to precipitate behavioural 
change, this needs to be specified, as does the specific anticonvulsant probably 
responsible, if at all this is possible. This also has prognostic and therapeutic 
implications, as often the only course of action available to the treating professional is 
withdrawal of the offending agent.
• Details of AED therapy not known/not documented
• No change in AED treatment
• AED institution (in a 30-day period prior to psychiatric disorder)
•  AED withdrawal (in a 7-day period prior to psychiatric disorder)
• Both AED institution and withdrawal during 30-day period
• Note: Specify AEDs
While this classificatory system is by no means the ideal researchers have aspired for, 
its clinical basis, focus on epilepsy specific psychopathology, and inherent simplicity, 
are likely to make it applicable in many sellings bolh in Ihe developing/developed
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world. This opcralionai syslcm needs to he piloted, suitably modified, and validated in 
several settings, before it is widely acceptable. Nevertheless, it has provided a 
template that hitherto did not exist.
3.5. Methodological issues in Studies of Psychiatric Co-morbidity in Epilepsy
3.5.1. Problems with Ascertainment
Incidence and prevalence figures of epilepsy have varied considerably in different 
studies with ascertainment methods having a significant role to play (Sander & 
Shorvon, 2002). Not all patients with epilepsy are aware of their attacks 1 here is 
significant under-reporting due to the transient nature of the illness with attacks often 
going un-witnessed. Medical professionals in primary care have a small number of 
patients in their register and limited expertise and therefore, patients with epilepsy 
often do not consult their GP for their seizures, especially if they are in remission 
(Sander & Shorvon, 1996). There are also problems in making an epilepsy diagnosis 
even in specialist settings, with 5-20% of all subjects with epilepsy diagnosis being 
identified to have a non-epileptic attack disorder.
While major psychiatric illness, either schizophrenia like or affective 
psychosis less often goes un-reported or undiagnosed, common mental disorders may 
often be missed, and a significant burden of unreported CMD does exist in the 
community (Jenkins et al., 1998). Co-morbid psychiatric disorder in epilepsy poses 
other problems as these episodes (both psychotic and affective somalol'orm) are 
intimately linked to seizures, are often transient not lasting longer than 72 hours, are
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cliaraclcriscd by I'ealurcs such as (aligne and oilier soiiialie syniploms (alTeelive 
somatoform) or confusion and apparent behavioural changes (psychotic) that also are 
linked with epileptic seizures (Blumer, 2000). Further, these disturbances often do not 
match conventional descriptions or psychiatric criteria, even when this is clinically 
applied. Ascertainment of co-morbid psychiatric disorder can therefore be as difficult 
as the ascertainment of epilepsy.
3.5.2. Problems with Register-Based Studies
Register-based studies rely on the accurate documentation of clinical information. The 
use of pre-existing records offers a number of advantages. First, such information is 
relevant to the entire cohort and can be expensive to obtain, in addition, since the data 
were collected prior to any knowledge of the individual’s development of the outcome 
under study and, in most cases, for reasons totally unrelated to the investigation the 
use of such information will allow objective and unbiased classification of exposure 
status, in a cohort design for example. However, the level of detail present in pre­
existing records is often insufficient, and data on potential confounding factors is for 
example often lacking (Hennekens & Buring, 1987). Further, registers rely upon 
historical information and clinical impressions as documented in the case records, 
which in turn vary depending on the ability of the individual physician to make 
accurate diagnosis. Registers may also under-report the burden of psychiatric co­
morbidity individuals with less severe illness being left undocumented, while those 
with more severe problems are included. Further, given the problems in dig^nosis and 
ascertainment at this interface, register-based studies seem inadequate. Nevertheless, a 
number of studies including some of the most widely quoted studies of psychiatric
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cpidcniii)log\ in epilepsy (Jalava and Sillanpaa, 1996 Ibr example) have relied on 
case regislers.
3.5.3. Problems with Psychiatric instruments and Criteria
Generic tools used in psychiatric research have been applied in a number ot epilepsy 
studies. The semi-structured clinical examination relies upon the skill and experience 
of the clinician to reduce measurement error. A degree of structure is introduced to 
increase reliability. However, the validity of the semi-structured examination has not 
been the sub ject of extensive investigation and they have been assumed to bring their 
credentials with them, from their development with psychiatric patients and their use 
in clinical research (Dohrenwend, 1995). The use of such instruments in epilepsy 
settings does confer certain advantages, provided, of course the clinician concerned 
has expertise in the neuropsychiatry of epilepsy. A variant of this approach is the 
structured measure. Structured Clinical Interview for DSM (SCID), the Composite 
International Diagnostic Interview (CIDl), Diagnostic Interview Schedule (DIS), and 
Clinical Interview Schedule-Revised (CIS-R) all of which rely on trained interviewers 
in some cases with mental health backgrounds, as opposed to clinical psychiatrists. 
While these tend to have good psychometric properties, they do not allow unlike their 
semi-structured peers, the luxury of expert clinical interpretation. Further, these 
generic instruments do not ask questions relevant to epilepsy, and rely on computer 
programs and operational rules to generate diagnosis based on standard ICD and DSM 
criteria, which again do not take into account the psychopathologies specific to 
epilepsy (Krishnamoorthy 2000a; 2002; submitted).
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Other psychometric measures such as the Cieneral I lealth Questionnaire 
(CiitQ), Hospital Anxiety and Depression Scale (HADS), Beck Depression Inventory 
(ISDI), Hamilton Anxiety and Depression Ratings Scales (HARS/HDRS), Minnesota 
Multiphasic Personality Inventory (MMPI), Schedule for Affective Disorders and 
Schizophrenia (SADS) etc. In general, all these instruments have demonstrated good 
psychometric properties in relevant populations, both normal individuals and those 
with psychiatric disorder. Further, the ability of these instruments to identify “cases” 
with relevant psychiatric disorders is not in question. However, that these are in most 
cases screening and not diagnostic tools is rather conveniently ignored and several 
papers are published each year with “psychiatric diagnosis” having been made in 
epilepsy patients using one of these instruments The identification of “caseness” 
without re-confirmation using accepted diagnostic instruments is potentially flawed, 
and must be approached with caution.
The other potential problem in many studies is the use of criteria such as ICD 
and DSM. While this results in identification of “cases” as described in psychiatric 
literature, it is suspected to exclude many cases with disabling clinical psychiatric 
problems linked to epilepsy, as they fail to meet temporal or other diagnostic criteria. 
Thus, while a depressive episode needs to last as along as two weeks in ICD-10 (ref), 
interictal dysphoric disorder of epilepsy (IDD) is often punctuated by severe but brief 
bouts of depression, anxiety and other somatic symptoms, which do not last longer 
than hours to days in many cases (Blumer, 2000). The other problem alluded to 
elsewhere in this review is the tendency of these systems to label all psychiatric 
disorders in someone with epilepsy as organic, thus presuming a direct link, which in 
both clinical and research terms is unhelpful.
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3.5.4. The problem ol Lonlbunding in Population Studies at this Interlace 
While a number of potential confounding factors have been identified, aetiology, 
seizures themselves, and anti-epileptic drugs prescribed for the management of 
seizures are the three specific confounders that have a significant influence in this 
interface.
Population-based studies of aetiology in epilepsy are few, limited mainly by costs and 
logistical problems in carrying out extensive surveys involving neuroimaging and 
other investigations (Krishnamoorthy, 2003a). As a consequence, studies of aetiology 
at this interface have largely been hospital-based, and have had conflicting results: 
some studies linking aetiology to patterns of psychopathology, and others failing to do 
so. In general, various components of the limbic system and the pre-frontal 
association cortex have been implicated in schizophreniform and affective illness, co- 
morbid with epilepsy (Engel et al., 2002). Firm evidence that certain epileptogenic 
lesions may be associated with certain forms of psychopathology, also emerges from 
the epilepsy surgery literature, gangliogliomas being strongly associated with 
psychotic episodes post-operatively (Bruton, 1988) when compared to other 
developmental lesions associated with epilepsy.
While seizure type and focus have been associated with psychopathology in 
epilepsy (Bear, 1979), studies attempting to link seizure type and focus with patterns 
of psychopathology have had conflicting results, both supporting and negating such 
links. In general, refractory partial seizures arising from the temporal lobe are 
considered more likely to lead to psychopathology, than other forms of seizures,
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depression for e.g., being more likely wilh eomplex parlial seizures than with 
generalised seizures (Devinsky & Vasque/, 1993). I here are of course specific 
patterns of psychopathology linked with certain idiopathic generalised epilepsies. 
Juvenile Myoclonic Epilepsy for example (Trimble, 2000), and these have been 
associated with frontal lobe dysfunction ( Woermann & Duncan, 2000) indicating that 
anatomical correlates for behavioural dysfunction in epilepsy exist outside the limbic 
system, as one would expect.
The role of anti-epileptic drugs (AEDs) must also be taken into account, and 
this is fraught with difficulties. While AEDs have been shown to be thymoleptic and 
have a significant role to play in stabilising mood and controlling aggression, 
impulsivity etc. (Post, 1995), they are well known to provoke de novo 
psychopathology, particularly in temporal correlation with drug introduction, less 
commonly withdrawal or other change. The commonest anticonvulsant reported to 
date in the literature as inducing psychoses has been ethosuximide, although it is 
reasonable to say that nearly all anticonvulsants have at some time been anecdotally 
reported to provoke these effects. However, some anticonvulsants may be more 
relevant than others, and efficacy as an anti-epileptic may be correlated with 
propensity to develop psychopathology (Trimble, 1998). Certainly there has been an 
upsurge in the reporting of cases in the last decade, with the introduction of new anti­
epileptic drugs. These prescriptions essentially have been given as add-on therapy to 
patients who have not responded to standard anticonvulsant therapy. They are patients 
who have regular seizures, usually focal, and usually limbic related, which in any case 
makes these patients susceptible to develop psychopathology (45). Psychosis (5% of 
cases) and affective disorder (19-15% of cases) have been reported with most new
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Al-Ds including felbamate, lamolriginc, liagabinc. lopiraniale. vigabalrin and 
/onisamide (43), often in the context of forced normalisation, not even the newest of 
AI:Ds, Levetiracetam being spared (Krishnamoorthy et al., 2002b).
It is not yet clear if any particular chemical class of drugs is interlinked with 
these problems, although studies to date suggest that drugs that are GABergic may be 
particularly involved. A further problem to be resolved is the differences between 
prescribing these drugs in monotherapy as opposed to polytherapy (nearly all the 
cases reported have been when the drugs have been given as add-on). The extent, to 
which these problems may occur in patients, for e.g., with less severe forms of 
epilepsy, who can be managed with monotherapy , is unclear (Krishnamoorthy & 
Trimble, 1999). Recent literature of interest also includes evidence of AED 
withdrawal emergent psychopathology (Ketter, 1994), and elegant proposals 
differentiating AEDs on the basis of cognitive and behavioural symptoms (Ketter,
1999).
3.6. The Assessment of Psychiatric Co-morbidity in Epilepsy
3 .6.1. Assessment in Hospital-Based Studies
The vast majority of studies of psychiatric co-morbidity in epilepsy have been 
hospital-based. Assessment in these studies has varied enormously and included 
techniques such as retrospective surveys of case notes and unstructured clinical 
assessments (Currie et al., 1971); screening instruments such as the General Health 
Questionnaire, Hamilton Anxiety and Depression Rating Scales, Beck Depression
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Inventory given alone (R on. 1979: Mendez el al.. 1986); semi-slruclured interviews 
such as the Present State Examination (PSE) (Standage & Fenton, 1979); structured 
tools such as and Structured Clinical Interview for DSM (SCID) (Victoroff, 1994), 
Clinical Interview Schedule (CIS) (Edeh & Toone, 1987) etc. The latter (semi­
structured and structured interviews) have been used to generate ICD and DSM 
diagnosis. In some cases (Victoroff, 1994, for example) these tools have been adapted 
for epilepsy, although not always validated. A number of studies have used the 
Minnesota Multiphasic Personality Inventory (MMPI), and several others the Bear & 
Fedio Inventory (later Neurobehavioral Inventory (NBI), many with interesting 
results, and these are reviewed in some detail later in this section.
3.6.2. Assessment in Community-based Studies
Just like hospital-based studies, community-based studies have varied considerably in 
the techniques of assessment used. A number of these (Bredkjaer et al., 1998 for 
example) have been register-based and have relied on case registers with their 
attendant imperfections (reviewed herein). A few have used screening tools to 
estimate the burden of psychiatric co-morbidity (O’Donoghue et al., 1998 for 
example) and reported psychiatric caseness on this basis, an approach that may clearly 
be flawed in the absence of validation. A few others (Edeh & Toone, 1987 for 
example) have used semi-structured or structured instruments, leading to psychiatric 
diagnostic criteria-based assessment of caseness. Some studies have employed the 
Bear & Fedio scale or the Minnesota Multiphasic Personality Inventory (see below) to 
community-based populations with epilepsy. As far as we are aware, no studies have
13
compared these methods ol assessment in the setting ol the community, as we have 
done in this study.
3.6.3. Measures Commonly Used in Epilepsy Studies
3.6.3.1. The Minnesota Multiphasic Personality Inventory (MMPI)
The Minnesota Multiphasic Personality Inventory is a test used to gather information 
on personality, attitudes, and mental health of persons aged 16 or older and to aid in 
clinical diagnosis. It consists of 556 true-false questions, w ith different formats 
available for individual and group use. The MMPI is un-timed and can take anywhere 
from 45 minutes-2 hours to complete. This is normally done in a single session, but 
can be extended to a second session if necessary. Specific conditions or syndromes 
that the test can help identify include hypochondriasis, depression, hysteria, paranoia 
and schizophrenia. Raw scores based on deviations from standard responses are 
entered on personality profile forms to obtain the individual results. There is also a 
validity scale to thwart attempts to "fake" the test. Because the MMPI is a complex 
test whose results can sometimes be ambiguous (and/or skewed by various factors), 
professionals tend to be cautious in interpreting it, often preferring broad descriptions 
to specific psychiatric diagnoses, unless these are supported by further testing and 
observable behavior. A sixth-grade reading level is required in order to take the test. 
However, a tape-recorded version is available for those with limited literacy, visual 
impairments, or other problems (Strickland, 2000).
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A number ol sludies in cpilcps> and non-cpileplic allack disorder, especially 
those emerging from the North American continent, have used the MMPI. While the 
validity of this instrument in epilepsy has been questioned (Bear, 1979; Flor-Henr> , 
1972), there are studies that have indicated its validity in epilepsy (Dikmen et al., 
1983). Whitman et al. (1984) used a MMPI sequential diagnostic system to reanalyse 
87 published profiles of patients with epilepsy, other neurological disorders and 
chronic physical illnesses, encompassing a total of 2786 patients. This included 10 
studies of epilepsy encompassing a total of 809 subjects. They found that patients 
with epilepsy were at higher risk of psychopathology than normal controls. However, 
no difference was found between people with epilepsy and those with other chronic 
disorders, or between people with 1 LH and those with generalised epilepsy. A similar 
investigation was also reported by Dodrill and Batzel (1986) who found that patients 
with epilepsy demonstrated more psychopathology than normal controls and patients 
with other neurological disorders, but that there were no differences in rates of 
psychopathology between TLB and other forms of psychopathology.
3.6.3.2. The Neurobehavioral Inventory for Epilepsy
The Neurobehavioral Inventory (NBI) (Blumer, 1995) was derived from the scale 
originally developed by Bear and Fedio (1977). They based their questionnaire on 
behavioural features described in temporal lobe epilepsy, the common manifestations 
of which best described by Geschwind with contributions to the concept having come 
from the work of Gastaut (Trimble, 1991). The Bear & Fedio Inventory attempts to 
determine the effects of a unilateral temporal epileptic focus on specific psychosocial 
aspects of behaviour. The need to develop such an inventory followed the author's
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perception lhal the MMPI failed lo either detect or account for the temporal lobe 
personality (Bear & Fedio, 1977).
Blumer et al. (1995) have revised the original inventory of Bear and Fedio.
The Neurobehavioral Inventory as it is now called thus has a patient and next of kin 
version (Personal Behaviour Survey) each with 100 questions requiring true and false 
responses across 20 scales (5 items in each scale). While the questions in the patient 
version are presented in random fashion and ordered according to scale at the time of 
scoring, the questions in the carer version are presented in the order of the scales. The 
interview has a number of personal questions including questions on sexuality, 
making it difficult for a carer who is not in a cohabiting relationship with the subject, 
to complete these parts. A total score greater than 20 (true responses) of one hundred, 
is suggested to be indicative of caseness on this measure. A score of greater than 2 on 
any scale is taken to indicate a positive rating on that scale. While not validated for 
general clinical use, the author believes that it facilitates a comprehensive 
understanding of the psychological changes that may be present specifically in 
patients with epilepsy.
Studies that have compared patients with temporal lobe epilepsy (TLE) with 
other groups have tended to show a greater burden of psychopathology as measured 
by this instrument in the TLE group, although not always with statistically significant 
differences. Patients with left sided lesions have tended over time to demonstrate a 
greater burden of psychopathology than those with right sided lesions, although the 
laterality differences described by Bear & Fedio (1977) have not been replicated in 
many studies since (Perini, 1986 for example). Studies using the Bear & Fedio scale
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have been eonipiehensively reviewed relatively recently hy I rinible ( IVVI ) and 
Shetly & I rimble ( 1997).
3.6.3.3. The Structured Clinical Interview for DSM (SCID) & the Hpilepsy Version 
(SCID-E)
The Diagnostic Interview Schedule (DIS) lead to controversy about whether a 
structured interview administered by non-clinicians could yield accurate psychiatric 
diagnosis. This coincided with the development of the DSM-III and DSM-III-R by the 
American Psychiatric Association Task Force chaired by Dr. Robert Spit/.er, MD. 
Spitzer concluded that clinicians were necessary for the diagnostic process (Spitzer, 
1983). and the need to have a clinician administered diagnostic procedure, which 
could produce diagnosis according to the latest diagnostic criteria at that time, seemed 
clear
Thus began the development of the Structured Clinical Interview for DSM, 
oriented specifically to DSM-lll-R, with the aims that it would be shorter, take less 
time to administer, require less training and make the diagnostic process shorter than 
the Schedule for Affective Disorders and Schizophrenia, once training was completed. 
Hence, nearly all items in SCID are specifically designed to assess DSM-lll-R 
diagnostic criteria, and detailed dimensional information on current status is not 
obtained (Hasin & Skodol, 1989). The SCID has been adapted to DSM-IV and comes 
in two major sections: SCID-1 is a semi-structured interview for making the major 
DSM-IV Axis I diagnoses and SClD-11 is a semi-structured interview for making 
DSM-IV Axis II (Personality Disorder) diagnoses. The SCID comes in several
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versions; paliciU, oulpaliciit. non-patienl. psxchoiic s\ nipioiii screen and exists in both 
clinical and research versions. A number oTsoftware programs that can be used 
alongside SCID for purposes such as diagnosis generation.
The SCID has been adapted for use in epilepsy patients (Victoroff, 1994) and 
while this version the SCID-E as it is referred to, has been discussed in epilepsy 
circles, there is no suggestion that it has been widely used. Comparative data against 
other common measures of psychopathology is for example not available in 
populations with epilepsy.
3.7. Methodological Problems in the Assessment of Psychiatric Co-Morbidity at 
this Interface
A number of methodological issues impact on the assessment of psychopathology in 
studies of patients with epilepsy and will be reviewed briefly here.
3 .7 .1. The Generic Nature of Instruments
As reviewed herein, the vast majority of studies have used instruments that are 
developed for general populations with psychopathology, rather than people with 
epilepsy. As very specific forms of psychopathology exist in epilepsy, the use of 
generic instruments alone is inadequate. Thus while the use of generic measures of 
psychopathology is both important and relevant, especially for the purposes of 
comparison with population-based controls, the use of measures that are specifically 
derived to examine psychopathology in epilepsy is extremely important.
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3.7 2. riic Noii-availabilily ol Valid lipilepsy Specific Measures
Thai having been said, epilepsy specific measures are lew and lar between. I he one 
measure lhal was developed specifically for epilepsy, and has seen fairly wide usage 
in populations wilh epilepsy, is the Neurobehavioral Inventory (Blumer, 1995). 
However, its development first as the Bear-Fedio scale and later in its current form as 
the NBI has been largely opinion led. The instrument arose from the observations of 
Geschw ind, the studies of Bear and Fedio, and most recently the work of Blumer. 
However, the psychometric properties of this measure have never been examined in 
any detail, and we have no knowledge of its reliability, validity, sensitivity and 
specificity. It has also aside from early comparisons with the MMPI (which arguably 
cannot be described as gold-standard), has never been tested against a gold-standard 
measure of psychopathology.
3.7 .3 . A Gold Standard?
But then, is there such a gold standard measure for the assessment of co-morbid 
psychopathology in epilepsy? At present, no measures exist that have been developed 
from scratch for the assessment of co-morbid psychopathology in epilepsy 
populations, using modem techniques of questionnaire development. Instruments 
w idely accepted as close to the gold standard in the assessment of psychopathology in 
epilepsy, the SCID, SCAN, ClS-R and ClDl have all been used in studies of epilepsy 
with varying results. Apart from the adapted SCID (SCID-E), none of these other 
measures has been modified to suit specific issues and concerns in epilepsy. Nor has 
any one of these been compared against the gold standard of clinician lead diagnosis.
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l urlhcr. even in the assessment of generic ps\ ch(>pathc)log> in eomnuinity-based 
studies, the relative benefits of these various instruments are the subject ot 
considerable debate (Brugha et al., 2001 for e.g.) and there is little consensus about a 
gold standard. The NBI is therefore by default, the closest we have to a gold standard, 
albeit a poor gold standard that has not been subjected to the accepted rigors of 
modem day testing.
3.7.4. Self, Observer/Carer-Rated Measures of Psychiatric Co-Morbidity
A number of studies reviewed herein have used self-rated and interview-based 
measures that rely upon accurate reporting by the subject about his epilepsy and his 
emotional state. Epilepsy per se is a highly stigmatising illness, and not surprisingly 
many patients choose to ignore psychological issues, viewing them as part of the 
epilepsy process. The measurement of psychopathology at this interface has to be 
more indirect than within general clinical practice, and the reporting of outcomes is 
often influenced by the caregiver (Espie et al., 1997). Clinical experience also 
indicates that even cognitively unimpaired subjects with intractable epilepsy under­
report psychopathology (particularly of the ictal variety), and the value of carer 
reports for the measurement of psychiatric outcome in this population cannot 
therefore be underscored.
There are however, few carer report-based measures of psychopathology in 
widespread use, the NBI being an exception. In recent years, a new instrument called 
the Neuropsychiatrie Inventory has emerged. This is a validated informant-based 
interview, widely used in clinical research studies to evaluate neuropsychiatrie
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syniploms (C ummings cl al., i W4). The NPI lias been shown lo have adeqiiale lesl/re- 
lesl and inicr-raler reliability, and lias been used widely lo study patients wilh 
dementia, as well as a number of conditions in which cognition can be impaired to 
varying degrees, including Parkinson’s disease (Aarsiand et al., 1999), multiple 
sclerosis (Diaz-Olavarrietta el al., 1999), cortico-basal degeneration and progressive 
supranuclear palsy (Litvan et al., 1998)etc. The instrument is also in use for the 
differential analysis of behaviours in dementia and as an outcome measure in trials of 
drugs used in the treatment of dementia (Cummings, 1997).
The use of a carer-rated measure such as this, in combination with self and 
observer-rated measures is probably appropriate for a complex and chronic clinical 
disorder such as epilepsy, characterised by episodic alterations in sensorium and 
progressive memory loss in some cases.
3.8. The Impact of Epilepsy and the Psychiatric Co-morbidity Thereof
3.8.1. Psychosocial Impact of Epilepsy
Epilepsy is a highly stigmatised condition, with social perceptions towards this 
disorder remaining adverse, even in developed nations (Morrell & Pedley, 2000). It 
has been shown in a large European study of 5000 people that perceived stigma has a 
significant impact on quality of life (QOL). Perceived stigma was associated with 
worry, negative feelings about life, long term health problems, injuries and perceived 
side effects of medication (Baker, 1998a). The perception of stigma was also strongly 
associated with Q()l> in that while 35% of those who described themselves as
139
dclighlcd wilh lilc I'cit sliginaliscd. a staggering 79% oTthose who described life as 
terrible felt stigmatised
The impact of epilepsy is revealed in a number of recent comprehensive 
studies. In a survey of 1023 people with epilepsy in two community-based samples, 
Fisher et al. (2000) found that patients with epilepsy had less education, were less 
likely to be employed or married, and came from lower income households. Half the 
respondents had poor control of their seizures, and most listed uncertainty and tear of 
having a seizure, as the worst thing about epilepsy. While problems with lifestyle, 
school, driving and employment limits were all reported, cognitive impairment was 
ranked highest in a list of potential problems.
In another study, as part of a door-door prevalence study of epilepsy in India 
(Radhakrishnan et al., 2000), knowledge, attitudes and practices were evaluated in 
over 1000 subjects from households without epilepsy. Although 99% of the 
respondents had heard of. or read about epilepsy, there were a number of adverse 
beliefs. About a third of those surveyed thought that the condition was hereditary 
40% felt that individuals with epilepsy could not be educated or employed properly. 
29% felt that a person with epilepsy could not lead a normal married life. 11% even 
said that they would object to their children being in contact with children who 
suffered from epilepsy. While women and those with poor education were more likely 
to hold many of the aforementioned beliefs, men were more likely to regard epilepsy 
as a mental illness (27% of respondents held these beliefs).
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A number ol studies have investigated these psychosocial outcomes in 
different countries, and ditTiculties in marriage, relationships, employment and 
emotional adjustment, are reported in most cultures (Mielke et al., 2000; Swinkels et 
al., 2000).
3.8.2. Seizure Frequency, Severity and Disablement
The elTicacy of epilepsy treatment continues to he determined hy the rather arbitrary 
benchmark of a greater than 50% reduction in seizure frequency (Satishchandra and 
I rimble, 2001). The importance of QOL measures in clinical trials of epilepsy is now 
well established. However, opinion has tended to vary about the relative importance 
of seizure frequency and seizure severity, as predictors of QOL, some studies 
emphasising the importance of seizure frequency (Jacoby et al., 1996) and others the 
importance of seizure severity (Smith et al., 1991 ).
Baker et al. (1998b) as part of a cross-sectional, multi-centre, retrospective 
study of QOL across three European countries -  France, Germany and the UK, 
examined data in 300 patients drawn from 30 neurologists, with information on 
seizure type, frequency, demographic characteristics and presence of co-morbidities. 
Seizure frequency was stratified into five groups and classified seizure severity into 
three increasing classes of severity, simple partial, complex partial, partial seizures 
evolving into secondaiy generalisation. The functional status questionnaire (FSQ) a 
generic measure of QOL (Jette et al., 1986) was used. Those patients who were 
seizure-free had a significantly better profile on the FSQ than those who were having 
more than one seizure per-week. The overall trend indicated a worsening of scores on
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the I'SQ associated with an increase in the lrei|uene\ oI'seizures; however several 
correlations obtained in this regard had potentially weak effects as the author points 
out. When the 10 relevant FSQ scores across the three participating countries were 
compared, overall significant ditïerences were obtained for the following domains; 
mental health, quality of interaction, sexual relations and feelings about health.
Regression analysis of seizure severity lead the authors to conclude that the 
frequency of more severe seizure types has a more detrimental effect upon patients’ 
QOL than does the frequency of the less severe seizure type. This effect as measured 
at the 95% confidence level was found for 7 of 10 FSQ scales, and at the 90% level 
for 9 of 10 scales. Only the mental health scale did not show separation between the 
impact of seizure frequency across the three seizure types, though it did show a 
constant decline as severity increased.
3.8.3. The Impact of Psychiatric Co-morbidity on Disablement in Epilepsy
In the study by Baker et al. (1998b) described above, the mental health scales of FSQ 
were found to be associated both with frequency and severity, and to be affected 
whatever the type of seizure. Such studies, however, are rare and most have not 
examined the relationship between psychiatric co-morbidity and disablement while 
controlling for the effects of seizure related variables. There is considerable evidence 
however, from primary care studies of depression for e.g., that the level of 
disablement in these conditions is significant and depression across different levels of 
severity is a strong predictor of disablement (Kruijshaar et al., 2003). Further, chronic 
medical illness is strongly associated with psychiatric disorder, with one study
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showing ill subjects to have a 41% greater relative risk ol eo-morhiil psychiatric 
illness when compared with those without medical illness (Rapp et a l. 1988). A 
number of studies have also shown increased prevalence ot'alTective illness in 
patients with chronic illnesses, diabetes, heart disease, chronic obstructive pulmonary 
disease (COPD) being examples (Katon & Ciechanowski, 2002). Further, as these 
authors elucidate depression increases costs; amplifies symptoms of medical illness; 
increases functional disability; impacts on self-care and adherence to treatment 
regimens; and increases the risk of mortality (cardiovascular risk in particular). With 
epilepsy being a chronic illness with significant impact on psychosocial well-being, 
there seems little doubt the psychiatric co-morbidity will have independent effects on 
disablement, once seizure related effects have been accounted for. However, we have 
not come across any published evidence to date in this regard
3.9. The Treatment of Psychiatric Disorders in Epilepsy
The treatment of psychiatric disorders in epilepsy remains poorly researched and 
controversial. Thus, the literature on psychiatric management techniques in epilepsy 
remains largely “opinion lead”. Evidence from randomised controlled trials is 
relatively scant and few systematic investigations have been conducted in this specific 
area.
There are several controversies that further complicate matters. First, the 
relationship between epilepsy and psychopathology is by itself controversial. Both 
agonistic (Slater & Beard, 1963) and antagonistic (Landolt, 1953) relationships have
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been proposed, and il is likely lhal both types of relationships do exist in dillereni 
individuals and possibly al dillereni limes in the same individual.
Second, psychopathology in epilepsy can apparently be provoked by a number 
of factors, many of which are related lo treatment. The seizures themselves (Lancman,
1999), the anticonvulsant drugs used lo treat seizures (Trimble, 1998), the withdrawal 
of anticonvulsant drugs (Ketter, 1994), other biological treatments, epilepsy surgery 
specifically (Anhour), 2000) and the social consequences of epilepsy (Fisher el al.,
2000) have all been linked to the development of psychopathology.
Third, as it has been pointed out, psychotropic treatments are proconvulsant: 
both antipsychotics and antidepressants can lower the seizure threshold, and can 
provoke seizures in those with no past history of seizures (Trimble, 1998). On the 
other hand, many anticonvulsant drugs have psychotropic properties and some of the 
best known and most widely used mood stabilisers today are anticonvulsants like 
carbamazepine, sodium valproate and lamotrigine (Post et al., 1996).
Fourth, the development of psychiatric disorder with the treatment of epilepsy 
is known to include other biological treatments for epilepsy, thus renewing interest in 
questions such as the role of seizure cessation in the development of 
psychopathology. It is interesting too that Electroconvulsive Therapy (ECT), the use 
of seizures to treat psychiatric disorder, can by increasing the seizure threshold result 
in a cessation of seizures, at least transiently (Kellner, 1993).
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In Ihis section, the management ol these disorders is discussed. In the absence 
ol hard evidence from randomised controlled trials, anecdotal experience and the 
writings o f experts have been relied upon.
3 .9.1. An Overview of Therapies
The management tools available to the psychiatrist can be broadly classified into -  
biological and psychological. Of the biological treatments, treatment with 
psychotropic agents is by far the most popular, antidepressants, anxiolytics, 
neuroleptics and mood stabilisers being employed extensively. The Serotonin 
Selective Reuptake Inhibitors (SSRI) have become the antidepressants of choice in 
epilepsy. Although some interactions, for e.g., fluoxetine and carbamazepine (Spina 
& Perucca, 2002) or sertraline and lamotrigine (Besag, 2003) have been observed, the 
SSRIs have a generally low seizurogenic potential and are deemed safe in epilepsy. 
Indeed, there have been some case reports of a paradoxical improvement in seizure 
status with the addition of these drugs to the AED regimen. Of the older neuroleptic 
agents, Haloperidol remains by far the safest drug in epilepsy (McConnell & Duncan,
1998). The newer agents save one exception clozapine (Miller, 2000) generally have 
less potential to lower the seizure threshold. Sulpiride and risperidone are deemed to 
be relatively safe and effective drugs to employ (McConnell & Duncan, 1998). 
Opinion is divided about the seizure potentiating effects of olanzapine, while 
quetiapine appears to have fewer side effects and a reasonable safety profile 
(Centorrino et al., 2002). While the use of clozapine is generally discouraged due to 
its known seizurogenic potential, refractory psychoses of epilepsy does on occasion 
necessitate its use. A series of patients with intractable psychosis of epilepsy,
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succcssI'u IIn Ircalcd w ilh C’Io/apinc. has rcccnlly been reporlecl (I angoseh &  Trim ble. 
2003).
Ben/odiazepines, especially those with anticonvulsant properties, lorazepam, 
clobazam and clonazepam for e.g., can be very effective adjunct agents in anxious, 
agitated and confused states, leading to the resolution of psychopathology, while 
helping to maintain or indeed improve seizure control (Allen et al., 2001). The 
intermittent use of clobazam in loading doses has the potential, both with regard to 
tacking exacerbations of seizures, and with regard to behavioural exacerbations. 
Further, as a number of AEDs are thymoleptic, they may help in achieving some 
control and stabilisation of behaviour. There have been elegant proposals recently that 
have called for rationalisation of drug therapy-based on the cognitive and behavioural 
side effects of the AED concerned, activating as opposed to sedating (Ketter et al.,
1999). In dealing with a chronic illness, such proposals have value especially as they 
limit disruption due to intermittent behavioural instability.
Electroconvulsive Therapy, although an important tool in mainstream 
psychiatry, is rather infrequently employed in subjects with epilepsy, and this too 
largely in specialist settings. However, new treatments that are shown to have 
beneficial effects possibly on both seizures and psychopathology have emerged in the 
past decade. Vagus Nerve Stimulation (VNS) and Transcranial Magnetic Stimulation 
(TMS) being important examples of such development. The advantage of VNS in 
epilepsy and co-morbid depression is that it might have positive benefits for both 
disorders (Harden et al., 2000; Eiger et al., 2000). These technologies are however at 
their infancy, a better understanding of the brain mechanisms they influence is
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required, and debales and discoveries are likely to continue for years to come 
(George, 2001 ).
A recent meta-analysis of psychological therapies in epilepsy concluded as 
follows "In view of the methodological deficiencies and limited number of patients 
studied, we have found no reliable evidence to support the use of these treatments and 
further trials are needed" (Ramaratnam et al., 2001). The techniques reviewed in this 
study included relaxation therapy, cognitive behaviour therapy, EEC hiofeedhack and 
educational interventions. The caveat of course, was that very few studies were 
randomised or quasi-randomised, and the vast majority of studies were thus excluded 
from the analysis.
There is empirical evidence however, suggesting a role for psychological 
interventions of this nature in subjects with epilepsy. It is common experience in 
epilepsy units privileged enough to have dedicated psychological support that these 
methods significantly contribute to effective patient management.
Several models of cognitive behaviour therapy have been applied in epilepsy, 
ranging from more generic applications of cognitive behaviour theory (Beck, 1993), 
to rather more specific models based on original research among patients with 
epilepsy or NEAD (Goldstein. 1990 for review). Cognitive Behaviour Therapy (CBT) 
as a technique does lend itself to the RCT model of testing. However, with RCTs of 
even psychotropic treatment in epilepsy being rare, an RCT comparing CBT to other 
models of psychological treatment may be rather difficult to establish. In general 
however, as CBT is amenable to adaptation, its use to develop an epilepsy focussed
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ircalincnt lcchnit|uc is possible and such eiVorls iiiei il encouragement. Many treatment 
teams in specialist centres in the UK, have successlully developed in-house 
approaches based on the CBT model, and use these to some elTect.
The brief form of psychotherapy is another technique frequently used by 
psychologists. This is usually directed at more psychologically minded individuals, 
especially those with difficult backgrounds and past emotional trauma, issues that the 
skilled therapist is able to address. The role of specialist epilepsy nurses must also not 
be underscored and there is emerging evidence of success with such nurse practitioner 
interventions (Ridsdale et al., 1999; 2000). Group psychotherapy or patient support 
groups, family therapy and counselling (often by trained lay counsellors), may all be 
helpful in the management of patients with epilepsy. There have also been efforts 
recently to develop neurobehavioral treatments specific to epilepsy (Andrews et al.,
2000), and the results of formal trials with such therapies are awaited. Undoubtedly, 
as the authors of the meta-analysis conclude, randomised controlled trials that meet 
current scientific standards need to be carried out (Ramaratnam et al., 2001).
All these techniques can be employed singly or in combination in the 
treatment of psychiatric disorders in the patient with epilepsy. As a general principle 
as outlined previously in the section on treatment of CMD, it is believed that the 
combination of biological and psychological treatments is superior to either treatment 
alone and the vast majority of experts in clinical practice, effectively deploy both 
avenues individually, in tandem, or sequentially, depending on the complexity of the 
clinical situation they are faced with.
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3 » .2. ManaucniLMil ol lipilcpsy and Co-morbid i\sychopalholog> in Mriman C arc
The recent CSAG report (Department of Health, 1999) states that the GP has a central 
role in the provision of care for patients with epilepsy. However, it also points out that 
epilepsy is not a condition that should or could be managed in general practice alone. 
In the primary care setting, dealing with the co-morbidity of epilepsy and psychiatric 
disorder can be a challenge. This is especially because there is widespread awareness 
about the seizure potentiating effects of common psychotropic agents (antidepressants 
for e.g.) and to a lesser extent perhaps of the psychogenic effects of some APDs. As a 
consequence, even if psychiatric disorder is identified, it is often un-treated or treated 
sub-optimally. Further, psychological therapies (apart from counselling) are not 
generally available in primary care settings and when available are subject to long 
waiting lists. Mental Health Professionals in these settings also experience difficulties 
in dealing with the co-morbidity, as their knowledge of epilepsy for e.g., may be 
limited. The role of the specialist nurse practitioner with both epilepsy and mental 
health experience is invaluable where available, but sadly they are a rare commodity 
in UK primary care.
The CSAG report also recommends that practices have a register of patients 
with epilepsy. It may be wise to red flag cases with co-morbid psychiatric disorder 
and establish follow-up plans. Group practices or primary care trusts may also seek to 
identity and develop specialists with higher training in this area. However, with 
appointments in primary care lasting between seven and half to ten minutes on 
average in the UK, there is little time for monitoring or performing the duties as 
suggested above. Further, each GP has relatively few patients with epilepsy, and may
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nol gain enough experience lo leel conlidenl lo gain or maintain expertise. Some (il\s 
may be working in isolation and may not be reminded about the importance of regular 
monitoring and data collection. Further, rapid advances in treatment protocols, and the 
introduction of new drugs with attendant interactions, often result in the GP finding 
the new regimen suggested by the consultant difficult to implement, or the 
complications difficult to manage. Finally, there are in the UK variations in local 
health authority prescribing guidelines with regard to approved anti-epileptic drug 
therapy and logistical problems therefore for the GP in continuing a newer AFD 
initiated in hospital but unfamiliar to primary care (Redhead, 2003).
Other problems stem from the stigmatising nature of epilepsy and its effects 
on employment, marriage, and children. The consequences of the condition such as 
loss of driving etc., may lead patients to hiding seizure frequency from their doctor 
(Dalrymple & Appleby, 2000), or indeed co-morbid psychopathology thereof 
(especially common mental disorders). There is also a risk in this setting that minor 
psychiatric symptoms like anxiety and depressive symptoms are accepted as part of 
the epilepsy process, leading thus to a treatment gap. Surveys show that even where a 
service exists mainly problems of a psychosocial nature continue (Redhead, 2003).
At present, while patients may receive advice and counselling about the 
consequences and social implications of epilepsy, there is generally no accepted way 
in which specialists or generalists take responsibility for and allocate time to the 
provision of this advice (Ridsdale, 1995). There are models of the utilisation of 
epilepsy liaison nurses working with neurologists in the UK. This has strengthened 
secondary care. The nurses themselves can then be active in the community visiting
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priniaiA carc educating patients, practice nurses and (iPs. Basic mental health training 
I'or all specialist nurse practitioners in epilepsy may be step in the right direction. 
There are models for nurse-led clinics for patients with epilepsy (Ridsdale et al.,
1997). These are well attended, and they have been shown to improve level of advice, 
reduce hospital admissions, A&E attendances and emergency call outs. Such clinics 
require disease register, prescription register, re-call system, computer reminders and 
may stimulate locally agreed protocols. The unique system of patients registering with 
GPs in the UK allows audit and has been shown to produce important research 
(Taylor. 1994; Taylor et al., 1994).
The future will reveal whether improved teamwork and communication 
between primary and secondary care and management plans based on locally agreed 
initiatives will improve the care of patients with epilepsy, particularly those with a 
disabling co-morbid psychiatric disorder.
3.10. Studies Conducted as Part of This Thesis
Two studies, one based in an institution for epilepsy, and another based in primary 
care were conducted as work leading to this thesis. The effort was to study and 
describe the prevalence and patterns of psychiatric co-morbidity in these different 
populations with epilepsy; to compare a range of psychiatric measures, generic and 
specific, as well as self, observer, and carer-rated; and to test specific hypothesis 
related to the neuropsychiatry of epilepsy. A further analytical component of these 
studies was to examine the relative contributions of psychiatric co-morbidity and 
seizure severity to disablement, in both these populations.
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The scclioiis (hat Ini low will describe Ihe objeelives. inelhnds and results in 
these studies, as well as the in-depth analysis of data using techniques sueh as factor 
analysis. Receiver Operating Characteristics (ROC) analysis, generalised linear 
modelling SPSS, linear regression etc., in an effort to clarify these associations.
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SK( I ION 4:
STUDY I: PREVALENCK, PATTERNS AND ASSESSMENT OF 
PSYCHIATRIC CO MORBIDITY IN EPILEPSY A STUDY IN PRIMARY  
CARE
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4.1 Aims
I he primary care study described herein was designed with the Ibllowing aims;
(1) To estimate the period prevalence ol common mental disorder in a 
representative community-based sample of subjects with epilepsy and 
to compare this with the period prevalence in matched controls in this 
population
(2) To compare screening (GHQ-28, HADS & PSQ) structured-diagnostic 
(Clinical Interview Schedule- Revised (CIS-R) and epilepsy specific 
(Neurobehavioral Inventory) instruments in a population of subjects 
with epilepsy, and compare with the Schedules for Clinical Assessment 
in Neuropsychiatry (SCAN) as gold-standard
(3) To examine relationships if any, between psy chiatric co-morbidity and 
seizure severity, and psychiatric co-morbidity, seizure severity and 
disablement.
4.2. Hypothesis and Estimation of Sample Size
Based on published literature (Edeh and Toone, 1987), we hypothesised that 
psychiatric co-morbidity will be significantly greater in patients with epilepsy (48%) 
compared with population-based controls matched for age and sex (20%) (Jenkins et 
al, 1998). We further hypothesise that specific patterns of psychopathology will help 
distinguish patients with epilepsy from controls.
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I he power calculalion was based on Ihe albremenlioned hypothesis A sample 
size ot'37 cases and 74 controls would provide 80% power lo detect prevalence ratios 
o f 2.4 or greater at 5% significance .
43. Setting
The participating centres. King’s Lynn in Norfolk and Bradford in Yorkshire, were 
selected because of the existence in each of a well-maintained community-based 
register of ftilly worked up prevalent cases of epilepsy. As will be seen, the registers 
were differently constituted, but otherwise comparable in cover and detail. The 
Institute of Neurology has established relationships with those responsible for each of 
the registers.
4.3,1. Population and Demographic Features 
4.3.1.1 King’s Lynn, Norfolk
King's Lynn is a small coastal city in the county of Norfolk in Eastern England. An 
active port, it has two enclosed docks and regular traffic of materials such as timber, 
steel, chemicals, fertilisers and grain. In mid 1999, the population of King's Lynn and 
its surrounding parishes was 43,385. The county of Norfolk is mainly rural with a 
population of 772,000 in seven districts, and a relatively low population density of 
144-persons/sq km. Unemployment in the county stands at 4.2% when compared to 
3.4% in the eastern region and 4.6% for the UK. The ethnic minority community is 
less than 1% of the population (national average 5.5%) (www.go-eastern.gov.uk).
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4.3 .1 2 Bradford, West Yorkshire
Bradford District in 1998 had 486,000 residents, which is expected to grow to 
511,000 by 2011. Bradford's reliance on textiles and engineering has given way to 
high technology and service sector industries, such as finance and exports. A very 
diverse community, Bradford has, for over a century attracted settlers from Ireland, 
Germany, many countries in Eastern Europe, and over the last 50 years, countries in 
the Indian sub-continent and Africa. The city of Bradford has a population of 301,000 
people, with diverse conditions of housing and employment, ranging from the older 
city centre to the new suburbs, which once were free standing villages. 97,000 of 
Bradford's residents (20%) are Black or Asian, of whom 71.000 ( 15%) are of 
Pakistani or Bangladeshi origin. The ethnic minority population is expected to grow 
to 26% by the year 2011.
4.3.2. Participating GP Surgeries
4.3.2.1. King's Lynn
The population served by St. James House Surgery was 16,878 and that served by 
Southgate Surgery 7,898. St. James had ten GP Principals in active practice, and 
Southgate six. St. James serves areas in an around the city centre whereas Southgate 
serves a more sub-urban and semi-rural population. One of the GP Principals in St. 
James's House Surgery has a specialist interest in epilepsy, and the practice has an 
epilepsy nurse specialist who maintains a register; conducts annual review; provides
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inrorrnalion, support and counselling services; conducts audits; and maintains links 
with local support agencies and services.
4.3.2.2. Bradford
Girlington Road Surgery served a population of 7,836 persons in an inner-city area of 
Bradford, and had 5 GP Principals in active practice. The Ridge Medical Practice 
(sub-urban) had 10 GP Principals and served 16,358 people, while The Wilsden 
Surgery had 6 GP Principals and served 9190 people. All three practices came under 
the Bradford South and West Primary Care Group, subscribed to the Bradford 
Epilepsy Service, had computerised patient records and were willing to co-operate in 
this effort, which was the rationale for their choice. There were no GP Principals with 
special interest in epilepsy in these practices, nor were there any epilepsy specialist 
nurses directly employed by these practices. However, they had access both to 
specialist nurses and consultant epileptologist support through the Bradford Epilepsy 
Service. Patients chosen for this study were drawn from the Bradford Epilepsy 
Service register.
4.3.2 3. Rationale for Choice of Settings
The two settings for this study were chosen for a combination of pragmatic and 
scientific reasons. Both settings had links (or were keen to establish links) with the 
epilepsy programme at the Institute of Neurology and National Hospital. Both settings 
had recently established primary care-based epilepsy registers, and were willing to 
allow access to these registers lor research reasons. Both settings had potential
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C()llalx)ralors involved closely vvilh ihe running ol epilepsy services and management 
ol the register, who expressed personal interest in this research project being carried 
out. Both settings had computerised practice registers, and adequate space and 
facilities for this project.
King's Lynn and Bradford also were thought to be of scientific interest as both 
settings were somewhat removed from University Centres where neurological 
services tend to be concentrated, and thus did not have easy access to specialist 
services. Further, neither population had been recently exposed to large-scale research 
efforts, a concern with regard to many primary care-based studies in London and 
other major centres for example.
4.4. Subjects
4.4.1: Establishment of Epilepsy Case Register- St. James' House Surgery, King's 
Lynn
The case register in St. James’ House Surgery in King's Lynn was established during 
a previous primary care study of epilepsy led from the National Hospital, Queen 
Square, in which the surgery participated (O’ Donoghue et al, 1999). At that time, the 
disease and drug treatment registers were searched to identify persons having at least 
one non-febrile epileptic seizure (excluding seizures confined to the first year of life). 
This had been supplemented by a manual search of medical records, in a proportion of 
those registered, using the key word "epilepsy". The records of identified cases were 
then reviewed to determine seizure type, epilepsy syndrome, age at onset, date of
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niosl rcccnl seizure and currenl trealnienl status An epilepsy register was maintained 
and updated from that time by the CiP Principal, with a special interest in epilepsy, 
and formed the basis for an epilepsy clinic within the practice in which all patients 
with epilepsy were managed. He is assisted in these duties by specialist nurse 
practitioner for epilepsy based in the same surgery.
4.4.2. Establishment of Epilepsy Case Register in Southgate Surgery, King's Lynn
As Southgate Surgery did not have an operational epilepsy register, inclusion of 
subjects from this surgery did not form part of the original study plans in King’s 
Lynn. However, during the investigation in St. James’ House Surgery, GP Principals 
from Southgate Surgery expressed a keen interest in the project and in setting up an 
epilepsy register in that surgery. As such a measure would also aid local service 
development significantly, it was decided to adopt similar methods to those used in 
St. James' House Surgery. As case records in Southgate Surgery were fully 
computerised, a keyword search (as above), with "epilepsy" and the names of 
common anti-epileptic drugs as keywords was carried out by the research assistant 
working on this project. The records of patients identified in this way were scrutinised 
manually by the research assistant and subjects with diagnosis of epilepsy identified, 
this being confirmed by this researcher.
4.4.3. Establishment of the Bradford Epilepsy Service and Register
The Bradford Epilepsy Service Register was developed by an epilepsy nurse 
specialist, searching practice databases using diagnostic codes and from repeat
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prescribing dala. The nurse reviewed records in 39 practices covering a population ol 
225,439. We included only those subjects registered with the alorementioned 
practices. Clinical review was undertaken where there was limited information 
available in the records. In total, 1643 cases of epilepsy were identified. I he data was 
reviewed by a Consultant Neurologist, and cases with doubtful ascertainment re­
examined and classified personally. The register thus developed formed the basis of a 
unique primary care service, the Bradford Epilepsy Service. This service led by a 
Consultant Neurologist, assisted by a team including two specialist nurses and a co­
coordinator, offers care through community based clinics for epilepsy, held several 
times every week in community locations around Bradford. The co-coordinator and 
the specialist nurse practitioners, one with specific interest in learning disability, and 
another with specific interest in epilepsy, support the service by maintaining a 
register: conducting periodic reviews; providing information, support and counselling 
services; and maintaining links with local support agencies and services.
4.4.3.1. Identification of Cases for the Present Study
The aforementioned epilepsy registers formed the basis of case identification. In St. 
James' House Surgery, King's Lynn, and all three participating surgeries in Bradford, 
a search of computerised case records was carried out, to further validate the epilepsy 
register. As in Southgate Surgery, King's Lynn, this used the keywords "epilepsy" and 
the names of anti-epileptic drugs that were commonly prescribed in the United 
Kingdom, at the time that this project commenced -  phenytoin, carbamazepine, 
sodium valproate, vigabatrin, lamotrigine, gabapentin, topiramate, and clobazam. This 
was to ensure that all cases with epilepsy, including those not in the register, or indeed
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Ihose lhal developed epileps\ in the interim period between the establishment ol the 
register and the present study, were identified.
Patients with epilepsy identified in this way were further classified as having 
active or inactive epilepsy. Active epilepsy was defined using the International 
League Against Epilepsy"- Commission on Epidemiology & Prognosis (1993) 
recommended criterion of at least one seizure in the past five years, whether on or off 
treatment with anti-epileptic drugs. Only cases with active epilepsy were considered 
for inclusion in the present study. Cases identified in this way were further screened 
by the research assistant in a telephonic interview, using exclusion criteria for this 
study.
4.4.4. Exclusion Criteria
• Extremes of age- below 18 and over 70 years
• Cognitive impairment (score of less than 24 on the MMSE)
• Physical disability making participation in study difficult (such as visual or 
hearing impairment)
• Subjects who do not identify English as being the primary medium of 
communication
4.4.5. Rationale for Exclusion of Certain Groups
Paediatric epilepsy has been well studied (Menkes, 2000), and consists of spectrum of 
syndromes of varying aetiology. The diagnosis and clinical features of psychiatric
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disorders in children are also somewhat dillerent from those in adults, and hence it 
was decided that this group should be excluded. We did however include in our study 
adults who fulfilled criteria for active epilepsy, and in whom epilepsy began in 
childhood or adolescence.
Older people on the other hand, often have symptomatic seizures that can be 
attributed to brain injury (cerebrovascular disease for e.g.); degeneration (dementia 
for e.g.); a spectrum of co-morbidity including psychiatric co-morbidity (subclinical 
mood disorders for example) (Burke, 2003). Further it was felt that there was too 
much heterogeneity with older people, both within, and between older and younger 
people.
There is an over-representation of both epilepsy and behaviour problems in the 
learning disabled as reviewed earlier herein. It has been estimated that between 15% 
(mild learning disabilities with IQ>50) and 30% (severe learning disabilities- IQ<50) 
have co-morbid epilepsy (Corbett, 1988). On the other hand, it has been estimated that 
around 50% of subjects with mental retardation in a hospital/institutional setting will 
pose management problems due to psychiatric disturbance (Reid, 1983). Thus, given 
the background of high psychiatric co-morbidity in the two conditions, i.e., learning 
disability and epilepsy, one would expect the burden of psychiatric co-morbidity to be 
significant in cases where both co-exist.
Further, all these populations cannot be assessed in a valid way, using 
measures of psychiatric co-morbidity (both generic and epilepsy specific) that are 
widely available to us, and need special measures that are then further validated in
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these populations As this study was intended to he a study ol adult, non-learning 
disabled, non-geriatric subjects w ith epilepsy, these special groups were not included.
4.4.5.1. Identification of Controls
Controls were identified from the general practice register (computerised) and were 
the next two persons of the same age and sex on the GP register. Three attempts were 
made to contact each control subject identified in this way, and if these attempts 
failed, the next two people matching the description on the GP register were chosen, 
and approached in a similar way. In this way an effort was made to find two 
population-based controls for each subject who consented to take part in the study
4.5. Measures
4.5.1. Review of Case Records
The case records of people identified using the case identification procedure (above) 
were reviewed. Demographic details were noted, and the records screened to ensure 
that the subject qualified for inclusion. The diagnosis of epilepsy with a reasonable 
level of ascertainment and clear documentation was confirmed, and whether subjects 
thus identified fulfilled criteria for active epilepsy determined. As reliable and 
consistent data on epilepsy classification is often difficult to obtain in the primary care 
setting (Commission on Epidemiology, 1993) and brain imaging or BEG were not 
planned as part of the present study, the decision was made to focus on seizure 
severity, for the quantification of epilepsy. Seizure severity has been show n to have a
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sigiiillcanl impacl on disablement (Baker. 1996). and hence this approach was 
considered to be appropriate.
4.5.2. Mini Mental State Examination (MMSE)
The Mini Mental State Examination (MMSE) (Folstein, 1975) has been used 
extensively in screening for cognitive impairment. In the USA it was chosen as the 
sole cognitive component of the Diagnostic Interview Schedule (Robins et al, 1981 ). 
The test consists of two parts: verbal and performance. Four verbal sub-tests have a 
maximum score of 21 points and evaluate orientation in time, memory and attention 
Two performance sub-tests have a maximum score of nine points, and involve the 
naming of objects, execution of written or spoken orders, writing, and copying a 
complex polygon (Copeland, 1989). In sum the MMSE tests memory, language, 
praxis and attention and takes between five and ten minutes to administer. It is well 
validated in hospital populations although the lack of validation work in community 
and non-hospital populations has been pointed out (Nelson et al, 1986), and is known 
to be influenced by factors such as ethnicity and socio-economic status (Dick et al, 
1984). However, it correlates well with organic changes in the brain (Tsai and 
Tsuang, 1979), has a well-established cut-off score of 23 or 24 (Anthony et al, 1982), 
and is one of the most widely used screening tools for cognitive impairment in the 
clinical setting.
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4 5.3 National I lospital Sci/iirc Severity Scale
Seizure severity scales have in recent years been identified as an important additional 
outcome measure in trials of anti-epileptic drugs. Most available scales share core­
components. seizure frequency, seizure type, seizure duration, post-ictal events, post­
ictal duration, automatisms, seizure clusters, known patterns, warning, tongue biting, 
incontinence, injuries and functional impairment (Cramer, 2001). The National 
Hospital Seizure Severity Scale (NHS3) (O'Donoghue, 1996) was derived from the 
Chalfont Seizure Severity Scale (Duncan, 1991), and proposed to be refined, quicker 
and simpler version of the original scale, with better psychometric properties, by the 
authors fhe scale is administered by a health professional during an interview with a 
patient and a witness to seizures. It derives information about three different seizure 
types and seven seizure related factors, and generates a score from I to 27. An intra­
class coelTicient of 0.90 was obtained during inter-observer and test-retest reliability 
assessment, suggesting that the measure is sufficiently reliable for group studies. 
However, it has been noted that scores for an individual patient should be interpreted 
with caution in light of the limits of agreement obtained (O'Donoghue, 1996).
4.5.4. Subjective Handicap in Epilepsy (SHE) Scale
The SHE (O'Donoghue, 1998) is a measure of the handicapping effect of epilepsy in 
daily life. The six sub-scales measure the effect on daily activity ('work/activity'), 
social life ('Social/Personal'), the physical effects of epilepsy ('Physical), worry and 
self-confidence ('self-perception'), happiness with life ('Life Satisfaction') and change 
over the past year ('Change'). All the sub-scales are scored from 'O'-'lOO', 'O'
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representing the most severe handieap. The scale is speeillc to epilepsy, has been 
demonstrated to have good psychometric properties, and has been used in a 
community-based population with epilepsy with results that compare well with more 
established generic measures such as the SF 36 (O' Donoghue, 1998). Our choice of 
an epilepsy specific measure of disablement was because these tend to be condition 
specific and therefore more responsive. However, they are limited by being not 
comparable across conditions.
4.5.5. General Health Questionnaire (GHQ)- 28 Item Version
The GHQ is the most widely used screening test and is available in versions as short 
as 12 items and as long as 60 (Goldberg and Williams, 1988). Since the questionnaire 
was designed for use in consulting settings, it is focussed on breaks in normal 
functioning and is concerned with a person's inability to continue with normal healthy 
functions and experience of new phenomena of a distressing nature. The GHQ 
assesses “state” not “trait” both because of the “last week” frame it employs, and 
because of the comparison with “usual”.
Each item consists of a question asking whether the respondent has 
experienced a particular item or behaviour within the previous four weeks on a four- 
point response scale ranging from less than usual to much more than usual. The GHQ- 
12 takes only 2 minutes to complete, while the GHQ 60 takes between 10-12 minutes.
The GHQ-28 is a scaled version, which consists of four sub-scales for somatic 
symptoms; anxiety and insomnia; social dysfunction; and severe depression; which
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have been derived bv I'aclor analysis. DilTerent scoring melhods have been proposed, 
bul the modified scoring method that produces a normal distribution ol test scores and 
hence has better statistical properties is probably preferred. Patients with physical 
disorders may be over-represented among respondents classified as false positives 
because of their responses to items concerned with somatic symptoms and social 
dysfunction (Goldberg and Williams, 1988).
4.5.6. Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression scale was developed by Zigmond and Snaith 
(1983) in an attempt to overcome a specific problem, that of patients in general 
hospital practice who have both physical and psychiatric problems. Some of these, for 
e.g., cardiovascular disease with palpitations, or gastrointestinal disease with 
constipation or nausea, could give misleadingly high scores on most of the depression 
and anxiety rating scales, which include somatic symptoms on the basis that they are 
psychogenic (see GHQ above for example). A scale without this contamination would 
be valuable in the self-assessment of mood disorders in a general hospital. Depression 
items were included if they made no reference to physical functions. Anxiety items 
were included from the Present State Examination, although as the items in the FSE 
are mainly autonomic in nature, surprise has been expressed about this choice of 
source instrument (Thompson, 1989). In a medical population the depression scale 
correlated 0.70 with an independent global rating, and the anxiety scale 0.74. Each 
sub-scale was independent in that they failed to correlate significantly with the rating 
of the other mood (Zigmond and Snaith, 1983). The scale scores were independent of
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physical illness, as physically ill palicnls with low global severity scores ol cither 
depression or anxiety scored very low on the questionnaire ( I hompson, 1989).
4.5.7. Clinical Interview Schedule (Revised)
The Revised Clinical Interview Schedule (CIS-R) (Lewis et al, 1992) is a standardised 
semi-structured interview to assess the mental state of subjects with non-psychotic 
psychiatric disorders. The revised version, unlike the original, does not require the 
interviewer's clinical judgement so minimises observer bias. Most aspects of the 
interviewing style are prescribed by the interview, including the exact wording of the 
questions and specific rules for coding each symptom. The revised version is suitable 
for use by lay interviewers. The CIS-R limits the period of interview to the previous 
week, on the ground that memory for psychological symptoms, and thus validity of 
responses, becomes poor when a longer period is used. However, the subject is also 
asked about the total duration of symptoms.
The instrument has 14 sub-sections: somatic symptoms, fatigue, concentration, 
sleep problems, irritability, worry over physical health, depression, depressive ideas, 
worry, anxiety, phobia, panic, obsessions and compulsions. Scores for sub-sections 
range from 0-4 (0-5 for depressive ideas). The ratings obtained at interview provide a 
score for each section, which together can be summed up to yield an overall score, 
which is taken to indicate the severity of any minor psychiatric disorder. A cut-off 
score of 11/12 has been validated to determine caseness (Lewis et al, 1992). 
Algorithms using CIS-R data can be employed to generate ICD-IO diagnosis of mild, 
moderate and severe depressive episodes, agoraphobia, social phobia, panic disorder.
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generalised anxiety disorder, obsessive eompiilsive disorder and neurasthenia. The 
CIS-R has been shown to have high inter-rater reliability (Lewis et al, 1992) and has 
been employed in many investigations ol'non-psychotic psychiatric morbidity.
4.5.8. Psychosis Screening Questionnaire (PSQ)
The Psychosis Screening Questionnaire (PSQ) was specially developed for the 
National Psychiatric Morbidity Surveys of Great Britain (Jenkins et al, 1997), as no 
suitable pre-existing screening questionnaire was available. The PSQ comprises of 12 
questions than enquire about positive psychotic symptoms in the preceding 12 months 
and in preliminary testing in a clinical population it performed well (Bebbington & 
Nayani, 1995). Two main problems have been identified. First, even with high 
sensitivity and specificity, the positive predictive value of a test becomes quite poor 
when the prevalence of a condition is low. Second, the instrument failed to identify 
those with a past history of psychotic symptoms who were in remission, as they did 
were not experiencing any current psychotic symptoms. In the psychiatric morbidity 
survey these limitations were overcome in part by screening for anti-psychotic 
medication and contact with a mental health professional (Jenkins, 1997). However, 
given the higher proportion of cases with psychosis even in population samples with 
epilepsy (Krishnamoorthy, 2001), and the relative absence of validated measures to 
screen for psychotic symptoms in the community, the PSQ was chosen as a screening 
tool in this study.
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4.5.9. Neurobehavioral !nvcnlor\ (Nl^i)
Reviewed in detail in the epilepsy and co-morbid psychopathology section (3.6.3.2, 
pg 130).
4.5.10. Schedules for Clinical Assessment in Neuropsychiatry (SCAN) & Present 
State Examination (PSE)
The SCAN system (WHO, 1992) was developed jointly by the World Health 
Organisation and (WHO) and the National Institutes of Health (NIH). SCAN 
represents the latest stage in a 30-year strategy of development that began in the 
1950s (with the PSE versions 7, 8 and 9). SCAN consists of a set of instruments to 
assess, measure and classify psychopathology and the behaviour associated with the 
major psychiatric syndromes of adult life.
It has four components; the tenth edition of Present State Examination (PSE 
10), the Glossary of Differential Diagnosis, the Item Group Checklist (IGC) and 
Clinical History Schedule (CHS).
The PSE 10 itself has two parts. Part one covers somatoform, dissociative, anxiety, 
depressive and bipolar disorders, problems associated with basic bodily functions, the 
use of alcohol and other substance use. Part two covers psychotic and cognitive 
disorders with observed abnormalities of speech, affect and behaviour. Data from the 
schedules can be recorded in a variety of ways; on the SCAN schedules themselves, 
on coding booklets, on the f ree entry record booklet, into the computer data entry
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program, by employing a computer program to administer SC AN, the new version 
being a WINDOWS version (WHO, 1995). A set of computer algorithms (CA 11:00) 
is used to process data entered from SCAN schedules. The output is presented as a 
series of options including a range of profile of symptoms and IGC scores, an index of 
definition, ICD and Diagnostic and Statistical Manual categories, and a pre-diagnostic 
profile of categories. In its complete form SCAN is meant only for use by clinicians 
with knowledge of psychopathology who have taken a course at a WHO designated 
training centre. Although, exhaustive in its coverage, SCAN is time consuming.
In this study the main component of the SCAN that was employed was PSE 
10. The interviews were perlbrmed by this researcher who was blinded to responses to 
the other instruments employed in this study, at the time of carrying out the PSE 
interview. Sections 2-12 of the PSE interview (Part I-Neurosis) were completed in all 
subjects, as was Section 14 the screening section for Part II (Psychosis). Part II was 
completed for all subjects who failed the psychosis screening.
4.6. Protocols and Procedures
4.6.1. Preliminary public education programme (King’s Lynn)
Although there was an established epilepsy service in St. James's House Surgery, 
there had been no programme of on-going education or public communication on 
epilepsy. The GP Principal and his team felt that the proposed study would therefore 
provide an opportunity to educate those in their register and other interested members 
of the public about epilepsy. I he target audience for this programme was patients.
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Ihcir carers, palicnl inlcresl groups and la> members of Ihe public. The 
announcements and invitations were done through personal contact, ll> ers. posters 
and announcements in the local radio station. The objective was to increase awareness 
and to encourage the establishment of a local interest group.
The programme was conducted by staff from the Centre for Education, 
National Society for Epilepsy- Centre for Epilepsy, Chalfont St. Peter, 
Buckinghamshire, UK. No specific mention of the proposed research project was 
made, although interested members of public were told that some research in 
collaboration with the National Hospital in London was expected to commence soon. 
The programme was well attended, with around 80 people taking part, and 
engendered considerable interest.
4.6.2. On-going Public Communication (Bradford)
The Bradford Epilepsy Service, as an independent primary care service, has an on­
going programme of public communication, including a periodic newsletter, flyers, 
posters, announcements in local media etc. As this was an on-going process, it was 
opined that an educational programme similar to that in King's Lynn was not a 
specific need, and information about this on-going study would be disseminated 
among those in the service register.
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4.6.2.1. Ralionalc
I'he obvious concern in supporting an educational programme in one study setting and 
not in the other was how this might ditTerentiaiiy affect response rate in the present 
study. In both settings, there was no specific et'fort to advertise the study, given 
ethical concerns in this regard. Apart from the measures outline herein, any mention 
of the proposed study in both settings, via these public communications was therefore 
incidental. After consultation we concluded that the efTect of the on-going 
communication in Bradford was likely to match the educational programme that was 
held in King's Lynn, and these effects on the response rate (if any) would he 
negligible.
4.6.3. Role of Epilepsy Nurse Specialists in King's Lynn and Bradford
As the study was taking place off site (outside London and away from the sphere of 
the National Hospital's influence) and in primary care, it was opined by local 
collaborators in both settings, that supportive contact of individual subjects by these 
specialist nurses was essential and desirable. Further, epilepsy nurse specialists in 
both settings had close contact with subjects on the study register, and were in the 
majority of cases familiar with individual subjects. They were therefore charged with 
the responsibility of informing subjects that the proposed study was imminent, and to 
expect contact from the research assistant. While these efforts were primarily taken to 
reassure potential participants that their local service was involved in the current 
research effort, they may have augmented response rates, and this is to be 
acknowledged.
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4.6.4. Invilalion to Subjects
A letter was sent to all potential subjects inviting them to take part in this study. In 
King's Lynn, the letters were in the respective letterheads of the two practices that 
were taking part, and were co-signed by the GP Principal co-coordinating the effort in 
that surgery and this investigator (section 9.8; pg. 435).
As the Bradford Epilepsy Service had direct contact with the potential subjects 
in all three participating surgeries, the letters in that setting were on the letterhead of 
that service and were co-signed by the lead consultant heading the service and this 
investigator. Information sheets outlining the nature and purpose of the proposed 
study, accompanied the letters in both settings (section 9.8; pg. 435).
4.6.5. Protocol with Non-Responders
Non-responders were sent a second letter of invitation after a two-week period. If 
there was no response to this second letter within a month, a third letter was sent out. 
If no response was received after all three letters the subject was considered a non­
responder, and no further attempts at contact made.
4.6.6. Protocol with Responders
Responders were contacted by the research assistant responsible for the project, and 
an appointment arranged for the first phase assessment. This they were told could take
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place either at their own CiP surgery, or at home, whichever they preferred most. I he> 
were also reminded that assessment hy this investigator maybe necessary within 30 
days of this first phase assessment.
4.6.7. First Phase Assessment by Research Assistant
The research assistant met with participants by appointment. These meetings took 
place either in the GP’s Surgery w here the patient was registered, in a consulting 
room allocated for that purpose, or if the patient were to so prefer, in the patient’s own 
home. The assessment began with an explanation about the study, formal completion 
of informed consent procedures and brief review and clarification of records. At this 
stage subjects also handed in self report measures sent to them, GHQ-28 and HADS 
for cases and controls, and in addition the SHE and NBl measures for subjects with 
epilepsy. All participants were assessed using the mini-mental state examination, and 
those who obtained a score of less than 24 excluded from the study at this stage. In 
reality, due to careful screening procedures, very few subjects were excluded at this 
stage. Subjects completed the CIS-R (computer self-report version) in the presence of 
the RA, were screened with the PSQ by the RA, and those in the epilepsy group were 
in addition interviewed with the National Hospital Seizure Severity Scale.
4.6.8. Second Phase Assessment by this Investigator
All subjects with epilepsy seen in phase 1 and all controls identified to have co- 
morbid psychiatric disorder in Phase 1 were invited to attend a second appointment 
with this investigator, during which clinical diagnosis of epilepsy was clarified, and
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subjccls interviewed using the SCAN. I his interx iew was conducted either in the CiP 
surger> or in the subject’s residence, depending on his/her preference, l o ensure that 
there was concordance between the screening data and SCAN data, all SCAN 
interviews were accomplished within the period during which prevalence of 
psychiatric disorders was being studied (30 days). The two stage approach to 
assessment was preferred as it lent clarity to the process both for patient and 
investigator; shortened the overall assessment time, which would otherwise exceed 
three hours in subjects taking part in the SCAN interview, as well as other measures; 
and was widely endorsed by the GP’s taking part in the study. This investigator 
remained blinded to the results of all screening instruments at the time of conducting 
the phase 11 interview, in an effort to minimise bias.
This investigator reviewed all subjects in the control group who were positive 
on either the ClS-R or PSQ, and those with clinically significant psychopathology 
brought to the attention of their General Practitioner, in line with good clinical 
research practice.
Patients with epilepsy responded to the Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN) administered by this investigator, using the computer 
assisted interview program, WINDOWS version 2.1.
The responses were rated in two ways. First, the algorithms in the WINDOWS 
programme were run, in the conventional manner, to elicit ICD-10 diagnoses. Given 
the relatively small size of the sample, lCD-10 diagnoses were coded in the following 
broad categories: organic mental disorder; substance abuse disorder; psychoses;
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mania or cyclothymia: depression, dysthymia. other iinspceilled mood disorder; 
anxiety or phobic disorder; somatolbrm disorder; eating, sleep, sexual disorder
Second, this investigator rated each symptom category for clinical 
significance, this being defined as the presence of three or more symptoms in each 
broad symptom category. These categories followed the PSE sections and were: 
somatoform; worry; anxiety; phobia; obsession; depression; dysthymia; thinking; 
sleep, appetite & sexual symptoms; alcohol; substance abuse; psychotic symptoms.
An overall rating of clinical significance was also made; subjects were rated to have 
clinically significant psychiatric symptoms if they had positive ratings in two or more 
PSE symptom categories. This rating of clinical significance was undertaken, as it has 
been frequently observed that patients with epilepsy have clinically significant 
psychopathology that fails to achieve diagnostic significance using conventional 
criteria.
4.7. Ethical Issues
4.7.1. Ethics Committee Approval
Local Area Ethics Committee approval was sought and obtained both in King’s Lynn 
and in Bradford. In King’ Lynn, the GP Principal in St. James’ House Surgery Dr. 
Keith Redhead was a co-applicant, and in Bradford the Consultant Neurologist 
heading the Bradford Epilepsy Service, Dr. Nigel Hakin, was a co-applicant.
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4.7.2 C'on.sciil
Procedures for informed consent were followed carefully. Subjects were sent an 
invitation to participate and an information sheet (Appendix- section 9.8). The 
information in these was verbally reiterated by the RA who also provided 
clarifications if any were required. This investigator contacted those subjects 
requiring further clarifications. All subjects completed and signed consent forms in 
the presence of the RA, and these were witnessed by another person- either an 
accompanying relative/friend/carer of the subject, or a member of the surgery staff.
4.7.3. Confidentiality
Data was entered directly into the statistical program for social sciences (SPSS) 
windows version 10.0. Data was code and password protected with only this 
investigator and RA able to access data files.
4.7.4. Rewards and Inducements
Taxi fares were reimbursed for all patients who attended research appointments in the 
GP surgery in exchange for receipts. Patients seen at home did not receive any 
financial reimbursement. While participation lead to a discussion of clinical issues 
and on occasion a review of clinical care with the concerned GP principal or 
consultant as appropriate, no special inducements in terms of patient care were 
offered in advance of patient assessment.
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4.7.5. Clinical Issues
A decision was made at the outset of the study that if subjects were identified to have 
clinically significant psychiatric symptoms this would be brought to the attention of 
their GP, for appropriate action. Informed consent was obtained on this basis. In both 
locations community mental health teams were informed about the proposed study 
and the possibility that an increased throughput of referrals may be expected during 
the course of this study. Arrangements were also set in place to deal with psychiatric 
emergencies if  any were to emerge during the study process.
4.8. Statistical Methods
Data was entered on to the statistical program for social sciences (SPSS) WINDOWS 
version 10.0. All analysis was carried out using SPSS for WINDOWS version 10.0
Psychiatric measures used were considered in the following categories for the 
purpose of meaningful comparison. The GHQ-28 and HADS were considered as 
generic screening measures used widely in psychiatric research, the former in 
population studies and the latter mainly in hospital-based studies. The CIS-R was 
considered a generic diagnostic instrument that generates ICD-10 diagnosis of 
common mental disorder. The NBl was considered an epilepsy specific measure of 
psychopathology.
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I wo gold standards measures ol ps\ehiatrie cascness were used in this study.
I he Collins English Dictionary (1984) defines a gold standard as ‘ a monetary system 
in which the unit of currency is defined with reference to gold ’. In clinical science 
and epidemiology, gold standard is used to imply a measure of such standard that 
other measures could be compared with or alternately aspire to match.
At the first level of comparison, the screening instruments HADS & GHQ-28 were 
compared with the structured clinical interview the CIS-R, which can be used to 
generate ICD-10 criteria based psychiatric diagnosis. In the next level of comparison, 
HADS, GHQ-28 & CIS-R were compared against the ICD-10 diagnosis based ratings 
of psychiatric caseness derived from the PSt interview. These instruments were also 
then compared with a clinical significance gold standard.
4.8.1. The Clinical Significance Gold Standard
As conventional psychiatric diagnostic criteria have been deemed insensitive to 
identifying Neuropsychiatrie disorders in epilepsy, we decided to assume a clinical 
significance gold standard in addition to the ICD-10 diagnosis based gold standard. 
The clinical significance gold standard was a decision on psychiatric caseness made 
based on multiplicity of symptoms. If  the participant reported 3 or more symptoms in 
one symptom category in the PS E/SCAN (for e.g., anxiety) then they were considered 
to be a case. This kind of decision-making based on operational rules has precedence 
in psychiatric research, and in particular was used in the WHO primary care study of 
psychological disorders (Ustun & Sartorius, 1995).
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Wc there lore compared in stages;
( I ) Cases and controls across Cîl IQ-28, HADS and CIS-R using 
independent samples /-test for continuous measures and the chi- 
square test with Yates correction and Fisher’s exact test for 
categorical data. Symptom categories across measures were 
compared using Spearman correlations. A paired samples t-test was 
employed to compare cases and controls.
(2) Cases were further assessed by comparing GHQ-28, HADS and 
CIS-R data with the two gold-standard measures of psychiatric 
caseness- ICD-10 diagnosis generated from the SCAN interview, 
and the clinical significance gold-standard. ROC analysis 
(described below) was used to study these associations and to 
establish sensitivity, specificity, and optimal cut-off scores to 
determine psychiatric caseness in epilepsy in each of the 
instruments.
(3) NBl patient and carer scales were also subjected to a range of 
comparisons. First both patient and carer scores were compared 
with CIS-R and the two gold standard measures for psychiatric 
caseness to determine cut-off scores in this population. Second, 
NBl patient and carer scales were compared for agreement in 
symptomatology.
In depth analysis comparing the performance of different instruments against “gold- 
standard” measures was assessed using Receiver Operating Characteristics (ROC) 
analysis. Details of this procedure are reviewed here.
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4.x.2. Receiver Operating Characteristics (ROC ) Analysis
This technique was originally developed for use with radar to separate observed 
variability from innate detectability of a signal (Swets, 1964). It produces a curve, 
which has been described as “a function, which summarises all possible noise”. It is 
thought to be particularly useful in epidemiological research, and several investigators 
have used this form of analysis in psychiatry (Goldberg & Williams, 1998).
This technique can be used to assess the ability of a screening instrument to 
discriminate between “cases” and “non-cases” using different threshold scores (i.e., 
the discriminating ability of an instrument across the total spectrum of morbidity, 
rather than limiting the scope of a validation study by presenting the sensitivity and 
specificity at a single chosen threshold score), and it has the advantage of enabling 
clinicians to compare the relative performance, in terms of discriminating power, of 
two or more competing screening instruments.
To apply this technique, true positive rate (sensitivity) and false positive rate 
( I -specificity) are calculated from the contingency tables drawn up for each possible 
threshold score. By plotting these against each other for each threshold score, a graph 
is constructed and the area under the ROC curve summarises the discriminating 
performance. The area can vary from 0.5 (a test with no useful discrimination) to 1.0 a 
test with perfect discrimination.
A Synopsis of the study methods in flow chart form is presented in the 
following pages.
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Study I : Primary Care - Cases
Identification of cases with 
Active epilepsy
Telephonic interview for 
Exclusion criteria
G H Q -2 8 ;  HADS; 
SHE; NBl
First phase assessment by RA 
Including M M SE
1 r
C I S - R ; PSQ; NHS3
(ICD-10)
*1*  Second phase assessment in 30 days
*1*  Confirm diagnosis of epilepsy
❖ SCAN by blinded Investigator
50 - Refused (26%)
^ 60 - No response (31 %]
6 - Dropped out (7.2%) 
❖ 7 - Excluded
11 - Did not complete
Primary diagnosis on CIS - R 
Secondary diagnosis on CIS - R
8 - PSQ Positive
2------^  Dropout
I ------► Hospital
I ------► Terminated
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Study I  : Primary Care - Controls
Identification of Controls
r
111 Controls 
Response to G HQ  -  28 &  HADS
T
Followed By 
Phase assessment RA 
(Including M M SE)
CIS -  R; PSQ; NHS3
Total - 582
Refused - 139(23.9%)
No Response after 3 invitation - 300 (51.5%) 
Dropped out at^ er accepting - 32 (5.5%)
-► 8 - Primary diagnosis on CIS - R 
-► 0 - Secondary diagnosis on CIS - R
4 - PSQ Positive
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5. RKSULTS I ROM I NK PRIMARY ( ARK SI UDV
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5.1 Demography & Response Rates
5.1.1. Subjects
A total of 193 subjects with epilepsy were identified to meet inclusion criteria for the 
study and invited to take part. Of these 83 subjects (43%) accepted the invitation to 
participate. Fifty subjects (26%) refused, and no response was received despite three 
letters of invitation in 60 cases (31%).
Of those who accepted, 6 subjects (7.2%) dropped out after initial acceptance, 
and 7 (8.4%) met exclusion criteria when interviewed in phase I and were thus found 
to he unsuitable. A further 11 (13.3%) did not complete the study. 59 of the 83 who 
initially agreed to take part (71.1%) completed the study and form the case group.
5.1.2. Controls
A total of 582 controls were identified and invited to take part in the five practices. 
The selection and invitation of controls took place in two stages in each surgery as 
described in the methods section (4.4.4.1, pg. 160). 143 (24.5%) of those invited 
agreed to participate, and 139 (23.9%) refused. 300 of 582 subjects (51.5%) failed to 
respond after three letters of invitation. Of the 143 who initially agreed to participate, 
32 (22.4%) dropped out. 111 of 143 control subjects who originally accepted (77.6%) 
our invitation, took part in the study and form the control group.
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I 11 population based controls (at least one per case) were recruited to take 
part in this study. While the case-eontrol study was originally designed for matched 
pairs, we could not for all cases manage to recruit two, or for some cases even one 
suitably matched control (next person of the same age and sex in the GP register). 
Therefore, in general we carried out unmatched analyses. We did, however, have 51 
closely matched pairs and for this subset of participants we tested the main hypothesis 
using appropriate statistical tests, taking account of the matching.
Table-2 details response rates by setting.
Table 2, GP surgeries & response rates.
Surgery
No.
Invited
No.
accepted
No. of 
dropouts
No.
unsuitable
No. who 
did not 
complete
No. of 
refusals
No
response
KING’S 
LYNN St. 
James’ 
House
Patients 60 36 1 5 2 14 10
Controls 200 50 3 0 0 45 105
Southgate
Patients 30 15 3
6
0
0
4 6 9
Controls 60 20 0 10 30
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BRADI-ORD
Wilsden
30 10 10 ^Patients 10 2 0 1
Controls 60 15 5 0 0 28
Ridge
Patients 48 12 0 0 2 r 14 1 22
Controls 164 38 12 0 0 40 86
Girlington
Patients 25 10 0 2 2 6 9
Controls 98 20 6 0 0 27 51
Fifty-nine subjects from general practice case-registers for epilepsy and 111 controls 
from the same practices were identified as meeting inclusion criteria for the study. 
Thirty of these subjects with epilepsy (50.8%) came from the two practices in King's 
Lynn, and the remaining 29 from the three practices in Bradford. 61 of the control 
subjects (55.0%) came from the two practices in King's Lynn, and the remaining 50 
controls from the three practices in Bradford.
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5 13. C omparisons between Study Locations
When the two locations were compared:
• The acceptance rate (patients who responded to invitation and agreed to take 
part):
- For patients 51/90 (56.6%) in King’s Lynn and 32/103 (31.1%) in 
Bradford (Chi Square (Yates corrected) = 11.82; p= 0.006)
- For controls 70/ 260 (26.9%) in King’s l.ynn and 73/ 322 (22.6%) in 
Bradford (Chi Square (Yates corrected) = 1 .18; p= 0.28)
• The refusal rate (patients who were contacted and refused to take part):
- For patients 20/90 (22.2%) in King's l ynn and 30/103 (29.1%) in 
Bradford (Chi Square (Yates corrected) = 0.86; p= 0.36)
- For controls 55/260 (21.2%) in King’s Lynn and 84/322 (26.1%) in 
Bradford (Chi Square (Yates corrected) = 1.66; ;?= 0.19)
• The non-responder rate (patients who did not respond to 3 invitations):
- For patients 19/90 (21.1%) in King’s Lynn and 41/103 (39.8%) in 
Bradford (Chi Square (Yates corrected) = 6.99; p= 0.008)
- For controls 135/260 (51.9%) in King’s Lynn and 165/322 (51.2%) in 
Bradford (Chi Square (Yates corrected) = 0.01 ; p= 0.93)
• The drop out rate (after having agreed to take part):
- For patients 4/51 (7.8%) in King’s Lynn and 2/32 (6.3%) in Bradford 
(Chi Square (Yates corrected) = 0.03; p= 0.87)
- For controls 9/70 (12.9%) in King’s Lynn and 23/ 73 (31.5%) in 
Bradford (Chi Square (Yates corrected) = 6.12; p= 0.01 )
• The non-completion rate (attended hut could not complete interview):
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I or palicnls 6/47 ( 12.8%) in King's Lynn, and 5/30 (16.7%) in 
Bradford (Chi Square (Yates corrected) = 0.02; p= 0.89)
- No controls failed to complete the study in either location
Patients with epilepsy were significantly more likely to agree to take part (/;=0.006), 
and to respond to the invitation (/?=0.008) in King's Lynn than in Bradford. Control 
subjects in Bradford were significantly more likely to drop out, having agreed to take 
part (/y=O.OI). There were no other differences between the two populations in terms 
of response.
We could not examine further associations between failure to respond, age, 
gender, social class, co-morbid illness etc. not having collected this data at the time 
the study was carried out. This was partly due to local reasons with practitioners in 
both King's Lynn and Bradford being keen that we did not a. contact individuals 
directly unless they responded to the initial invitation and b. not include data on 
individuals who had not given informed consent to be thus included.
5.1.4. Age
At the time of the study, the youngest participant with epilepsy was 2 1 years old, and 
the oldest 70 years old. The youngest person in the control group was 20 years old, 
and the oldest 69 years old. The mean patient age was 46.6 years and the mean control 
age 49.8 years. The median patient age was 46.0 years and the median age for 
controls 50.0 years. When patient and control groups were compared for age overall,
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no statislical dilTcrcnccs were round between patient (mean 46.6 years) and control 
(mean 49.8 years) groups (/;=0.483).
5.1.5. Sex
There were 29 females and 30 males in the patient group; and 51 females and 60 
males in the control group. There were no statistically significant differences between 
the two groups (Chi Square- Yates Corrected= 0.06; /?= 0.81 ; 0R= 0.88).
5.2. Common Mental Disorders in Patients with Epilepsy and Controls
5.2.1. CIS-R in Patients and Controls
Derived from the CIS-R (and based therefore on ICD-10 criteria), 11 of 59 cases w ith 
epilepsy (18.6%) had a primary psychiatric diagnosis (CMD). In comparison 8 of 111 
subjects (7.2%) in the control group were identified to have a primary psychiatric 
diagnosis (CMD) the difference being statistically significant (Chi Square Yates 
Corrected= 3.99;p=0.045; 0R= 2.95 (1.02-8.68)). The primary psychiatric diagnosis 
in the patient and control groups, are detailed in Table 3.
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Table 3. Primary psychiatric diagnosis
Subject group
Total
Controls Patients
Mild depressive episode 2 1 3
Mixed disorder 6 4 10
Primary Moderate Depressive episode 1 1
psychiatric Specific (isolated) phobia 1 1
diagnosis Obsessive -compulsive disorder 2 2
Severe depressive episode (F32.2) 1 1
Social phobia 1 1
No diagnosis identified 103 48 151
Total I I I 59 170
Six of 59 patients with epilepsy and none of the controls had a secondary psychiatric 
diagnosis, the difference being statistically significant (Chi Square Yates Corrected- 
8.90; Fisher’s Exact Testp=  0.001 (two tailed)). The secondary psychiatric diagnoses 
were agoraphobia (I), mild depressive episode (I), mixed disorder (1), obsessive- 
compulsive disorder (I), panic disorder ( I ), social phobia (I); figures in brackets 
indicating patient numbers affected.
We compared mean total scores on the CIS-R between patient and control 
groups, using the independent samples /-test. There was a significant difference 
between the two groups, patients with epilepsy having a mean score of 8.85 when
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compared with ihc conlrol mean ol 4.51 (f= -2.729; /;= ().()()8: Mean dilTerence -4.33; 
Cl; 1.17 10-7.49).
As described earlier, while the case-control study was designed for matched 
pairs, we did not in fact manage to recruit two matched controls (next person of the 
same age and sex in the GP register) for each subject. We did have however 51 
matched pairs (persons with epilepsy and matched controls) and examined if the 
difference was significant in the two groups using the McNemar Chi Squared test. 
Patients with epilepsy were notably more likely to suffer from a common mental 
disorder, however this trend did not quite reach statistical significance (OR=4.0 Cl 
0.9-18.8; p= 0.06; Chi Sq 1 DF= 3.6).
Differences in the pattern of common mental disorder symptoms between the 
epilepsy and control groups were compared using the independent samples /-test. 
Patients with epilepsy were more likely to suffer from poor concentration (/?=0.003); 
depression {p= 0.006); worry (p= .009); worry over physical health (p=0.05); 
compulsions (/t=0.036). Irritability, depressive ideas and anxiety approached but 
failed to achieve significance. There were no other statistically significant differences 
in terms of CIS-R symptoms the results being expressed in Table 4 and Figure 1.
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Table 4. CIS-R symptoms in patients and controls.
CIS-R
Symptoms
/ Df
Sig. (2- 
tailed)
Mean
Difference
Std.
Error
95% Cl
Lower Upper
Somatic
symptoms
-0.54 168.0 0.591 -0.08 0.15 -0.37 0.21
Worry over 
physical health
-1.99 82.1 0.050 -0.29 0.15 -0.58 0.00
Fatigue -1.00 168.0 0.321 -0.23 0.23 -0.70 0.23
Sleep problems -0.86 168.0 0.392 -0.16 0.19 -0.53 0.21
Irritability -1.88 94.9 0.063 -0.37 0.19 -0.75 -0.02
Poor
concentration
-3.06 90.2 0.003 -0.50 0.16 -0.82 -0.18
Depression -2.80 71.7 0.006 -0.43 0.15 -0.73 -0.12
Depressive
ideas
-1.84 83.9 0.069 -0.39 0.21 -0.81 -0.03
Phobias -1.51 168.0 0.132 -0.12 0.07 -0.27 0.03
Worry -2.66 84.5 0.009 -0.49 0.18 -0.85 -0.12
Anxiety -1.88 87.7 0.063 -0.35 0.19 -0.73 0.02
Panic -1.56 168.0 0.120 -0.14 0.08 -0.31 0.04
Compulsions -2.13 68.2 0.036 -0.24 0.11 -0.47 -0.02
Obsessions -1.462 168.0 0.146 -0.22 0.15 -0.52 0.08
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Figure 1. CIS-R symptoms stratified by primary psychiatric diagnosis.
specific (isolated) 
phobia
social photWa
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severe depressive ep 
isode (F32.2)
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mild depressive epis 
ode-10
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Subject group
5.2.2. Common Mental Disorders: Comparisons between Screening and Diagnostic 
Measures in Patients and Controls
Figs 2-9 (histograms) depict the distribution of scores in the two screening measures, 
GHQ-28 & HADS, and the structured diagnostic measure the CIS-R, in both patient 
and control groups.
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Figure 2. Histogram depicting GHQ total scores in population-based controls
Histogram depicting GHQ total scores 
in population based controls
std Dev = 12.33 
Mean « 19.5
N - 56.00
5 0  15.0 25 0 35 0 45 0 55 0
100 20.0 30.0 40.0 5 0 0  60.0
GHQ Total Score
Figure 3. Histogram depicting the GHQ total scores in patients with epilepsy.
Histogram depicting GHQ total scores in
patients with epilepsy
40
Std. Dev = 9.13 
Mean = 16.2 
N = 111 00
5.0 15.0 25.0 35.0 45.0 55.0
10.0 20.0 30.0 40.0 50.0 60.0
GHQ Total Score
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Figure 4. Histogram depicting HADS Anxiety scores in population-based controls.
Histogram depicting HADS Anxiety scores 
in population based controls
14
12
10
8
6
4
Std Dev -  5.25 
Mean ■ 6 7 
N - 5 5  00
2
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HADS Anxiety Raw score
Figure 5. Histogram depicting HADS Anxiety scores in patients with epilepsy.
Histogram depicting HADS Anxiety scores in 
patients with epilepsy
40
Std. Dev = 4.03 
Mean = 5.2 
N = 111.00
0.0 2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0
HADS Anxiety Raw score
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Figure 6. Histogram depicting HADS Depression scores in patients with epilepsy.
Histogram depicting HADS Depression scores 
in patients with epilepsy
std Dev = 2.56 
Mean = 3.2
N -  111.00
0.0 2.0 4 0  6 0  8.0 10.0 12.0
HADS Depression Raw score
Figure 7. Histogram depicting HADS Depression scores in population-based 
controls.
Histogram depicting HADS Depression scores 
in population based controls
std. Dev = 4.73 
Mean = 4.2
N - 55.00
0.0 2.5 5.0 7.5 to o  12.5 15.0 17.5 20.0
HADS Depression Raw score
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Figure 8. Histogram depicting CIS-R total scores in patients with epilepsy.
Histogram depicting CIS-R total scores 
in patients with epilepsy
std. Dev .  6.63 
Mean = 4,5
N = 111.00
0.0 5.0 10.0 15,0 20.0 25.0 30.0 35.0
Clinical Interview Schedule - Revised: Total Score
Figure 9. Histogram depicting CIS-R total scores in population-based controls.
Histogram depicting CIS-R total scores 
in population based controls
Std Dev = 11,20 
Mean = 8.8 
N = 59.00
0.0 5.0 10.0 15.0 20,0 25.0 30.0 35.0 40.0 45.0 50.0
Clinical Interview Schedule - Revised: Total Score
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In line wilh prcdiclion. both case and conlrol group scores are positively skewed, 
indicating that a greater proportion ok subjects irrespective of group have below 
average scores on these measures, with a minority recording markedly high levels of' 
morbidity.
We compared GHQ-28 total scores and HADS Anxiety and Depression raw 
scores in patient and control groups, using the independent samples /-test.
The mean GHQ total score was 19,5 in the patient group, and 16.2 in the 
control group; the difference of 3.3 points narrowly failed to achieve statistical 
significance (/= 1.793; p= 0.08; CI= -7.0-0.4).
When the scaled GHQ-28 responses were compared in patients and controls 
across the four constituent scales: somatic symptoms, anxiety and insomnia, social 
dysfunction, and depression; only somatic symptoms were found to he significantly 
more common in the cases (mean= 5.6) than controls (mean= 3.9) (/= 2.7; p= 0.007; 
Cl: -2.9 to -.5). There was a non-significant trend for difference between cases and 
controls in the anxiety and insomnia sub-scales (/= -1.9;/?= 0.06; Cl; -2.9 to 6.9).
The mean HADS- Anxiety raw score was 6.7 in cases and 5.2 in controls; this 
difference also approached hut failed to achieve significance on the independent 
samples /-test (/= -1.83; p= 0.07; CI= -3.1 to 0.1). The mean HADS- Depression raw 
scores were 4.2 in cases and 3.2 in controls, the difference of 1.0 not being significant 
(/= -1.5; p= 0.14; Cl= -2.4 to 0.3).
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We compared cases as delecled hy ihe I IADS Aii\iel\ and Depression sub- 
scales in patient and control groups using the Chi Square test. 13 of 55 (23.6%) of 
cases and II of 111 (9.9%) of controls were identified as cases on the HADS Anxiety 
sub-scale using the published cut-off score of 8 and above as being positive, the 
ditTerence being statistically significant (corrected Chi Square= 4.6; Fisher’s Exact 
test p= 0.03 two tailed). Six of 55 (10.9%) cases, and 2 of 111 (1.8%) controls were 
identified as cases on the HADS Depression sub-scale, the difference being 
statistically significant (corrected Chi Square= 4.8; Fisher’s exact test p= 0.02 two 
tailed).
5.2.2.1. Comparison between Generic Screening Measures (GHQ-28 & HADS) and 
the Diagnostic Measure (CIS-R) in Cases and Controls
We examined non-parametric correlations between the screening instruments for 
CMD, GHQ-28 (total score) and HADS (anxiety and depression raw scores), and the 
gold-standard structured diagnostic instrument, ClS-R (total score) separately in both 
patients with epilepsy and controls. While the spearman correlations were generally 
significant at thep= 0.01 level (Tables 5 & 6), there was generally greater agreement 
between the instruments in controls as compared to cases.
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Table 5. Non-paramclric corrclaliDiis bclwccn screening and diagnostic instruments in
population-based controls.
GHQ
HADS
Anxiety
HADS
Depression
CIS-R
GHQ total 
score
Correlation
Coefllcient
1.00 0.75 0.75 0.81
Sig. (2-tailed) <0.001 <0.001 <0.001
HADS
Anxiety
Correlation
CoelTicient
1.00 0.77 0.78
Spearman's raw score Sig. (2-tailed) <0.001 <0.001
RHO HADS
Depression
Correlation
Coefficient
1.00 0.76
raw score Sig. (2-tailed) <0.001
CIS-R; 
Total score
Correlation
Coefllcient
1.000
Sig. (2-tailed)
202
Table 6. Non-paramclric corrclalions between screening and diagnostic instruments in
patients with epilepsy
GHQ
HADS
Anxiety
HADS
Depression
CIS-R
GHQ Total Correlation Coefficient
1.000 0.49 0.51 0 53
Score
Sig. (2-tailed) <0.001 <0001 <0.001
HADS Correlation Coefficient 1.000 0.60 0.50
Spearman's
Anxiety 
Raw score
Sig. (2-tailed)
<0.001 <0.001
RHO
HADS Correlation Coefficient 1.000 0.45
Depression 
Raw score
Sig. (2-tailed)
<0.001
CIS-R: Correlation Coefficient 1.000
Total Score Sig. (2-tailed)
5.2.3 ROC Analysis comparisons of screening measures with the diagnostic measure 
(CIS-R) in patients with epilepsy and controls
We tested the ability of the screening instruments, GHQ-28 and HADS, to 
discriminate psychiatric cases from non-cases, when compared to the gold-standard 
structured clinical instrument, the CIS-R, in both epilepsy and control groups. CIS-R 
caseness was decided based on the recommended cut off value of 12 (Lewis G, 1992). 
The total GHQ-28 score, the HADS Anxiety raw score and the HADS Depression raw
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score were compared using Receiver Operating Characteristics Analysis (Section 
4.8.2; pg. 178).
Of 55 patients with epilepsy in whom complete data on all instruments was 
available, 40 were non-cases on CIS-R and 15 were cases. GHQ-28 and HADS 
Anxiety and Depression scales were comparable as measures of psychiatric caseness, 
when compared to the CIS-R gold standard. Fig-10 and Table-7 depict and detail the 
area under the curve for GHQ-28 and HADS Anxiety and Depression sub-scales.
Figure 10. ROC Curve comparing GHQ-28 & HADS with CIS-R as gold standard in 
patients with epilepsy.
ROC Curve
1.00
.75
Source of the Curve
“ Reference Line.50
°  HADS Depression Raw 
score
“ HADS Anxiety Raw SCO
1 “ GHQ Total Score0.00
1.000.00 25 .50 .75
1 - Specificity
Diagonal segments are produced by ties
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Tahie 7. Area under the ROC eurve comparing (il IQ-28 and I IADS 
with the CIS-R Gold Standard in patients with epilepsy.
Area Std. Error Asymptotic 95% Cl
Test result variable(s) Lower
bound
Upper
bound
GHQ total score 0.95 0.03 0.88 1.00
HADS Anxiety raw score 0.93 0.03 0.87 1.00
HADS Depression raw score
0.93 0.03 0.86 0.99
Of 11! controls, 99 were non-cases on CIS-R and 12 were cases. GHQ-28 and HADS 
Anxiety and Depression scores were compared as described above, as measures of 
psychiatric caseness. Fig-11 and Table-8 depict and detail the area under the curve for 
GHQ-28 and HADS Anxiety and Depression sub-scales.
205
Figure I I .  ROC Curve comparing GHQ-28 & HADS with CIS-R as gold standard in 
population based controls.
ROC Curve
1.00
.75
Source of the Curve
°  Reference Line.50
°  HADS Depression Raw 
score
Î ”
w 0.00
°  HADS Anxiety Raw sco
o GHQ Total Score
0.00 .25 .50 .75 1.00
1 - Specificity
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Table 8. Area under the ROC curve area under the ROC curve comparing 
GHQ-28 and HADS with the CIS-R gold standard in controls.
Area
Std.
Error
Asymptotic 95% Cl
Test result variable(s) Lower
bound
Upper
bound
GHQ total score 0.86 0.08 0.70 1.00
HADS Anxiety raw score 0.91 0.04 0.84 0.99
HADS Depression raw score 0.91 0.05 0.82 1.00
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I he cul-olTscores in Table 9 achieved the best maleh ol sensilivily and speeillcily, 
w ith lower scores in the control group generally being discriminative of psychiatric 
caseness, when compared with the patient group. The scores that simultaneously 
optimised sensitivity and specificity were chosen as the optimal cut point.
Table 9. Cut-off values for GHQ-28, HADS-Anxiety and HADS-Depression.
Case Control
Scale Cut Sensitivity Specificity Sensitivity Specificity
point (%) (%) (%) (%)
16/17 86.7 77.5 83 3 76.8
17/18 83.3 79.8
GHQ-28 18/19 75 82.8
19/20
20/21
21/22 80.0 85.0
22/23 80.0 87.5
23/24 80.0 92.5
24/25 80.0 95.0
26/27 80.0 97.5
27/28 73.3 97.5
6/7 93.3 72.5 91.7 73.7
HADS-A
7/8 93.3 77.5 83.3 85.9
8/9 93.3 80.0 75.0 90.9
9/10 80.0 87.5
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3/4 100.0 75.0 91.7 73.7
IIADS-D
4/5 86.7 82 5 91.7 83.8
5/6 73.3 87.5 83.3 89.9
6/7 66.7 93.9
5.2.4. Psychotic Symptoms in Patients in Controls
Eight of 59 patients and 4 of 111 controls were rated positive on the psychotic 
symptom questionnaire, the dift'erence being statistically significant on the Chi Square 
test (Chi Square; Yates Corrected- 4.4; Fisher's exact test p= 0.025, two tailed; 0R= 
4.20; 95% Cl 1.2-14.6).
53. Psychiatric Disorders in Patients with Epilepsy
As the cases (patients with epilepsy) had also been administered the SCAN and NBI 
measures, we proceeded to examine the response to these measures and compared the 
same with the generic screening and diagnostic measures described in the previous 
sections.
5.3.1. Psychiatric symptoms as rated using the PSE components of the SCAN
Fifty-five of 59 patients completed the SCAN interview. Of the remaining four 
subjects, two failed to attend the second stage interview despite being contacted on 
three separate occasions, and two others could not complete the interview, one due to 
serious physical illness resulting in hospitalisation and subsequent failure to recover
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adcqiialely, and the other requested termination because the content was distressing to 
her.
Depressive and anxiety disorders were the most common ICD-10 psychiatric 
disorders overall in this population, with psychoses, mania/cyclothymia, alcohol and 
substance abuse, and somatoform disorders being relatively uncommon. ICD 
diagnosis (broad categories) identified in this patient sample are shown in Table 10
Table 10. ICD-10 Diagnostic C ategories in patients with epilepsy.
ICD diagnostic category Number rated positive (n=55) (%)
Alcohol & substance abuse 2 3.6
Psychoses I 1.8
Mania/cyclothymia I 1.8
Depression 12 21.8
Anxiety/ other neurosis 10 18.2
Somatisation 2 3.6
Eating, sleep, sexual dysfunction 5 9.1
Any ICD diagnosis 16 29.1
As described previously, we also rated clinically significant PSE symptoms in this 
population. Impaired biological functioning (weight, appetite, sleep, sexual 
functions); anxiety and phobic disorders; depression (including dysthymic symptoms)
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VNcrc common, while symptoms oI psychoses, obsessions and compulsions, alcohol 
and substance abuse were uncommon in this population. PSli symptoms rated by the 
investigator to be clinically significant” are shown in Table 11.
Table 11, Clinically significant psychiatric symptoms in patients with epilepsy.
PSE Symptom
Number clinically | 
significant N=55 |
(%)
Somatoform symptoms 10
1
18.2
Worry 16 1
i
29.1
Anxiety & panic 16 29.1
Phobia 15 27.3
Obsessions 3 5.5
Depression 10 18.2
Persistent depressive symptoms 8 14.5
Impaired thinking, concentration, interests 13 23.6
Impaired weight, appetite, sleep, sexual function 19 34.5
Eating disorder symptoms 4 7.3
Symptoms of hypomania, mania, cyclothymia 2 3.6
Alcohol abuse 2 3.6
Substance abuse 1 1.8
Psychosis 3 5.5
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5.3.2. “Clinical Significance' and IC'D-10 Diagnosis as Measures of fs)chiatrie 
Caseness
We examined agreement between psychiatric caseness derived via ICD-10 diagnosis 
(i.e., ICD-10 criteria were met) and psychiatric caseness derived by the clinical 
significance ratings (psychiatric caseness decided on the basis of 3 or more symptoms 
in one category being present-described earlier herein). The kappa for the agreement 
between caseness based on PSE symptoms and caseness based on ICD diagnosis was 
0.762.
5.3.3. Agreement between CIS-R and SCAN Ratings
We examined agreement between psychiatric caseness ascertained via CIS-R using 
ICD-10 diagnostic criteria and psychiatric caseness ascertained via SCAN using ICD- 
10 diagnostic criteria. The kappa for the agreement between psychiatric caseness 
based on CIS-R derived ICD-10 diagnosis and PSE/SCAN derived ICD-10 diagnosis 
was 0.604.
5.3.4. Agreement between CIS-R and “Clinical Significance” Ratings
We also examined agreement between psychiatric caseness derived from CIS-R using 
ICD-10 criteria and psychiatric caseness as defined by clinical significance ratings. 
The kappa for agreement between CIS-R derived ICD-10 criteria and PSE/SCAN 
derived ratings of clinical significance was 0.417.
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5.3.5. Performance of the GHQ-28, HADS & CIS-R against the ICD-10 and “Clinical 
Significance’ Gold-Standards
We used receiver operating characteristics (ROC) analysis to study the relative ability 
of the screening instruments GHQ-28 and HADS, and the structured diagnostic 
instrument CIS-R to discriminate psychiatric cases and non-cases when compared to 
the gold-standards: SCAN derived ICD-10 criteria based diagnosis and clinical 
significance ratings of psychiatric caseness. Figures 12 & 13 depict the ROC curves, 
and Tables 12 & 13 the area under the curve for ICD-10 diagnosis and caseness based 
on PSE clinical significance respectively.
Figure 12. ROC curve comparing screening and diagnostic measures with ICD-10 
diagnosis derived by SCAN interview in patients with epilepsy.
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Table 12. Area under the ROC curve comparing the performance of screening and 
diagnostic measures against the ICD-10 diagnosis gold standard.
Area Std. 
Error
Asymptotic 95% 
Confidence Interval
Test result variable(s) Lower
Bound
Upper
Bound
Clinical Interview Schedule - Revised: 
Total Score
0.90 0.06 0.80 1.00
HADS Anxiety Raw score 0.85 0.05 0.75 0.96
HADS Depression Raw score 0.88 0.05 0.79 0.98
GHQ Total Score 0.85 0.06 0.73 0.98
Figure 13. ROC curve comparing screening and diagnostic measures with psychiatric 
caseness derived from PSE clinically significant symptom ratings.
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Table 13. Area under the ROC' curve comparing the perlbrmanee of screening and 
diagnostic measures against the clinical significance gold standard in patients with 
epilepsy.
Area
Std.
Error
Asymptotic 95% confidence 
interval
Test result variable(s) Lower bound Upper bound
Clinical interview schedule - 
revised; l otal score
0.92 0.05 0.84 1.00
HADS Anxiety raw score 0.89 0.04 0.81 0.98
HADS Depression raw score 0.85 0.06 0.74 0.96
GHQ total score 0.83 0.06 0.71 0.95
In both cases the CIS-R performed best in relation to the gold standard, followed by 
HADS scales and GHQ-28, in that order. The area under the curve is greater with the 
clinical significance gold standard, as compared with the ICD-10 diagnostic criteria 
based gold standard.
Comparing measures with the two gold standards it becomes apparent that the 
cut-off scores are generally higher (except for the HADS depression scale) with the 
ICD-10 diagnostic criteria based gold standard, and match those generally 
recommended in the published literature for the aforementioned instruments. 
However, with the clinical significance gold standard, lower cut-off scores generally
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i csull ill Ihc best malch o f  sensilivily and speciHcil>. The implicalions o f these 
llndings w ill be addressed in the discussion section. The range o f  scores, sensitivity 
and specificity figures are given in Table 14 with the recommended cut-o ff values 
derived from optimal matching o f  sensitivity and specificity, with each instrument, 
being underlined.
Table 14. Sensitivity, specificity and cut-off values, of GHQ-28, HADS, and CIS-R, 
against the 2 gold standards. Clinical Significance diagnosis, and ICD-10 diagnosis.
Score (CS Sensitivity Specificity Score Sensitivity Specificity
Scale diagnosis) (%) (ICD
diagnosis)
(%) (%)
18/19 75.0 71.0 17/18 86.7 69.4
GHQ
19/20 70.0 71.0 19/20 80.0 69.4
20/21 70.0 74.2 20/21 80.0 77.2
21/22 60.0 80.6 21/22 1 66.7 77.8
5/6 85.0 74.2 5/6 80.0 63.9
6/7 80.0 74.2 6/7 73.3 63.9
HADSA m 80.0 80.6 7/8 73.3 69.4
8/9 75.0 80.6 8/9 73.3 72.2
9/10 9/10 66.7 83.3
2/3 80.0 64.5 2/3 86.7 61.1
HADSD 3/4 80.0 77.4 % 86.7 77.2
4/5 70.0 87.1 4/5 73.3 80.6
CIS-R 5/6 90.0 80.6
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6/7 90.0 87.0 6/7 93 3 77.8
7/8 80.0 87.0 7/8 80.0 77.8
8/9 9/10 80.0 88.9
9/10 11/12 80.0 94.4
10/11 12/13 73.3 94.4
5.3.6. Performance of the Psychotic Symptom Questionnaire against the ICD-10 and 
“Clinical Significance” Gold Standards
Although CMD were the focus of our study, we applied the psychotic symptom 
questionnaire as a screening instrument for psychosis. Even a single positive response 
among five responses, is considered to be positive for psychosis on this measure.
Eight of 59 subjects were rated as PSQ positive.
We compared the psychotic symptom questionnaire as a screening measure of 
psychiatric caseness with the two gold standards: SCAN derived ICD-10 criteria 
based diagnosis of psychosis and “clinical significance” ratings. Three of 55 subjects 
interviewed were rated as having clinically significant psychotic symptoms, in 
comparison to one of 59 subjects receiving an ICD-10 diagnosis of psychosis. The 
kappa for agreement between PSQ positive ratings and comparative measures were 
ICD-10 criteria derived overall caseness (0.380); PSE/SCAN clinical significance 
ratings derived overall caseness (0.322); ICD-10 psychosis diagnosis (-0.033); 
PSE/SCAN clinical significance derived psychosis diagnosis (0.309). The agreement 
between PSQ ratings and criteria based as well as clinical significance based ratings 
was therefore generally poor.
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5.4. Psychiatrie Disorders Spécifié to Kpilcpsy: Results Iroiu the 
Neurobehavioral Inventory (NBI) for Epilepsy
NBI total score data were available on 46 subjects, missing values (due to non­
completion of sections) being replaced with a zero score in 4/46 sub jects. The mean 
NBI total score on the patients scale was 24.4 and the mean for the carer scale 
(personal behaviour survey) was 23.1. The median value for both patient and carer 
scales, was 16.
5.4.1. Agreement between Patient/Carer Ratings on the NBI
The intra-class correlation coefficient between NBI patient and carer scales was 0.76 
(significant at the p=O.OI level), thus indicating reasonable agreement between NBI 
patient and carer scales.
5.4.2. The NBI as a Measure of Generic Psychiatric Caseness
We tested the ability of the NBI patient and carer scales to discriminate psychiatric 
cases from non-cases, when compared to the gold-standard structured clinical 
instrument, the CIS-R. CIS-R caseness as previously was decided based on the 
recommended cut off value of 12 (Lewis, 1992). The total NBI patient score and NBI 
carer score were compared using Receiver Operating Characteristics Analysis.
Figure 14 and Table-15 depict and detail the area under the curve for the NBI patient 
and carer scales.
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Figure 14. ROC Curve comparing NBI patient and carer scales with CIS-R as gold
standard in patients with epilepsy.
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Table 15. Area Under the ROC Curve NBI patient and carer scales vs. 
CIS-R > 12.
Area Std. Error Asymptotic 95% Cl
Test result variable(s) Lower bound Upper bound
NBI: total score -  Patient 0.94 0.04 0.87 1.00
NBI: total score -  Carer 0.83 0.07 0.69 0.97
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We also compared the ability of the NBI patient and carer scales to discriminate 
psychiatric cases from non-cases, using the ROC analysis and with the PSE/SCAN 
derived ICD-10 criteria based diagnosis and psychiatric caseness derived through the 
clinical significance gold standards. Complete NBI and SCAN data was available in 
43 individuals. Of these 15 (34.8%) were cases based on clinically significant PSE 
ratings, and 12 (27.9%) were cases based on SCAN derived ICD-10 diagnosis. The 
area under the curve for the NBI patient and carer scales is depicted in Figures 15 & 
16, and described in Tables 16 & 17.
Figure 15. ROC Curve comparing NBI patient and carer scales with PSE clinically 
significant symptoms as gold standard in patients with epilepsy.
ROC Curve
1.00
.75
Source of the Curve50
Reference Line
NBI: Total Score - C
>. 25
>
(0
œ 0.00
NBI: Total Score - P
atient
1.000.00 .25 .50 .75
1 - Specificity
Diagonal segments are produced by ties.
219
255Table 16. Area Under the Curve (NBI patient and carer scales vs. PSE Clinical 
Significance).
Area Std. 
Error
Asymptotic 95% 
confidence interval
Test result variable(s) Lower
bound
Upper
bound
NBI: total score -  patient 0.87 0.07 0.74 0.99
NBI: total score -  carer 0.77 0.08 0.61 0.92
Figure 16. ROC Curve comparing NBI patient and carer scales with ICD-10 
diagnosis as gold standard in patients with epilepsy.
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Table 17. Area under (he curve (NBI patient and carer scales vs. IC'D-It) diagnosis) 
area under the curve
Area Std. 
Error
Asymptotic
Sig.
Asymptotic 95% 
confidence interval
Test result variable(s) Lower
bound
Upper
bound
NBI: total score -  patient 0.82 0.08 .002 0.65 0.98
NBI: total score carer 0.79 0.08 .003 0.63
.
0.95
.......... ..  ^  ^
5.4.3. Cut o l ïScores on NBI Patient and Carer Scales
The cut off scores in Table 18 achieved the best match of sensitivity and specificity 
against CIS-R as also the two gold standards (ICD-10 and clinical significance) 
adopted for comparison, and represent cut-off points for NBI patient and carer scales. 
A higher score was required on the patient scale as opposed to the carer scale, in order 
most effectively to discriminate psychiatric cases and non-cases among patients with 
epilepsy. However, the same patient optimal cut-off score (32.5) and same carer cut­
off score were applicable against all three measures tested. The best match of 
sensitivity and specificity was achieved with the CIS-R gold standard, followed by 
PSE symptom gold-standard & the ICD-10 diagnosis gold-standard, with this being 
most pronounced in the NBI-patient scale ratings.
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Tahk* I  H. C'lil-olT values for NBI Patient and Carer scale scores
Scale
NBI-P
NBI-C
-
Score
(CISR)
Sensi
tivity
(%)
Specifi 
city (%)
Score
(PSE)
Sensitivity
(%)
Specifi
city
(%)
Score
(ICD)
Sensiti
vity
(%)
Specifi
city
(%)
19/20 100.0 79.4 17/18 86.7 71.4 17/18 83.3 64.5
25/26 100.0 82.4 24/25 86.7 82.1 24/25 83.3 74.2
32/33 100.0 85.3 32/33 86.7 8&7 32/33 83.3 77.4
36/37 83.3 88.2 36/37 73.3 89.3 36/37 75.0 83.9
38/39 83.3 91.2 38/39 73.3 192.9 38/39 75.0 87.1
18/19 83.3 70.6 18/19 73.3 67.9 18/19 75.0 64.5
19/20 83.3 73.5 19/20 73.3 71.4 19/20 75.0 67.7
21/22 83.3 76.5 21/22 73.3 75.0 21/22 75.0 71.0
22/23 75.0 76.5 22/23 66.7 75.0 22/23 66.7 71.0
5.4.4. NBI Patient/Carer Scales: Descriptive Data from the Sub-Scales
We examined the individual NBI sub-scales, both patient/carer ratings. A positive 
rating on the individual NBI sub-scale was assigned when a score of 3 was exceeded 
(of a maximum of 5), in line with published recommendations (Blumer, 1995). The 
results are presented in Table 19.
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Table 19: NHI palicnl and carcr-ralcd s> inpionis.
NBI Scale Patient positive (N=46) Carer positive (N=46)
Writing 6(13.0%) 4 (8.7%)
Morals 16(34.8%) 17(37%)
Religion 6(13.0%) 3 (6.5%)
Temper 11 (23.9%) 10(21.7%)
Order 15 (32.6%) 15(32.6%)
Sex 22 (47.8%) 18(39.1%)
Fear 12(26.1%) 13(28.3%)
Guilt 7(15.2%) 4 (8.7%)
Seriousness 6(13.0%) 7(15.2%)
Sadness 13 (28.3%) 10(21.7%)
Emotionality 9 (19.6%) 10(21.7%)
Suspiciousness 3 (6.5%) 8(17.4%)
Detail 18 (40%) 15 (32 (#4)
Cosmic interests 4 (8.7%) 1 (2.2%)
Destiny 4 (8.7%) 3(6 5%W 
12(26.1%)Persistence 17(37.0%)
Hatred 3 (6.5%) 5(10.9%)
Dependence 8(17.4%) 8(17.4%)
Happiness 7(15.2%) 6(1394)
Physical/Somatic 17(37.0%) 19(41.3%)
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S.5. Seizure Severit>
All subjects with epilepsy responded to the National Hospital Seizure Severity Scale 
(NHS3). Subjects and their carers were interviewed with the NHS3 for a maximum of 
3 seizures types, each of these being scored on one scale NHS3-I, NHS3-II, and 
NHS3-III, as well as NH S3-Total Score. All 59 patients with epilepsy as one would 
expect had at least one seizure type. 44 had only one-seizure type, and a further 15 
had a second seizure type. No patient had more than 2 types of seizure.
5.5.1. Descriptive Data on Seizure Severity
The mean NHS3 Type-1 (the first type of seizure recorded) score was 12.05 and the 
mean NHS3 type 2 (the second type of seizure recorded) score was 1.78. The mean 
NHS3 total score was 13.83. There were no significant differences in mean total 
scores between males and females (/= -1.69; p=  0.097; 95% Cl -5.79 to .49).
5.5.2. Seizure Severity and Psychiatric Caseness
We examined associations between NHS3 type-1, type-2 and total score with the 
main psychiatric caseness variables using the independent samples /-test. No 
significant associations between seizure severity and psychiatric caseness as described 
by PSE-SCAN derived ICD-10 criteria based diagnosis were identified.
We also examined the relationship between seizure severity as measured by 
the NHS3 and psychiatric caseness as measured by the epilepsy specific measure of
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psychopalhology, Ihe Neurobcliavioral Inventory, both patient and earer versions, 
with the revised cut-otVscores (33 and 2 1 respectively) identified by us. No 
significant associations between seizure severity scores and epilepsy specific 
psychopathology either patient or carer rated were observed. The results are described 
in Table 20.
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Table 20: Indcpcndcnl samples l-lcsl comparing seizure severity and 
psychiatric caseness across measures
Scale a
CIS-R
t df Sig. Mean
Diff.
Lower Upper
NHS3-Typel 0.13 19.69 0.898 0.25 -3.61 4.10
NHS3-Type 2 -2.08 18.20 0.05 -2.98 -5 99 3 53
NHS3-total score 
NBI Patient
-1.37 20.80 0.19 -2.73 -6 88 1.42
NHS3- Type 1 -0.25 18.49 0.81 -0.49 -4.58 3 59
NHS3 Type 2 -1.29 16.37 0.21 -1.79 -4.71 1.14
NHS3- total score 
NBI Carer
-1.01 17.32 0.33 -2.28 -7.04 2.48
NHS3 Type 1 0.09 32.36 0.92 0.15 -3.29 3.60
NHS3 Type 2 -0.97 24.47 0.34 -1.17 -3.67 1.33
NHS3- total score -0.52 28.51 0.61 -1.02 -5.05 3.02
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5.6. Disablemenl in PiUiciUs with lipilcpss
Disablement was estimated in 53 of 59 patients (89.8%) with epilepsy using the 
Subjective Handicap in Epilepsy scale. This scale has six sub-scales measuring work: 
social & personal; physical; self-perception; life-satisfaction and change domains. 
Higher scores indicate lower levels of disablement. Table 21 provides descriptive data 
of SHE subscales.
Table 21. SHE -  Descriptive data.
Work
Social & 
personal
Physical
Self
perception
Life
satisfaction
Change
Mean 68.6 80.3 61.8 66.3 65.0 53.9
Std. Error of 
Mean
3.8 3.7 3.5 3.9 3.4 2.3
Median 75.0 94.0 65.0 70.0 69.0 54.0
Mode 100.0 100 56.0 100.0 56.0 50.0
Std.
Deviation
27.5 27.0 25.7 28.6 24.6 16.9
Minimum 3.12 6.25 0.00 0.00 0.00 14.28
Maximum 100.00 100.00 100.00 100.00 100.00 100.00
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5 6 .1 PsNchialric Co-morbidily and Disablement
We examined the relationship between psychiatric caseness as determined by ICD-IO 
criteria Ibllowing SCAN interview and disablement in epilepsy. Patients with a 
diagnosable psychiatric disorder had significantly greater disablement as measured on 
the social & personal”, “physical”, and “life satisfaction” subscales of the SHE, and 
approached significance on the “self perception” scale of the SHE. The change 
subscale of the SHE was also significantly associated with ICD-IO psychiatric 
diagnosis There were however no associations between the “work” subscale and 
ICD-IO psychiatric diagnosis. Table 22 has the details.
Table 22. Independent Samples Test comparing ICD-IO psychiatric diagnosis with 
disablement
Sig.
Mean Std. Error
95% Cl
T df (2-
tailed)
Difference Difference Lower Upper
She work 1.75 46.0 0.09 14.83 8.48 -2.24 31.91
She social/personal 2.38 20.94 0.03 21.96 9.23 2.76 41.16
She physical 3.52 24.91 0.002 26.49 7.52 11.00 41.97
She self perception 1.93 46.0 0.06 17.55 9.07 -0.72 35.81
She life satisfaction 3.98 27.93 0.001 27.41 6.88 13.31 41.51
She change 2.52 21.67 0.02 14.45 5.74 2.53 26.36
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As palicnls with epilepsy oflen I'aii to meet conventional diagnostic criteria, while 
sulTering from disabling psychiatric symptoms (Krishnamoorthy, 2002a), we 
compared scores on the SHE subscales with psychiatric caseness on the symptom 
based measure, the CIS-R, assuming the recommended cut-off score of 12. CIS-R 
caseness was significantly associated w ith all sub-scales of the SHE (Table 23). We 
also examined epilepsy specific psychopathology as defined by the NBI. NBI-Patient 
total score (>20) caseness was significantly associated with all sub-scales except 
SHE-Work and SHE-Change. Caseness as defined by the revised NBI patient cut-off 
score (>38.5) was associated with “social & personal, physical & change” but not 
with “work, self-perception & life-satisfaction”. On the other hand, caseness as 
defined by the NBI total carer scale score was associated with “social & personal, 
physical and life satisfaction” sub-scales, but not work, self-perception and change 
sub-scales.
Table 23. Comparisons of SHE & CIS-R caseness.
t df
Sig. (2- 
tailed)
Mean
Difference
Std. Error 
Difference
95% Cl
Lower Upper
Work 2.7 19.8 0.01 22.9 8.4 5.3 40.5
Social/personal 4.0 15.8 0.001 35.1 8.7 16.6 53 6
Physical 5.0 22.4 0.001 32.6 6.6 19.0 46.2
Self perception 2.6 16.5 0.019 25.8 9.9 4.9 46.8
Life satisfaction 3.8 19.0 0.001 27.3 7.3 12.1 42.6
Change 3.2 18.0 0.005 17.37 5.3 6.1 28 5
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5 6.2. Seizure Severity & Disablemenl
We tested for associations between seizure severity and disablement scores using 
spearman correlations. Correlations were generally stronger among those with two 
seizure types rather than one seizure type only. The NHS3 total score was 
significantly correlated with all SHE scales except the “work” scale where it 
approached but failed to achieve significance. The results are described in Table 24.
Table 24. Correlations between scales for seizure severity and disablement.
Work
Social/
Personal
Physical
Self
perception
Life
satisfaction
Change
N H S3-
one
Spearman
Correlation
-0.8 -0.2 -0.1 -0.3 -0.3 -0.2
seizure
type
Sig. (2- 
tailed)
0.6 0.3 0.54 0.06 0.07 0.3
NHS3 -  
two
Spearman
Correlation
-0.3 -0.3 -0.4 -0.3 -0.3 -0.3
seizure
types
Sig. (2- 
tailed)
.0.01 0.01 0.01 0.05 0.002 0.03
N H S3-
total
Spearman
Correlation
-0.3 -0.3 -0.3 -0.4 -0.5 -0.3
score Sig. (2- 
tailed)
0.08 0.04 0.01 0.01 0.001 0.03
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5.7. I'lie Relative ( oiitribiitloiis of Seizure Severity and Psyehiatrie ( o- 
morbidity to Disablement in Kpilepsy
A well-established association between seizure severity and disablement in epilepsy 
exists (Baker, 1996). However, while disablement has been demonstrated in many 
psychiatric disorders, there are few studies that have examined the contribution of co- 
morbid psychopathology to disablement in epilepsy (Baker, 1996 for example). 
Having examined associations between seizure severity and disablement, psychiatric 
caseness and disablement, and seizure severity and psychiatric caseness, we 
proceeded to examine post-hoc, the relative contributions of seizure severity and 
psychiatric co-morbidity to disablement in epilepsy.
Generalised Linear Modelling in SPSS (GLM-SPSS) was used to test this 
hypothesis in all patients with epilepsy in whom NHS3, SHE, PSE “clinical 
significance” and ICD-IO data were available (49 subjects).
Each of the SHE scales were in turn selected as the dependent variable, w ith 
sex being the fixed factor in all instances. Age, rating of caseness on “clinical 
significance” and lCD-10 criteria were entered as covariates in this model.
5.7.1. Clinical Significance, ICD-IO Diagnosis, Seizure Severity & Subjective 
Handicap
For each of the SHE scales, psychiatric co-morbidity accounted for the greatest 
proportion of shared variance, when compared to the other covariates in the model,
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sci/urc severity (NI IS3) total score aiul se\. I urther, once the proportion oT variance 
explained by the psychiatrie co-morbidity variable had been accounted for, previously 
demonstrated associations between seizure severity total score and disablement (Table 
25) were no longer significant in some instances. Thus “Clinical Significance’' 
explained the greatest proportion of'the shared variance when compared with seizure 
severity, age and sex. While the physical and self-perception subscales of the SHE 
were also influenced by seizure severity and showed a significant association in this 
regard, here too the impact of co-morbid psychiatric disorder appeared greater. The 
work sub-scale of the SHE was alone not affected either by seizure severity or co- 
morbid psychopathology
When ICD-IO ratings of psychiatric caseness were entered into the GEM 
equation as the measure of psychiatric caseness, the results were similar. Once again, 
the work subscale of SHE was not affected either by seizure severity of psychiatric 
co-morbidity. ICD-IO diagnosis explained the greatest proportion of the shared 
variance for other sub-scales, except the self-perception sub-scale in which seizure 
severity appeared to explain a greater proportion of the shared variance. The change 
subscale of the SHE also did not follow prediction in this instance, with sex 
accounting for the greatest proportion of shared variance with regard to this subscale.
Tables 25 and 26 have details of the F values, eta-square values 
and significance ratings of these associations.
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Table 25. CiLM-SPSS comparing "C linical Signillcancc rating 
with NHS3 & SHE scales.
SHE -  Work Sex NHS3 Age "CS"
F value 1.4 2.2 0.3 2.5
Partial Eta Squared 0.03 0.05 0.01 0.05
Significance 0.3 0.2 0.6 0.1
SHE -  Social/Personal
F value 2.7 3.7 6.7 17.2
Partial Eta Squared 0.06 0.08 0.13 0.28
Significance 0.1 0.1 0.01 .001
SHE -  Physical
F value 0.7 4.9 1.2 8.2
Partial Eta Squared 0.01 0 10 0.03 0.16
Significance 0.43 0.03 0.3 0.01
SHE -  Self perception
F value 3.5 5.6 0.7 7.5
Partial Eta Squared 0.07 O il 0.02 0.15
Significance 0.07 0.02 0.39 0.01
SHE -  Life satisfaction
F value 0.1 4.2 0.2 9.7
Partial Eta Squared 0.002 0.09 0.005 0.18
Significance 0.76 0.05 0.63 0.003
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SHI: -  C hange 
F value 03 1.5 2.9 7.0
Partial Eta Squared 0.01 0.03 0.06 0.14
Significance 0.59 0.23 0.09 0.01
Table26. GLM-SPSS comparing ICD-IO diagnosis with 
NHS3/SHE scales.
SHE- Work Sex NHS3 Age ICD-IO
F Value 1.3 2.7 0.2 2.4
Partial Eta Squared 0 03 0.09 0.003 0.05
Significance 0.25 0.11 0.70 0.13
SHE- Social & Personal
F Value 2.7 5.9 3.5 6.8
Partial Eta Squared 0.09 0.12 0.07 0.13
Significance 0.11 0.02 0.07 0.01
SHE- Physical
F Value 0.55 5.93 1.2 13.1
Partial Eta Squared 0.01 0.12 0.03 0.23
Significance 0.46 0.02 0.29 0.001
SHE- Self Perception
F Value 3.6 7.4 0.3 4.3
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Partial Eta Squared 0.08 0.14 j 0.01 0.09
Significance % o T 0.01 I
:
0.60 0.05
SHE- Life Satisfaction
F Value 0.1 5.41 0.1 10.6
Partial Eta Squared 0.002 O il 0.002 0.2
Significance 0.78 0.03 0.78 0.002
SHE- Change
F Value 0.24 2.3 2.1 5.1
Partial Eta Squared 0.01 0.05 0.05 0.01
Significance 0.62 0.14 0.16
i _ _______
0.03
The aforementioned results were replicated with the CIS-R and NBI- Patients Total 
Score, both these variables emerging as more significant predictors of disablement 
when compared to seizure severity scale scores. However, the NBI-Carer total score 
failed to demonstrate similarly significant associations with either SHE or NHS3 
scores.
5.8. Summary of Results from the Primary Care Study
The primary care study demonstrated clearly that psychiatric co-morbidity was over­
represented in persons with epilepsy when compared with population-based controls 
in the overall sample, although the differences narrowly missed achieving 
significance in the paired samples t-test. Core symptoms of common mental disorder, 
worry, depression and anxiety etc., were significantly more common in the epilepsy
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group. These dilTerenees he I ween cases and controls were generally relleeled across 
the screening and diagnostic measures.
The screening measures generally compared well with the diagnostic 
measures. ROC analysis was used to derive the cut off scores on each measure, both 
in epilepsy and in control groups, simultaneously optimising sensitivity and 
specificity.
In depth analysis of the SCAN data in the epilepsy group revealed that CMD 
symptoms were most common in these patients.
Both the CIS-R and the NBI appeared to perform well as measures of overall 
psychiatric caseness, and performed comparably against both the PSE-based gold 
standards used, ICD-IO diagnosis and clinical significance ratings. Revised cut-off 
scores for these instruments representing the optimal sensitivity and specificity are 
presented. The psychosis symptom questionnaire did not however perform well in 
comparison to both gold standards.
We did not find any evidence for associations between seizure severity 
(NHS3) and psychiatric co-morbidity either generic (diagnosed in SCAN interview) 
or specific to epilepsy (NBI). Psychiatric co-morbidity, however measured was 
significantly associated with disablement among people with epilepsy. This was true 
for all sub-scales of the SHE except the work subscale. Seizure severity (NHS3) was 
also associated with disablement (SHE) overall, except the work subscale. Using 
GLM-SPSS, we found psychiatric co-morbidity to be strongly associated with
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siibjcclivc handicap, and once ihis had hccn accounlcd for, the associations between 
seizure severity and subjective handicap became largely irrelevant.
The implications of these findings will be addressed in some detail in the 
discussion section.
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6. STIIDV-II
PREVALENCE, PATTERNS AND ASSESSMENT OF PSYCHIATRIC CO- 
MORBIDITY IN AN INSTITUTION FOR EPILEPSY
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6.1. Background and Kationalc to the Present Study
While a number of studies have examined co-morbidity between learning disability 
(LD) and epilepsy, and LD and psychiatric disorder, in hospital, institutional and 
community-based populations; the literature on neuropsychiatrie epidemiology at this 
important interface between epilepsy and LD remains rather scant. A detailed review 
of available literature is presented in the review sections of this thesis (section 3.3) 
and reveals a number of lacunae in the available literature.
Specifically, a number of the studies have:
(1) Used generic measures that have not been specifically developed 
either for use in epilepsy populations, or learning disability 
populations, or indeed in populations where epilepsy and learning 
disability are co-morbid.
(2) Failed to rate carer/observer information systematically using valid 
measures, carer/observer ratings being an important source of 
information in these populations, limited as they may be in their 
ability to share health related information adequately and 
accurately.
(3) Failed to differentiate between psychiatric co-morbidity that is 
generic, and psychiatric co-morbidity that is specific to either 
epilepsy, or learning disability, or the co-morbidity thereof.
There are relatively few psychiatric outcome measures designed to assess the subject 
with acquired cognitive impairment or learning disability (Kerr, 1997). Further, as
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nicasiirc'mciil within learning disability (and dementia) is often indirect, with reliance 
being placed on caregiver or observer reports, the reporting of outcomes is ot'ten 
inlluenced by the caregiver (Espie, 1997). Given that clinical experience indicates 
even cognitively unimpaired subjects with intractable epilepsy under-report 
psychopathology (particularly of the ictal variety), carer reports are an essential 
element of the measurement of psychiatric outcome.
Improved management methods, changing attitudes to epilepsy, and the 
progressive closure of institutions in the western world in the past three decades or 
more, have resulted in people with epilepsy no longer being admitted to institutions, 
for epilepsy alone. Indeed, institutionalisation today is most often for younger 
moderate to severely learning disabled people with intractable epilepsy, and often 
with significant concomitant behavioural problems (Espie, 1997). Thus the vast 
majority of adults with severe refractory epilepsy are resident in the community (with 
or w ithout support), and those who reside in institutions are housed in that setting 
mainly because of co-morbid learning disability, psychiatric disorder or both. The 
opportunity in this generation to study adults resident in an institution for epilepsy, 
with the primary reason for their residence in that setting being intractable epilepsy, is 
thus no longer common place. The National Society for Epilepsy- Centre for 
Epilepsy, in Chalfont St. Peter, Buckinghamshire, a few miles outside Greater 
London, is unique in this respect.
The NSE centre houses nearly 300 people with intractable epilepsy at any one 
time. About 10% of these are individuals with epilepsy normally resident in the 
community or other residential care settings, attending the assessment unit within the
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ccnlrc, l'or periods iisuali> bclwecn one and eight weeks to undergo a detailed 
evaluation. A further 15-20% (45-60 individuals) are in various rehabilitation 
programmes, projects that encourage progress into supported or independent living 
and in many cases eventual return to the community.
The majority of residents (over 70%) have been housed in the centre for the 
long term, in many cases (especially older residents) for decades. Long-term residents 
are spread out among 14 houses that offer individual rooms for residents with shared 
facilities. The placement of individual cases is dependent to some extent on the level 
of disability (physical or behavioural), some houses being better equipped to deal with 
greater disability than others, for staffing, facilities and other logistic reasons. Lach 
house has a team of care workers lead by a house manager. One component of the 
rehabilitation program, a supported living project for those progressing to independent 
living, consists of apartments that residents share with nominal support from carers.
Until the beginning of this study in October 1998, psychiatric care at the NSE 
was largely informal, and provided as part of the neuropsychiatry assessment service 
from the National Hospital for Neurology and Neurosurgery in London. The reporting 
of an increased burden of behavioural problems by the staff at the centre, and the felt 
need for a formal psychiatric service led to the director of the NSE centre 
commissioning a formal review of mental health service needs, thus providing the 
opportunity to survey this population.
The institutional study reported herein was therefore established with the 
following aims.
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6.2. Aims
To survey residents at the NSE Centre for Epilepsy, Chalfont St.Peter, to determine:
(1) The prevalence and patterns of psychiatric co-morbidity in this 
population;
(2) Compare responses to instruments of psychiatric research that 
assess psychiatric co-morbidity using dit'ferent sources of 
information: the patient himself, the informed/ expert observer; and 
the caregiver;
(3) To assess both generic and epilepsy specific domains of 
psychopathology in this population;
(4) To study the ability of these diflerent measures to identify 
psychiatric caseness, when compared to the gold-standards of ICD- 
IO diagnosis ''clinical significance";
(5) To estimate mental health needs in this population.
Aims 1-4 are central to the objective of this thesis and the results of these 
investigations are described in detail. Aim 5 formed the service component of the 
review, and has been presented as a formal report to the National Society for 
Epilepsy.
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6.3. Methods
6.3.1. Setting
The National Society for Epilepsy- Centre for Epilepsy, Chalfont St. Peter, 
Buckinghamshire, UK.
6.3.2. Participants
All people with epilepsy resident at the centre during the study period (October 1998 
to September 1999) were included in the survey. People with epilepsy attending the 
assessment unit were excluded, as they would largely have been unrepresentative of 
this population. People with epilepsy in various rehabilitation programmes were 
however included, as they were long term residents, staying at least one year at the 
centre (thus representative populations in residential care), and contributed to the 
mental health service needs at the centre.
There were 272 long-term residents in the centre database at the time of 
commencement of the study. Full medical records could be obtained for 261 (96%) of 
these residents. Seventeen of these 261 residents (henceforth referred to as cases) 
could not be located subsequently due to logistic problems such as resident movement 
(house transfers) within the centre, resident leaving the centre during the course of the 
study etc. A further sixteen refused consent to be interviewed and assessed in person. 
228 of 261 cases (87%) were recruited to participate in the interview and assessment 
components of the study.
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6.3.3. Measures
6.3.3.1. Review of Case Records & Interview with Professional Caregiver
The case notes of all residents were systematically reviewed for mental health 
problems, and a report from the house manger on each resident was sought. The 
professional caregiver interviewed had to have known the person with epilepsy for at 
least one year. Professional caregivers chosen in this way also completed the 
Neuropsychiatrie Inventory (NPl) (Cummings, 1994) a carer rated measure of 
behavioural dysfunction in neurological disorders with the research assistant. The NPI 
(reviewed in greater detail subsequently) is a widely used measure in a number of 
conditions and has been demonstrated to have good psychometric properties in 
neurological populations (Aarsland, 1999; Diaz-Olivierretta, 1999; Litvan, 1998).
6.3.3.2. Interviews with Persons with Epilepsy
Cases who consented to being personally interviewed by the research assistant (an 
experienced mental health professional) were first assessed using the Mini-Mental 
State Examination (Folstein, 1975). Based on the MMSE scores they were classified 
as cognitively impaired (<24) or cognitively unimpaired subgroups (> 24). This was 
done as assessments of cognitive status were not available in all cases, and when 
available were not necessarily current.
Cases underwent a general interview about their health, psychological and 
social well being with the RA over a 30-min. period, and were rated on the Brief
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INycliialric katiiiii Scale (Overall & (iorham, 1962), a valid and reliable observer 
rated measure ol psychopathology in psychiatry settings (reviewed in greater detail 
below).
Cases who on the basis of the aforementioned assessments were considered 
suitable for an in-depth psychiatric interview (not cognitively impaired and able to 
respond adequately to questions in interview), and who consented to take part in the 
same, were interviewed in phase II by this candidate, using the Present State 
Examination (PSE) components of the Schedules for Clinical Assessment in 
Neuropsychiatre (SCAN) (WHO, 1992b). The computer version for WINDOWS was 
used for this purpose (WHO, 1995), and an ICD-IO diagnosis generated based on the 
SCAN algorithms The PSE components of the SCAN were used in this study, 
sections 2-12 of PSE (section I) being completed, as also section 14 (screen for PSE- 
section 2). A rating of “clinical significance” was also made by the candidate, an 
experienced neuropsychiatrist, based on the responses to each domain of the PSE. A 
patient was rated to have a clinically significant mental disorder, if they had 3 more 
symptoms that were disabling in that domain of the PSE. The rational for this 
strategy, which has been adopted in major international studies has been addressed in 
the previous section. As psychiatric co-morbidity in epilepsy is believed not to follow 
conventional descriptions and criteria, it was felt that such an operationalised clinician 
rating of caseness was necessary, in order to make effective comparisons between 
instruments.
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6.3.3.3. Other Measures
Cases judged to be suitable for phase II were also requested to complete the patient 
sections of the Neurobehavioral Inventory (NBI) (Blumer, 1995), described in detail 
in section 4, with the named professional caregiver for each case being asked to 
complete the caregiver section of this instrument. This was done in order to assess 
psychiatric co-morbidity specific to epilepsy in this population, and to compare this 
generic psychiatric disorder as rated on SCAN, and caregiver as well as observer 
ratings of psychiatric co-morbidity on the NPI and BPRS respectively.
6.3 .4. Review of NPI & BPRS
6.3.4.1 Neuropsychiatrie Inventory (NPI)
The NPI (Cummings, 1994) was developed to assess a wide range of behaviours 
encountered in dementia patients, to provide a means of distinguishing frequency and 
severity of behavioural changes and to facilitate rapid behavioural assessment through 
the use of screening questions. The behavioural domains to be assessed were chosen 
after a careful review of the literature occurring in different dementias and 
preliminary studies of behavioural changes in patients with vascular dementia and 
fronto-temporal dementia. Ten behavioural domains are evaluated by the NPI: 
delusions, hallucinations, agitation/aggression, dysphoria, anxiety, euphoria, apathy, 
disinhibition, irritability/lability, aberrant motor behaviour. Each behavioural domain 
is explored with a caregiver who has at least daily contact with the patient, with a 
screening question, which if the caregiver answers in the affirmative is followed up by
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a series ol queslioiis relevanl lu behaviours in lhat domain, liach abnormal behaviour 
identified is rated on severity ( i=mild; 2= moderate; 3= severe) and frequency (1 = 
occasionally, less than once a week; 2= often, about once a week; 3= frequently, 
several times a week; 4= very frequently, once or more per day or continuously).
Cummings (1994) reports the psychometric properties of this (then) new scale. 
Content validity was assessed by a Delphi panel of ten international experts, each of 
whom rated each question between 1 (well assessed) and 4 (poorly assessed). 
Concurrent validity was assessed with respect to BEHAVE-AD (Reisberg, 1987) and 
HDRS (HDRS, 1967). The delusions, hallucinations, dysphoria, anxiety, 
agitation/aggression, and aberrant motor behaviour subscales of the NPI were 
compared with delusions, hallucinations, affective disturbances, anxiety and phobias, 
aggressiveness, and activity disturbances subscales of the BEHAVE-AD; the 
dysphoria subscale of NPI with the HDRS. Between rater reliability was assessed by a 
team of qualified raters in 45 patients/caregivers. Test-retest reliability was 
determined by conducting a second caregiver interview within 3 weeks of the initial 
interview, this being performed in 20 caregivers by a different clinician. Forty 
caregivers of non-demented control subjects were also interviewed.
Spearman’s correlations were assessed to compare NPI subscale scores and 
the BEHAVE-AD subscale and HDRS scores. Cronbach’s coefficient alpha was 
determined to assess internal consistency; reliability and Pearson’s correlations were 
calculated for the item-independence study.
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The authors report that (Cummings, IVV4).
• The screening questions were judged to have an acceptable false positivity 
and false negativity rate.
• Content validity as Judged by the Delphi panel was good, the troublesome 
behaviour alone being reformulated as “aberrant motor behaviour”.
• All NPI items were expressed throughout the population surveyed the scores 
in general being low. Apathy was the most frequent behaviour expressed, 
and euphoria the least frequent.
• Good concurrent validity was established with NPI items correlating 
generally well with BEHAVE-AD and HDRS scales. The dysphoria subscale 
alone correlated less well (but adequately) with both the above scales.
• Internal consistency of the NPI for both frequency and severity was good, a 
Cronbach’s Alpha Score of between 0.87 and 0.88 for all scales overall
• Between rater reliability was very high and test-retest reliability correlations 
were for 0.79;p= 0.0001 (frequency) and 0.89;/?=0.0001 (severity).
The results establish the NPI as an instrument in which the clinician can have 
confidence as a means of assessing and quantitating behavioural changes in dementia 
(Cummings, 1994).
The NPI has been used widely to study patients with dementia, as well as a 
number of conditions in which cognition can be impaired to varying degrees, 
including Parkinson’s disease (Aarsland, 1999), multiple sclerosis (Diaz-01 avarietta, 
1999), cortico-basal degeneration and progressive supranuclear palsy (Litvan, 1998) 
etc. The instrument is also in use for the differential analysis of behaviours in
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dcmcnlia and as an outcome measure in trials ol'drugs used in the treatment ol 
dementia'  ^ I lovvever, there are no published reports examining the ps> ehometrie 
properties of the NPI in populations with epilepsy.
6.3.4.2. Brief Psychiatric Rating Scale (BPRS)
One of the more commonly used interview rating scales is the Brief Psychiatric 
Rating Scale (BPRS) (Overall and Gorham, 1962). To use the BPRS, the mental 
health professional completes a mental status interview with the patient and then rates 
that patient on a series of 18 psychiatric symptoms such as motor retardation, blunted 
affect, conceptual disorganization, anxiety, and guilt. Expanded definitions of each of 
these terms are provided to the examiner. The interviewer rates each domain on a 
seven-point Likert scale from "not present," the lowest rating, to "extremely severe," 
the highest rating. An experienced interviewer can complete the ratings in 2/3 
minutes. The BPRS has been used extensively in drug-outcome and other studies. The 
advantage of the BPRS is that the inter-rater reliability is reasonably high for a rating 
scale of this nature. A summary of over 300 studies using the BPRS found an inter­
rater reliability correlative of .80 or above on the total score in most studies (Sadock, 
2004).
Originally the scale had 16 items to which two items were then added, the 
BPRS-18. Factor analysis has shown that the items of the BPRS-18 can he grouped in 
clusters or factors, each comprising a set of items that correlate highly among 
themselves, hut associate little with the remaining items (Czohor, 1996).
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Bcncllls o f the BPRS;
• Well established -  among the most researched instruments used in psychiatry
• Well known -  clinicians tend to be familiar with symptom scores and changes
• Sensitive to change -  may be used to rate treatment response
• Broad evaluation -  allows rating of severity of a number of different 
symptoms
• Used in many classic studies of new anti-psychotics
• Psychometric properties and underlying factor structure is well-established
• Grouping on item scores allow scoring on distinct factors (tension; emotional 
withdrawal; mannerisms and posturing; motor retardation; uncooperativeness)
Challenges of the BPRS:
• Limited in scope - focus on positive and general psychopathology. Does not 
focus on negative symptoms. Needs to be utilised in combination with a 
negative symptom assessment tool, if negative symptomatology is to be 
captured
• Ambiguous interpretation - there are several ways symptoms are reported (eg., 
on a scale of 0-6 or a scale of 1-7); the dual reporting scale must be taken into 
consideration when interpreting scores
• Use of 1-7 scale -  the non-linearity into the scale can complicate 
interpretation changes over time, particular with regards to response rates
• Examiner subjectivity
• Examiners can only rate what they observe during interview
A Synopsis of study methods in flow chart form is presented below.
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Study II : Residential Care
Identified Cases 261
1 r
Carer NPI 222
1 r
188
BPRS / Interview &  M M SE
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Cognitively
Unimpaired
Cognitively
Impaired
64SCAN
34 - refused to complete 
BPRS interview or were 
uncontactable
NBI 60
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6.3.5 Analysis
Data was analysed using SPSS for WINDOWS (version 10.0). Descriptive statistics 
were examined using the frequencies and descriptives functions of SPSS. Both 
parametric and non-parametric correlations between NPI and BPRS total scores and 
sub-scale scores were examined as appropriate (Pearson, Spearman and Kendall’s Tau 
values as appropriate being obtained). ROC analysis (Section 4.8.2; pg. 178) was 
carried out to compare the case-finding abilities of the different scales against the 
ICD-IOand clinical significance gold standards.
A technique employed in the institutional study and not the primary care study 
was Factor Analysis.
Factor Analysis (FA) and Principal Components Analysis (PCA);
The goal of these techniques is to examine the structure of the relationship between 
variables and not to see how they relate to other variables, such as group membership 
or a set of dependant variables. These techniques are therefore used 
( 1 ) To explore the relationship among variables
(2) To see if the pattern of results can be explained by a smaller 
number of underlying constructs (sometimes called latent variables 
or factors)
(3) Test some hypothesis about the data
(4) Reduce the number of variables to a more manageable size
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PCA is currcnUy used as the I’lrsl slop in I A One purpose ol die PCA and I A is lo 
determine if numerous measures (paper and pencil tests, individual items on tests, 
physical characteristics or other measures) can be explained on the basis of a smaller 
number of factors. Factor analysis may thus be confirmatory (to confirm a hypothesis 
that the results of 15 différent tests can be explained by three factors for example) or 
exploratory (when it is not known how many factors exist).
Whether variables are unique or not is measured in this technique, by 
measuring the converse of uniqueness, what is called the communality of a variable. 
The communal ity of a variable can be approximated by its multiple correlation, R \ 
with all of the other variables: that is, how much it has in common with them and can 
be predicted by them The uniqueness of an index variable (variable-1 for example) is 
1-R ;^ th^ portion of variable 1 that cannot be predicted by (i.e., is unrelated to) the 
remaining variables. (Norman and Streiner, 2000).
6.4. Results
6.4.1. Descriptive Data
228 persons with epilepsy were recruited; of these 164 (71.9%) were men and 64 
(28.1%) women. 67 persons with epilepsy (25.7% of the total population) had 
previously identified psychiatric problems that required consultation with a mental 
health professional. The broad classification and frequency of these problems as 
described in the records is detailed in Table 27.
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Table 27. Psychialric co-morbidily as rcporlcd in 
clinical case-notes.
Diagnosis Cases Percent
Total 67 25.67%
Psychosis 19 7.2%
Depression 17 6 5%o
Aggression 10 3.8%
Behavioural problems 5 1.9%
Other neurotic disorder 5 1.9%
Dementia 6 2.2%
Bipolar disorder 1 0.38%
Alcohol dependence 1 0.38%
Personality disorder 1 0.38%
Unspecified 2 0.76%
6.4.2. Descriptive Data from the Neuropsychiatrie Inventory (NPI)
Completed NPI data was available for 222 of 228 subjects (85.1%), as reliable 
professional carers who had contact with the individual for at least one year could not 
be identified for a further six subjects. The mean NPI score was 13.1, the median 
score 8, with a standard deviation of 15.8 and range from 0 to 108. The histogram 
below shows the distribution of scores (Fig. 17).
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Figure 17.: Histogram showing distribution ol the NPI variables total score.
NPI variables total score
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6.4.3. Factor Analysis of the NPI -  Performance as a Carer Rated Measure for 
Epilepsy
As the psychometric properties of the NPI have not been assessed in populations with 
epilepsy, we examined the internal consistency and factor structure of this measure. 
The internal consistency of the total NPI scores was calculated from the individual 
NPI sub-scale scores; the scale demonstrated good internal consistency (Cronbach’s a 
= 0.76). A principal components analysis (PCA) with varimax rotation was then 
performed on the NPI sub-scale data. Table 5 presents the communalities and factor 
loadings of the variables, plus the Eigen values and percentage of variance accounted 
for by each factor. Four factors with an Eigen value greater than I were extracted,
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accoiinling loi 58.8% ol'lhc lolal variance. Communaiilies were generally salislaclory 
(range 0.5-0.7). Relatively low communaiilies were found for the apathy (0.35) and 
delusions (0.39) variables.
An examination of the factor loadings in table-28 suggests that the PCA 
produced an interpretable factor matrix. Factor 1, which accounts for 28.4% of the 
total scale variance, has relatively high loadings for NPI delusions, hallucinations, 
motor disturbance and sleep disturbance; Factor 1 was interpreted as a psychosis 
factor. Factor 2, which accounts for 11.8% of the total scale variance, has relatively 
high loadings for agitation, apathy, disinhibition and irritability This suggests that 
factor 2 might represent an inter-ictal dysphoric disorder factor. Factor 3, which 
accounts for 10.1% of the total scale variance, has relatively high loadings for 
depression and appetite change. This factor was interpreted as a depression factor. 
Finally, factor 4, which accounted for 8.5% of the total scale variance, has relatively 
high loadings for anxiety and euphoria. We interpreted this as an anxiety factor.
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Table 28. I'aclor loadings, communaiilies, l-igcn values and pcrecntages of variance 
for PCA o f NPI sub-scale data.
NPI Sub-scale
Factor 1 
(Psychosis)
Factor 2 
(IDD)
Factor 3 
(Depression)
Factor 4 
(Anxiety)
Communal ity
Delusions 0.45 0.39
Hallucinations 0.80 0.70
Motor disturbance 0.73 0.58
Sleep disturbance 0.60 0.41 0.56
Agitation 0.80 0.72
Apathy 0.46 0.35
Disinhibition 0.55 0.49
Irritability 0.83 0.70
Depression 0.75 0.60
Appetite change 0.66 0.57
Anxiety 0.75 0.71
Euphoria 0.77 0.70
Eigen value 3.41 1.42 1.21 1.02
% of variance 3.41 1.42 1.21 1.02
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6.4.4. Descriptive Data from the Brief Psychiatric Rating Scale (BPRS)
Completed BPRS data was available in 188 of 261 subjects (70%), a further 40 
subjects failing to complete the 30 minute interview with the research assistant, for a 
variety of reasons (refusal when contacted, premature termination, inadequate 
information available for BPRS ratings etc.).
The mean BPRS score was 20.4, with a standard deviation of 39.4 and range 
from 0-162. Fig. 18 describes the distribution of BPRS scores.
Figure 18. Histogram showing the distribution of the BPRS scores.
BPRS Total Scores
0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0
2.5 7.5 12.5 17.5 22.5 27.5 32.5 37.5
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6.4.5. C omparison ol Larcr/lixperl-Ohserver Rated Instruments (NPI and I^PRS)
We examined non-parametric correlations between NPI (caregiver rated psychiatric 
co-morbidity) and BPRS (observer rated psychiatric co-morbidity) total scores. NPI 
and BPRS total scores were correlated with one another, albeit somewhat weakly. The 
results are expressed in Table 29.
Table 29. Non-parametric correlations between NPI and BPRS total scores.
NPI variables 
total score
BPRSTOTL
NPI variables total 
score
Correlation
Coefficient
1.000 0.21
Kendall's tau b
Sig. (2-taiIed) 0.001
BPRSTOTL
Correlation
Coefficient
0.21 1.000
Sig. (2-taiIed) 0.001
NPI variables total 
score
Correlation
Coefficient
1.000 0.30
Spearman's rho
Sig. (2-taiIed) 0.001
BPRSTOTL
Correlation
Coefficient
0.30 1.000
Sig. (2-tailed) 0.001
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6 4.6. C orrelations between NPI and BPRS Siibscales
We examined correlations between NPI and BPRS subscales. In general NPI and 
BPRS subscales appeared to correlate poorly. I hose subscales for which a correlation 
coefficient (Spearman’s Rho) of 0.2 or higher were found are summarized below.
1. NPI Delusions: Not correlated with any BPRS items
2. NPI Hallucinations: BPRS Anxiety- 0.20: BPRS Guilt- 0.25; BPRS 
Unusual thought content- 0.23
3. NPI Agitation: BPRS conceptual disorganisation- 0.22; BPRS 
Tension- 0.21; BPRS mannerisms and posturing- 0.21; BPRS hostility- 
0.20; BPRS hallucinations- 0.21; BPRS uncooperativeness- 0.20; 
BPRS unusual thought content- 0.22; BPRS disorientation- 0.23
4. NPI Depression/ dysphoria: BPRS emotional withdrawal- 0.24; BPRS 
guilt feelings- 0.21; BPRS depressed mood- 0.26; BPRS hostility- 
0.24; BPRS uncooperativeness- 0.23
5. NPI Anxiety: BPRS anxiety 0.18
6. NPI Euphoria/Elation: BPRS unusual thought content- 0.20
7. NPI Apathy/indifference: BPRS emotional withdrawal 0.23; BPRS 
unusual thought content- 0.22
8. NPI Disinhibition: Not correlated with any BPRS items
9. NPI Irritability/Lability: BPRS tension- 0.20; BPRS hostility- 0.27; 
BPRS hallucinatory behaviour- 0.22
10. NPI aberrant motor behaviour: BPRS tension- 0.22; BPRS 
uncooperativeness- 0.24; BPRS blunted affect- 0.20
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11. NPI abcrranl sleep behaviour. HPRS mannerisms and posturing- 0.23: 
BPRS grandiosity- 0 30: BPRS hostility- 0.25; BPRS 
uncooperativeness- 0.20
12. NPI- appetite/eating change: Not correlated with any BPRS items
6.4.7. NPI & BPRS Comparisons in Cognitively Impaired and Cognitively 
Unimpaired Populations
There were no differences between cognitively impaired and cognitively unimpaired 
populations in terms of age (/=().388; p=0.699; Cl= -3.6 to 5.3) or sex (chi 
square=0.074; p=0.786).
MMSE, NPI and BPRS data was available in 188 persons with epilepsy. 64 of 
these individuals (34%) scored 24 or more on the MMSE, and were judged not to be 
cognitively impaired. The remaining 124 (66%) were judged to have cognitive 
impairment.
We used the independent samples t-test to compare NPI and BPRS total scores 
in the cognitively impaired and non-cognitively impaired groups of patients with 
epilepsy. Both BPRS and NPI total scores were significantly elevated in the 
cognitively impaired group, the difference being statistically significant, more so with 
BPRS than with NPI (table-30).
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Table M). Indcpcndenl samples Mesl comparing NPI and BPRS lolal scores in 
cognilively impaired and non-cognilively impaired groups.
t df
Sig. (2- 
tailed)
Mean
Difference
Std.
Error
95% Cl
Lower Upper
NPI -2A1 167.65 0.014 -5.58 1 2.26 -10.04 -1.13
BPRS -2.94 182.70 0.004 -14.1 4.82 -23.63 -4.63
6.4.8. Psychiatric Co-morbidity as Assessed by ihe Present State Examination in a 
Cognitively Unimpaired Subgroup
Sixty-four subjects judged to be suitable for a full psychiatric interview were 
examined by this researcher using the PSE components of the Schedules for Clinical 
Assessment in Neuropsychiatry (SCAN) (WHO, 1990) and an ICD-10 diagnosis 
made where relevant. 13 of 66 subjects (19.7%) thus examined met ICD-10 criteria 
for a psychiatric diagnosis. The ICD-10 psychiatric diagnosis thus made, are 
enumerated in Table 31.
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Table M . ICD-10 psychialric diagnoses in insliiiiiionaliscd subjccls
with epilepsy.
ICD category
Organic mental disorders
Alcohol/substance abuse
Psychoses
Alcohol/substance abuse
Depression
Anxiety/neurotic disorders
Somatoform/dissociative disorders
Eating/slecp/sexual disorders
Frequency 
(64 cases)
0
11
Percent(%)
16.7
1.5
1.5
3.0
We also estimated clinically significant symptoms as rated by the clinician, using the 
Present State Examination components of the Schedules for Clinical Assessment in 
Neuropsychiatry (WHO, 1992b). A symptom category was rated positive if the 
subject in question was found to have three or more clinically significant symptoms in 
that category, clinically significance indicating that the symptoms were not Just 
present, but disabling. Of sixty-four subjects who had clinical symptom ratings 
performed in this way, 31 (48.4%) rated positive on at least one PSE symptom 
category. The prevalence of clinically significant PSE symptoms is detailed in Table 
32.
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Tabic .^2. C linically signillcanl PSI: symptoms in 
institutionalised patients with epilepsy.
PSE symptom category
Frequency 
(64 cases)
%
Somatoform 4 6.3
Worrying/tension 14 21.9
Panic/anxiety 15 23.8
Obsessional 5 7.8
Depressive 9 14.1
Decreased
concentration/th ink ing/energy/interests
5
1
7.8
Sleep/appetite 10 15.6
Eating disorder 4 6.3
Expansive mood 2 3.1
Alcohol/substance abuse 2 3.1
Psychotic symptoms 6 9.4
We examined agreement between ICD-10 diagnosis and clinically significant PSE 
symptoms as valid measures of psychiatric caseness in this population. A Kappa of 
0.31 was estimated (Cl: 1.7-43.6)
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6.4.9. I 'pilcpsN Spccillc l^s>chopalhology as Assessed b> the Neurobehavioral 
InvenlorN (NBI)
Subjects who were cognitively unimpaired, and their professional carers, were asked 
to complete the patient and carer versions respectively of the NBI. Sixty respondents 
completed both patient and carer versions of the NBI inventory .
We examined spearman correlations between patient and carer measures of the 
NBI. Correlations were modest, and only in a few suhscales did they reach statistical 
significance, notably, religion (Rho=0.35,p=0.006); temper (Rho=0.3l,/7=0.0l5); sex 
(Rho=0.28,/?=0.030); fear (Rho=0.29, /t=0.023); seriousness (Rho=0.48, /7<0.001); 
emotionality (Rho= 0.42, 0.001); persistence (Rho=0.37, /;=0.004) and hatred
(Rho=0.30, /?=0.021 ).
A positive rating in an individual symptom category was made with a score of 
2 or more (5 being maximum) in that category, in line with recommendations made 
by Blumer (1995). Table 33 depicts the frequency of patient and carer reported 
symptoms on the NBI.
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Table33. NBI palicnl and carci-ialcd s\iiipii>niali)U)g>
NBI Scale Frequency (patient) % Frequency (carer) %
Writing 3 5.0 2 3.3
Morals 12 20.0 2 3.3
Religion 18 30.0 3 5.0
Temper 7 11.7 9 15.0
Order 9 15.0 2 3.3
Sex 13 21.7 5 8.3
Fear 5 8.3 1 1.7
Guilt 5 8.3 1 1.7
Seriousness 12 20.0 1 1.7
Sadness 5 8.3 3 5.0
Emotionality 14 23.3 8 13.3
Suspiciousness 5 8.3 0 0.0
Detail 20 33.3 8 13.3
Cosmic interests 15 25.0 1 1.7
Destiny 13 21.7 3 5.0
Persistence 5 8.3 11 18.3
Hatred 2 3.3 5 8.3
Dependence 6 10.0 2 3.3
Happiness 5 8.3 2 3.3
Physical 8 13.3 1 1.7
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6.4.10. Comparison of Psychiatric Measures Against One Another and with the Gold 
Standards of “Clinical Significance” and “ ICD-10 Diagnosis”
We compared the NPI. BPRS, and NBI patient and carer scales with one another and 
as measures of psychiatric caseness against the two gold-standards for psychiatric 
diagnosis; the rating of “ clinical significance” based on the PSE interview (described 
above) and ICD-10 diagnosis derived using the SCAN program. Receiver Operating 
Characteristics (ROC) Analysis was used to perform these comparisons.
None of the instruments appeared to perform well against either gold standard- 
clinical significance or ICD diagnosis. The ROC curves for clinical significance (Fig. 
19) and ICD-10 diagnosis (Fig. 20) are depicted below with tables 34 & 35 detailing 
the area under the curve in each case.
Figure 19. ROC curve depicting performance of the NPI. BPRS and NBI (patient and 
carer scales) against the “clinical significance” gold standard.
ROC Curve
1.00
Source of the Curve
.75-
°  Reference Line
° nbi carer total scor
.50-
°  nbi patient total sc 
ore
.25-
°  BPRSTOTR
“ NPI variables total
CO 0.00 score
1.00.750.00 25 .50
1 - Specificity
Diagonal segments are produced by ties.
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Table 34. Area under the curve- clinical significance gold standard.
Area
Std.
Error
Asymptotic 95% 
Confidence Interval
Test Result Variable(s) Lower
Bound
Upper
Bound
NPI variables total score 6.3 0.1 0.44 0.82
BPRSTOTL 0.55 0.09 0.37 0.73
NBI patient total score 0.58 0.09 0.40 0.77
NBI carer total score 0.64 0.09 0.46 0.82
Figure 20. ROC curve depicting performance of the NPI, BPRS and NBI (patient and 
carer scales) against the “ ICD-10” gold standard.
ROC Curve
1.00
Source of the Curve
.75
° Reference Line
°  nbi carer total scor
.50
°  nbi patient total sc 
ore
° BPRSTOTR
(/)c
(DO) 0.00
° NPI variables total
score
1.00.50 .750.00 .25
1 - Specificity
Diagonal segments are produced by ties.
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Tahte 35. Arcii under ihc curve: IC'D-10 gold slandard.
Area
Std.
Error
Test result variable(s) Asymptotic
Sig.
NPI variables total score 0.51 0.15 0.22
BPRSTOTL 0.62 0.13 0.35
NBI patient total score 0.76 0.10 0.56
NBI carer total score 0.58 0.13 0.32
Asymplolic 95% 
confidence Interval
vOwer
bound bound
Table 36 depicts the cut off score for each instrument that yields the best match of 
sensitivity and specificity. As is evident, the sensitivity and specificity of these 
measures as global measures of psychiatric caseness is generally poor, with the cut­
off scores being rather low.
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Table 36. Scnsilivilv and spccillciiy oflhc NPI, BPRS, NBI-P and NBI-C againsl (he 
ICD-10 and clinical .significance go Id-slandard.
instrument
Cut-oIT 
score (ICD)
Sensitivity
(%)
Specificity
(%)
Cut-otY 
score (CS)
Sensitivity
(%)
Specificity
(%)
1/2 60 75 1/2 58.8 86.4
NPI m 66.7 2/3 52.9 77.3
3/4 60 58.3 3/4 41.2 72.7
3/4 60 77.8 3/4 76.5 77.3
BPRS 4/5 72.2 4/5 70.6 72.7
5/6 60 66.5 5/6 64.7 68.2
14/15 80 91.7 14/15 88.2 95.5
15/16 88.9 15/16 82.4 90.9
NBI-P 16/17 60 86.1
18/19 82.4 86.4
21/22 82.4 81.8
8/9 80 86.1
NBI-C
9/10 80 83.3 9/10 76.4 86.4
10/11 80 77.8 10/11 70.6 86.4
11/12 58.8 77.3
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7. DISCUSSION Ol n iK  RI SU I I  S: PRIMARY ( ARI: STUDY
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7.1. ( riliqiic of Primary ( arc Study
7.1.1. Factors inherent to this Study
While the results reported herein are in line with prediction, a number of factors could 
have influenced these findings. These are considered in detail herein.
7.1.1.1 .Response Rates:
The response rate in the primary care study was low in both settings King’s Lynn and 
Bradford. Only 43% of 193 subjects with epilepsy who were invited to take part in the 
study eventually took part. A significant proportion (over half) either refused (26%) or 
failed to respond to the invitation (31%). The response rate in control subjects was 
similarly low. Of 582 controls contacted, 51.3% failed to respond to three letters of 
invitation, and 22.4% dropped out having accepted. This of course may influence the 
results as it may have caused a “response bias”, with subjects who agreed to take part in 
the study, being non-representative of the population as a whole, either because they 
suffered from a greater burden of psychosocial morbidity (hence the interest in 
participation) or because they did not recognise these complaints (hence the lack of 
interest in taking part).
It would have been ideal to compare responders and non-responders and study 
these characteristics based on available information in the GP records. However, this 
was not possible, as the study was not adequately resourced for such an extensive 
exploratory investigation. Personal or telephonic contact with suitable subjects may also
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Ihave increased Ihe response rale. This loo could nol he iinderlaken holh lor resource and 
elhical reasons. We did however encourage parlicipatlon via Ihe public communicalions 
and the specialist epilepsy nurse service. Other perceptible reasons for the low response 
rates that were put forward locally in King’s Lynn and Bradford included
a. Recent epilepsy research efforts in the locality (King’s Lynn)
(O'Donoghue et al, 1999) 
h. A general mistrust of such efforts and poor response rates as a whole 
(Bradford)
c. I he subject of study, psychological burden, which may not have appealed 
to many potential participants.
Psychological morbidity rates were low in both persons with epilepsy (about 19%) and 
control subjects (about 8%) in comparison to published results elsewhere (over 40% 
and 15% respectively) (Edeh & Toone, 1988; Jenkins et al, 1998). The response bias 
therefore is likely to have been skewed in the negative direction, in both groups. It may 
be argued that the difference in psychiatric co-morbidity between the two groups 
therefore, was demonstrated despite this low level of co-morbidity, rather than because 
of it, as the reductions in comparison to published figures, are approximately equal in 
both epilepsy and control groups. However, in the light of the generally low response 
rates, and the considerable consequent potential for bias, we must be guarded in the 
inferences drawn regarding the observed differences.
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7 1 1 .2.C 'hoicc of Study Locations
It is widely acknowledged within the UK, that neither King’s Lynn nor Bradford can he 
described precisely as representative of the UK population as a whole An interesting 
demographic contrast for example is that King’s Lynn has among the lowest 
proportions of non-white residents much below the national average, while Bradford 
has among the highest, much above the national average. Both locations fall below the 
national average in terms of opportunity, performance and social indicators. We chose 
the locations for a range of pragmatic reasons, the presence in both locations of a 
primar) care service and register for epilepsy lead by a senior clinician based in primary 
care, key factors in conducting a study of this magnitude, with few resources. However, 
these factors (including a significant primary care interest in epilepsy) may also 
contribute to reducing the representative nature of these populations, and this too needs 
to be acknowledged. It is not unknown for example for people to move residence in 
order to be within the catchment area of a responsive clinical service.
We do acknowledge therefore that the locations we chose could have per se 
introduced an element of selection bias, resulting in results that may not be readily 
extrapolated to other UK populations or those elsewhere, but do not feel that these are 
in excess of normal populations variations that are commonplace in epidemiology.
7.1 .1.3. Level of Ascertainment -  Epilepsy and Psychiatric Caseness
Cases of epilepsy for this study were recruited from the epilepsy register maintained
in the King’s Lynn practice, and maintained by the Bradford Epilepsy Service. Both
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registers had been established in rather similar ways, using a two-stage procedure to 
screen the records and identify all possible cases, followed by a personal examination 
of all cases by a neurologist (described in papers by O’Donoghue et al, 1999; Wright 
et al, 2000 respectively). This is the widely accepted method of ascertainment in 
epidemiology, as investigative evidence and the level of detail one has come to expect 
in hospital settings, do not exist in primary care.
All cases were reappraised by this candidate, an experienced clinician trained 
in psychiatry and neurology, and with an epilepsy interest. All patients included were 
determined clinically to have epilepsy, which met I LAE criteria for active epilepsy. 
There is a misdiagnosis rate of up to 20% in many settings including specialist 
settings, patients diagnosed to have epilepsy actually suffering from non-epileptic 
attack disorder and such like (Betts, 2002). This is a problem that afflicts all 
epidemiological studies of epilepsy, and one that is likely to impact on the present 
study, but no more than any other. There were variations in the methods used to 
establish these registers, the King’s Lynn register being established using more 
rigorous case-finding methodology when compared to the Bradford register. The 
reasons for this difference were
a. The significantly smaller size of the King’s Lynn register which covered 2 
practices in the locality, unlike the Bradford register which involved an 
entire Primary Healthcare Group (PCG).
b. The academic purpose of the King’s Lynn register, which was part of a 
PhD study, as opposed to the Bradford register, which was established, to 
meet a local health service need.
275
We however made elTorts to ensure lhal only cases with active epilepsy were 
included, by:
a. Carrying out our own searches of computer records, updating both 
epilepsy registers in the process
b. Matching our searches with the established registers, and including 
only those subjects who met criteria for active epilepsy as defined 
herein
c. Excluding at the outset cases in whom diagnosis was in doubt
d. Reappraisal of diagnosis being carried out by this candidate
We included a sample of subjects from the Southgate Surgery in King’s Lynn, which 
did not have an established register, and wished to establish such a register. In doing 
this we helped to fulfil a local primary care need. The procedures used for this 
screening were rigorous, and mirrored those used in the earlier studies. This candidate 
carried out the confirmation of diagnosis. In the event, only nine subjects with 
epilepsy from this practice eventually took part in our study, and are included in the 
epilepsy group. Admittedly, the inclusion of this group may have increased 
marginally the misdiagnosis rate in our sample, although we have no reason from our 
clinical examinations and review of records to believe that this is so.
7.1.1.4. Burden of Instruments
The employment o f multiple measures, with potential for overlap, may have 
influenced the findings of our study, as this increases the likelihood of inaccurate or
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invalid responses. While we did use a number ol measures in this study, we did by 
staggering their administration in a systematic way attempt reduce the burden. I bus 
all subjects received the self-rating measures, CiHQ-28, I IADS and SHE by post at 
which time an appointment was also made by the investigator to see them. They were 
requested to attend this appointment with the completed measures in hand. During the 
appointment they were assessed with the MMSE, NHS3 and CIS-R in that order. 
Subjects taking part in the second stage PS E/SC AN interview were then given the 
NBl to take home and complete (both patient and carer version) to bring with them to 
the appointment for the lengthier PS E/SC AN interview. All these appointments were 
made within the span of one month (within the week in most cases), I month being 
the duration of the “present state” assessed in all measures. By adopting this 
systematic and staggered procedure of instrument administration we believe we 
managed to maintain consistency and avoid the problems of instrument burden.
7.1.2. Factors Influencing Results in Epidemiology and Their Relevance to the Primary 
Care Study
Inference is described as “the process of passing from observations to generalisations”.
A number of factors are known to influence results in psychiatric epidemiology and to 
thus affect inferences made from epidemiological studies. An observed association 
between two factors does not mean that they definitely caused one another. Thus in 
epidemiology, before any consideration of cause and effect may be entered into, the role 
of chance, bias, confounding and direction of causality needs to be considered (Stewart, 
2003).
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7.1 2 I C hance
Chance operates through sampling error. We hypothesised in this study that cases with 
epilepsy were twice as likely as controls to suffer from co-morbid psychiatric disorder. 
We did indeed find such a difference in the population we studied, in the overall 
sample. In doing so, we believe that we have rejected the null hypothesis, i.e. that there 
is no difference in the prevalence of psychopathology between cases with epilepsy and 
controls, this inference being supported by the mean score and narrow confidence 
interval value. The finding could, however, still be a product of chance, as revealed by 
the failure to demonstrate a significant difference between cases and controls in the 
paired samples /-test.
In mitigation, the consistent trend in results, in line with prediction, the good 
agreement in general among the instruments of psychiatric research employed, the 
significant values, and not too wide confidence intervals of the difference between 
patient and control means, appear to indicate that the findings of our study are not 
merely an artefact of chance, and represent true differences between epilepsy and 
control populations.
7.l.2.2.Bias
Bias refers to systematic error arising from the design or execution of a study. Unlike 
confounding, bias cannot be “adjusted for” once data has been gathered. Bias can be 
categorised into that which arises from deriving the sample or comparison groups from
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the base population (selection bias) and that which arises from measurements made on 
study participants (inlbrmation bias) (Stewart, 2003).
Inlbimation Bias:
This arises t'rom a systematic error in the measurements applied, all measurements 
being potentially subject to error. Recall Bias is an important source of information 
bias, and could have impacted on the present study. However, as the period of 
examination (the present state) was one-month in all measures employed, and this is a 
relatively short period, the likelihood of the period per se causing recall bias is low. 
However, the possibility that people with epilepsy would be more likely to report 
changes to their mental state when compared to their peers in the community remains, 
given the chronic nature of epilepsy, and the considerable stigma attached to the illness. 
Further, people with epilepsy may be more forthcoming about mental symptoms than 
their peers in the population, considering these to be part of the illness, rather than an 
aberration in mood or behavior. These sources of recall bias albeit negligible, need 
consideration. Another form of information bias that may have influenced the results in 
this study is observer bias. The observers in phase-1 and phase-2 were not blinded to 
the disease status (group) of the individual participant being studied. However, the 
instruments employed in phase-1 such as HADS, GHQ-28, and ClS-R were largely 
structured and self-rating thus restricting the potential for observer bias. In phase-2 the 
interviewer while being aware that all participants had epilepsy, was blinded to the 
results of their phase-1 evaluation, both epilepsy and mental disorder variables. Thus 
there was an inherent source of observer bias, with the likelihood that common mental 
disorder symptoms may be over-rated by this observer on PSE-SCAN interview, given 
the knowledge that the participants in phase-2 had epilepsy, and the belief that persons
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wilh epilepsy had higher rales oTpsychiatric disorder. However, the good agreeiiieni 
demonslrated between the structured instruments employed in phase-1 and the results ol 
the PSE-SCAN interview, it may be argued that the impact of such bias, if any, on the 
results of this study was probably low
The employment of multiple measures all measuring common mental disorder 
may have led to error. It is well known that “re-testing” often results in conflicting or 
inaccurate responses in clinical research settings. The measures were employed in a 
systematic manner in all cases, the period of measurement (present state) was adhered 
to and was consistent across measures, and the results across measures were consistent 
as indicated by their general agreement. Random error would have led to 
underestimation of the association under study.
Selection Bias:
A further form of bias that atTects case-control studies in particular is selection bias. 
This arises from the failure of cases or controls being recruited to the study in 
question to be representative of cases and controls in the population as a whole. 
Selection bias may occur when the classification as case or control is to some extent 
dependent upon an exposure under study as a hypothesized risk factor. That both the 
base population from which cases and controls were drawn for this study may be 
unrepresentative of the UK has been acknowledged herein. Further, as pointed out 
earlier, factors such as the low response rates, the existence of a primary care based 
service for epilepsy, may all have resulted in a degree of selection bias creeping into 
this study.
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in this case there is also a thcorctieal possibility that the exposure under study, 
common mental disorder, may by itself inlluence the selection ol eases or controls. It 
is well known that seizures are over-represented in depression (ref- Hauser) as 
depression is in epilepsy. A number of factors may be responsible for this: shared 
biological risk/mechanisms, the use of psychotropic drugs (which are proconvulsant) 
in the treatment of common mental disorder, lifestyle and socio-cultural issues etc., 
which will be addressed further in the “direction of causality” section. It is not clear 
whether in this study this factor may have influenced the choice of case or controls.
We took care to include as cases only those subjects with active epilepsy as defined 
by ILAH. We also employed fairly rigid exclusion criteria, ensuring thus that patients 
with active epilepsy alone were included. Nevertheless, our criteria do not specifically 
exclude patients judged to have symptomatic seizures, this being difficult to establish 
in a community study. It is possible therefore that these factors may have induced a 
degree of selection bias.
Prevalence Bias:
Prevalence (proportion of people with the illness at any a particular period of time) is 
a product of both incidence (number of new cases with the illness during the time 
period) and number of cases who cease to have the condition during the period, due to 
recovery or death. In general, epilepsy is a condition with significant morbidity and 
mortality (Sander, 2002) and this creates the potential for prevalence bias. Exposures 
associated with epilepsy may in fact be associated with survival with epilepsy rather 
than with incidence of epilepsy per se. This is a theoretical (although, arguably, 
unlikely) possibility with respect to common mental disorder, since prevalent as well 
as more recently incident cases were included.
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7 .1.2.3. Confounding
Confounding describes a situation in which the measured effect of an exposure is 
distorted by the association of that exposure with other factors that influence the 
disease or outcome under study. Confounding may result in true associations being 
missed as well as false associations being identified (Stewart, 2003). A number of 
factors that may confound the results of this case control study were eliminated 
through the employment of rigid exclusion criteria. These included age (paediatric 
and geriatric populations having different causes, rates and manifestations of epilepsy 
being excluded); learning disability (both epilepsy and mental disorder are over­
represented in learning disabled populations); serious co-morbid physical illness 
and/or disability (which may independently be associated with CMD); and non- 
English speaking populations who may have other causes, rates and manifestations of 
epilepsy and/or CMD. The role of Anti-Epileptic drugs (AEDs) in the development of 
psychopathology must also be considered as reviewed earlier. Further, the role of 
ongoing sub-clinical seizure activity in the development of psychopathology must be 
kept in mind.
We have not controlled for AEDs in the cases as in a population study this would 
have been difficult to achieve, and because systematic approaches to this (scales for 
example) are lacking. There was also the issue of instrument burden and resource 
limitation. We have not controlled for seizure activity manifesting as 
psychopathology, as this would have involved doing EEC’s in all persons with 
epilepsy, which is beyond the scope of this investigation, and for which the resources
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were not available. I^ olh ihcsc faclors may have inlluenced the burden ol 
psychopalhology in (he eases (not in controls), and may in part aeeoiint lor the 
increased burden of psychiatric co-morbidity in cases with epilepsy in this population.
Other potential confounders that have not been accounted for in this study include 
life events and social class, factors that are known to impact on mental state in both 
patients with epilepsy and control populations. We did not include a life events scale 
in this study, partly in order not to increase instrument burden, and partly because 
such a scale would have to be adapted for use in epilepsy. For example, “temporality 
of seizures is known to be an important factor that mediates mood in people with 
epilepsy. Life-event scales employed in epilepsy need to incorporate questions about 
seizures as life events and their putative impact on (present) mental state. We also did 
not measure social class in any systematic manner, mainly due to the poor resourcing 
of the study. Social class may be associated with both CMD and epilepsy. Other 
important variables such as social support, education and employment status are also 
potential confounders that we have failed to take account of in a systematic manner.
It must be therefore be acknowledged that these potential sources of confounding 
may influence the results reported herein. Collecting baseline data on these potential 
confounders may have been beneficial, as it would have enabled us to adjust for these 
factors in the analysis.
However, the in-depth statistical analysis described previously using multivariate 
methods, has enabled taking into account some potential confounders. The use of 
Generalised Linear Modelling (GLM) SPSS in order to study the complex
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rclalionships bclwccn sci/urcs. I  M l) and disablcmenl has helped to establish beyond 
reasonable doubl lhal an associalion belween CMD and disablemenl exisls, and lhal ii 
is independent ol the association belween seizures and disablemenl.
7.1.2.4. Direction of Causality
Could there be a cause-etTect relationship in the reverse direction to the one 
anticipated? Such “reverse causality” is possible in studies of this nature. For example 
in this study the presumed direction of causality is that of epilepsy causing CMD, 
more often when compared to control populations without epilepsy. In other words 
epilepsy is assumed to be the risk factor that provokes CMD. An alternate possibility 
of course is that the cause-effect relationship operates in the reverse direction, with 
CMD causing epilepsy in some subjects but not others, within the population 
surveyed. In general, CMD is a more common (about 20% of populations surveyed) 
when compared to epilepsy (5 per thousand in most population studies). Further, there 
is epidemiological evidence to suggest that depression for example is a risk factor for 
the development of seizures, for reasons discussed earlier in this chapter. A causal 
relationship in the reverse direction is therefore possible. Flowever, the consensus in 
epilepsy research, with epilepsy being a significant neurological illness, with a 
biological basis in the limbic system in most cases, and with significant morbidity, 
mortality and disablement, tends to veer towards epilepsy being a cause of depression 
and other psychiatric disorders (Kanner, 2003). Whatever the direction of causality 
however, the effort in this study is to demonstrate a greater burden of CMD in 
epilepsy as compared to that seen in a matched control population, which we have 
demonstrated.
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7 .1.3. Discussion oflhc Rcsulls
7.1.3.1. Hypothesis- Common Mental Disorders ARE Commoner in Epilepsy
Our findings are in line with prediction. Common mental disorders are commoner 
in patients with epilepsy when compared to population based controls, the difference 
being statistically significant. Patients with epilepsy were significantly more likely to 
have a primary psychiatric diagnosis (ICD-IO) derived from the CIS-R interview. 
Although there has been considerable evidence to suggest the over-representation of 
psychiatric disorders in patients with epilepsy, this is to our best knowledge the first 
primary care based, hypothesis driven study that has used valid instruments of 
psychiatric research, and matched population based controls to confirm this increased 
burden of psychological morbidity. The demonstration of significantly higher co­
morbidity of CMD in the epilepsy group, both in the overall samples, and in the 
paired samples design, is evidence that CMD are over-represented in epilepsy.
There were interesting differences too in the patterns of psychiatric co-morbidity 
in epilepsy. Mild depressive episode and mixed anxiety and depression were the two 
diagnoses identified both in controls, and in patients with epilepsy. Patients with 
epilepsy however demonstrated a wide spread of other ICD-10 psychiatric diagnoses 
including moderate depressive episode, severe depressive episode, specific (isolated) 
phobia, obsessive-compulsive disorder, and social phobia. Patients with epilepsy were 
also more likely than control subjects to have a secondary psychiatric diagnosis (ICD- 
10). Indeed no control subject ( I I I )  met ICD-10 criteria for a secondary psychiatric 
diagnosis in comparison to six of 59 subjects with epilepsy.
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There were inlcrcsling di Keren ces loo bolh in the burden of psychological 
morbidity and in the patterns of psychological symptoms expressed between the two 
groups. Patients with epilepsy were more likely to sutler from poor concentration, 
depression, worry, worry over physical health and compulsions, when compared to 
their peers in the population. The “load” of psychological symptoms was also greater 
in the epilepsy group; mean CIS-R total scores being significantly more in this group 
when compared to controls.
Overall, these results indicate an increased burden of psychiatric co-morbidity in 
epilepsy, in terms of symptom severity and multiplicity (load). While these factors 
may result in patients with epilepsy meeting criteria for a diagnosable psychiatric 
disorder, this is by no means assured, as criteria based instruments differ considerably 
from symptom-based measures. Given these findings, we may argue that symptom 
based measures are more likely to reflect the true burden of psychological morbidity 
in epilepsy, and that the use of such measures is a more valid and reliable technique in 
epilepsy research. Further, these findings are in keeping with past evidence reviewed 
herein as well as empirical observation. The fact that they arise from a relatively 
representative population in primary care, increase their validity, and provide the 
necessary evidence to inform and influence public health planners and providers 
about the importance of psychiatric issues in epilepsy.
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7 .1.3.2. Agrccmciil bclwccn Screening and Diagnostic Measures in Patient and
C ontrol (iroups
Unlike the diagnostic measure used in the case-control component of the 
study, the CIS-R, which showed a difference in total scores between patients and 
controls, the screening measures, HADS and GHQ-28 (with the exception of the 
somatic symptom scale on GHQ-28) failed to show differences between the two 
groups in terms of mean total scores. As the HADS has been used in a number of 
population studies in epilepsy, as a measure of psychiatric caseness, we used the cut 
off score of 11 to diagnose anxiety and depression based on the respective subscales, 
and found no difference between patient and control groups in terms of psychiatric 
caseness. When non-parametric correlations were examined, the two screening 
measures appeared to agree with one another and with the CIS-R in both groups, 
although the correlation co-efficient values were higher in the control group than the 
epilepsy group (tables 5 & 6).
The results of the ROC analysis show that the screening measures GHQ-28 
and HADS perform reasonably well against the CIS-R gold standard of psychiatric 
caseness, in both epilepsy and control groups, with sensitivity and specificity of 
generally above 80%. However, it is interesting to note that,
a. The cut-off scores that indicate psychiatric caseness are considerably
lower in both epilepsy and control populations than employed in previously 
published studies of HADS (Baker et al, 1996; Jacoby et al, 1996; 
O’Donoghue et al, 1999 for example)
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h The cul oH scores llial corresponded wilh psychialric caseness on Ihe
CIS-R were lower in conlrols lhan in persons wilh epilepsy for bolh Ihe GHQ- 
28 and HADS-Anxiely subscales, and comparable for Ihe depression subscale.
These results indicate that while it would be acceptable to utilise these screening 
measures in large population based studies, thus making these studies more 
economical, less time consuming, and viable, the cut off scores for “caseness” may 
need to be suitably revised in order to identify all subjects with psychological 
morbidity. Indeed, it is entirely possible that the estimates of psychological morbidity 
published in previous studies, using these screening measures with previously 
published cut off scores derived from non-epilepsy populations, have been lower that 
the actual morbidity that may have existed in the communities surveyed.
There are of course other explanations for these lower cut off scores in the two 
groups, including:
a. The presence of a generally high level of psychological morbidity in the 
participants, not supported by the overall levels of psychiatric caseness 
which were generally low
b. A lack of consistency in responses to these measures (not supported again 
due to the high correlations between the measures employed).
Interestingly also, the greater consistency across measures in the control group, did 
not yield cut-off scores in this group that were more in line with published literature.
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Needless (u say, as discussed earlier, a response bias may have been operational and 
contributed to these results as discussed extensively earlier in this section.
7.1.3.3. Psychotic Symptoms in Patients and Controls
13.6% of patients with epilepsy as opposed to 3 .6% of controls scored positively on 
the Psychosis Symptom Questionnaire, the dilTerence being statistically significant. 
This is in line with prediction, as the vast majority of studies (for example: Bredjkaer 
et al, 1998: Stefansson et al, 1998) have shown an over-representation of psychosis in 
patients epilepsy, which has also been consistently predicted in expert reviews of the 
literature.
PSQ has been noted to have poor specificity in population based research (Jenkins 
et al, 1998), and comparison with a gold standard such as SCAN or CIDl would be 
necessary, before the results of this screening test can be accepted. Indeed, the 
comparison of the PSQ with SCAN described in the results section, highlights the 
importance of this. The use of the PSQ in population-based studies of epilepsy must 
therefore be judicious, and after taking into consideration items like question-1 “Over 
the past year, have there been times when you felt very happy indeed without a break 
for days on end?” This particular question may need alteration in our opinion, as a 
number of cases and controls when first asked the question were puzzled by it, and 
sometimes answered in the affirmative. Cross checking and repeated clarifications by 
the interviewer were required in many cases.
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7 .1.3.4. Psychialric Disorders in Paliciils wilh llpilcpsy
7.1.3.4.1.Psychiatric caseness in epilepsy: comparison of ICD, clinical significance 
and CIS-R
55 of 59 subjects with epilepsy completed the PSE components of the SCAN 
interview with this candidate. 29.1% of subjects met criteria for at least one ICD-10 
diagnosis. O f the broad diagnostic categories depressive disorders followed by 
anxiety disorders were the most common, in line with previous research findings 
reviewed herein, and in line with prediction.
In contrast 40% of 55 subjects with epilepsy were rated positive on at least one 
PSE symptom category. The most common symptom categories were biological 
(sleep, appetite, weight and sexual fiinction); worry; anxiety & panic; depression; and 
somatoform symptoms in that order, representing the spectrum of common mental 
disorder symptomatology. Indeed, when clinical significance ratings and ICD-10 
categories were compared, correlations between key common mental disorder 
symptom categories became immediately apparent, underlining the importance of this 
construct in the psychiatric epidemiology of epilepsy. The higher prevalence of 
clinically significant symptoms when compared to ICD-10 diagnoses is in line with 
prediction. Taken together with the earlier finding that that lower scores on screening 
instruments appear to correlate with psychological morbidity, these data appear to 
reinforce the importance of symptom based approaches to diagnoses in epilepsy 
studies, as well as the potential pitfalls of relying exclusively on structured criteria 
based diagnostic approaches in these special populations.
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It is notcworlliN alst> that clinical significance ratings ol psychiatric caseness 
were highly correlated with ICD-IO diagnosis. Interestingly, when CIS-R derived 
caseness was compared with caseness derived through clinical significance ratings on 
PSE, and with ICD-10 diagnosis derived through the PSE interview, there was greater 
agreement between the CIS-R and ICD-10 ratings of caseness, than between CIS-R 
and clinical significance ratings. While in part this may be explained by the CIS-R 
relying on ICD-10 diagnostic rules to make ratings of psychiatric caseness, it 
nevertheless is surprising, as greater agreement between two symptom based 
measures (CIS-R and clinical significance) was expected.
7.1.3.4.2. Measures of Psychiatric Caseness: A Comparative Analysis
When the screening instruments employed in this study, the GHQ-28 and HADS, and 
the diagnostic instrument used (CIS-R), were compared using ROC analysis with the 
two gold standards of psychiatric caseness, ICD-10 diagnosis and clinical 
significance, a number of interesting observations emerged. First, all three 
instruments compared well with both gold standards. Second, subtle differences in 
performance became apparent: the CIS-R performing best, followed by the HADS 
and then the GHQ in relation to both gold standards. Third, a suggestion that clinical 
significance ratings compared better overall with the instrument ratings, rather than 
ICD-10 diagnosis, as revealed by the area under the curve in the two ROC analysis 
(figures I2&I3).
Interestingly, in this analysis also, the cut off scores of the different 
instruments were lower when compared with the clinical significance gold standard as
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opposed lo Ihe IC'D-10 gold standard, indeed, the scales when compared with ICD-IO 
appeared to follow established cut-olT scores for caseness for several ol the 
instruments including CIS-R= 11.5 (Lewis G et af 1992); HADS- Anxiety= 8.5 
(O’Donoghue, 1999); and GHQ-28= 20.5 (Goldberg, 1988), but not HADS- 
Depression which at 3.5 was much lower. In contrast the corresponding scores for the 
clinical significance gold standard were CIS-R= 6.5; GHQ-28= 17.5; HADS- 
Anxiety= 7.5; and HADS-Depression= 3.5. We may on the one hand assume based on 
these results that the cut off scores with ICD-IO diagnosis are the ideal, compare as 
they do with published cut-off scores. On the other hand, this is but to be expected, as 
the cut off scores are derived in studies that have used the very same criteria based 
gold standards. The interesting counterpoint therefore is whether the clinical 
significance gold standard is a better gold standard to apply in epilepsy studies, not 
only because it appears to perform well in the ROC analysis, but also because it is 
symptom based, more sensitive to psychological morbidity, and more likely to 
diagnose “cases” with disabling psychiatric symptoms. These results appear to 
indicate therefore that the established gold standards with which we compare 
screening and diagnostic measures may need to be reviewed.
In contrast, the psychosis symptom questionnaire did not agree with either the 
ICD-10 diagnosis or the clinical significance gold standards. The results once again 
demonstrate the high sensitivity but poor specificity of this measure (Bebbington & 
Nayani, 1995), even in a population with epilepsy and with theoretically, an increased 
prevalence of psychosis. Currently a positive rating on a single question on this 
measure is adequate to ensure scale positivity. The question most likely to yield a 
f alse positive response was in our observation the question relating to Hypomania
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"Over ihe past year, have there been limes when you fell very happy indeed without a 
break tor days on end" (Appendices Section 9.3, pg. 363) and this as mentioned 
earlier may be subject to revision.
While the importance of such a screening measure for population based 
research cannot be underscored, the scale perhaps needs to be altered to provide a 
safety net especially for vulnerable items such as that aforementioned.
7.1.3.4.3. I he Neurobehaviora! Inventory (NBI): A Valid Measure of “Psychiatric
Caseness"
I he analysis of the NBI showed that a significant prevalence of its constituent 
symptoms was present, even in this community based sample. Although the patient 
and carer responses in the NBI exhibited good agreement, the comparisons of these 
measures against three different gold standards, CIS-R derived ICD-IO diagnosis, 
clinical significance based on the PSE interview, and SCAN derived ICD-IO 
diagnosis, demonstrated quite clearly, the superior ability of the patient questionnaire 
as a measure of psychiatric caseness. Total scores on the patient questionnaire were 
able to discriminate psychiatric cases from non-cases, across the three measures, 
agreement being best with the CIS-R, less robust with clinical significance ratings 
based on the PSE interview, and least robust based on ICD-IO criteria based 
diagnosis.
The superior ability of the patient measure as opposed to the carer measure is 
expected, this being a primary care sample of non-cognilively impaired subjects. The
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bcllcr agrccmciU wilh ihc C'lS-R is also understandable, the C'lS-i< being a symptom 
based measure, and thus similar lo the NBI. While the superior agreement between 
the NBI and the clinical significance ratings may also be explained by the symptom 
based nature of such ratings, it illustrates once again the greater sensitivity of the 
clinical significance gold standard, as opposed to criterion based gold standards such 
as ICD-IO.
Even more interesting perhaps is the demonstrable ability of the NBI, a measure 
of epilepsy specific psychopathology, to compare well with generic measures of 
psychiatric caseness. There are several possibilities in this regard. First, the NBI, 
although it is intended to be a measure of epilepsy specific psychopathology, may 
actually be measuring generic psychopathology. Second, both generic and epilepsy 
specific psychopathology may co-exist in a number of patients with epilepsy and the 
association demonstrated may be a chance association. Third, the burden of epilepsy 
specific psychopathology may influence generic psychopathology scores adequately, 
in order for patients to score positively on these measures. Fourth, the concept of 
epilepsy specific psychopathology may be erroneous, the behaviours observed being 
no more than indicators of generic psychopathology: stickiness a reflection of 
obsessional ity, suspiciousness a reflection of paranoid ideation, and so on, as many 
dissenting reviewers have often commented (Devinsky, 1999). Finally, a degree of 
epilepsy specific psychopathology may be present in all individuals with 
demonstrable temporal lobe pathology (such as hippocampal sclerosis), these cases 
constituting between 30 and 40% of a community-based sample such as this. What is 
described as epilepsy specific psychopathology may therefore be no more than end of 
spectrum “normal” behaviours seen in people with brain disease. I he implications of
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Ihcsc llndings loi epidemiological research, and employmenl ol the NIil in liitiire 
studies are discussed section 7.1.3.4.3 (pg. 283) below.
7.1.4. Seizure Severity, Psychiatric Co-morbidity & Subjective Handicap
Seizure severity was measured using the National Hospital Seizure Severity Scale 
(NHS3) a validated measure, and was not associated with either generic or epilepsy 
specific psychopathology in our study. This is not in line with prediction, a number of 
previous studies have demonstrated clear associations between the severity of seizures 
and co-morbid psychopathology (Jacoby, 1996; Baker, 1996). That having been said, 
the assessment of psychiatric co-morbidity in a number of these studies has left much 
to be desired, hitherto un-validated screening measures such as HADS being 
employed to discriminate psychiatric cases from non-cases in many studies.
Other seizure related measures that have been associated with psychological 
morbidity include seizure frequency, which we did not measure in our study as we 
found this to be subjective, unreliable, and a validated instrument for measurement of 
the same lacking. Other variables that have been associated with psychosocial 
outcome include temporality of last seizure, type of seizure, and the prescription of 
AEDs (Baker et al, 1996). We did not classify the type of seizure, as such a 
classification would have been based on clinical impressions, and made in the absence 
of supportive investigations, this being a community based study. In hindsight, 
however, the recording of this information may have provided interesting insights.
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Sc i/Il 1C severity was however associated strongly with many scales on the 
disablement measure, in line with prediction. Having more than one type ol seizure 
was as expected more disabling. Further, total seizure severity scores were associated 
with all scales on the disablement measure except the work scale, indicating that 
increased seizure severity impacted on several aspects of the patients life including 
physical, social, self-perception and life-satisfaction. The impact of seizure severity 
on psychosocial variables has been well demonstrated in a number of studies and in a 
number of settings (O’Donoghue et al, 1999; Jacoby et al, 1996; Fisher et all, 2000).
Psychiatric co-morbidity was also associated with disablement, both criterion 
based psychiatric caseness (ICD-10 diagnosis) and psychiatric caseness evolving from 
symptom based measures (CIS-R), an association that has been well demonstrated in 
a number of studies (see Baker et al, 1996 for example).
The relative contributions of seizure severity and psychiatric co-morbidity to 
disablement have not been examined extensively in previous studies. Jacoby et al,
1996 showed in multivariate analysis that both psychological morbidity and seizure 
severity contributed to disablement in epilepsy, as did other expected predictors such 
as age of onset. A further report arising from this study in a large epilepsy cohort 
(Baker et al, 1996) did examine this issue using multivariate techniques and found 
psychological morbidity to explain the greatest proportion of shared variance 
followed by seizure severity, and other indicators. However, these studies were 
pedestrian in their approach to the measure of psychological morbidity, employing the 
HADS with published cut-off scores used in non-epilepsy populations. Our approach 
w as to study these associations across a range of validated measures including CIS-R
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derived ICD-IO diagnosis. OS I derived ratings ol elinieal significance, SCAN derived 
ICD-IO diagnosis, and NBI derived measures o f psychiatric caseness.
Interestingly, it was established across the entire range of measures except the 
NBI carer scale, that co-morbid psychiatric disorder explained the greatest proportion 
of shared variance, followed by seizure severity, other predictors such as age and sex 
having limited effects if at all. The failure of the NBI carer scale to demonstrate such 
an association is not surprising, given its poor correlation to gold standards, and low 
levels of consistency. Indeed, this only goes to reinforce the previously stated belief 
herein, that such a carer rated measure may have poorer validity in adult non- 
cognitively impaired sub jects in primary care. Of the measures employed, CIS-R 
appeared to be the best predictor for disablement, followed by ICD-10, and clinical 
significance ratings. While one might surmise that symptom load may influence 
disablement, and be responsible for this association between symptom based 
measures and disablement scales, if one were to believe that disablement scales 
measure what they are meant to measure, and are accurate in doing so, then surely the 
employment of measures of psychiatric caseness that are closely linked to such 
measures of disablement, is both necessary and ideal.
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7.2. I hc inslilutioiial Study 
7 .2.1. Critique o f the Institutional Study
7.2.1.1. Chance
The possibility that the observations in this population are a product of chance must 
be considered. The patterns of psychopathology as described by NPl and BPRS in this 
study, are generally in line with prediction; the behaviors reported being generally 
observed in institutional and/or learning disabled populations. The confidence 
intervals of the mean score, especially with respect to the NPl scores, less so for the 
BPRS scores, also appear to indicate that the findings with this instrument may reflect 
valid associations beyond chance. Especially in the case of the NPl, NPl and BPRS 
correlations, both total score as well as individual items, are generally weak, and may 
be explained by chance. While the prevalence figures for NBI domains and PSE 
clinical significance ratings appear to be in line with prediction, in this population, the 
prevalence of various ICD-10 criteria based diagnostic categories do not, and may 
reflect chance outcomes, or indeed alternately reflect the relative ineffectiveness of 
such criteria based diagnosis in institutional populations.
When we compared NPl and BPRS scores in cognitively unimpaired and 
cognitively impaired populations, we found significant differences. Here too the 
confidence intervals for the difference in mean scores of the NPl appeared to more 
confidently exclude the null hypothesis value, than the confidence intervals for the 
mean difference in BPRS scores. It could be argued therefore that the differences 
observed between the cognitively unimpaired and cognitively impaired sub-groups
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were less likely lo he a product ol'chance w ith regards lo the NPl, while chance may 
explain the dilTerences observed on the BPRS.
7.2.1.2. Bias
This data emerges from a population of institutionalised individuals with epilepsy. 
While persons with epilepsy resident in institutions are not representative of persons 
with epilepsy residing in the community, they are representative of institutionalised 
populations as a whole, and to a lesser extent perhaps of populations with learning 
disability and epilepsy. Further, as pointed out in the introductory sections of the 
institutional study, people with epilepsy living in institutions, the main reason for their 
residence being epilepsy and not co-morbid learning disability or behavioural 
disorder, are relatively unique today. The population we have chosen is therefore in 
our view more representative of institutional populations with epilepsy, than those 
residing in mental hospitals, institutions for learning disability, and other similar 
locations.
The response rate in this study was in excess of 85%, considered reasonable 
by any standards, and it may be argued that a selection bias overall is unlikely. 
However, a selection bias may have been operational in the PSE-SCAN interview 
component of the study, as a relatively small proportion of the overall population 
surveyed took part in this component, and generally low levels of psychopathology 
meeting ICD-10 criteria were reported. We may have therefore inadvertently 
“selected” for this component, relatively well preserved cognitively unimpaired 
individuals, with low burdens of psychopathology.
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A recall bias is possible, Ihe period of the NPI ascerlainmenl being I year. Ibis 
being a relatively long period, and thus subject to error. From the perspective of the 
caregiver response, both errors of omission (driven by relatively good recent 
behaviour as opposed to poor past behaviour) and commission (relatively poor recent 
behaviour as opposed to good past behaviour) are possible. However, the overall 
consistency of the NPI results, which are in line with prediction mitigates against a 
significant recall bias having impacted on these findings. Further, factors such as 
seizure frequency, seizure severity, co-morbid medical illness and other outcome 
measures may have influenced the reporting of behaviours by the caregiver, while 
responding to the NPI interview.
An observer bias may have been operational in the BP RS components of the 
study, the ratings having been made following a thirty-minute interview and period of 
observation, albeit by an experienced mental health professional. This may in part 
explain the inconsistencies in the BPRS findings. The possibility that these 
inconsistencies were a product of random error as opposed to observer bias must also 
be kept in mind.
7.2.1.3. Confounding
Admittedly, our data have failed to take into account several potential confounding 
factors in studying associations between cognitive impairment and psychopathology, 
as the also the prevalence of psychopathology variables across instruments.
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1. riic role ol'sei/.ure rrcqucncy and severily (d illlc iilt lo operalionalise in 
those with cognitive impairment), but with potential to impact on the 
results o f the psychopathology outcome measures.
2. The role of anti-epileptic drugs (AEDs), diftlcult to operationalise as most 
residents were on AED polytherapy, and had been on these drugs for 
months if not years. However, a considerable burden of AED induced 
psychopathology has been reported in epilepsy, and this may be a potential 
confounder of psychopathology studies in populations with epilepsy.
In the absence of reliable baseline data on seizure variables and AED 
variables, we could not adjust for these potential confounders in the 
analysis comparing psychopathology across cognitively impaired and 
unimpaired groups, and this may have impacted on the results of our study 
described herein.
3. The role of learning disability (neuropsychological data was not available 
in all residents surveyed, and the data that was available had been 
collected at different times using varying techniques, many residents 
having lived in the centre for years). However, we did study associations 
between cognitive impairment and psychopathology, and found the burden 
of psychopathology to be significantly greater in the cognitively group as 
opposed to the unimpaired group. While this finding was in line with 
prediction and present with both NPI and BPRS, the NPI findings were by 
virtue of their consistency and narrower confidence intervals, robust.
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7 2 1.4. Oil CCI ion ol Causalily
As in the primary care study, the direction of causality in the institutional study may 
have been in the direction opposite to that expected. Thus, cognitive impairment could 
be the result of co-morbid psychopathology rather than cause of co-morbid 
psychopathology. Psychopathology is well known to affect performance on cognitive 
tests in general, and patients with severe psychopathology, especially negative 
symptoms, are known to perform poorly on cognitive measures In epilepsy, a 
significant association between mood change and cognition has been reported, with 
depression being associated with memory complaints as opposed to objective 
cognitive impairment (Piazzini, 2001). Further, there are reports of negative 
symptoms in epilepsy being associated with cognitive impairment (Getz, 2002). We 
did not in this study differentiate between subjective and objective cognitive 
impairment; nor did we distinguish between developmental and acquired cognitive 
impairment. Thus while we did demonstrate an association as predicted between 
cognitive impairment and psychopathology, and expect cognitive impairment to be 
the risk factor for psychopathology, we have no means of confirming that this 
direction of causality was operational.
7.2.2. Discussion of the Results
7.2.2.1. Documented Psychopathology in the Case Records
About a quarter of the population surveyed had previously documented 
psychopathology. Not surprisingly more serious forms of psychopathology, psychosis
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Ibr example, were recorded in Ihe notes, in proportions that were in line with the 
published literature in epilepsy (psychosis in 7-10% of cases; I rimble, 1991), 
whereas the prevalence ol mood disorders, depression in particular, and other 
common mental disorders, was lower than that expected. These results reiterate the 
importance of surveying institutional populations such as these, rather than relying 
purely on records, as only more serious forms of psychopathology tend to be 
documented in case records.
7.2.2.2. Descriptive Data from the NPI
Although the range of scores on the NPI was wide (0-108), the mean &median scores 
were generally low, the histogram being skewed to the left in line with prediction. 
This indicates that the vast majority of individuals scored low on this instrument, a 
greater burden of psychopathology (and hence higher scores) being a feature only in a 
proportion of this institutional population.
1 2 2 3 . Factor Analysis of The NPI; A New Carer Rated Measure for Institutional 
Populations with Epilepsy, and Those with Learning Disability
The factor analysis of the NPI in a large number of subjects with epilepsy has yielded 
results that appear to be both reliable and interpretable. Four clear patterns of 
behaviour (factors) emerge in our interpretation of this factor analysis.
The psychosis factor, which accounts for 28.4% of the variance is 
characterised by delusions, hallucinations, aberrant motor behaviour and sleep
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behaviour. Il is well known lhal psychoses are over-represented in epilepsy, being 
several times more common in that condition, as compared to population figures 
(Trimble, 1991; Krishnamoorthy, 2001 ) and are characterised often by acute clinical 
manifestations of psychotic behaviour. Further, the epileptic psychoses often manifest 
with florid symptoms in subjects with learning disability and in those living in 
institutions, and the high loading on this factor may reflect the nature of the 
population studied. We therefore consider this factor to be clinically relevant.
We interpreted Factor-2, characterised by agitation, apathy, disinhibition and 
irritability as the inter-ictal dysphoric disorder (IDD) factor. IDD is a Kraeplinian 
concept that has been recently re-invoked in epilepsy by Blumer(1999). It is 
proposed, based on literature reviews and prospective investigations, that a pattern of 
intermittent clustering of symptoms such as depressive moods, anxiety, agitation, 
irritability, euphoria, inertia, insomnia, atypical pains and phobic fears (3 of 8 
symptoms) over periods of two or three days is characteristic of this disorder. Factor 2 
with several of the core behavioural components of that condition seems to represent 
IDD, accounting for 11.8% of the total variance in this group of subjects. This seems 
to be a reasonable assumption given that IDD may well form a substantial component 
of the burden of depression in epilepsy.
Factor 3, with depression and appetite change (also sleep disorder although the 
loading for this on the psychosis factor was higher) was interpreted as the depression 
factor. Co-morbid depression is common in epilepsy and is seen in over 50% of 
subjects in some studies (Lambert & Robertson, 1999). Further, depression of this 
nature is often indistinguishable from depression seen in the community and in other
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chronic medical conditions (Krishnamœrlhy, 2(K)0a). Wc there lore interpreted this 
factor to represent depression of the co-morbid type. Together this factor accounting 
for 10.1% of the variance and the IDD factor accounting for 11.8% of the variance 
comprise a significant component of the shared variance, which is in keeping with the 
significant overall burden of depression in epilepsy.
The fourth factor characterised by anxiety and euphoria accounted for 8.5% of 
the total scale variance and was interpreted by us to be the anxiety factor. Anxiety is a 
common symptom in epilepsy (Torta & Keller, 1999) and is manifest in a number of 
ways including ictal anxiety, acute attacks (panic) and phobic fears. Both anxiety and 
euphoria are frequently observed in the period immediately following temporal 
lobectomy ( Anhoury et al, 2000) and may well represent limbic dysfunction. Further, 
there is epidemiological evidence to suggest that there is a significant co-morbidity 
between anxiety and bipolar disorder (Angst, 1998), and the correlation between 
euphoria and anxiety seen here may reflect this. The presence of an anxiety factor was 
therefore considered to be in keeping the general patterns of co-morbid 
psychopathology encountered in clinical practice.
This study shows that the NPI has good internal consistency (Cronbach’s a =
0.758) and its factor analysis yields a four-factor solution accounting for a good 
proportion of the shared variance. The factors thus derived from the NPI appear to be 
clinically relevant and interpretable, indicating that the NPI has face validity in this 
population with epilepsy. However, these results are subject to interpretation and must 
be treated with a degree of caution. Further studies that prospectively examine the 
Nl l^ against other gold standard measures (including carer rated measures) are
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rci|iiiiccl before Ihe inslriimenl can he adopted I'or widespread application. It is clear 
though with the limited evidence presented herein, that the NPI may well he a useful 
and valid carer-rated measure for the assessment of behaviour in epilepsy.
7.2.2.4. Descriptive Data from the BPRS
Like the NPI scores the BPRS scores were also generally skewed to the left, and 
indicated that the vast majority of subjects were rated low overall on various 
behavioural domains. However the range of BPRS scores was greater, and the 
standard deviation wider, indicating the presence of outliers. Taken together with the 
lower completion rates with this instrument, these data indicate that the BPRS as 
applied in this study has limited validity for application in epilepsy populations. This 
is not entirely surprising given that the BPRS was developed as an observer rated 
measure for use in patients with Schizophrenia and other psychotic disorders with 
positive and negative symptoms. The recent reports of negative symptoms in epilepsy 
and their relationship with cognitive status (Getz, 2002) do however provide an 
interesting counterpoint, and indicate the need for behavioural scales of this nature in 
epilepsy studies.
122.5. Agreement between NPI and BPRS
Overall agreement between NPI and BPRS total scores while present was not 
particularly impressive, and may be explained by chance alone. Indeed, when 
individual domains of NPI (12 domains) and BPRS (18 domains) were correlated, 
while a number of correlations in the 0.2 level emerged, they were not particularly
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mciuiingliil. nor rcprcsciUalivc of published iilcralurc as a w hole Perhaps ol 
relevance, the key behavioural domains in the NPI, that we have come to recognize as 
being important in epilepsy populations: agitation, irritability, apathy, aberrant motor 
and sleep behaviours, correlated with more BPRS items in general, when compared 
with other domains of the NPI. This perhaps represents the importance of specific 
behaviours in epilepsy, and their tendency to influence overall psychopathology 
ratings Aside from this, no meaningful interpretations could be made of NPI and 
BPRS correlations.
I his discrepancy between caregiver (NPI) and expert-observer (BPRS) ratings 
may also be explained by a number of factors.
a. Difference in experience and perception of the RA, a mental health 
professional, and the professional caregivers (nurses and social 
workers) resulting in differences in the description and assessment 
of behavioural abnormalities.
b. The stressful nature of the assessment for the subjects- many of 
whom had lived in such institutional settings for years, producing 
unusual manifestations of their psychopathology, especially during 
the expert-observer interview that resulted in the BPRS ratings.
c. Erroneous ratings of psychopathology either by the expert-observer 
and /or the professional caregiver.
While correlations between individual NPI and BPRS scales are generally weak 
indicating that sub-scales on the two instruments showed poor agreement in this
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population, the putative accuracy overall of these observations is supported by the 
results not being inlluenced by other variables such as age or sex; and the 
concordance between NPI and BPRS global ratings of psychopathology described 
below. Further, the patterns of psychopathology identified with these instruments are 
consistent with the published literature, the triad of agitation, irritability and 
apathy/depression identified on NPI, characteristic of the inter-ictal dysphoric 
disorder of epilepsy (Blumer, 2000), and symptoms such as dysphoria, anxiety, 
somatic concern, rated highly in the BPRS, widely reported in epilepsy (Lambert & 
Robertson, 1999). The patterns of psychopathology identified in this study therefore 
are generally comparable with other studies in similar populations with refractory 
epilepsy, fhese findings also highlight the pre-eminence of co-morbid 
psychopathology in populations with refractory epilepsy.
Overall, however, with the NPI appearing to consistently outperform the 
BPRS in this study, greater emphasis needs to perhaps be placed on the findings from 
that instrument, rather than the BPRS.
7.2 2.6 Comparing Behavioural Domains in Cognitively Impaired and Cognitively 
Unimpaired Persons with Epilepsy
We took MMSE scores as overall measures of cognitive impairment in this study. 
There were nearly twice as many cognitively impaired subjects as there were 
cognitively unimpaired subjects.
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There were no dilTerences belween eognilively impaired and cognitively 
unimpaired groups in terms of age, rellecting perhaps the generic nature cognitive 
impairment in this population. That there were no age or sex differences between the 
groups also indicates that the dilTerence in psychopathology scores between 
cognitively impaired and unimpaired groups is a true difference, not influenced by 
these potential confounders. That both measures of psychopathology, NPI and BPRS 
demonstrate differences, albeit with different degrees of significance, provides 
support overall to the validity of these findings.
While both NPI and BPRS scores were significantly different between the two 
groups, the difference in BPRS scores was greater when compared to the NPI scores. 
The NPI has provided more consistent results in all the prior analysis described 
herein, and in this instance too the confidence intervals of the difference in means are 
wider with BPRS ratings than with NPI ratings. However, even as rated by the NPI, 
there is a significant difference in the psychopathology scores between cognitively 
impaired and unimpaired groups. This is in line with prediction, a greater burden of 
psychopathology in cognitively impaired subjects being expected. The finding 
appears relatively robust, as it is demonstrated with two competing measures, carer 
and observer rated, and is unlikely to be a chance association.
While sources of bias: selection, recall, and observer do exist, as reviewed 
earlier in this section, these appear unlikely to influence any more than already stated, 
the demonstrated differences between cognitively impaired and cognitively 
unimpaired groups. Potential confounders like age and sex have been accounted for. 
However, we have limited descriptive data available, due to limited resources
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available lo Ibis study, and have ikH there lore accounted lor all sources of 
confounding. As mentioned earlier in this section, the possibility of reverse causality, 
influencing these results remains. However, the association between cognitive 
impairment (both learning disability and dementia) and psychopathology is one that 
has been well established (Deb & Hunter, 1991 a & b; Krishnamoorthy, 2003a for 
review), and the current findings are therefore fully understandable in the context 
from which they emerge.
Cognitive impairment in this study was however established using the MMPI, 
may have been state or trait, and may have been developmental or acquired, 
distinctions which are important, as has been highlighted recently (Besag, 2001).
7.2 2.7. Psychiatric Co-morbidity in the Cognitively Unimpaired Subgroup: 
Comparative Analysis of Measures
When clinical significance ratings and ICD-IO diagnostic categories were compared, 
there were significant differences between the two ratings, clinical significance 
ratings yielding a higher prevalence of psychopathology. In this sample too, as with 
the primary care sample, there was limited agreement between the NBI patient and 
carer scales, and this was restricted to key indices of psychopathology that are over­
represented in epilepsy. When the different measures employed in the study, NPI 
(carer rated), BPRS (expert-observer), NBI (epilepsy specific) were compared with 
the two gold standards of clinical significance and ICD-IO diagnosis using ROC 
analysis, some interesting observations merged. No instrument appeared to perform 
well against either gold standard, the performances being roughly comparable and
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generally poor. I he eiil-oll scores were low, and the sensilivily and specificity scores 
they yielded poor.
This generic failure of instruments to agree with one another may be explained 
in a number of ways.
1. The sources of information for each instrument are clearly 
different, professional carer, expert observer and self-ratings all 
being employed in different instruments. Such a variety of sources 
attempting to measure a common psychopathology construct is 
probably inherently unworkable.
2. The nature of the instruments employed in this study, the NPI 
(developed primarily for neurodegenerative disorders specifically 
dementia where the patient is unable to give reliable information 
about his or her status); the BPRS (developed for populations with 
psychoses usually quite severe with a number of positive and 
negative signs); the NBI (an epilepsy specific measure of 
psychopathology that examines existential and philosophical issues 
and opinions, making it most suitable for application in educated 
and unimpaired populations with epilepsy), may have inherent 
limitations when applied to an institutional population with 
epilepsy.
3. Given their status as institutional residents, with reduced exposure 
to the outside world, generally low levels of education, and 
probably with decreased ability to perceive correctly abstract 
concepts such as emotions and feelings, it is in some ways not
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surprising lhal Ihe cognilivcl> unimpaired group when inlerviewed 
using the PSE components ol the SCAN interview, appeared to 
provide inconsistent responses. The high prevalence of symptoms 
reported in the PSE contrast with the prevalence of lCD-10 
psychiatric diagnosis. The PSE clinical significance was based on a 
positive rating on one symptoni category, and it is multiplicity of 
symptoms that usually results in criteria for diagnosis, thus 
explaining the divergence of ratings using these two approaches. 
Another possibility of course would arise due to the highly 
controlled and supportive nature of the institutional setting, 
resulting in subjects experiencing symptoms, but not perceiving 
disablement as a consequence of these, disablement being an 
important aspect of criteria based diagnosis.
73. Use of the NPI in Institutional Populations with Epilepsy
In this study the NPI has emerged as viable carer rated instrument that may be 
applied in institutional populations with epilepsy. The instrument appears to 
have good content validity as revealed by the exploratory factor analysis, and 
good concurrent validity at least for psychiatric caseness with instruments 
such as the BPRS. The failure of the NPI to agree with more established 
instruments of psychopathology (gold standard measures) used in population 
based studies such as the PS E/SCAN and ICD-10 derived criteria thereof, may 
be more a reflection of the poor suitability of such measures in institutional 
populations with high levels of cognitive impairment, as opposed to poor
312
performance of Ihe NPI in these populations. Indeed, it may be argued that the 
NPI is the more appropriate instrument for application in studies involving 
cognitively impaired patients with epilepsy. The NPI also has the advantage 
that it may be applied in both learning disabled patients and those with 
acquired cognitive impairment.
The prospective use of the NPI to assess caregiver rated psychopathology in 
these settings will;
• Help in identifying more subjects with hitherto unidentified behavioural 
disturbance
• Aid in assessing the need for specialist mental health services for patients with 
epilepsy, the learning disabled and those in residential care in particular
• Aid in the rehabilitation process
• Provide data in support of the need for improved mental health service 
provision in these settings
• Perhaps most importantly, improve outcome for people with epilepsy in 
residential care
7.4. Integrating Discussion, Conclusions &  Recommendations for Future 
Research:
These studies have shown that a considerable burden of psychopathology exists in 
epilepsy, both in primary care and in institutional populations. The precise 
prevalence figures appear to vary depending on the instruments employed, as has
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been amply dcmonslralcd in the review sections of this thesis, importantly, the 
primary care study has demonstrated quite unequivocally that subjects with 
epilepsy have a significantly greater prevalence and burden of psychopathology 
than their peers in the community. The institutional study also reveals a greater 
burden of psychopathology in cognitively impaired individuals, when compared 
with their cognitively unimpaired peers. Given the significant co-morbidity that 
exists between epilepsy, learning disability and psychiatric illness in the 
community, the results in a relatively stable institutional population are of 
considerable relevance. Overall, these data underline the importance of psychiatric 
co-morbidity in epilepsy, in public health terms. Future studies, interventions and 
the planning and development of services for epilepsy clearly need to address 
psychiatric co-morbidity within their remit.
So what if patients with epilepsy have a greater burden of co-morbid 
psychopathology than their peers? Surely it is control of seizures that is paramount 
for their well being? While a small number of studies have addressed this issue 
using sophisticated statistical techniques (Jacoby et al, 1996; Baker et al, 1996) 
our primary care study is unique in having made detailed head to head 
comparisons across a range of measures, albeit in a small but representative 
population. It is apparent that psychiatric co-morbidity has a greater impact on 
disablement than seizure severity, and this finding is remarkably consistent across 
measures of psychological burden employed in this study. While seizure severity 
is undeniably an important outcome measure, and a predictor of well being for 
patients with epilepsy, it is clear that psychological morbidity is an equally if not 
more important a predictor of outcome in this chronic and disabling illness. It
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seems clear there I me lhal Hiliire studies ol'outcome in epilepsy must employ 
reliable and valid measures o f psychiatric co-morbidity, in addition to measures ol 
seizure frequency and severity, and measures o f disablement.
A question that has bogged researchers in this arena is “which measure” 
resulting in a plethora of poorly validated measures being employed. We have for 
probably the first time compared a range of measures screening, diagnostic, 
generic and epilepsy specific, in a primary care population. Examining the results 
it becomes apparent that screening measures such as the HADS and GHQ perform 
well when compared with established gold standards. We have presented herein 
cut off scores for these measures based on the best match of sensitivity and 
specificity The HADS consistently outperformed the GHQ in this study in a 
range of comparisons. Although originally developed for the assessment of 
hospital patients (Zigmond & Snaith, 1983), this instrument has shown itself to be 
good at assessing symptom severity and caseness of anxiety and depression, in a 
number of different populations (Bjelland et al, 2002). It is not surprising 
therefore that in a population of individuals with a chronic illness, it outperforms 
the scaled GHQ-28. Interestingly, a number of epidemiological studies in the UK 
(Jacoby et al, 1996; O’Donoghue et al, 1999) have employed the HADS as a 
measure of psychological morbidity, but have used the published cut-off score of
11. The study reported here reveals lower cut-off scores as being more sensitive 
markers of caseness, a factor which future studies must explore.
It is clear from our study that the CIS-R is superior to the HADS and GHQ 
when compared lo the ICD-IO and clinical significance gold standards. However,
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Ihc C'IS-K is an insirumcnl lhal is more cumbersome lhan ihe I IADS lo employ, 
and lakes longer lo complete. Indeed the self-report version is computer based and 
necessitates the use of a portable computer. The marginal advantages that the CIS- 
R enjoys in relation to the HADS and GHQ are likely to be sacrificed in the altar 
of response and non-completion rates, essential requirements for most 
epidemiological studies. Indeed, there is evidence from the National Psychiatric 
Morbidity Surveys that the ClS-R suffers from pragmatic constraints in this 
setting, researchers in that study having to abandon it in favour of the GHQ, 
following initial sample collection and feedback thereof (Jenkins et al, 1998).
The other instrument that has yielded interesting results in our study is the 
NBI. the only epilepsy specific measure in existence, to our best knowledge, and 
one that has never been subject to rigorous psychometric testing. While the 
prevalence of epilepsy specific psychopathology variables is generally high as 
rated on this measure, it is interesting that the patient total scale scores appeared to 
be a good measure of generic psychiatric caseness, providing evidence of this 
measures concurrent validity. However, the carer scale proved to be unhelpful in 
discriminating psychiatric cases from non-cases, and compared poorly with 
measures across the board. Our study was not adequately powered to explore the 
internal consistency of the NBI. With 100 patient and 100 carer items, the scale is 
likely to have a number of overlapping and redundant items all of which relate to 
a limited number of constructs. An exploratory factor analysis of this measure 
needs to be undertaken, and with the large number of items, the rule of thumb 
dictates a sample of at least 1000 subjects (10/item) (Tabachnik & Fiddell, 2000).
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I he BPRS proved lo be less lhan robiisl in Ihe presenl study, lading lo yield 
either evidence ol good internal consistency, or indeed evidence of concurrent 
validity. However, the NPI, while failing in concurrent validity tests with the gold 
standard measures, yielded a reliable and interpretable four-factor solution, that 
appeared to have clinical correlates. With the relative paucity of gold standard 
carer rated measures that may be employed in learning disabled, otherwise 
cognitively impaired, or institutionalised populations with epilepsy (see Kerr et al 
& Espie et al, 1997 for example) the NPI may prove to be a useful carer rated 
measure of psychopathology in epilepsy. Indeed, the failure may not be that of the 
NPI; it may be the failure of the so-called gold standard measures to provide valid 
data in an institutional population. The performance of the NBI in this population 
also left much to be desired, highlighting the need to identify valid and reliable 
measures that may be employed in studies at this interface.
Which brings us to the interesting question of what the gold standard should 
be in these settings. Two contrasting gold standard measures have been used for 
comparison with the range of instruments both studies. The ICD-IO criteria based 
measure of psychiatric caseness is the more straightforward of the two. These 
international criteria were developed by the WHO and are now in their tenth 
edition (WHO, 1992a). These criteria arose fi'om original research efforts across a 
number of centres worldwide, as well as a consultation process that involved 
experts from across the globe. The ICD-IO criteria were also somewhat influenced 
by DSM criteria from the United States of America. Although intending to be a 
framework of guidelines that aid clinical diagnosis and attempt to bring 
uniformity lo psychiatric diagnosis across the globe, criteria such as these, have
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perhaps duc lo Iheir specific nature, achieved exalted status in clinical and 
epidemiological psychiatric research, and are relied upon to discriminate 
psychiatric cases from non-cases.
However, this ideal of criteria based diagnosis does in several situations leave 
much to be desired. Transcultural settings where conventional rules may fail to 
apply are one example (Ustun & Sartorius, 1995). Disorders such as epilepsy in 
which the burden of psychopathology is high, and may not ftilfil conventional 
criteria, another (Krishnamoorthy 2000,2001). Indeed, Trimble (1991) and 
Blumer (1999) have among others elegantly described a psychopathology that is 
unique, distinct and specific to epilepsy.
In settings such as these it is believed that the development and use of special 
operational rules may well be the solution (Prince, 1998). Indeed, even prestigious 
international collaborative epidemiological studies such as the “WHO Study of 
Psychological Problems in Primary Health Care” (Ustun & Sartorius, 1995) have 
relied on this approach. In the current study, given the perceived burden of sub- 
clinical psychological morbidity in epilepsy that fails to meet conventional criteria 
for caseness, we operationalised a system of rating clinical significance, that relied 
upon the PSE interview, and used symptom load and attendant disablement as the 
base criteria. Interestingly, this approach appeared to yield dividends, not just by 
diagnosing a greater burden of psychopathology than that identified by ICD, but 
also by demonstrating better concurrent validity across the range of measures 
employed. Interestingly also, this measure of caseness appeared to outperform the 
ICD diagnosis measure as a predictor of disablement. Not surprisingly, the WHO
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sliid\ rclcrrcd lo herein also Ibund heller agreeiiienl belween Ihe screening 
measures employed and clinician ratings ol'caseness when compared lo the so 
called gold standard o f criteria based diagnosis.
It may be argued on the one hand, that this result is but expected. Clinical 
significance ratings are like the other measures used in this study for comparison, 
primarily symptom based, and thus more likely to demonstrate agreement. On the 
other, the consistency of these observations, and the link with disablement, further 
considerably the argument that epilepsy neuropsychiatrists have often put forward, 
in favour of a sub-clinical burden of psychopathology that fails to meet 
conventional criteria, but is nevertheless disabling
While arguments have recently been put Ibrw ard in favour of doing away with the 
clinical significance ratings in DSM-IV (Spitzer & Wakefield, 1999), we propose 
that these are merely the reflection of established “criteriologists” digging their 
heels in, unwilling to change. Based on our findings, we choose to take the 
opposite view, at least in epilepsy, that clinical significance ratings arising from 
clinician administered semi-structured interviews, and following operational rules 
have the potential to be robust measures of caseness (Williams et al, 2002), 
perhaps with greater validity than arbitrary criteria that have resulted from 
international consensus (and compromise).
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As Prince ( IWX) has cleganll> pul il, Ihc argument in psychiatric 
epidemiology must move from is it a case?” lo “a case for what?” I he studies 
described in this thesis have in our belief provided the evidence for clinical 
researchers in the epilepsy arena to make this paradigm shift, leading to more 
meaningful and clinically relevant data in the years to come.
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9.1. M IN I MICN I AI S I A l l: EXAM INA I ION
ITEM PATIENT N(
SCORE
ORIENTATION
Dale (1)
Day (1)
Month (1)
Year (1)
Season (1)
Country (1)
County (1)
City (1)
Hospital (1)
Floor (I)
REGISTRATION
Apple, Table, Penny (3)
No of trials
ATTENTION/CALCULATION
Serial 7’s backwards (5)
(93,86,79,72,65)
‘World’ backwards (dirow)
RECALL
Apple (I)
KMAL COMMENTS
367
lablc
Penny
LANGUAGE
Name pencil & watch
Repeat sentence : NO IPS ANDS 
OR BUTS”
Follow 3 stage command;
Take paper in right hand. Ibid, put 
on table
Read and obey the command
Write a sentence of your choice
Copy the design
(I)
(1)
(2)
(3)
(1)
(1)
(1)
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9.2. NA I lONAL IIOSIM I AL SKI/AIRK SKVKRi rV S( AI I:
1. Record the name of'the seizure types that occur under 
headings:
Type 1 Type 2 Type 3
SINCt I Hf£ LAS r VISIT:
2. Does the patient have a generalised convulsion during 
this type of seizure?
Yes 4 4 4
No 0 0 0
3. How often has the patient fallen to the ground in this 
type of seizure ’
4Nearly always or always: 4 4
Often 3 3 3
Occasionally 2 2 2
Never 0 0 0
4 Has this type of seizure caused any of the following? 
(score only the worst)
Bums, scalds, deep cuts, fractures 4 4 4
Bitten tongue, severe headaches 3 3 3
Milder injuries or headaches 2 2 2
No injuries 0 0 0
5. How often has the patient been incontinent of urine in 
this type of seizure?
Nearly always or always: 4 4 4
369
( )rtcn i 3 3 3 1
Occasional In 2 2
Never 0 0 0
6. irthc seizure causes loss of consciousness, is there a
warning long enough for the patient to protect
himsell/herselt? (no loss of consciousness/seizures only
1 while asleep 0)
1 Never
I 2 2 2
j Sometimes 1 1 1
1 Nearly always or always 0 0 0
7 How long is it until the patient is really back to
' normal after the seizure?
I Less than 1 minute 0 0 0
Between 1 and 1 Cm minutes 1 1 1
i Between 10 minutes and 1 hour 2 2 2
! Between 1 and 3 hours
f
3 3 3
More than 3 hours 4 4 4
8. Do the following events occur in this type of seizure?
Seriously disruptive automatisms: shouting, wandering. 4 4 4
undressing
Mild automatisms or focal jerking 2 2 2
None 0 0 0
1 Add 1 point to each column
1
1 1 I
t otal score for each seizure type
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INS I Rl ( ' I IONS lO R  ( O M I l K I ION: National Hospital Seizure Severity
Scale (NIIS3)
Define how many seizure types occur: e.g., aura, complex partial, generalised 
convulsion, and call these type 1,2,3 arbitrarily.
Apply questions 2-8 to each seizure type separately. As the NHS3 indicates current 
seizure severity, define the time frame: e.g., 1-3 months or time since last clinical 
visit. Use clinical judgement whether each factor occurs in the seizure type. Allow the 
patient to judge the frequency of the event. Then tick the box opposite the response 
options I he number in the box is the score for the question.
03: Only actual falls are recorded. If  the seizures could cause falls but have not 
because they all occurred while in bed, then the score is 0.
Q7 refers to the time until the patient feels fully functional.
The column totals give the seizure severity score.
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9.J. ps \ ( ii( )s is  s( q i  k s t io n a ir k
In this health survey we have to ask about a whole range of experiences. Some of 
these experiences are quite rare. However, I would be very obliged if you would bear 
with us and answer the questions I am going to ask you now.
Q l . Over the past \ ear, have there been times when you felt very happy indeed 
without a break for days on end?
Y es.................................1 — -— a)
Unsure........................... 2-----------------(Q2)
No..................................3-------- -—““(Q2)
(a) Was there an obvious reason for this?
Yes............... I --------------- (02)
Unsure 2----- ------- (Q2)
No---------------- 3---------------(b)
(b) Did your friends or relatives think it was strange or complain about it?
Yes....................1------------Screen positive, end schedule.
Unsure...............2--------- (Q2)
No..................... 3--------- (02)
02  Over the past year, have you ever felt that your thoughts were directly interfered 
with or controlled by some outside force or person?
Yes.................... 1--------- (a)
Unsure............... 2---------- (03)
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No.......................3........... (03)
(a) Did this come about in a way that many people would find hard to believe, for 
instance, through telepathy?
Yes.......................I ---------------Screen positive. End schedule.
Unsure................... 2-------------(Q3)
No.......................... 3------------ -(Q3)
Q3. Over the past year have there been times when you felt that people were against 
you?
Yes.......................I -------------- (a)
Unsure.................. 2------------- (Q4)
No.......................... 3-------------- (Q4)
(a) Have there been times when you felt that people were acting deliberately to harm
you or your interests?
Yes....................... 1---------------(b)
Unsure...................2---------------(Q4)
No...........................3------------- (Q4)
(b) Have there been times when you felt that a group of people was plotting to cause
you serious harm or injury?
Yes....................... I --------------Screen positive, End Schedule
Unsure..................2------------- (Q4)
N o .............................3--------------- (0 4 )
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Q4. Over the past year, have there been times when you felt that something strange 
was going on?
Yes----------------------- I ----------------(a)
Unsure....................... 2——————(Q 5 )
No............................... 3--------------- (Q5)
(a) Did you feel it was so strange that other people would find it very hard to believe?
Yes............................... I  Screen positive. End Schedule.
Unsure..........................2------------—{Q5 )
No.................................... 3---- -—-(Q5)
Q5. Over the past year have there been times when you heard or saw things that other 
people couldn't?
Y es............................... I —-----------(a)
Unsure..........................2 End schedule
No.................................... 3------------ End schedule
(a) Did you at any time hear voices saying quite a few words or sentences when there 
was no one around that might account for it?
Yes................................... 1-------------- Screen positive, End Schedule
Unsure...............................2—  -----—End Schedule
No.......................................3-------------- End Schedule
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9.4. IIOSIM I AL ANXIi: lA A M ) DLLKLSSION S( ALL
NAME:_________  DA'l'E:
Doctors are aware that emotions play an important part in most illnesses. If your 
doctor knows about these feelings, he will be able to help you more. This 
questionnaire is designed to help your doctor to know how you feel. Read each item 
and place a firm tick in the box opposite the reply which comes closest to how you 
have been feeling in the past week. Don’t take too long over your replies: your 
immediate reaction to each item will probably be more accurate than a long thought- 
out response.
T IC K  ONLY ONE IN EAC H SECTION
1 feel tense or ‘wound up’
Most of the time i
A lot of the time i
Time to time, occasionally 11
Not at all U
I still enjoy the things I used to enjoy.
Definitely as much 
Not quite so much 
Only a little 
Hardly at all
375
I gel a sort ol frighlcncd Iccling as il something awful is about to happen; 
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn't worry me 
Not at all
I can laugh and see the funny side of things:
As much as I always could i
Not quite so much now i 1
Definitely not so much now i !
Not at all
Worrying thoughts go through my mind:
A great deal of the time ï ]
A lot of the time I i
From time to time but not too often [ J
Only occasionally □
I feel as if  1 am slowed down:
Nearly all the time > 1
Very often i
Sometimes 
Not at all
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I get a sort o f  rrighlencd feeling like  ‘bu llerllies ' in the stomach; 
Not at all il
Occasionally
Q uite  often :
Very often
I have lost interest in my appearance; 
Definitely
I don't take as much care as I should 
I may not lake as much care 
I take just as much care as ever
I feel restless as if 1 have to be on the move:
Ver> much indeed
Quite a lot
Not very much
Not at all
I look forward with enjoyment to things:
As much as ever I did 
Rather less than I used to 
Definitely less than I used to 
Hardly at all
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I led cheer fui:
Nol at all 
Not often 
Sometimes 
Most of the time
I can sit at ease and feel relaxed:
Definitely 
I Isually 
Not often 
Not at all
I get sudden feelings of panic:
Very often indeed 
Quite often 
Not very often 
Not at all
I can enjoy a good book or radio or T V. programme:
Often
Sometimes
Not often
Very seldom
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9.5. Nciirobchavioiiral liiviMitorv
9.5.1. Introduction
On the following pages there are statements of personal attitudes and opinions. For 
each statement, please indicate whether the statement seems true or false from your 
point of view.
Simply place a check (V), under the appropriate column for each item, leaving no 
blanks. There are no right or wrong answers to this inventory, and what is most 
important is the honesty of your answers.
9.5.2. Patient Identification
NAME:____________________________________________ SEX:
AGE:
Highest grade you completed in school 
Occupation:
Hand used for writing:
If  left handed, are you the only one in the family?
Age when seizures started;
Number of seizures on the average per month:
Are you: Married ( ) Divorced ( ) Separated( ) Single( ).
With whom do you live: Alone ( ) Spouse( ) Parents( ) Other;
Do you live in: the Country ( ) Small town ( ) City ( ).
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Have you been in trouble with the police.  ^ II so, what 
kind?
Have you had a problem with alcohol?
Have you been addicted to drugs?___
Have you attempted suicide?_______
hospital?______
If so, which ones?
 Have you been in a psychiatric
If  so. how many times?__________ Have you had psychiatric
treatment? If so, what type?
Date:
9 ^ 3 . Personal Inventory
1. I think people would learn a lot from the story of my life.
2. I have at times feelings of blissful joy
3. I feel like a pawn in the hands of others
4. I can never forgive myself for some of the things that I have done
5. I have a habit of counting things or memorising numbers
6. It makes good sense to keep a detailed diary
7. Sex is less important that most people believe
8. I frequently have trouble getting a good night’s sleep
9. For me, feelings may suddenly take the place of thinking
10. I am hardly ever preoccupied with thoughts about sex
11. 1 believe that I serve a supreme purpose in life
12. Fate appears to be working against me.
True False
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Truc lalsc
13. My religious bciicls have become very important
14. I am more sensitive to distractions than other people
15. I have gotten people angry by asking them to do so much for me
16. 1 am very worried about hurting other people’s feelings
17. I am open to attack from many sides
18. I write poetry, stories or biographies
19. It makes me personally furious to see people disobeying the law
20. Little things make me angrier than they used to
21. I f  things are not just right, it upsets me
22. People tend to take advantage of me
23. Almost everything triggers some emotional reaction in me
24. The Bible has a special meaning which 1 am beginning to understand
25. My temper has gotten me into trouble
26. Sometimes I get terribly confused by little details
27. Powerful forces are acting through me
28. 1 seem to depend on other people for many things
29. Few things are really funny
30. 1 am often bothered by severe headaches or other troublesome aches and 
pains
31. Often, I get into such a good mood that I do foolish things
32. I am sure there is a significant meaning behind my suffering
33. I have had periods of days or weeks when 1 could not get going at all
34. Sometimes I hear sounds or see things that are really not there
35. I cannot get oIT the point sometimes
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rue iilsc
36. I am losing control of my temper more rrequently
37. Nothing is more important than trying to understand the forces that govern 
this world
38. Life is a strain for me much of the time
39. Sometimes 1 feel so helpless that I want people to do everything for me
40. I may become fearful of being alone
4 1. Often I am the only one to stand up for what is right
42. Sometimes my mind gets stuck on so many different ideas that I cannot 
make a decision of do anything
43. When I get angry. I often explode
44. Sometimes my mind gets stuck on one idea so that I cannot make a
decision or do anything
45. People do not seem to appreciate my jokes
46. 1 spend a lot of time thinking of the origins of the world and life itself
47. 1 suffer from frequent periods of exhaustion or fatigue
48. I have had some very intense religious experiences
49. Almost everyday I am infuriated by cases where justice has not been done
50. It is useless to tell people something without giving them all the details
51. Powerful forces outside my control are working with my life
52. My sexual activity has decreased
53. 1 write down or copy many things
54. Emotions control my life
55. Much of the time I feel as if I have done something wrong or harmful
56. I have a tendency to break things or hurt people when I get infuriated
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I rue •also
57. I ol'lcn led suddenly learlul without apparent reason
58. Before I make a decision, I need to know every detail
59. Sometimes I feel so good that ideas come faster into my mind than I can
handle them
60. Once I start to talk to someone, I have trouble breaking otT 
61 I have not lived the right kind of life
62. I record special details of my life and thinking.
63. At times I believe in something that in fact is not taking place
64. I tend to avoid crowds
65 I have had periods when I was so full of pep that sleep did not seem
necessary for several days
66 People should think more careftilly about the point of many jokes instead 
of just laughing at them
67. I need more details than most people do before I understand something
68. My feelings of hatred can be very intense
69. I am subject to big shifts in mood
70. When I accidentally hurt someone’s feelings, I cannot forgive myself for a 
long time
71. I tend to get bogged down with the fine points of a situation
72. Finally I am beginning to understand the real meaning or nature of this 
world
73. I really am down in the dumps most of the time
74. I worry often about my physical health
75. I would go out of my way to make sure that the law is followed
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1 rue •aise
76. I have more ol a feeling than most people lor the order and purpose of life
77. 1 can do easily without sexual activity
78. Sometimes 1 keep at a thing for so long that others may lose their patience 
with me
79. Sometimes without any reason or even when things are going wrong I feel 
excitedly happy, on top of the world
80. 1 really make myself suffer after even a small mistake
8 1. People sometimes tell me that I have trouble getting to the point because 
of all the details
82 1 would like to rip some people to shreds
83. I detest people who try to break the rules
84. I have trouble becoming sexually aroused
85. I have often felt so bad that I was close to ending my life
86. I am more afraid of doing the wrong thing than most people
87. I he thought of revenge bums inside me
88. Most jokes do not seem ftinny to me
89. My emotions have been so powerful that they have caused trouble
90. Sometimes a particular thought will run through my head and bother me 
for days
91. I am often said to be hot-headed
92. The future may suddenly seem hopeless to me
93. I am fortunate to receive so much help from people around me
94. 1 am very religious (more than most people) in my own way
95. 1 am bothered off and on by odd physical sensations
384
Truc lalsc
96. When I Chink ol sonic of the things that people have done to me, it makes ( ) ( )
me absolutely lurious
97. Sometimes I think an illness has been given to me so that I would meet ( ) ( )
certain people at the right time
98. I would like to write a book ( ) ( )
99. Religion and God are more personal experiences for me than most people ( ) ( )
100. There is too much foolishness in the world these days ( ) ( )
Thank you for your honest and patient completion of the survey. Would you please 
check to be sure that all the questions were answered.
9.5.4. Personal Behaviour Inventory 
(Carer Version)
Instructions
On the following pages are statements about personal habits, preferences, feelings and 
beliefs. For each statement, please indicate if the statement seems more true of false 
about the person you are describing. On the basis of your experiences with the patient, 
please give your first and most honest response to each item, leaving no blanks. There 
are no right or wrong answers -  no rating of better or worse, so please be guided by 
your memory and your impressions.
We appreciate your sincere co-operation in completing the survey.
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PLKASK FILL IN:
1 -------------------------------------------------------------------
Name of the person you are describing
Your name
3 ------------------------------------------------------------------
Your relation to the patient
Your sex
Your age
Highest grade you completed at school
 7------------------------------------------------------------------
Number of years you have known the patient
 8  ------------------------
Date
True False
(A) Writing Tendency ( ) ( )
1. Believes it would be good sense to keep a detailed diary ( ) ( )
2 Writes poetry, stories or biography ( ) ( )
3. Writes down many things, copies passages from books, and so forth ( ) ( )
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4. Records details about personal experiences and thinking ( ) ( )
5. Speaks about or is writing a book
(B) Sense of law and order
6. Personally very upset when people disobey the law
7. Often believes that he or she is the only person who is right
8. Infuriated by cases where justice is not done
9. Goes out of the way to make sure the law is followed
10. Detests people who break the law
(C) Religious Convictions
11. Religious beliefs have become very important
12. Believes that the Bible has special meaning that he or she can understand
13. Has had some very intense religious experiences
14. Very religious (more that most people) in own way
15. Religion and God are more personal experiences for him/her than most 
people
(D) Anger and Temper
16. Little things make him or her more angry than they used to ( ) ( )
17. Gets into trouble because of temper ( ) ( )
18. Loses control of temper more frequently ( ) ( )
19. When angry, often explodes ( ) ( )
20. Often said to be hot-headed ( ) ( )
(E) Orderliness
21. Has a habit of counting things or memorising numbers ( ) ( )
22. Seems more sensitive to distractions than most people ( ) ( )
23. Becomes upset if things arc not just right ( ) ( )
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24 Mind gels stuck on so many ideas that lie or she cannot make a decision ( ) 
about anything
25 l ends to get bogged down with the tine points ol'the situation ( )
(I ) Feelings About Sex True
26. Sex is less important than most people believe ( )
27. Flardly ever preoccupied with thoughts about sex ( )
28. Sexual activity has decreased ( )
29. Can do easily without sexual activity ( )
30. Has trouble becoming sexually aroused ( )
(G) Fearfulness
31 Is very worried about hurting other people's feelings
32. May become fearful of being alone ( )
33. Often becomes fearful without apparent reason ( )
34. Tends to avoid crowds
35. Is more afraid of doing the wrong thing than most people
(H) Feelings of Guilt
36. Can never forgive himself for some of the things he has done
37. Much of the time feels as if  he or she has done something wrong or 
harmful
38. Believes he or she has not lived the right kind of life
39 After accidentally hurting someone’s feelings cannot forgive himself or
herself for a long time
40. Really suffers even after a small mistake
(I) Seriousness
4 1. Finds few things really funny
( )
( )
False
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42 People do not seem to appreciate his or her jokes ( ) ( )
43 1 cels that people should think about the point oI many jokes caretully ( ) ( )
instead ol just laughing at them
44 Feels that most jokes are not funny ( ) ( )
45. Says there is too much foolishness in the world these days ( ) ( )
(J) Sadness
46. Has had periods of days or weeks when he or she could not get going at ( ) ( )
all
47. Feels that life is a strain much of the time ( ) ( )
48 Really down in the dumps most of the time ( ) ( )
49 Has often felt close to ending his or her life ( ) ( )
50 May feel suddenly that the future is hopeless ( ) ( )
(K) F mot ions True Fa
51. Feelings may suddenly take the place of thinking ( ) ( )
52. Almost everything triggers some emotional reaction ( ) ( )
53. Fmotions control his or her life ( ) ( )
54. Subject to big shifts of mood ( ) ( )
55. Fmotions have been so powerful that they have caused trouble ( ) ( )
(L) Suspicion
56. Feels that fate is working against him/her ( ) ( )
57. Open to attack from many sides ( ) ( )
58. Believes that people tend to take advantage of him or her ( ) ( )
59. Sometimes may see things or hear sounds which are not really there 0 ( )
60. At times may believe in something that in fact is not taking place ( ) ( )
(M) Interest in Details
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6 1. Sometimes gets terribK eon I used liy little details ( )
62. Rarely tells people something without giving them all the details ( )
63. Needs to know every detail he tore making a decision ( )
64. Needs more details than most people to understand something ( )
65. Has trouble getting to the point because of all the details ( )
(N) Cosmic Interests
66. Believes that nothing is more important than trying to understand the ( )
forces that govern this world
67. Spends a lot of time thinking about the origins of the world and life ( )
68. Believes that powerful forces beyond control are working with his or her ( )
life
69. Believes he or she understands the real meaning or nature of this world ( )
70. More preoccupied than most people with the order and purpose of life ( )
(O) Sense of personal Destiny
71. Feels people would learn a lot from the story of his or her life ( )
72. Thinks that he or she serves a supreme purpose in life ( )
73. Believes that powerful forces are acting through him or her ( )
74. Seems sure there is a significant meaning behind personal suffering ( )
75. Feels that the illness has been given so that she or he would meet certain ( )
people at the right time
(P) Persistence and Repetitiveness True
76. Cannot get off the point sometimes ( )
77. Sometimes gets stuck on one idea so that he or she cannot make a ( )
decision or do anything
78. When talking to someone has trouble breaking off ( )
•alse
( )
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79. Somclimcs keeps al a tiling so long that others may lose their patience
80. Is bothered for days by the same thoughts
(0) Hatred and Revenge
81. Has a tendency to break things or hurt people when infuriated
82. Feelings of hatred can be very intense
83. Talks about ripping some people to shreds
84. Preoccupied by thoughts of revenge
85. Infuriated by some of the things people have done to him or her
(R) Dependency
86. Feels like a pawn in the hands of others
87. Has gotten people angry by asking them to do so much
88. Seems to depend on other people for many things.
89. Sometimes feels so helpless that he wants other people to do everything
90. Feels fortunate to receive so much help from people
(S) Happiness
9 1. Has at times feelings of intense joy
92. Often does foolish things while in a good mood
93. Sometimes feels so good that ideas come into mind faster that he or she 
can handle them
94. Has periods full of pep that sleep did not seem necessary for several days
95. Sometimes feels excitedly happy, on top of the world, without any reason 
or even when things are going wrong
(T) Physical Well-Being
96. Frequently has trouble getting a good night’s sleep
97. Is often bothered by severe headaches or other troublesome aches and
( )
( )  
( )
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pains
98. S II II ers Irom Irequenl periods orexhaustion or l'atigiie ( ) ( )
99. Worries about his or her physical health ( ) ( )
100. Is bothered by various odd bodily sensations off and on ( ) ( )
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9.6. Neuropsychiatrie Inventory 
General Instructions
• Mark ‘ YES’ or NO for whether the behaviour is present or not, or if the question is 
not applicable (screening question).
• Mark all boxes for which the answer to the corresponding question is ‘YES’.
• Give a score for the frequency of the behaviour (1-4) and for the severity of the 
behaviour (1-3)
• Give a score for the distress of the caregiver (0-5).
• Calculate the total score as frequency x severity.
Instructions for administration of NPI
• The interview is best conducted with the caregiver in the absence of the patient to 
facilitate an open discussion of behaviours that may be difficult to describe with the 
patient present. Information may be augmented by direct observation and questioning 
of the patient.
Questions should be asked exactly as written. Clarifications should be provided if the 
caregiver does not understand the question.
Acceptable clarifications are restatements of the questions in alternate terms. The 
answers pertain to changes in the patient’s behaviour that have appeared since the 
onset of the illness. Behaviours that have been present throughout the patient’s life 
and have not changed in the course of the illness are not scored even if they are 
abnormal (e.g., anxiety, depression). Behaviours that have been present throughout 
life but have changed since the illness are scored (e.g., the patient has always been 
apathetic but there has been a notable increase in apathy during the period of inquiry).
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Remind the respondent periodieali\ (hat the answers pertain to changes in the 
patient's behaviour that have appeared since the onset ol the illness.
• The NPI may be used to address changes occurring in response to treatment or that 
have changed since the last clinic visit. I he time frame of the question would than be 
revised to reflect this interest in recent changes. Emphasize to the caregiver that the 
questions pertain to behaviours that have appeared or changed since the onset of the 
illness. For e.g., the questions might be phrased “Since he/she began treatment with 
the new medications..." or “Since the dosage o f was increased................... ”.
• The screening question is asked to determine if the behavioural change is present or 
absent. If  the answer to the screening question is negative, mark NO and proceed to 
the next screening question without asking the sub-questions. If  the answer to the 
screening question is positive or if there are any uncertainties in the caregiver’s 
response or any inconsistencies between the response and other information known by 
the clinician (e.g., the caregiver responds negatively to the euphoria screening 
question but the patient appears euphoric to the clinician).The category is explored in 
more depth with the sub-questions.
• If  the sub-questions confirm the screening question, the severity and frequency of 
the behaviour are determined according to the criteria provided with each behaviour. 
When determining frequency and severity use the behaviours identified by the sub­
questions as most aberrant. For example, if  the caregiver indicates that resistive 
behaviour is particularly problematic when you are asking the sub-questions of the 
agitation section, then use resistive behaviour to prompt judgements regarding the 
frequency and severity of agitation. If two behaviours are very problematic, use the 
frequency and severity of both behaviours to score the item. For e.g., if the patient has
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[ \ \o  lypcs or more ol delusions, then use the severity ol the most severe and the 
Irequency o f any delusional behaviours.
• In some cases, the caregiver will provide a positive response to the screening 
question and a negative reply to all sub-questions. If this happens, ask the caregiver to 
expand on why they responded affirmatively to the screen. If  they provide 
information relevant to the behavioural domain but in different terms, the behaviour 
should be scored for severity and frequency as usual If the original affirmative 
response was erroneous, leading to a failure to endorse any sub-questions, then the 
behaviour is rescored as absent ( ‘NO ’ on the screen).
• Some sections such as the questions pertaining to appetite are framed so as to 
capture whether there is an increase or decrease in the behaviour (increased or 
decreased appetite or weight). If  the caregiver answers yes’ to the first member of the 
paired question (such as has the patient’s weight decreased?), do not ask the second 
question (has the patient’s weight increased?) since the answer to the second question 
is contained the in the answer to the first. If  the caregiver answers no’ to the first 
member of the pair of questions, then the second question must be asked.
• When determining frequency, say to the person being interviewed ‘‘Now I want to 
find out how often these things (define using the description of the behaviours they 
noted as most problematic on the sub-questions) occur. Would you say that they occur 
less than once per week, about once per week, several times per week but not every 
day, or every day?” Some behaviours, such as apathy, eventually become 
continuously present, and then are constantly present’ can be substituted for every 
day . When determining severity, tell the person being interviewed ‘‘Now I would like 
to find out how severe these behaviours are. By severity, I mean how disturbing or 
disabling they arc for the patient. Would you say that (the behaviours) are mild,
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nu>dcralc or severe?" Additional descriptors are provided in each section that may be 
used to help the interviewer clarify each grade ol severity. When beginning the 
inventory, say to the caregiver “These questions are designed to evaluate your 
(husband’s/wife’s/etc.) behaviour. They can usually be answered “yes” or “no” so 
please try to be brief in your responses”. If  the caregiver lapses into elaborate 
responses that provide little useful information, they may be reminded of the need to 
be brief. In each case, be sure that the caregiver provides you with a definite answer 
as to the frequency and severity of the behaviours. Do not guess what the caregiver 
would say based on your discussion.
• In very impaired patients or in patients with special medical circumstances, a set of 
questions may not be applicable. For e.g., bed-bound patients may exhibit 
hallucinations or agitation but could not exhibit aberrant motor behaviour. If  the 
clinician or the caregiver believes that the questions are inappropriate, then the section 
should be marked not applicable, and no further data are recorded for that section. 
Likewise, if the clinician feels that the responses are invalid (e.g., the caregiver did 
not seem to understand the particular set of questions asked), not applicable should 
also be marked.
• When each domain is completed and the caregiver has completed the frequency and 
severity rating, you may want to ask the associated caregiver distress question. To do 
this, simply ask the caregiver how much, if any, “emotional or psychological” distress 
the behaviour he or she just discussed causes him or her (the caregiver).The caregiver 
must rate their own distress on a five point scale from 0 -  no distress, I -  minimal, 2 -  
mild, 3 -  moderate, 4 -  moderately severe, 5 -  very severe or extreme.
396
9.6.1. Nciinipsycliiah'ic liivciKory with CaregivcM* Distress Scale
Subject's initials
A. Delusions
Does the patient have beliefs that you know are not true? For example, insisting that 
people are trying to harm him/her or steal from him/her. Has he/she said the family 
members are not who they say they are or that the house is not their home? I ’m not 
asking about mere suspiciousness, I am interested if  the patient is convinced that these 
things are happening to him/her.
I i not applicable no ( proceed to next screening question) n  yes ( proceed to 
subquestions)
( ] Does the patient believe that he/she is in danger -  that others are planning to hurt 
him/her?
[ 1 Does the patient believe that others are stealing from him/her?
I ] Does the patient believe that his/her spouse is having an affair?
[] Does the patient believe that unwelcome guests are living in his/her house? 
n Does the patient believe that his/her spouse or others are not who they claim to be?
[ 1 Does the patient believe that his/her house is not his/her home?
! I Does the patient believe that family members plan to abandon him/her?
; 1 Does the patient believe that television or magazine figures are actually present in 
the home? (does he/she try to talk or interact with them?)
I Does the patient believe any other unusual things that 1 haven’t asked about? 
A-Frequency:
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occasional I \ less lhan once per week 
often -  about once per week
I frequently -  several times per week but less than every day 
I i very frequently -  once or more per day
B-Severity:
I ] mild -  delusions present but seem harmless and produce little distress in the patient
I ] moderate -  delusions are distressing and disruptive
[ 1 marked -  delusions are very disruptive and are a major source of behavioural 
disruption
(if  PRN medications are prescribed, their use signals that the delusions are of marked 
severity)
C-Distress;
How emotionally distressing do you find this behaviour?
[ : not at all
I I minimally 
□ mildly
! J moderately 
[ I severely
i i very severely or extremely
Date of this examination 
I 2 fam. day month year 
Total Delusions (AxB)
398
Subjccl's initials
B. Hallucinations
Does the patient have hallucinations such as false visions or voices? Does he/she 
seem to see, hear or experience things that are not present? By this question we do not 
mean just mistaken beliefs such as stating that someone who has died is still alive, 
rather we are asking if the patient actually has abnormal experiences of sounds, or 
visions
not applicable no ( proceed to next screening question) yes ( proceed to 
suhquestions)
Does the patient describe hearing voices or act as if he/she hears voices?
Does the patient talk to people who are not there?
Does the patient describe seeing things not seen by others or behave as if he/she is 
seeing things not seen by others (people, animals, lights, etc.)?
Does the patient report smelling odours not smelled by others?
Does the patient describe feeling things on his/her skin or otherw ise appear to be 
feeling things crawling or touching him/her?
Does the patient describe tastes that are without any known cause?
Does the patient describe any other unusual sensory experience?
A-Frequency;
occasionally -  less than once per week 
often -  about once per week
frequently -  several times per week but less than every day
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very IrequenUy once or more per day 
B-Severity:
i  I  mild -  hallucinations present but seem harmless and cause little distress for the 
patient
11 moderate -  hallucinations are distressing and are disruptive to the patient
I ! marked -  hallucinations are very disruptive and are a major source of behavioural 
disturbance.
(PRN medications may be required to control them).
C-Distress:
How emotionally distressing do you find this behaviour?
1J not at all 
[ ! minimally
I I mildly
f  ] moderately 
[ i  severely
□ very severely or extremely
Date of this examination 
I 2 fam. day month year 
Total Hallucinations (AxB)
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Subject s initials 
( Agitalioii/Aggrcssioii
Does the patient have periods when he/she refuses to cooperate or won’t let people 
help him/her? Is he/she hard to handle?
not applicable no ( proceed to next screening question) yes ( proceed to 
sub-questions)
Does the patient get upset with those trying to care for him/her or resist activities 
such as bathing or changing clothes?
Is the patient stubborn, having to have things his/her way?
Is the patient uncooperative, resistive to help from others?
Does the patient have any other behaviours that make him/her hard to handle? 
Does the patient shout or curse angrily?
Does the patient slam doors, kick furniture, throw things?
Does the patient attempt to hurt or hit others?
Does the patient have any other aggressive or agitated behaviours?
A-Frequency:
occasionally -  less than once per week 
often -  about once per week
frequently -  several times per week but less than every day 
very frequently -  once or more per day
B-Severity:
mild -  behaviour is disruptive but can be managed with redirection or reassurance
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modcralc bcha\ u>urs clisriiplivc and ditTiciill lo redirect or control 
marked -  agitation is ver\ disruptive and dilllcult to redirect or control: there may 
be a threat of personal harm. Medications are often required
C-Distress:
How emotionally distressing do you find this behaviour?
{! not at all 
11 minimally 
i  ! mildly 
I ! moderately 
severely 
I i  very severely or extremely
Date of this examination 
1 2 fam. day month year 
Total Agitations/Aggression (AxB)
Subject's initials
D. Depression/Dysphoria
Does the patient seem sad or depressed? Does he/she say that he/she feels sad or 
depressed?
1 1  not applicable no ( proceed to next screening question) i i yes ( proceed to 
subquestions)
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Ddcs ihc patient have periods o I tear I ill ness or sobbing that seem to indicate 
sadness?
Does the patient say or act as it he/she is sad or in low spirits?
! Does the patient put him/herself down or say that he/she feels like a failure?
I ! Does the patient say that he/she is a bad person or deserves to be punished?
! ! Does the patient seem very discouraged or say that he/she has no future?
i ! Does the patient say he/she is a burden to the family or that the family would be 
better o tï without him/her?
' Does the patient express a wish for death or talk about killing him/hersell7
I I Does the patient show any other signs of depression or sadness?
A-Frequency:
11 occasionally -  less than once per week
I often -  about once per week
II frequently -  several times per week but less than every day 
I i very frequently -  essentially continuously present
B-Severity:
U mild -  depression is present but usually responds to redirection or reassurance 
i I moderate -  depression is distressing, depressive symptoms are spontaneously 
voiced by the patient and difficult to alleviate
i  i marked -  depression is very distressing and a major source of suffering for the 
patient
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C -Disircss;
I low cmolionally distressing do you find this behaviour? 
not at all 
minimally 
mildly 
moderately 
severely
very severely or extremely
Date of this examination 
I 2 fam. day month year 
fotal Depression/Dysphoria (AxB)
Subject's initials
E. Anxiety
Is the patient very nervous, worried or frightened for no apparent reason? Does he/she 
seem very tense or fidgety? Is the patient afraid to be apart from you?
not applicable Ü no (□ proceed to next screening question) i yes (U proceed to 
subquestions)
Does the patient say that he/she is worried about planned events?
Does the patient have periods of feeling shaky, unable to relax, or feeling 
excessively tense?
Does the patient have periods of (or complain of) shortness of breath, gasping or 
sighing for no other reason other than nervousness?
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Docs Ihc patient complain ol hiittci Hies in his/her stomach, or of racing or 
pounding of the heart in association with nervousness? (Symptoms not explained by 
ill health)
I Does the patient avoid certain places or situations that make him/her more nervous 
such as riding in the car, meeting with friends, or being in crowds? 
i I Does the patient become nervous and upset when separated from you (or his/her 
caregiver)? (does he/she cling to you to keep from being separated?)
’ ) Does the patient show any other signs of anxiety?
A-Frequency:
[ ! occasionally -  less than once per week 
: 1 often -  about once per week
U frequently -  several times per week but less than every day 
! J very frequently -  once or more per day
B-Severity:
□ mild -  anxiety is distressing but usually responds to redirection or reassurance
□ moderate -  anxiety is distressing, anxiety symptoms are spontaneously voiced by 
the patient and difficult to alleviate
□ marked anxiety is very distressing and a major source of suffering for the patient 
C-Distress:
How emotionally distressing do you find this behaviour?
11 not at all 
I I minimally
405
mildly
moderately
severely
very severely or extremely
Date of this examination 
1 2 fam. day month year 
Total Anxiety (AxB)
Subject's initials
F. Elation/Euphoria
Does the patient seem to be too cheerful or too happy for no reason? I don’t mean the 
normal happiness that comes from seeing friends, receiving presents, or spending time 
with family members I am asking if the patient has a persistent and abnormally good 
mood or finds humour where others do not
[ ] not applicable 11 no ( proceed to next screening question) □ yes (□ proceed to 
subquestions)
□ . Does the patient appear to feel too good or to be too happy, different from his/her 
usual self?
( 1 Does the patient find humour and laugh at things that others do not find funny?
I j Does the patient seem to have a childish sense of humour with a tendency to giggle 
or laugh inappropriately (such as when unfortunate things happens to others)?
[ I Does the patient tell jokes or make remarks that have little humour for others but 
seem funny to him/her?
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Docs lic/shc pla> childish pranks such as pinking or playing keep away” for ihc 
fun ol it?
Does the patient “talk big” or claim to have more abilities or wealth than is true? 
Does the patient show any other signs of feeling too good or being too happy?
A-Frequency:
11 occasionally -  less than once per w eek 
I 1 often -  about once per week
I 1 frequently -  several times per week but less than every day 
I I very frequently -  essentially continuously present
B-Severity:
I ! mild -  elation is notable to friends and family but is not disruptive 
IJ moderate -  elation is notably abnormal
LI marked -  elation is very pronounced, patient is euphoric and finds nearly 
everything to be humourous
C-Distress:
How emotionally distressing do you find this behaviour?
I ] not at all 
[ I minimally 
1 ! mildly
I ) moderately
II severely
I I very severely or extremely
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Dale or this examination 
I 2 fam. day month year 
Total Elation/Euphoria (AxB)
Subject's initials
G. Apathy/lndifTerence
Has the patient lost interest in the world around him/her? Has he/she lost interest in 
doing things or lack motivation for starting new activities? Is he/she more difficult to 
engage in conversation or in doing chores? Is the patient apathetic or indifferent?
not applicable IJ no (LJ proceed to next screening question) □ yes (□ proceed to 
subquestions)
; Does the patient seem less spontaneous and less active than usual?
I Is the patient less likely to initiate a conversation?
Is the patient less affectionate or lacking in emotions when compared to his/her 
usual self?
L1 Does the patient contribute less to household chores?
! Does the patient seem less interested in the activities and plans of others?
; Has the patient lost interest in friends and family members?
Is the patient less enthusiastic about his/her usual interests?
Does the patient show any other signs that she doesn’t care about doing new 
things?
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A-lrct|uciicy:
occasionally -  less than once per w eek 
often -  about once per week
frequently -  several times per week but less than every day 
very frequently -  nearly always present
B-Severity:
I mild -  apathy is notable but produces little interference with daily routines; only 
mildly different from patient s usual behaviour; patient responds to suggestion to 
engage in activities
moderate -  apathy is very evident; may be overcome by the caregiver with coaxing 
and encouragement; responds spontaneously only to powerful events such as visits 
from close relatives or family members 
J marked -  apathy is very evident and usually fails to respond to any encouragement 
or external events
C-Distress:
How emotionally distressing do you find this behaviour?
L ] not at all 
! 1 minimally 
! ] mildly 
1 moderately 
i i severely
i very severely or extremely
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Dale of this c\aniinalii>n 
1 2 lam. day month year 
Total Apathy/lndilTerence (AxB)
Subject's initials 
fi. Disinhibition
Does the patient seem to act impulsively without thinking? Does he/she do or say 
things that are not usually done or said in public? Does he/she do things that are 
embarrassing to you or others?
1 not applicable no ( proceed to next screening question) □ yes (□ proceed to 
subquestions)
□ Does the patient act impulsively without appearing to consider the consequences? 
[ J Does the patient talk to total strangers as if he/she knew them?
□ Does the patient say things to people that are insensitive or hurt their feelings?
□ Does the patient say crude things or make sexual remarks that they would not 
usually have said?
□ Does the patient talk openly about very personal or private matters not usually 
discussed in public?
[ J Does the patient take liberties or touch or hug others in a way that is out of 
character for him/her?
( ] Does the patient show any other signs of loss of control of his/her impulses?
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A-lrcqucncy:
occasionally -  less than once per week 
often -  about once per week
frequently -  several times per week but less than every day 
very frequently -  essentially continuously present
B-Severity:
mild -  disinhibition is notable but usually responds to redirection and guidance 
1 moderate -  disinhibition is very evident and difficult to overcome by the caregiver 
marked -  disinhibition usually tails to respond to any intervention by the caregiver, 
and is a source of embarrassment or social distress
C-Distress:
How emotionally distressing do you find this behaviour?
; not at all 
i minimally 
I mildly 
I 1 moderately 
[ ] severely
i very severely or extremely
Date of this examination 
1 2 fam. day month year 
Total Disinhibition (AxB)
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Suhjecl s inilials 
I. Irntability/Labilit>'
Does the patient get irritated and easily disturbed? Are his/her moods very 
changeable? Is he/she abnormally impatient? We do not mean frustration over 
memory loss or inability to perform usual tasks; we are interested to know if the 
patient has abnormal irritability, impatience, or rapid emotional changes different 
from his/her usual self.
not applicable Li no (□  proceed to next screening question) I i yes (□ proceed to 
subquestions)
Does the patient have a bad temper, flying “off the handle” easily over little things? 
Does the patient rapidly change moods from one to another, being fine one minute 
and angry the next?
Does the patient have sudden flashes of anger?
Is the patient impatient, having trouble coping with delays or waiting for planned 
activities?
Is the patient cranky and irritable?
Is the patient argumentative and difficult to get along with?
! i Does the patient show any other signs of irritability?
A-Frequency:
occasionally -  less than once per week 
often -  about once per week
frequently -  several times per week but less than every day 
very frequently -  essentially continuously present
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B-Scverily;
mild -  irritabilily or lability is notable but usually responds to redirection and 
reassurance
moderate -  irritability and lability are very evident and difficult to overcome by the 
caregiver
marked -  irritability and lability are very evident, they usually fail to respond to 
any intervention by the caregiver, and they are a major sources of distress
C-Distress:
How emotionally distressing do you find this behaviour? 
not at all 
minimally 
mildly 
moderately 
severely
very severely or extremely
Date of this examination 
1 2 fam. day month year 
Total Irritability/Lability (AxB)
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Subjccl s initials
.1. Aberrant Motor Behaviour
Does the patient pace, do things over and over such as opening closets or drawers, or 
repeatedly pick at things or wind string or threads?
not applicable no ( proceed to next screening question) yes ( ; proceed to
subquestions)
Does the patient pace around the house without any apparent purpose?
Does the patient rummage around opening and unpacking drawers or closets?
Does the patient repeatedly put on and take off clothing?
Does the patient have repetitive activities or “habits ' that he/she performs over and 
over?
Does the patient engage in repetitive activities such as handling buttons, picking, 
wrapping string, etc.?
Does the patient fidget excessively, seem unable to sit still, or bounce his/her feet 
or tap his/her fingers a lot?
Does the patient do any other activities over and over?
A-Frequency: 
occasionally -  less than once per week 
often -  about once per week
frequently -  several times per week but less than every day 
very frequently -  essentially continuously present
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1^-Scvciil> :
mild - abnormal motor activity is notable but produces little interlerence with daily 
routines
moderate -  abnormal motor activity is very evident; can be overcome by the 
caregiver
marked -  abnormal motor activity is very evident, it usually fails to respond to any 
intervention by the caregiver and is a major source of distress
C-Distress:
I low emotionally distressing do you find this behaviour? 
not at all 
minimally 
mildly 
moderately 
severely
very severely or extremely
Date of this examination 
I 2 fam. day month year 
Total Aberrant motor behaviour (AxB)
Subject's initials 
K. Sleep
Does the patient have difficulty sleeping (do not count as present if the patient simply 
gets up once or twice per night only to go to the bathroom and falls back asleep
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inimcdialcK Is hc/shc up al nighl? Docs hc/shc wander al nighl, gel dressed or 
disturb your sleep?
not applicable t i no ( i  I proceed to next screening question) i I yes ( I  I proceed to 
subquestions)
Does the patient have difficulty falling asleep?
Does the patient get up during the night (do not count if the patient simply gets up 
once or twice per night only to go to the bathroom and falls back asleep 
immediately)?
Does the patient wander, pace or get involved in inappropriate activities at night?
Does the patient awaken you during the night?
Does the patient awaken during the night, dress and plan to go out, thinking that it 
is morning and time to start the day?
Does the patient awaken too early in the morning (earlier that was his/her habit)?
Does the patient sleep excessively during the day?
Does the patient have any other night-time behaviours that bother you that we 
haven’t talked about?
A-Frequency:
occasionally -  less than once per week
often -  about once per week
frequently -  several times per week but less than every day
very frequently -  once or more per day
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B-Scverily;
mild -  night-time behaviours occur but they are not particularly disruptive 
I I moderate -  night-time behaviours occur and disturb the patient and the sleep of the 
caregiver; more than one type of night-time behaviour may be present 
I i marked -  night-time behaviours occur; several types of night-time behaviour may 
be present; the patient is very distressed during the night and the caregiver’s sleep is 
markedly disturbed
C-Distress:
How emotionally distressing do you find this behaviour?
I I not at all 
! j minimally 
( ] mildly 
U moderately 
Cl severely
□ very severely or extremely
Date of this examination 
1 2 fam. day month year 
Total Sleep (AxB)
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Subjccl s initials
I Appetite and Kating Disorders
Has he/she had any change in appetite, weight, or eating habits (count as NA if the 
patient is incapacitated and has to be fed)? Has there been any change in type of food 
he/she prefers?
not applicable I J  no ( L J  proceed to next screening question) t I yes ( L I  proceed to 
subquestions)
Has he/she had a loss of appetite?
Has he/she had an increase in appetite?
Has he/she had a loss of weight?
Has he/she gained weight?
Has he/she had a change in eating behaviour such as putting too much food in 
his/her mouth at once?
Has he/she had a change in the kind of food he/she likes such as eating too many 
sweets or other specific types of food?
Has he/she developed eating behaviours such as eating exactly the same types of 
food each day or eating the food in exactly the same order?
Have there been any other changes in appetite or eating that I haven’t asked about?
A-Frequency:
occasionally -  less than once per week 
ollen -  about once per week
frequently -  several times per week but less than every day 
very frequently -  once or more per day
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B-Sevciil> ;
mild -  changes in appelile or eating are present but have not led to changes in 
weight and are not disturbing
moderate -  changes in appetite or eating are present and cause minor fluctuations in 
weight
marked -  obvious changes in appetite or eating are present and cause fluctuations 
in weight, are embarrassing, or otherwise disturb the patient
C-Distress;
How emotionally distressing do you find this behaviour? 
not at all 
minimally 
mildly 
moderately 
severely
very severely or extremely
Date of this examination 
1 2 fam. day month year 
Total Appetite and eating disorders (AxB)
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Summary Seme Sheet
Caregiver Distress
(A) Delusions...............................
(B) Hallucinations........................
(C) Agitation/Aggress ion............
(D) Depression/Dysphoria..........
(E) Anxiety..................................
(F) Elation/Euphoria...................
(G) Apathy/Indift'erence.............
(H) Disinhibition........................
(!) Irritability/Lability.................
(J) Aberrant motor behaviour.....
(K) Sleep......................................
(L) Appetite and eating disorders
Total
(maximum 144) (minimum 60)
Subject’s initials:
Date of this examination:
1 2 fam. day month year
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9.7. Brief Psychiatrie Rating Scale
Introduce all questions with "During the past week have you..."
1 SOMATIC CONCERN: Degree of concern over present bodily health. Rate the 
degree to which physical health is perceived as a problem by the patient, whether 
complaints have a realistic basis or not. Do not rate mere reporting of somatic 
symptoms. Rate only concern for (or worrying about) physical problems (real or 
imagined). Rate on the basis of reported (i.e., subjective) information pertaining to the 
past week.
1 = Not reported
2 = Very Mild: occasionally is somewhat concerned about body, symptoms, or 
physical illness
3 = Mild: occasionally is moderately concerned, or often is somewhat concerned
4 = Moderate: occasionally is very concerned, or often is moderately concerned
5 = Moderately Severe: often is very concerned
6 = Severe: is very concerned most of the time
7 = Very Severe: is very concerned nearly all of the time
9 = Cannot be assessed adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
*2. ANXIETY: Worry, fear, or overconcem for present or future. Rate solely on the 
basis of verbal report of patient's own subjective experiences pertaining to the past 
week. Do not infer anxiety from physical signs or from neurotic defense mechanisms. 
Do not rate if restricted to somatic concern.
1 = Not reported
2 = Very Mild: occasionally feels somewhat anxious
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}  -  Mild; (iccasionalK (eels moderately anxious, or ollen feels somewhat anxious
4 = Moderate: occasionally feels very anxious, or ollen feels moderately anxious
5 = Moderately Severe; ollen feels very anxious
6 = Severe: feels very anxious most of the time
7 = Very Severe: feels very anxious nearly all of the time
9 = Cannot be assessed adequately because of severe formal thought disorder,
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
3. KMOTIONAL WITHDRAWAL: Deficiency in relating to the interviewer and to 
the interview situation. Overt manifestations of this deficiency include poor/absence 
of eye contact, failure to orient oneself physically toward the interviewer, and a 
general lack of involvement or engagement in the interview Distinguish from 
BLUNTLD AFFECT, in which deficits in facial expression, body gesture, and voice 
pattern are scored. Rate on the basis of observations made during the interview.
1 = Not observed
2 = Very Mild, e.g., occasionally exhibits poor eye contact
3 = Mild: e.g., as above, but more frequent
4 = Moderate: e.g., exhibits little eye contact, but still seems engaged in the 
interview and is appropriately responsive to all questions
5 = Moderately Severe: e.g., stares at floor or orients self away from interviewer, 
but still seems moderately engaged
6 = Severe: e.g., as above, but more persistent or pervasive
7 = Very Severe, e.g., appears "spacey" or "out of it" (total absence of emotional 
relatcdness), and is disproportionately uninvolved or unengaged in the interview (DO 
NO l SCORE IF EXPLAINED BY DISORIENTATION.)
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4. CONCliPrUAL DISORCjA N I/A  I ION: Degree of speech incomprehensibility. 
Include any type of formal thought disorder (e.g., loose associations, incoherence, 
flight of ideas, neologisms). DO NOT include mere circumstantiality or pressured 
speech, even if marked. DO NO l rate on the basis of the patient's subjective 
impressions (e.g., "my thoughts are racing. I can't hold a thought," "my thinking gets 
all mixed up"). Rate ONLY on the basis of observations made during the interview.
1 = Not observed
2 = Very Mild: e.g., somewhat vague, but of doubtfni clinical significance
3 = Mild: e.g., frequently vague, but the interview is able to progress smoothly; 
occasional loosening of associations
4 = Moderate: e.g., occasional irrelevant statements, infrequent use of neologisms, 
or moderate loosening of associations.
5 = Moderately Severe: as above, but more frequent
6 = Severe: formal thought disorder is present for most of the interview, and the
interview is severely strained
7 = Very Severe: very little coherent information can be obtained
5. GUILT FEELINGS: Overconcem or remorse for past behavior. Rate on the basis 
of the patient's subjective experiences of guilt as evidenced by verbal report 
pertaining to the past week. Do not infer guilt feelings from depression, anxiety or 
neurotic defenses.
1 = Not reported
2 = Very Mild: occasionally feels somewhat guilty
3 = Mild: occasionally feels moderately guilty, or often feels somewhat guilty
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4 = Modcralc. occasionally Iccls very guilty, or ollen I eels moderately guilty
5 = Moderately Severe: often feels very guilty
6 = Severe: feels very guilty most of the time, or encapsulated delusion of guilt
7 = Very Severe: agonizing constant feelings of guilt, or pervasive delusion(s) of 
guilt
9 = Cannot be assessed adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
6. TENSION: Rate motor restlessness (agitation) observed during the interview. DO 
NOT rate on the basis of subjective experiences reported by the patient. Disregard 
suspected pathogenesis (e.g., tardive dyskinesia).
1 = Not observed
2 = Very Mild: e.g., occasionally fidgets
3 = Mild, e.g., frequently fidgets
4 = Moderate, e.g., constantly fidgets, or frequently fidgets, wrings hands and 
pulls clothing
5 = Moderately Severe: e.g., constantly fidgets, wrings hands and pulls clothing
6 = Severe: e.g., cannot remain seated (i.e., must pace)
7 = Very Severe: e.g., paces in a frantic manner
7. MANNERISMS AND POSTURING: Unusual and unnatural motor behavior. Rate 
only abnormality of movements. Do not rate simple heightened motor activity here. 
Consider frequency, duration, and degree of bizarreness. Disregard suspected 
pathogenesis.
I = Not observed
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2 Very Mild: odd behavior but ol doubUiil clinical signilleanee, e.g., occasional 
unprompted smiling, infrequent lip movements
3 = Mild: strange behavior but not obviously bizarre, e.g., infrequent head-tilting 
(side to side) in a rhythmic fashion, intermittent abnormal linger movements
4 = Moderate: e.g., assumes unnatural position for a brief period of time, 
infrequent tongue protrusions, rocking, facial grimacing
5 = Moderately Severe: e.g., assumes and maintains unnatural position throughout 
interview, unusual movements in several body areas
6 = Severe, as above, but more frequent, intense, or pervasive
7 = Very Severe: e.g., bizarre posturing throughout most of the interview, 
continuous abnormal movements in several body areas
*8. GRANDIOSITY: Inflated self-esteem (self-confidence), or inflated appraisal of 
one's talents, powers, abilities, accomplishments, knowledge, importance, or identity. 
Do not score mere grandiose quality of claims (e.g., "I'm the worst sinner in the 
world, " "The entire country is trying to kill me ") unless the guilt/persecution is related 
to some special, exaggerated attributes of the individual. Also, the patient must claim 
exaggerated attributes: e.g., if patient denies talents, powers, etc., even if  he or she 
states that others indicate that he/she has these attributes, this item should not be 
scored. Rate on the basis of reported (i.e., subjective) information pertaining to the 
past week.
1 = Not reported
2 = Very Mild: e.g., is more confident than most people, but of only possible 
clinical significance
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}  -  Mild; eg . dclliiitcK inllalcd sell-estccm or cxaggcralcs talents somewhat out
ol proportion to the circumstances
4 = Moderate: e.g., intlated self-esteem clearly out of proportion to the 
circumstances, or suspected grandiose delusion(s)
5 = Moderately Severe: e.g., a single (definite) encapsulated grandiose delusion, 
or multiple (definite) encapsulated grandiose delusion, or multiple (detlnite) 
fragmentary grandiose delusions
6 = Severe: e.g., a single (definite) grandiose delusion/delusional system, or 
multiple (definite) grandiose delusions that the patient seems preoccupied with
7 = Very Severe: e.g., as above, but nearly all conversation is directed towards the 
patient's grandiose delusion(s)
9 = Cannot be assessed adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
*9. DEPRESSIVE M(30D: Subjective report of feeling depressed, blue, "down in the 
dumps," etc. Rate only degree of reported depression. Do not rate on the basis of 
inferences concerning depression based upon general retardation and somatic 
complaints. Rate on the basis of reported (i.e., subjective) information pertaining to 
the past week.
1 = Not reported
2 = Very Mild: occasionally feels somewhat depressed
3 = Mild: occasionally feels moderately depressed, or often feels somewhat
depressed
4 = Moderate: occasionally feels very depressed, or often feels moderately
depressed
426
5 = Modcralcl\ Severe: oUen feels very depressed
6 = Severe: feels very depressed most o f the time
7 = Very Severe: feels very depressed nearly all of the time
9 = Cannot be assessed adequately because of severe formal thought disorder,
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
*10. HOSTILITY : Animosity, contempt, belligerence, disdain for other people outside 
the interview situation. Rate solely on the basis of the verbal report of feelings and 
actions of the patient toward others during the past week. Do not infer hostility from 
neurotic defenses, anxiety or somatic complaints.
1 = Not reported
2 = Very Mild: occasionally feels somewhat angry
3 = Mild: often feels somewhat angry, or occasionally feels moderately angry
4 = Moderate: occasionally feels very angry, or often feels moderately angry
5 = Moderately Severe: often feels very angry
6 = Severe: has acted on his anger by becoming verbally or physically abusive on 
one or two occasions
7 = Very Severe, has acted on his anger on several occasions
9 = Cannot be assessed adequately because of severe formal thought disorder,
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
*11. SUSPICIOUSNESS: Belief (delusional or otherwise) that others have now, or 
have had in the past, malicious or discriminatory intent toward the patient. On the 
basis of verbal report, rate only those suspicions which are currently held whether
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IhcN concern past or present circumstances. Rate on the basis of reported (i.e., 
subjective) information pertaining to the past week.
1 = Not reported
2 = Very Mild: rare instances of distrustfulness which may or may not be 
warranted by the situation
3 = Mild: occasional instances of suspiciousness that are definitely not warranted 
by the situation
4 = Moderate: more frequent suspiciousness, or transient ideas of reference
5 = Moderately Severe: pervasive suspiciousness, frequent ideas of reference, or 
an encapsulated delusion
6 = Severe: definite, delusion(s) of reference or persecution that is (are) not wholly 
pervasive (e.g., an encapsulated delusion)
7 = Very Severe: as above, but more widespread, frequent, or intense
9 = Cannot be assessed adequately because of severe formal thought disorder,
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
*12. HALLUCINATORY BEHAVIOR: Perceptions (in any sensory modality) in the 
absence of an identifiable external stimulus. Rate only those experienced that have 
occurred during the last week. DO NOT rate "voices in my head," or "visions in my 
mind" unless the patient can differentiate between these experiences and his or her 
thoughts.
1 = Not reported
2 = Very Mild: suspected hallucinations only
3 = Mild: definite hallucinations, but insignificant, infrequent, or transient (e.g., 
occasional formless visual hallucinations, a voice calling the patient's name)
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4  ^ Modcralc; as above, but more rrequcnl or extensive (e.g., frequently sees the 
devil's face, two voices carry on lengthy conversations)
5 = Moderately Severe: hallucinations are experienced nearly every day, or are a 
source of extreme distress
6 = Severe: as above, and has had a moderate impact on the patient's behavior 
(e.g., concentration difficulties leading to impaired work functioning)
7 = Very Severe: as above, and has had a severe impact (e.g., attempts suicide in 
response to command hallucinations)
9 = Cannot be assessed adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
13. MOTOR RETARDATION: Reduction in energy level evidenced in slowed 
movements. Rate on the basis of observed behavior of the patient only. Do not rate on 
the basis of the patient's subjective impression of his or her own energy level.
1 = Not observed
2 = Very Mild and of doubtful clinical significance
3 = Mild: e.g., conversation is somewhat retarded, movements somewhat slowed
4 = Moderate: e.g., conversation is noticeably retarded but not strained
5 = Moderately Severe: e.g., conversation is strained, moves very slowly
6 = Severe: e.g., conversation is difficult to maintain, hardly moves at all
7 = Very Severe: e.g., conversation is almost impossible, does not move at all 
throughout the interview
14. UNCOOPERATIVENESS: Evidence of resistance, unfriendliness, resentment, 
and lack of readiness to cooperate with the interviewer. Rate only on the basis of the
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palicnl's attitude and responses to the interviewer and the interview situation. Do not 
rate on the basis of reported resentment or uncooperativeness outside the interview 
situation.
1 = Not observed
2 = Very Mild; e.g., does not seem motivated
3 = Mild: e.g., seems evasive in certain areas
4 = Moderate: e.g., monosyllabic, fails to elaborate spontaneously, somewhat 
unfriendly
5 = Moderately Severe, e.g., expresses resentment and is unfriendly throughout 
the interview
6 = Severe: e.g., refuses to answer a number of questions
7 = Very Severe: e.g., refuses to answer most questions
15. UNUSUAL THOUGHT CONTENT. Severity of delusions of any type— consider 
conviction, and effect on actions. Assume full conviction if patient has acted on his or 
her beliefs. Rate on the basis of reported (i.e., subjective) information pertaining to 
past week.
1 = Not reported
2 = Very Mild: delusion(s) suspected or likely
3 = Mild: at times, patient questions his or her belief(s) (partial delusion)
4 = Moderate: full delusional conviction, but delusion(s) has little or no influence
on behavior
5 = Moderately Severe: full delusional conviction, but delusion(s) has only 
occasional impact on behavior
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6 Severe: deliision(s) has significanl elTect, e.g., negleels responsibilities 
because of preoccupation with bel id that he/she is God
7 = Very Severe: delusion(s) has major impact, e.g., stops eating because believes 
food is poisoned
9 = Cannot be assessed adequately because of severe formal thought disorder,
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
16. BLUNTl£D AFFECT: Diminished affective responsivity, as characterized by 
deficits in facial expression, body gesture, and voice pattern. Distinguish from 
EMOTION At. WITHDRAWAL, in which the focus is on interpersonal impairment 
rather than afTect. Consider degree and consistency of impairment. Rate based on 
observations made during interview.
1 = Not observed
2 = Very Mild: e.g., occasionally seems indifferent to material that is usually 
accompanied by some show of emotion
3 = Mild: e.g., somewhat diminished facial expression, or somewhat monotonous 
voice or somewhat restricted gestures
4 = Moderate: e.g., as above, but more intense, prolonged, or frequent
5 = Moderately Severe: e.g., flattening of affect, including at least two of the three 
features: severe lack of facial expression, monotonous voice, or restricted body 
gestures
6 = Severe: e.g., profound flattening of affect
7 = Very Severe: e.g., totally monotonous voice, and total lack of expressive 
gestures throughout the evaluation
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17. I:XC i ri*MI:N I : Heightened emotional tone, including irritability and 
expansiveness (hypomanie afTect). Do not infer a fleet from statements of grandiose 
delusions. Rate based on observations made during interview.
1 = Not observed
2 = Very Mild and of doubtful clinical significance
3 = Mild: e.g., irritable or expansive at times
4 = Moderate: e.g., frequently irritable or expansive
5 = Moderately Severe: e.g., constantly irritable or expansive; or, at times, enraged
or euphoric
6 = Severe: e.g., enraged or euphoric throughout most of the interview.
7 = Very Severe: e.g., as above, but to such a degree that the interview must be
terminated prematurely
18. DISORIENTATION: Confusion or lack of proper association for person, place or 
time. Rate based on observations made during interview.
1 = Not observed
2 = Very Mild: e.g., seems somewhat confused
3 = Mild: e.g., indicated 1982 when, in fact, it is 1983
4 = Moderate: e.g., indicates 1978
5 = Moderately Severe: e.g., is unsure where he/she is
6 = Severe: e.g., has no idea where he/she is
7 = Very Severe: e.g., does not know who he/she is
9 = Cannot be assessed adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness; or Not assessed
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19. Sl VI-RI l Y Ol ILLNIiSS: Considering yoiir lolal clinical experience wilh this 
palienl population, how mentally ill is the patient at this time?
1 = Normal, not at all ill
2 = Borderline mentally ill
3 = Mildly ill
4 = Moderately ill
5 = Markedly ill
6 = Severely ill
7 = Among the most severely ill patients
20. CjLOBAL IMPROVEMENT: Rate total improvement whether or not, in your 
judgment, it is due to treatment.
At baseline assessment, mark "Not assessed" for item 20.
For assessments up to the start of double-blind medication, rate Global Improvement 
compared to baseline. For assessments following the start of double-blind medication, 
rate Global Improvement compared to the start of double-blind.
1 = Very much improved
2 = Much improved
3 = Minimally improved
4 = No change
5 = Minimally worse
6 = Much worse
7 = Very much worse
9 = Not assessed
Ratings based primarily upon verbal report
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9.8. 1 j ; n  i :ks  & in f o r m a n o N  s h e f rs (s u b .if (  rs & ( o n  i u o l s ) 
INFORMATION SHEET (SUBJECTS)
People who suffer from seizures (fits) often suffer from emotional problems like 
anxiety and depression that affect their lives. We are developing some simple 
questionnaires that would help your doctor identify these problems. We would like 
to see you and to have you reply to some questions, as this will help us in our 
research.
The assessment will begin with some questionnaires that we will send to you in the 
post. These will take about 40 minutes on average to complete. A Research Assistant 
will then meet with you to ask you some questions, in person and on a computer. This 
meeting could lake place in your doctors’ surgery, or in the comfort of your own 
home, as is your preference. This too should take no longer than 40 minutes.
Depending on the results of these assessments, you may be contacted by the epilepsy 
specialist nurse from your doctor’s surgery, and offered a consultation with a 
specialist team. This too could take place in the comfort of your home, or in the 
surgery, as is your preference.
With your permission we would also like to talk to a close relative, friend or carer, 
nominated by you, who knows you well. This would be to collect information about 
how the illness may have affected you as a person. This could be done over the
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Iclcphonc, or in person, depending on your preference. I hey would also be requested 
to reply to a questionnaire.
The decision whether to take part is entirely yours Whatever you decide, it will not 
afTect the medical care that you receive now or in the future. You could refuse to take 
part in any aspect of the study, and could withdraw consent at any time without giving 
reasons. The results of this examination will be summarised in a letter to your doctor, 
as this could help him/her make decisions about your treatment.
Information that you give us will be treated confidentially (like any medical notes). 
You will be identified only by a code, and not by your name. Data will be stored in 
computers and code protected. Scientific findings that are published will not identify 
individual participants in any way.
If  you have any queries please do not hesitate to get in touch with us and we will be 
happy to answer them. We hope you will find it possible o help us in our research.
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Letter to the subject with epilepsy (On Surgery Letterhead):
D e a r  ———
Doctors from the Institute ot Neurology and National Hospital for Neurology and 
Neurosurgery are working with us on a research project, about the emotional aspects 
of epilepsy. They would like to meet with you, and to ask you some questions in this 
regard. This could be done in the comfort of your home, if that is your preference. 
Alternately, we would be happy to arrange and pay for a taxi that will bring you to the 
surgery and take you home, if that is more convenient to you. Our epilepsy clinical 
nurse specialist, will introduce you to the concerned doctors, and help in clarifying 
any doubts you may have. I enclose an information sheet about the project, and look 
forward to your co-operation and support.
Signed
GP Principal/ Consultant Research Fellow
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IN IO R M A  I ION SIIKKI (( ON I ROLS)
People who suffer from seizures (fits) often suffer from emotional problems like 
anxiety and depression that affect their lives. We are developing some simple 
questionnaires that would help your doctor identify these problems. To do this 
effectively we need to compare their answers with those of people who do not suffer 
with epilepsy. We would like to see you and to have you reply to some questions, as 
this will help us in our research.
The assessment will consist o f two short questionnaires, each of which would take 
no more than 10 minutes on average to complete. You will also be asked to reply to 
a questionnaire on the computer, and this should take no more than 20 minutes. 
This could be done either in your doctor's surgery, by appointment, or in the 
convenience o f your own home, depending on your preference.
The decision about taking part is left to you. Whatever you decide, it will not affect 
the medical care that you receive, now or in the future. You could refuse to take part 
in the study or withdraw consent at any time without giving reasons.
Information that you give us will be treated confidentially (like any medical notes).
You will be identified only by a code, and not by your name. Data will be stored in 
computers and code protected. Scientific findings that are published will not identify 
individual participants in any way. The results of this examination will be discussed 
with you, and summarised in a letter to your doctor.
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Il' Noil have any queries please do not hesitate to get in touch with us and we will he 
happy to answer them. We hope you will find it possible to help us in our research.
Letter to Control subjects (On Surgery Letterhead):
Dear-
Doctors from the Institute of Neurology and National Hospital for Neurology and 
Neurosurgery are working with us on a research project, about the emotional aspects 
of epilepsy. They need to compare people who suffer from epilepsy (seizures/fits) 
with others like you, who do not suffer from this condition. You have been randomly 
selected from our practise register, and are being approached for this purpose.
We would like to meet with you, and to ask you some questions. This could be done 
in the comfort of your home, if that is your preference. Alternately, we would be 
happy to arrange and pay for a taxi that will bring you to the surgery and take you 
back home, if  that is more convenient to you. Our nurse specialist, will introduce you 
to the concerned doctors, and help in clarifying any doubts you may have. 1 enclose 
an information sheet about the project, and look forward to your co-operation and 
support.
Signed
GP Principal/Consultant Research Fellow
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